{"meta":{"query_hash":"63d93883b4e9","filters":{"venue":"The Journal of Clinical Pharmacology"},"cohort_total":238,"direct_labels_cover":1,"predictions_cover":238,"exported":238,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/63d93883b4e9","api":"https://metacan.xera.ac/api/v1/cohort?venue=The+Journal+of+Clinical+Pharmacology"},"results":[{"id":"W1522242651","doi":"10.1002/jcph.85","title":"The Predictive Value of the In Vitro Platelet Toxicity Assay (iPTA) for the Diagnosis of Hypersensitivity Reactions to Sulfonamides","year":2013,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Toxicity; Drug; In vitro; Predictive value; Pharmacology; Medicine; Drug reaction; Chemistry; Internal medicine; Biochemistry","score_opus":0.06895118288194685,"score_gpt":0.41296331738252545,"score_spread":0.3440121345005786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1522242651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94283795,0.00008399966,0.0002454161,0.052553665,0.002265607,0.001292755,0.00003561891,0.0000057287666,0.0006792796],"genre_scores_gemma":[0.99630946,0.0007532161,0.000118412914,0.0018914258,0.0007194706,0.00005611778,4.367737e-7,0.000015645352,0.00013580687],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9964336,0.0014769732,0.0013452593,0.00012372152,0.00035437162,0.000266044],"domain_scores_gemma":[0.96217406,0.035578307,0.0011522371,0.0003378888,0.00061635074,0.00014115161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0063508907,0.00013581147,0.00062423595,0.00007441278,0.00021060916,0.00000595809,0.00040661677,0.00013680788,0.000016848475],"category_scores_gemma":[0.0068470966,0.0000558917,0.00048974226,0.00030329416,0.00066814414,0.00010869101,0.00012238925,0.0012114161,0.0000059896706],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006680408,0.0038244405,0.0104679,0.00008086574,0.003595986,0.00002038068,0.0017194763,0.008328277,0.8200285,0.00035285222,0.024126157,0.12077475],"study_design_scores_gemma":[0.0054678842,0.0008539826,0.6876351,0.00015678811,0.0020377105,0.00030921894,0.0025733197,0.006227191,0.2514507,0.0012228929,0.0419252,0.00013998561],"about_ca_topic_score_codex":0.00019884885,"about_ca_topic_score_gemma":0.0000425885,"teacher_disagreement_score":0.67716724,"about_ca_system_score_codex":0.00011127141,"about_ca_system_score_gemma":0.00035281986,"threshold_uncertainty_score":0.8197109},"labels":[],"label_agreement":null},{"id":"W1536852940","doi":"10.1002/jcph.491","title":"Population pharmacokinetic analysis of certolizumab pegol in patients with Crohn's disease","year":2015,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Certolizumab pegol; Pharmacokinetics; Medicine; Population; Volume of distribution; Pharmacodynamics; Internal medicine; Covariate; Pharmacology; Antibody; Gastroenterology; Area under the curve; Immunology; Tumor necrosis factor alpha; Infliximab","score_opus":0.02767867091703045,"score_gpt":0.3688769333228261,"score_spread":0.34119826240579565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1536852940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988713,0.00010813825,0.00007096906,0.00026904588,0.0004236232,0.00018481885,0.000016592034,0.000001875608,0.0000535971],"genre_scores_gemma":[0.9992262,0.000052286174,0.000042866854,0.00030908076,0.00030278286,0.000002403298,0.000029183633,0.0000121010235,0.000023097624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976604,0.0008243248,0.0009504432,0.00012721439,0.00027432,0.00016330398],"domain_scores_gemma":[0.99821717,0.00010073489,0.0007919541,0.00018115596,0.00042244364,0.00028651764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006674427,0.00011631972,0.0003916001,0.00015819621,0.000019256584,0.0000036236418,0.0003020905,0.0000725146,0.00006704731],"category_scores_gemma":[0.00031568567,0.00007500757,0.00020903788,0.00023779103,0.00015018495,0.000010283003,0.000069329086,0.00021094304,0.0000020779717],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028767966,0.0006253103,0.95262676,0.000011938269,0.0009411106,0.00023537315,0.00003560072,0.014107476,0.00030635748,0.0000030138337,0.0016180496,0.0007210184],"study_design_scores_gemma":[0.006459952,0.00039089483,0.98935395,0.00000635903,0.0023316622,0.000003791244,0.0000125238785,0.00093494257,0.000098928045,0.000029894569,0.00028985116,0.000087242974],"about_ca_topic_score_codex":0.000007898756,"about_ca_topic_score_gemma":0.000015065847,"teacher_disagreement_score":0.03672717,"about_ca_system_score_codex":0.000021299838,"about_ca_system_score_gemma":0.00022231966,"threshold_uncertainty_score":0.305872},"labels":[],"label_agreement":null},{"id":"W1547449781","doi":"10.1002/jcph.131","title":"Investigation of an alternative generic model for predicting pharmacokinetic changes during physiological stress","year":2013,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Analytical Methods in Pharmaceuticals","field":"Chemistry","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; Defence Research and Development Canada","funders":"","keywords":"Pharmacokinetics; Stress (linguistics); Medicine; Pharmacology; Econometrics; Mathematics","score_opus":0.29991110018548345,"score_gpt":0.5003994818088313,"score_spread":0.20048838162334787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1547449781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919641,0.00017671693,0.005736864,0.0011384233,0.00059603504,0.000250303,0.000026523137,0.000020589176,0.00009044795],"genre_scores_gemma":[0.9856029,0.00053766236,0.009625944,0.0011020126,0.002987072,0.000030593084,0.0000025374366,0.000027811466,0.00008346504],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9966432,0.0008554897,0.0015893587,0.0002254613,0.00031975366,0.00036673003],"domain_scores_gemma":[0.9939197,0.0033961774,0.0015755987,0.00017883514,0.00056761975,0.00036212496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002361726,0.00020761925,0.0007486785,0.000064457854,0.00009452178,0.000010498482,0.0008099623,0.00018823569,0.0008294022],"category_scores_gemma":[0.0012330727,0.00013236281,0.00024724466,0.00012069628,0.00068084826,0.00019198687,0.00016838463,0.0009375444,0.0000035114529],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072683574,0.00021864545,0.0009319506,0.00016975042,0.00041456302,0.0000044933877,0.0002562495,0.021642528,0.9694768,0.000019664767,0.00052575703,0.0056127654],"study_design_scores_gemma":[0.002174422,0.00026794802,0.0010397031,0.000035610883,0.0005267676,0.000021495232,0.00008909634,0.58076304,0.410744,0.0042125178,0.000018813853,0.00010657976],"about_ca_topic_score_codex":0.000004385009,"about_ca_topic_score_gemma":4.4651117e-7,"teacher_disagreement_score":0.5591205,"about_ca_system_score_codex":0.00003764783,"about_ca_system_score_gemma":0.00008235163,"threshold_uncertainty_score":0.90813726},"labels":[],"label_agreement":null},{"id":"W1558836596","doi":"10.1002/jcph.326","title":"Pharmacokinetics, pharmacodynamics, and safety of pasireotide LAR in patients with acromegaly: A randomized, multicenter, open‐label, phase I study","year":2014,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"Novartis Pharmaceuticals Corporation; Novartis","keywords":"Pasireotide; Acromegaly; Medicine; Tolerability; Pharmacokinetics; Adverse effect; Pharmacodynamics; Internal medicine; Octreotide; Gastroenterology; Somatostatin; Randomized controlled trial; Pharmacology","score_opus":0.035298104734325035,"score_gpt":0.4234314662478706,"score_spread":0.38813336151354555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1558836596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954878,0.00041103805,0.0001656662,0.0010000824,0.00060848333,0.0021178396,0.000018079665,0.0000048150246,0.0001861697],"genre_scores_gemma":[0.99641204,0.0016784134,0.0002794444,0.0013982396,0.00016076301,0.000009614355,0.0000072462894,0.000021430016,0.00003278508],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99554807,0.0018314216,0.0018555158,0.00019993128,0.00030503827,0.00026003976],"domain_scores_gemma":[0.99619865,0.001984964,0.0010989871,0.00016957257,0.00029189192,0.00025595413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046619247,0.00022361017,0.0017283034,0.00012854181,0.00005918337,0.000009356992,0.00034634542,0.000060603696,0.00014180696],"category_scores_gemma":[0.00038784146,0.000117480864,0.00011824039,0.000143711,0.0004244827,0.00015284053,0.00017134432,0.00059144874,0.00000305672],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5694543,0.024928933,0.3913036,0.000038224713,0.0019479998,0.00007356095,0.00031124923,0.000039837832,0.00010742624,0.000004991312,0.0005585377,0.011231331],"study_design_scores_gemma":[0.88786,0.009566047,0.095607765,0.00007236678,0.0033979518,0.000020789796,0.00009863347,0.0025269664,0.000079756835,0.00007154977,0.0005816503,0.000116525815],"about_ca_topic_score_codex":0.000052985604,"about_ca_topic_score_gemma":0.000014662716,"teacher_disagreement_score":0.3184057,"about_ca_system_score_codex":0.000025316403,"about_ca_system_score_gemma":0.000098887744,"threshold_uncertainty_score":0.47907305},"labels":[],"label_agreement":null},{"id":"W1591834330","doi":"10.1002/jcph.180","title":"The effects of colesevelam HCl on the single‐dose pharmacokinetics of glimepiride, extended‐release glipizide, and olmesartan medoxomil","year":2013,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vertex Pharmaceuticals (Canada)","funders":"","keywords":"Olmesartan; Glimepiride; Glipizide; Pharmacokinetics; Pharmacology; Medicine; Chemistry; Endocrinology; Metformin; Insulin; Blood pressure","score_opus":0.02845270087263498,"score_gpt":0.3576267358791634,"score_spread":0.3291740350065284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1591834330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9786586,0.002613809,0.000059403534,0.015034973,0.0022086964,0.0008202809,0.000004111899,0.000007909944,0.00059218],"genre_scores_gemma":[0.98842114,0.0065781167,0.00009734802,0.0036482615,0.0007602369,0.000009151234,5.0330414e-7,0.000026179803,0.0004590731],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963673,0.0009061061,0.0017298898,0.0001448337,0.0005289706,0.00032295205],"domain_scores_gemma":[0.98780704,0.009805285,0.0013239097,0.00029134087,0.00050502276,0.00026738437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032996903,0.00021533242,0.00086722977,0.000067688496,0.0001416365,0.000008818943,0.0004921431,0.00014243335,0.0002172589],"category_scores_gemma":[0.0009554043,0.00008932385,0.00034363556,0.00017839797,0.0011832106,0.000055689048,0.00006177455,0.0010414475,0.000009779127],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017246945,0.0032334316,0.002013304,0.00051950815,0.0022136094,0.00021641554,0.00060666417,0.000050488863,0.85795623,0.0009586123,0.054515097,0.06046968],"study_design_scores_gemma":[0.029887583,0.015581212,0.15438505,0.000973111,0.006861975,0.0003779288,0.0008838501,0.0008477449,0.7522082,0.006363121,0.031210864,0.0004193827],"about_ca_topic_score_codex":0.000006602446,"about_ca_topic_score_gemma":0.0000044191684,"teacher_disagreement_score":0.15237175,"about_ca_system_score_codex":0.000019678733,"about_ca_system_score_gemma":0.0001968101,"threshold_uncertainty_score":0.4524629},"labels":[],"label_agreement":null},{"id":"W1603001808","doi":"10.1002/jcph.247","title":"Pharmacokinetic characterization of baclofen in patients with chronic kidney disease: dose adjustment recommendations","year":2014,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; McGill University Health Centre; Université de Montréal; inVentiv Health Clinical","funders":"","keywords":"Renal function; Pharmacokinetics; Kidney disease; Cmax; Medicine; Urology; Creatinine; Baclofen; Internal medicine; Pharmacology; Agonist","score_opus":0.026204088362263345,"score_gpt":0.36025406803543925,"score_spread":0.3340499796731759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1603001808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9755411,0.000101681486,0.00013061537,0.02247033,0.0011951732,0.00040941747,0.000008508946,0.0000069222333,0.0001362212],"genre_scores_gemma":[0.9879552,0.0026452413,0.00003950267,0.008828868,0.00042386094,0.0000037226177,0.000023952807,0.00001285778,0.00006678669],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976239,0.00081618276,0.0010620805,0.000112352005,0.0002119493,0.00017348606],"domain_scores_gemma":[0.99818134,0.00051182334,0.0007175767,0.0001163625,0.00016989923,0.0003030139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089985895,0.00011329583,0.00045693864,0.00009057715,0.000028113855,0.0000017673871,0.00016900734,0.000091328526,0.00087217684],"category_scores_gemma":[0.00025605332,0.000060200866,0.000120149496,0.00019028138,0.00020830108,0.00006070433,0.00003796397,0.0007213386,0.0000103507],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08802191,0.018627321,0.5998668,0.00046501672,0.0018657628,0.00006342702,0.0002910307,0.0018506924,0.056222387,0.00011072388,0.0352618,0.19735315],"study_design_scores_gemma":[0.018346205,0.0037164355,0.95888174,0.00009833939,0.0007570404,0.000005835425,0.000002397178,0.001170357,0.00024636387,0.000060819326,0.016644511,0.00006995664],"about_ca_topic_score_codex":8.7631935e-7,"about_ca_topic_score_gemma":3.6055545e-7,"teacher_disagreement_score":0.35901496,"about_ca_system_score_codex":0.000027855542,"about_ca_system_score_gemma":0.00018525051,"threshold_uncertainty_score":0.9549725},"labels":[],"label_agreement":null},{"id":"W1627148868","doi":"10.1177/0091270011433327","title":"An Algorithm to Detect Adverse Drug Reactions in the Neonatal Intensive Care Unit","year":2012,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","keywords":"Neonatal intensive care unit; Intensive care unit; Drug reaction; Drug; Algorithm; Medicine; Adverse drug reaction; Intensive care medicine; Computer science; Pharmacology; Pediatrics","score_opus":0.17150234742303946,"score_gpt":0.537568988025676,"score_spread":0.3660666406026365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1627148868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9543035,0.0027196151,0.00023421581,0.038658164,0.0029853622,0.00037740343,0.000006861615,0.000008433625,0.0007064325],"genre_scores_gemma":[0.95435214,0.0017116495,0.00045625117,0.0403291,0.0030927872,0.0000049422133,0.0000010121119,0.000009905676,0.000042192834],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99690783,0.001616597,0.0008111283,0.000085257474,0.00025979246,0.0003194018],"domain_scores_gemma":[0.99386066,0.0046847914,0.00037085582,0.00014854339,0.00056881394,0.00036635602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045727184,0.00011510486,0.00040940693,0.0000672768,0.00013377848,0.0000049817554,0.0003290029,0.000070186514,0.00031947915],"category_scores_gemma":[0.0014172727,0.00005614194,0.00016770232,0.0002317138,0.00019373125,0.00022332865,0.00007788393,0.0017104109,0.00006037977],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021849794,0.001341584,0.049483493,0.00008957578,0.0018050312,0.0009980623,0.05555419,0.00031084855,0.004708418,0.000049278184,0.09710254,0.7667072],"study_design_scores_gemma":[0.004215619,0.0016463876,0.088015504,0.000033952612,0.0014319869,0.001252714,0.05093958,0.00019540911,0.0008885394,0.0000674902,0.8511936,0.000119229866],"about_ca_topic_score_codex":0.00005176801,"about_ca_topic_score_gemma":0.000022282038,"teacher_disagreement_score":0.766588,"about_ca_system_score_codex":0.000038666803,"about_ca_system_score_gemma":0.00009250853,"threshold_uncertainty_score":0.74309796},"labels":[],"label_agreement":null},{"id":"W1681527344","doi":"10.1002/jcph.27","title":"Precision, Bias, and Clinical Utility of the Sheiner‐Tozer Equation to Guide Phenytoin Dosing in Critically Ill Adults","year":2013,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Interior Health","funders":"","keywords":"Phenytoin; Dosing; Critically ill; Econometrics; Computer science; Statistics; Pharmacology; Psychology; Medicine; Intensive care medicine; Economics; Mathematics; Neuroscience; Epilepsy","score_opus":0.2860625489160071,"score_gpt":0.5491888987463954,"score_spread":0.26312634983038835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1681527344","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.059783038,0.91322,0.0002564207,0.017015604,0.00499434,0.0040831263,0.000028429306,0.000015329437,0.00060371566],"genre_scores_gemma":[0.013038355,0.9721142,0.0005702338,0.0121941725,0.0019234455,0.000019546906,0.0000015089786,0.000029909417,0.00010861175],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98527086,0.007016783,0.0063547017,0.00039806677,0.00053257175,0.00042700957],"domain_scores_gemma":[0.96340835,0.031552035,0.002518403,0.00039788717,0.0016210524,0.0005022853],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.017631166,0.00041788557,0.0044792336,0.00016387423,0.00009825207,0.000013055966,0.0007231648,0.0006079303,0.00037068324],"category_scores_gemma":[0.039973,0.00017856975,0.0012396812,0.00044241882,0.0010188046,0.000087308,0.00065927824,0.0031106756,0.00002057118],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018323616,0.0012459672,0.0012045945,0.0016973509,0.00078791124,0.000033732395,0.000057056583,0.0000029702558,0.000026580477,0.000007838273,0.04449701,0.9486066],"study_design_scores_gemma":[0.0069345655,0.0037167983,0.02698963,0.009501117,0.008008646,0.00023136221,0.00004795241,0.00069631444,0.00002868622,0.00032907503,0.9432028,0.00031307255],"about_ca_topic_score_codex":0.000026851625,"about_ca_topic_score_gemma":0.000010008734,"teacher_disagreement_score":0.94829357,"about_ca_system_score_codex":0.000074367876,"about_ca_system_score_gemma":0.0006156616,"threshold_uncertainty_score":0.9991892},"labels":[],"label_agreement":null},{"id":"W1887924821","doi":"10.1177/0091270012445207","title":"Comparing the Pharmacokinetics of Doxylamine/Pyridoxine Delayed‐Release Combination in Nonpregnant Women of Reproductive Age and Women in the First Trimester of Pregnancy","year":2012,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Pharmacokinetics; Medicine; Pregnancy; Pyridoxine; Obstetrics; Pharmacology; First trimester; Gestation; Internal medicine; Biology","score_opus":0.07674815769701003,"score_gpt":0.4130702307158978,"score_spread":0.3363220730188878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1887924821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99030477,0.0043949233,0.000028393893,0.0039684037,0.00047278716,0.0005767678,0.000003394071,0.0000020498355,0.00024849598],"genre_scores_gemma":[0.995505,0.0034481175,0.000022804796,0.0006905493,0.00026117123,0.000017970233,9.1824535e-7,0.000009457315,0.000044032386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99644995,0.0010319643,0.0017723917,0.00010440955,0.00032019228,0.000321065],"domain_scores_gemma":[0.9952596,0.002639605,0.0015120832,0.00026382797,0.00018388325,0.00014101107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008433125,0.00012423415,0.0008002925,0.00014955451,0.000027362552,0.0000018026929,0.0003443663,0.000081605445,0.000051311847],"category_scores_gemma":[0.0012654599,0.000060106275,0.000096467506,0.000310085,0.00061577815,0.00012682348,0.00008094317,0.0007564751,4.7979086e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029108346,0.017053941,0.7151893,0.0015130792,0.0018176764,0.00015717973,0.1527038,0.00058660447,0.038503766,0.00019653438,0.004009231,0.039160557],"study_design_scores_gemma":[0.017497128,0.0027198552,0.9590636,0.0011399215,0.00052767905,0.00020022682,0.0024307335,0.00044912708,0.01455124,0.00035705647,0.0009666979,0.00009672243],"about_ca_topic_score_codex":0.000019182437,"about_ca_topic_score_gemma":0.0000031865648,"teacher_disagreement_score":0.24387433,"about_ca_system_score_codex":0.00006106787,"about_ca_system_score_gemma":0.00016449661,"threshold_uncertainty_score":0.328655},"labels":[],"label_agreement":null},{"id":"W1888845836","doi":"10.1002/jcph.272","title":"Breast milk concentrations of amiodarone, desethylamiodarone, and bisoprolol following short‐term drug exposure: Two case reports","year":2014,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Neonatal Respiratory Health Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Alexandra Hospital; University of Alberta","funders":"","keywords":"Bisoprolol; Amiodarone; Medicine; Drug; Pharmacology; Term (time); Anesthesia; Internal medicine; Atrial fibrillation; Heart failure","score_opus":0.07865113999192373,"score_gpt":0.4848256383696994,"score_spread":0.40617449837777564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1888845836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906329,0.0028470764,0.00024309974,0.0041978485,0.0013513456,0.0005165668,0.00000550824,0.000010861294,0.00019480665],"genre_scores_gemma":[0.9959484,0.0007029196,0.00029523027,0.0018562886,0.0011001515,0.000005881811,0.0000014082118,0.000023042436,0.00006668138],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99459183,0.0017406446,0.0024800845,0.00021279942,0.00056780997,0.00040682853],"domain_scores_gemma":[0.99351877,0.004133519,0.000898415,0.00031753402,0.00047080938,0.0006609749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011029862,0.00016827088,0.0009505967,0.00013517558,0.00016273936,0.000009036518,0.00015934161,0.00013065226,0.00011996229],"category_scores_gemma":[0.0014784599,0.00010897718,0.00027663956,0.00018735761,0.00067782326,0.00013733184,0.000114225026,0.0013513288,0.0000037081165],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015470528,0.0022168662,0.45958918,0.00092257897,0.0019954247,0.059219085,0.0011334245,0.00015231503,0.12694445,0.0001200513,0.011640126,0.32059598],"study_design_scores_gemma":[0.04354449,0.014328734,0.33907464,0.0007317414,0.0054705897,0.5251676,0.0008267196,0.003003151,0.03459005,0.0016205179,0.030818645,0.00082314544],"about_ca_topic_score_codex":0.000041505402,"about_ca_topic_score_gemma":0.00003704902,"teacher_disagreement_score":0.46594846,"about_ca_system_score_codex":0.0000492383,"about_ca_system_score_gemma":0.0007676166,"threshold_uncertainty_score":0.58709264},"labels":[],"label_agreement":null},{"id":"W1896423628","doi":"10.1002/jcph.369","title":"Studying the antiemetic effect of vitamin B6 for morning sickness: Pyridoxine and pyridoxal are prodrugs","year":2014,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Ottawa; Hospital for Sick Children; University of Toronto","funders":"Duchesnay","keywords":"Pyridoxine; Antiemetic; Pyridoxal; Vomiting; Pyridoxal phosphate; Pharmacology; Medicine; Nausea; Placebo; Internal medicine; Endocrinology; Vitamin; Active metabolite; Chemistry; Prodrug; Anesthesia; Pharmacokinetics; Biochemistry; Cofactor; Phosphate","score_opus":0.05338428958410776,"score_gpt":0.44640226233767777,"score_spread":0.39301797275357003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1896423628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832399,0.0009926542,0.0015105694,0.012181046,0.0013024248,0.0006858245,0.000002158493,0.00000808373,0.0000773433],"genre_scores_gemma":[0.99564147,0.0005748127,0.00012943751,0.0019955456,0.0015539846,0.00001078835,5.721981e-7,0.000014319178,0.000079056765],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9972261,0.0011685841,0.0010497462,0.00010586929,0.0002459921,0.00020370516],"domain_scores_gemma":[0.9878414,0.010346971,0.0012530965,0.0001711245,0.00022396148,0.00016341633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011340172,0.00012347454,0.0008005579,0.000065781685,0.00010008026,0.000004130412,0.00023521425,0.00008262679,0.0000349644],"category_scores_gemma":[0.0056654913,0.00005483895,0.00019578611,0.000103537845,0.00047065495,0.000058096288,0.00005675888,0.00064353936,0.0000019326571],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.054243416,0.0027292334,0.284925,0.0036189796,0.005168485,0.000075761694,0.005379368,0.0005386407,0.19397336,0.0002107286,0.09076461,0.35837242],"study_design_scores_gemma":[0.10088099,0.043372523,0.64558023,0.0037092369,0.018489232,0.0019908594,0.0013536969,0.015561853,0.12200073,0.0009942638,0.045472912,0.0005934746],"about_ca_topic_score_codex":0.0000015314048,"about_ca_topic_score_gemma":5.2314925e-7,"teacher_disagreement_score":0.36065522,"about_ca_system_score_codex":0.000011222643,"about_ca_system_score_gemma":0.0001060152,"threshold_uncertainty_score":0.6782532},"labels":[],"label_agreement":null},{"id":"W1898813812","doi":"10.1002/jcph.524","title":"Predicting neonatal pharmacokinetics from prior data using population pharmacokinetic modeling","year":2015,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"U.S. Food and Drug Administration","keywords":"Pharmacokinetics; Medicine; Pharmacodynamics; Population; Clinical trial; NONMEM; Pediatrics; Pharmacology; Internal medicine","score_opus":0.4984036333877825,"score_gpt":0.5614764744840787,"score_spread":0.06307284109629618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1898813812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9757587,0.0062767034,0.0047734403,0.006892846,0.0056668743,0.000345953,0.00004005419,0.000028961094,0.00021648213],"genre_scores_gemma":[0.97854257,0.003337484,0.0037824595,0.004998402,0.009262547,9.660748e-7,0.000023939174,0.00003441704,0.000017232862],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9955475,0.0011068528,0.001984396,0.00027544692,0.0007026333,0.0003832033],"domain_scores_gemma":[0.994724,0.0025661665,0.0012159486,0.00033484094,0.00052144635,0.0006376428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0059672086,0.00022943084,0.00083126395,0.00007669097,0.00016324349,0.000022856324,0.00077075744,0.00013751141,0.00031069602],"category_scores_gemma":[0.001880608,0.00014783879,0.00017609532,0.00022000408,0.00017826128,0.00047701143,0.00060606067,0.0017116907,0.000016932601],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07556626,0.0035956495,0.2627507,0.0002684164,0.011376152,0.0016295975,0.0022920377,0.18021077,0.0397425,0.000017927636,0.06413156,0.35841846],"study_design_scores_gemma":[0.010971375,0.0005096654,0.0024553596,0.00006400933,0.0062128576,0.00052510435,0.00027247478,0.9442229,0.00053891994,0.00024261307,0.03381552,0.00016915138],"about_ca_topic_score_codex":0.00020163883,"about_ca_topic_score_gemma":0.0000049252903,"teacher_disagreement_score":0.76401216,"about_ca_system_score_codex":0.000078583675,"about_ca_system_score_gemma":0.0003065669,"threshold_uncertainty_score":0.74365395},"labels":[],"label_agreement":null},{"id":"W1900044360","doi":"10.1002/jcph.616","title":"Folic acid supplementation for pregnant women and those planning pregnancy: 2015 update","year":2015,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Canadian College of Naturopathic Medicine; Hospital for Sick Children; SickKids Foundation; University of Toronto; Western University; Mount Sinai Hospital","funders":"","keywords":"Folic acid; Medicine; Fortification; Pregnancy; Folic acid supplementation; Food fortification; Family planning; Population; Environmental health; Food science; Internal medicine; Chemistry; Research methodology; Biology","score_opus":0.3434866197943854,"score_gpt":0.610873603915441,"score_spread":0.2673869841210556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1900044360","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00075204624,0.99528444,0.00006311739,0.0010155293,0.0011508318,0.0015927033,0.000050433046,0.000007566425,0.00008330579],"genre_scores_gemma":[0.00013612559,0.9962895,0.0002678063,0.00049765385,0.0019236878,0.00007768538,0.000038135113,0.000044497057,0.00072491675],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99580777,0.0011499937,0.0019910848,0.00020386341,0.00038388782,0.0004633963],"domain_scores_gemma":[0.9957208,0.0017691926,0.0014262395,0.00018781342,0.00042532646,0.00047061857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00666351,0.00026474785,0.002390887,0.00020778911,0.00007791264,0.000017114477,0.0003616707,0.00031419843,0.0002030538],"category_scores_gemma":[0.00047105775,0.00013744061,0.00040731265,0.00014791098,0.00022210696,0.00011012126,0.0001605536,0.0013393083,0.000020372667],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014858329,0.0002518612,0.000019816407,0.0040204725,0.001407623,0.00010335202,0.00035499714,7.362057e-7,0.000015171758,0.000003350898,0.13071936,0.8616174],"study_design_scores_gemma":[0.005379862,0.004223213,0.000013742306,0.008278142,0.0034839252,0.00052886264,0.00007718162,0.00002970869,0.000011235982,0.00018481688,0.97765994,0.0001293702],"about_ca_topic_score_codex":0.0000011552168,"about_ca_topic_score_gemma":4.503257e-7,"teacher_disagreement_score":0.86148804,"about_ca_system_score_codex":0.00012705888,"about_ca_system_score_gemma":0.0013906792,"threshold_uncertainty_score":0.58187026},"labels":[],"label_agreement":null},{"id":"W1937204132","doi":"10.1002/jcph.132","title":"Expression of Membrane Drug Efflux Transporters in the Sigmoid Colon of HIV‐Infected and Uninfected Men","year":2013,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pneumocystis jirovecii pneumonia detection and treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Maple Leaf Medical Clinic; St. Michael's Hospital; University of Toronto","funders":"Canadian Institutes of Health Research; Ontario HIV Treatment Network","keywords":"Efflux; Multidrug resistance-associated protein 2; Abcg2; Transporter; Drug resistance; P-glycoprotein; Drug; Multiple drug resistance; Downregulation and upregulation; Medicine; Biology; Immunology; Pharmacology; ATP-binding cassette transporter; Microbiology; Gene; Biochemistry","score_opus":0.025651267423343727,"score_gpt":0.36077684542340727,"score_spread":0.33512557800006354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1937204132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99392486,0.0001430453,0.000018245531,0.0047793332,0.00028043,0.0005182605,0.000003408817,0.0000059294134,0.00032650254],"genre_scores_gemma":[0.99825674,0.00085397554,0.0000380061,0.0006281074,0.0001378502,0.0000067676597,0.0000015551498,0.000009548776,0.000067438275],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99718535,0.0010310233,0.0012827849,0.000096891206,0.000252621,0.0001513277],"domain_scores_gemma":[0.99595106,0.0027806123,0.00082510256,0.00013868255,0.00018525722,0.000119272816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016590178,0.00012557617,0.00071442773,0.00012096886,0.00003210973,0.0000026263529,0.00016165999,0.00009987425,0.00026725075],"category_scores_gemma":[0.0002338408,0.000060925202,0.000168656,0.00019183994,0.00031787617,0.00006593288,0.00002070878,0.0005905896,0.0000036659933],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029412273,0.0012865876,0.057728425,0.00007739886,0.00026043423,0.000054176282,0.001004754,0.00009224334,0.9321121,0.0000046629752,0.0032554215,0.0011825621],"study_design_scores_gemma":[0.015740804,0.0026860884,0.72638065,0.00015185242,0.0009752002,0.00037023576,0.00042248346,0.00043027257,0.2520813,0.00005961722,0.00062000065,0.00008150415],"about_ca_topic_score_codex":0.00005040821,"about_ca_topic_score_gemma":0.0000071337827,"teacher_disagreement_score":0.6800308,"about_ca_system_score_codex":0.000020374584,"about_ca_system_score_gemma":0.00009373252,"threshold_uncertainty_score":0.29262084},"labels":[],"label_agreement":null},{"id":"W1957828017","doi":"10.1002/jcph.638","title":"Redefining the Recreational Drug User Population in Human Abuse Potential Studies","year":2015,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Substance Abuse Treatment and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vale (Canada)","funders":"","keywords":"Recreational Drug; Recreation; Drug; Recreational drug use; Medicine; Population; Drug user; Substance abuse; Drugs of abuse; Recreational use; Medical emergency; Pharmacology; Psychiatry; Environmental health; Biology","score_opus":0.2175119726011147,"score_gpt":0.5085854943548442,"score_spread":0.2910735217537295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1957828017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98403096,0.002105076,0.000006322634,0.011778329,0.0017287502,0.00016249804,2.2625547e-7,0.000008012999,0.0001798177],"genre_scores_gemma":[0.99366266,0.0013552775,0.00014998917,0.0027214377,0.0015712666,0.0000028011618,0.0000022601948,0.000009499162,0.00052482024],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99779797,0.0006840207,0.0009980614,0.00007799785,0.00029602338,0.00014592119],"domain_scores_gemma":[0.9975499,0.0014698209,0.000533657,0.00010551189,0.00025152648,0.00008956928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003475947,0.00009621315,0.0004723323,0.000075722455,0.00008568054,0.0000049208816,0.00015237981,0.000056981142,0.0000822448],"category_scores_gemma":[0.00046291263,0.000044339457,0.00015532205,0.0001245448,0.00017382763,0.000101236634,0.000025895597,0.000521302,0.0000112290745],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062578167,0.00054143125,0.900979,0.00000663667,0.0011413053,0.0002621726,0.00827684,0.0012505809,0.0005423341,0.00020266662,0.07819126,0.0023479539],"study_design_scores_gemma":[0.025827901,0.0010061209,0.9523709,0.0001538456,0.0019781291,0.00035742242,0.007850493,0.0002030855,0.0004077747,0.0038131946,0.00588426,0.00014690972],"about_ca_topic_score_codex":0.000011847681,"about_ca_topic_score_gemma":0.000044897482,"teacher_disagreement_score":0.072307,"about_ca_system_score_codex":0.00008041905,"about_ca_system_score_gemma":0.000092310656,"threshold_uncertainty_score":0.22648269},"labels":[],"label_agreement":null},{"id":"W1969996376","doi":"10.1177/0091270010365553","title":"Pediatric Cancer Rates After Universal Folic Acid Flour Fortification In Ontario","year":2010,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Centre for Addiction and Mental Health; Western University; St. Michael's Hospital; University of Toronto; Pediatric Oncology Group; SickKids Foundation; Hospital for Sick Children","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Incidence (geometry); Pediatrics; Confidence interval; Population; Cohort; Cancer; Food fortification; Internal medicine; Folic acid; Environmental health","score_opus":0.05833098450042797,"score_gpt":0.4459191695096926,"score_spread":0.3875881850092647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969996376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895764,0.00017807429,0.00007277725,0.0069424105,0.002762974,0.00022801622,0.0000016038045,0.0000053971753,0.00023232684],"genre_scores_gemma":[0.99394107,0.0006703201,0.00021253199,0.0018615975,0.0026273094,0.0000071967625,8.287782e-7,0.000014361094,0.0006648109],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979635,0.0003531989,0.0009741587,0.00012136648,0.0003026915,0.0002850756],"domain_scores_gemma":[0.99751174,0.0013393909,0.00044301455,0.00015189225,0.00030981694,0.00024412318],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026330655,0.00010626213,0.0004363921,0.00017723879,0.000032785778,0.000006199047,0.00029960487,0.00019483606,0.003034052],"category_scores_gemma":[0.00048194194,0.00006470388,0.00015316081,0.00020484028,0.00023521911,0.00010872488,0.00007429615,0.0023335645,0.000050291383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014602178,0.00071847223,0.91081065,0.00003409376,0.0002746896,0.00057761784,0.0007503106,0.000059919235,0.03593657,0.000016525517,0.03170857,0.0045103934],"study_design_scores_gemma":[0.009955699,0.0006876739,0.9698495,0.000015301175,0.0007690028,0.00031529725,0.00005418513,0.0007226802,0.0029951744,0.00018804254,0.01435292,0.00009447805],"about_ca_topic_score_codex":0.0021550918,"about_ca_topic_score_gemma":0.013173355,"teacher_disagreement_score":0.059038885,"about_ca_system_score_codex":0.00040303092,"about_ca_system_score_gemma":0.0037964485,"threshold_uncertainty_score":0.9999681},"labels":[],"label_agreement":null},{"id":"W1971397614","doi":"10.1177/0091270009333487","title":"Predictors of Prenatal Multivitamin Adherence in Pregnant Women","year":2009,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; York University; University of Toronto","funders":"","keywords":"Multivitamin; Medicine; Nausea; Vomiting; Pregnancy; Prenatal care; Constipation; Regimen; Obstetrics; Pediatrics; Population; Internal medicine; Environmental health; Vitamin","score_opus":0.06304768107717455,"score_gpt":0.44691062513871876,"score_spread":0.3838629440615442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971397614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944078,0.0011415886,0.00008926788,0.0026038138,0.0010184051,0.0002533167,0.0000031924983,0.000006068222,0.0004765855],"genre_scores_gemma":[0.9955972,0.002092257,0.00009997781,0.0015038443,0.0005021603,0.0000027019491,5.3482e-7,0.0000048546076,0.0001964841],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975599,0.0005005713,0.0013612653,0.00008323743,0.0002644467,0.00023059016],"domain_scores_gemma":[0.99740833,0.0012266376,0.00083891937,0.00014082807,0.00013236783,0.00025293685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032060556,0.000090164685,0.00059355743,0.00010608831,0.000015082482,0.0000011518559,0.00025879662,0.00011268927,0.00025757393],"category_scores_gemma":[0.0015198662,0.00005086717,0.00012821659,0.00015747506,0.00025394643,0.00009560705,0.00002546585,0.0007533173,0.0000053156527],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030939039,0.012637783,0.28581357,0.00037933854,0.0013837543,0.00068638986,0.012445849,0.00027593673,0.07425487,0.00006936003,0.034016512,0.5470976],"study_design_scores_gemma":[0.0154757695,0.011778208,0.94838345,0.0012668436,0.00036141335,0.00039995826,0.0002952125,0.00031938573,0.018686162,0.00034114637,0.0025907285,0.0001017416],"about_ca_topic_score_codex":0.0000024237222,"about_ca_topic_score_gemma":7.059347e-7,"teacher_disagreement_score":0.6625699,"about_ca_system_score_codex":0.00004412923,"about_ca_system_score_gemma":0.00043751876,"threshold_uncertainty_score":0.32728308},"labels":[],"label_agreement":null},{"id":"W1972752819","doi":"10.1177/009127002401102803","title":"Pharmacokinetics of GW433908, a Prodrug of Amprenavir, in Healthy Male Volunteers","year":2002,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Smiths Detection (Canada)","funders":"","keywords":"Amprenavir; Pharmacokinetics; Bioequivalence; Pharmacology; Prodrug; Bioavailability; Crossover study; Medicine; Chemistry; Protease; Biochemistry","score_opus":0.08639558196707112,"score_gpt":0.4306749514898969,"score_spread":0.3442793695228258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972752819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98617166,0.001232222,0.000020653484,0.010592427,0.00080346636,0.00036905418,0.0000067730984,0.0000048650463,0.00079884846],"genre_scores_gemma":[0.9915954,0.0040654973,0.0009005509,0.0013436398,0.00041629357,0.0000034060345,0.0000016289703,0.000015495494,0.0016581195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965114,0.00063282927,0.0021516166,0.00012185747,0.00033797548,0.0002442971],"domain_scores_gemma":[0.99761355,0.000829324,0.00090572494,0.00015726643,0.00027140375,0.00022273758],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023751163,0.00014105802,0.000909756,0.00018608215,0.00002154972,0.0000013839465,0.0002618667,0.00009945404,0.0016004647],"category_scores_gemma":[0.00020190381,0.00008726032,0.00020854874,0.00024986392,0.00030541685,0.00007218281,0.00004773561,0.00068446755,0.000020525507],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041491125,0.026706062,0.60883445,0.0007185245,0.0031931682,0.00096431497,0.008820977,0.0009777665,0.043480016,0.000056426972,0.20187427,0.06288288],"study_design_scores_gemma":[0.23758891,0.04587962,0.3575317,0.001500879,0.011630068,0.0043322286,0.0023753678,0.03024467,0.11042856,0.00066547166,0.19662032,0.0012022068],"about_ca_topic_score_codex":0.000009356691,"about_ca_topic_score_gemma":0.000005577458,"teacher_disagreement_score":0.25130278,"about_ca_system_score_codex":0.000044671146,"about_ca_system_score_gemma":0.0001910822,"threshold_uncertainty_score":0.9993122},"labels":[],"label_agreement":null},{"id":"W1974773091","doi":"10.1177/00912700222011607","title":"Clinical Pharmacokinetics of Verteporfin","year":2002,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"QLT (Canada)","funders":"","keywords":"Verteporfin; Pharmacokinetics; Cmax; Macular degeneration; Choroidal neovascularization; Medicine; Metabolite; Ophthalmology; Pharmacology; Urology; Internal medicine","score_opus":0.1711532709707249,"score_gpt":0.5130131808709297,"score_spread":0.3418599099002048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974773091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98610675,0.002759655,0.00004973587,0.00533387,0.0026589616,0.000202354,0.0000056289527,0.0000069372377,0.0028761039],"genre_scores_gemma":[0.97894263,0.014268305,0.00029103033,0.0040252325,0.0019022535,8.543556e-7,7.574391e-7,0.000014992894,0.00055392075],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9962466,0.00077836507,0.0023298906,0.0001106552,0.00033515645,0.00019937745],"domain_scores_gemma":[0.99584854,0.0020071825,0.0012459604,0.00018051435,0.00034286742,0.00037493737],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002029569,0.00012685287,0.00089208054,0.00005808058,0.000032715932,0.0000023727846,0.00025695944,0.000119354736,0.0027634334],"category_scores_gemma":[0.0005900255,0.000070151065,0.00069429073,0.00013017112,0.00045425261,0.00004204871,0.000057584206,0.00074910093,0.00008059976],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013489382,0.010733128,0.41266754,0.00011520085,0.003931158,0.0013727577,0.0001084691,0.00005460539,0.0028862264,0.000037050464,0.41481048,0.13979399],"study_design_scores_gemma":[0.041883525,0.015806165,0.75941896,0.00017589756,0.01342712,0.0016999423,0.00007949627,0.0038628958,0.0025329085,0.00048788285,0.16037819,0.00024700715],"about_ca_topic_score_codex":0.0000023588427,"about_ca_topic_score_gemma":1.5071818e-7,"teacher_disagreement_score":0.34675142,"about_ca_system_score_codex":0.0000140636375,"about_ca_system_score_gemma":0.00009446279,"threshold_uncertainty_score":0.9981482},"labels":[],"label_agreement":null},{"id":"W1978188503","doi":"10.1177/0091270011399577","title":"Opioid Receptor Modulation of Hedonic Taste Preference and Food Intake: A Single‐Dose Safety, Pharmacokinetic, and Pharmacodynamic Investigation With GSK1521498, a Novel μ‐Opioid Receptor Inverse Agonist","year":2011,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Neuropeptides and Animal Physiology","field":"Neuroscience","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"","keywords":"Overeating; Inverse agonist; Pharmacokinetics; Pharmacodynamics; Pharmacology; Endogenous opioid; Opioid; Agonist; Taste; Opioid receptor; Medicine; Receptor; Endocrinology; Chemistry; Internal medicine; Obesity; Food science","score_opus":0.1585381157846783,"score_gpt":0.33448284111702187,"score_spread":0.17594472533234357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978188503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975913,0.00012632814,0.00013634429,0.00045635193,0.00096672075,0.0004593152,0.00004330821,0.000020230093,0.0002001038],"genre_scores_gemma":[0.99278075,0.003530281,0.0009523699,0.0022237692,0.00042748594,0.000005863401,0.0000023487223,0.000034538243,0.00004259056],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965711,0.0010236899,0.0014063207,0.00038802042,0.000279535,0.00033130814],"domain_scores_gemma":[0.99641913,0.0012449322,0.0016575934,0.00015920731,0.00021423314,0.00030489324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010002835,0.0002818929,0.0006570571,0.00012987996,0.00015434518,0.000017201919,0.00045851598,0.00011551278,0.00022301292],"category_scores_gemma":[0.0003516031,0.00018897746,0.00010424946,0.00027714198,0.0015591716,0.00038807982,0.0002409459,0.00086900056,0.000008790163],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005973464,0.00044928328,0.0008105511,0.00006889196,0.00008508618,0.000005231329,0.00060770905,0.000100941135,0.9842398,0.00013627054,0.0004295806,0.0070931986],"study_design_scores_gemma":[0.019252496,0.021986425,0.044126756,0.00026769596,0.00094745116,0.0005209349,0.00021986217,0.008466133,0.89308596,0.0019373808,0.008486076,0.0007028511],"about_ca_topic_score_codex":0.000012247941,"about_ca_topic_score_gemma":0.000007785332,"teacher_disagreement_score":0.09115385,"about_ca_system_score_codex":0.000030044512,"about_ca_system_score_gemma":0.00018671731,"threshold_uncertainty_score":0.7706277},"labels":[],"label_agreement":null},{"id":"W1978332054","doi":"10.1177/0091270010373928","title":"Patterns of Antidepressant Medication Use Among Pregnant Women in a United States Population","year":2010,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Child and Family Research Institute","funders":"","keywords":"Antidepressant; Bupropion; Pregnancy; Medicine; Population; Telephone interview; Obstetrics; Pediatrics; Psychiatry; Environmental health; Smoking cessation","score_opus":0.05618413982299384,"score_gpt":0.4272779569408325,"score_spread":0.3710938171178386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978332054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967169,0.00007089734,0.000023651359,0.0012601141,0.0016487641,0.00025845724,0.000007336252,0.0000051424945,0.000008731662],"genre_scores_gemma":[0.9966013,0.0020437653,0.00004893366,0.00090903975,0.00030287457,0.0000046177215,0.0000090932635,0.000008870727,0.00007150164],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975282,0.0005509936,0.0014039197,0.00007581243,0.00022343863,0.00021766416],"domain_scores_gemma":[0.997281,0.001239947,0.0010186892,0.00012622257,0.00012278512,0.00021135448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003182605,0.000079546924,0.0004399842,0.00015496957,0.000025050806,0.000002983369,0.0001510079,0.00010736642,0.00019187872],"category_scores_gemma":[0.0003871928,0.00004741974,0.00006771515,0.000095755386,0.00010125235,0.00011519099,0.000037688616,0.0008715013,0.0000018007869],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028125097,0.00045708998,0.99357975,0.00039809296,0.00006376581,0.000044760294,0.00062943,0.0000893536,0.0010134628,0.000008696507,0.00007469207,0.0008283757],"study_design_scores_gemma":[0.002774814,0.00073140126,0.9913039,0.0012822566,0.00009571866,0.000082829065,0.00006003462,0.0007053561,0.002424483,0.00016582741,0.0003325918,0.000040795585],"about_ca_topic_score_codex":0.000396699,"about_ca_topic_score_gemma":0.000049473787,"teacher_disagreement_score":0.002795412,"about_ca_system_score_codex":0.000026128437,"about_ca_system_score_gemma":0.0000672415,"threshold_uncertainty_score":0.3786288},"labels":[],"label_agreement":null},{"id":"W1980311708","doi":"10.1177/0091270009334376","title":"Statin Effects on LDL and HDL Cholesterol in South Asian and White Populations","year":2009,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; William Osler Health System; Canadian Respiratory Research Network; St. Michael's Hospital","funders":"","keywords":"Statin; Ldl cholesterol; Medicine; Cholesterol; White (mutation); Internal medicine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Atorvastatin; Pharmacology; Endocrinology; Biology; Biochemistry","score_opus":0.05706845570309015,"score_gpt":0.43436605115318583,"score_spread":0.37729759545009567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980311708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97961646,0.00048618802,0.000095893505,0.018897468,0.0003699483,0.00030599546,9.3777396e-7,0.000004203542,0.0002228714],"genre_scores_gemma":[0.98815125,0.0004442955,0.00023184321,0.010171901,0.0009619245,0.0000011656816,4.2896608e-7,0.0000062654653,0.00003091074],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982481,0.0007099788,0.00062124734,0.000091933536,0.00017893233,0.00014982489],"domain_scores_gemma":[0.9991169,0.000284226,0.0002463293,0.00010363839,0.000047698242,0.00020119385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027512435,0.00008213447,0.0004928025,0.0000812872,0.000044211523,0.0000056977615,0.000054478427,0.00008255591,0.000015069906],"category_scores_gemma":[0.00023009827,0.0000482762,0.00010016721,0.00007584059,0.000068134876,0.00003982792,0.00001504007,0.0007121319,0.0000023499178],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053394674,0.00070520904,0.15793002,0.0001492191,0.00035785933,0.00035951502,0.0025428508,0.00010597605,0.0011634899,0.00006990406,0.003361477,0.827915],"study_design_scores_gemma":[0.007358492,0.0028617089,0.9874649,0.00008594663,0.00029419377,0.00023661395,0.00007863453,0.00008591937,0.00009974348,0.000388802,0.0009994864,0.000045542478],"about_ca_topic_score_codex":0.000005440769,"about_ca_topic_score_gemma":0.0000061271326,"teacher_disagreement_score":0.8295349,"about_ca_system_score_codex":0.0000151634395,"about_ca_system_score_gemma":0.000066701345,"threshold_uncertainty_score":0.30938983},"labels":[],"label_agreement":null},{"id":"W1980583128","doi":"10.1177/0091270005278808","title":"Conversion From Subcutaneous to Intravenous Erythropoietin in a Hemodialysis Population","year":2005,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Manitoba","funders":"","keywords":"Medicine; Erythropoietin; Dosing; Hemodialysis; Epoetin alfa; Anemia; Subcutaneous injection; Population; Route of administration; Anesthesia; Surgery; Internal medicine","score_opus":0.035477294615036126,"score_gpt":0.4016039375321011,"score_spread":0.366126642917065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980583128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9484418,0.00029832608,0.00006659518,0.049872614,0.0008890588,0.00021776203,0.0000028025327,0.000009176763,0.00020183496],"genre_scores_gemma":[0.9869595,0.0010177823,0.0020275242,0.0076133125,0.0022289578,0.0000012599021,0.000005600327,0.000012832345,0.00013319308],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977322,0.0004978453,0.0011726562,0.0001322142,0.00024244745,0.00022258832],"domain_scores_gemma":[0.9979103,0.0011869821,0.00040759344,0.00013213379,0.000109861125,0.00025309023],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014363449,0.000120415716,0.00065070146,0.00011090398,0.000044443997,0.0000044432327,0.00014771029,0.000133502,0.0014014735],"category_scores_gemma":[0.00025272483,0.00007501942,0.000213263,0.00015783937,0.000097747274,0.000040942203,0.000044498025,0.0005985715,0.00013649791],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0662177,0.011354281,0.29137814,0.00007985565,0.0021269121,0.004851143,0.005521377,0.0063479864,0.053710636,0.000026871743,0.14169548,0.4166896],"study_design_scores_gemma":[0.071267396,0.025573866,0.719199,0.0005754918,0.007573132,0.0056475196,0.0021747923,0.0049119457,0.0302765,0.0010065774,0.13089205,0.00090173975],"about_ca_topic_score_codex":0.00018428495,"about_ca_topic_score_gemma":0.000052781194,"teacher_disagreement_score":0.42782083,"about_ca_system_score_codex":0.0001681996,"about_ca_system_score_gemma":0.00010999052,"threshold_uncertainty_score":0.99951136},"labels":[],"label_agreement":null},{"id":"W1981726399","doi":"10.1177/0091270006292126","title":"The Anticholinergic Drug Scale as a Measure of Drug‐Related Anticholinergic Burden: Associations With Serum Anticholinergic Activity","year":2006,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Intensive Care Unit Cognitive Disorders","field":"Medicine","cited_by":662,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baycrest Hospital; University of Toronto","funders":"National Center for Research Resources; National Institute of Nursing Research; National Institute of Mental Health; National Institute on Aging","keywords":"Anticholinergic; Delirium; Drug; Medicine; Linear regression; Internal medicine; Regression analysis; Adverse effect; Pharmacology; Psychiatry; Statistics","score_opus":0.019733009001229835,"score_gpt":0.3669907101671299,"score_spread":0.3472577011659001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981726399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9465657,0.0010202046,0.000062959,0.04656776,0.0016632862,0.0005694989,0.000025671565,0.00003048205,0.0034944543],"genre_scores_gemma":[0.9892776,0.0010420951,0.00008333817,0.0059574083,0.0014895697,0.0000043469604,0.000009006651,0.000059764916,0.0020768552],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9937933,0.002194551,0.002166865,0.00028081538,0.0009642635,0.00060021196],"domain_scores_gemma":[0.98025227,0.0051341946,0.0025899895,0.00037005884,0.011396629,0.0002568337],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.005595629,0.00036747297,0.0013765839,0.00022696318,0.00036115517,0.000023805724,0.0005687517,0.00024984905,0.00013281418],"category_scores_gemma":[0.0046370905,0.0001965265,0.0006761977,0.0008220138,0.0014172064,0.00017517923,0.000106734566,0.002508411,0.000034182664],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05654784,0.01084367,0.28141472,0.00033293868,0.0149561735,0.0018750133,0.0035866133,0.015513575,0.2126888,0.0009397719,0.38962972,0.011671166],"study_design_scores_gemma":[0.07249356,0.006303926,0.7817392,0.0011313104,0.021354962,0.0039034083,0.007516698,0.0072752545,0.07614117,0.0030259772,0.017655171,0.001459379],"about_ca_topic_score_codex":0.00014647485,"about_ca_topic_score_gemma":0.00007381591,"teacher_disagreement_score":0.5003245,"about_ca_system_score_codex":0.00008461794,"about_ca_system_score_gemma":0.0008766207,"threshold_uncertainty_score":0.9997928},"labels":[],"label_agreement":null},{"id":"W1982887770","doi":"10.1177/0091270007305299","title":"Enzyme Replacement in Fabry Disease: Pharmacokinetics and Pharmacodynamics of Agalsidase Alfa in Children and Adolescents","year":2007,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institutes of Health","keywords":"Pharmacokinetics; Medicine; Dosing; Pharmacodynamics; Fabry disease; Plasma clearance; Enzyme replacement therapy; Anesthesia; Urology; Internal medicine; Disease","score_opus":0.031236489079753498,"score_gpt":0.4313814460170934,"score_spread":0.40014495693733987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982887770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992324,0.0045249136,0.000115649724,0.002109025,0.00029291093,0.0005766187,0.000008273073,0.000003665908,0.000044967615],"genre_scores_gemma":[0.9873705,0.010576808,0.00006734263,0.0016011116,0.00032944191,0.0000015504156,0.0000023054952,0.000017868932,0.000033082713],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99681437,0.0006010252,0.0016074931,0.00018462024,0.0004315377,0.00036097804],"domain_scores_gemma":[0.9979407,0.0008000672,0.0005250286,0.0001238725,0.00016352008,0.00044681542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056839716,0.00015602684,0.00064341904,0.000292729,0.000028972767,0.00000447405,0.00021715875,0.00010020941,0.000098309756],"category_scores_gemma":[0.00050613296,0.000110803325,0.00009712293,0.000266068,0.00047016583,0.00007688633,0.00017757082,0.0011965195,0.0000013822389],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021097906,0.0015829381,0.9432054,0.00013409964,0.00020002665,0.00034367334,0.00015462487,0.00007606133,0.013032079,0.0000040259215,0.0012089522,0.018960176],"study_design_scores_gemma":[0.020999331,0.0007822568,0.97309625,0.00016910395,0.0003689943,0.000228982,0.0000705391,0.0020851353,0.0017532517,0.000078268706,0.00026427372,0.00010362349],"about_ca_topic_score_codex":0.000029873197,"about_ca_topic_score_gemma":0.000011989752,"teacher_disagreement_score":0.029890804,"about_ca_system_score_codex":0.00006366989,"about_ca_system_score_gemma":0.00017649577,"threshold_uncertainty_score":0.5198348},"labels":[],"label_agreement":null},{"id":"W1983440297","doi":"10.1177/0091270010395940","title":"Anti‐EGFR Monoclonal Antibodies for Treatment of Colorectal Cancers: Development of Cetuximab and Panitumumab","year":2011,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Panitumumab; Cetuximab; Medicine; Bevacizumab; Colorectal cancer; Epidermal growth factor receptor; Monoclonal antibody; Clinical trial; Oncology; Internal medicine; Adjuvant; EGFR inhibitors; Pharmacology; Cancer; Antibody; Immunology; Chemotherapy","score_opus":0.26552730539843883,"score_gpt":0.5152066995027675,"score_spread":0.2496793941043287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983440297","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08563915,0.91167927,0.000011820533,0.00008293792,0.001169494,0.0011448403,0.00007273456,0.0000040596788,0.00019567995],"genre_scores_gemma":[0.013402813,0.9843917,0.0014510041,0.000040868,0.00053891743,0.000049373877,0.000007972637,0.000028490693,0.00008886989],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996384,0.00030626295,0.0026625982,0.00020167686,0.00018713741,0.0002582714],"domain_scores_gemma":[0.99457276,0.0020428787,0.0026981696,0.000118082535,0.0004265862,0.00014153199],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095370656,0.00037320828,0.0050139,0.00015034765,0.00009266914,0.0000025763547,0.00018337593,0.00021550633,0.00008032387],"category_scores_gemma":[0.000115677976,0.00018562668,0.0008881287,0.000106730724,0.00059344526,0.000033116205,0.0000821047,0.00024111879,0.00000108139],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006121636,0.0015212554,0.0007255712,0.00439114,0.010009317,0.000030865085,0.0010371488,4.6105126e-7,0.000028592154,0.000010030574,0.0009304802,0.9751935],"study_design_scores_gemma":[0.011328217,0.01698131,0.003230496,0.0023606785,0.023597147,0.0004044849,0.00017833036,0.000005984583,0.00051450793,0.00003947837,0.94112694,0.00023241133],"about_ca_topic_score_codex":0.000027095602,"about_ca_topic_score_gemma":0.00002515267,"teacher_disagreement_score":0.9749611,"about_ca_system_score_codex":0.0002726624,"about_ca_system_score_gemma":0.0021520585,"threshold_uncertainty_score":0.7569636},"labels":[],"label_agreement":null},{"id":"W1983767665","doi":"10.1177/0091270009343697","title":"Teaching Pharmacology in an Innovative Medical Curriculum: Challenges of Integration, Technology, and Future Training","year":2009,"lang":"en","type":"editorial","venue":"The Journal of Clinical Pharmacology","topic":"Innovations in Medical Education","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Curriculum; Relevance (law); Medical education; Set (abstract data type); Subject (documents); Engineering ethics; Task (project management); Medical knowledge; Problem-based learning; Psychology; Medicine; Mathematics education; Computer science; Pedagogy; Engineering; Political science","score_opus":0.0493189278868662,"score_gpt":0.498453784632757,"score_spread":0.4491348567458908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983767665","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26747465,0.004075141,0.00008378538,0.12665609,0.6006494,0.0005289209,0.0000063368875,0.000028043396,0.0004976049],"genre_scores_gemma":[0.12986185,0.016425572,0.0018231523,0.0040056473,0.8477527,0.000016325686,0.00003731853,0.00004442071,0.000033028195],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9924537,0.0019783871,0.0037438173,0.000339879,0.001102954,0.00038126556],"domain_scores_gemma":[0.9905815,0.0030209436,0.0030785745,0.00025318097,0.0028524494,0.00021332917],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.01731184,0.00034538482,0.0019306567,0.0014722941,0.000093609015,0.0000058634773,0.0007909956,0.0025280302,0.00023366993],"category_scores_gemma":[0.011754897,0.0002243526,0.00013119171,0.0011270775,0.0013414512,0.00018296172,0.000115777155,0.013213811,0.0000016251419],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008481355,0.001394847,0.00015575551,0.00011407572,0.00030905963,0.0000927967,0.002441586,0.0000010641809,0.0003377986,0.00069655565,0.5654322,0.42817616],"study_design_scores_gemma":[0.011606709,0.007500739,0.002117548,0.0010527043,0.0013745428,0.0006223764,0.010799103,0.000540687,0.00016939602,0.0025833037,0.96127003,0.00036285445],"about_ca_topic_score_codex":0.00000996373,"about_ca_topic_score_gemma":0.000014300147,"teacher_disagreement_score":0.42781332,"about_ca_system_score_codex":0.00013968007,"about_ca_system_score_gemma":0.0029122022,"threshold_uncertainty_score":0.9987669},"labels":[],"label_agreement":null},{"id":"W1987148753","doi":"10.1177/0091270005284389","title":"Use of Omeprazole as a CYP3A Probe Drug: Effect of Sex and Menstrual Cycle Phase on CYP3A Activity in Healthy Caucasian Adults","year":2006,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Luteal phase; Omeprazole; Follicular phase; Menstrual cycle; CYP3A; Medicine; Endocrinology; Internal medicine; Metabolism; Hormone","score_opus":0.1143286373631692,"score_gpt":0.5257836796528554,"score_spread":0.4114550422896862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987148753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926769,0.0009225338,0.000014894956,0.0022424688,0.002756475,0.00084177655,0.00009071679,0.000012332968,0.00044188517],"genre_scores_gemma":[0.9940689,0.0028000663,0.00007462651,0.001971146,0.00095750537,0.000014196825,0.0000030542133,0.000034456,0.00007603742],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9899412,0.006444614,0.0022964128,0.0003294935,0.00039123156,0.0005970682],"domain_scores_gemma":[0.9889556,0.008139488,0.0020295025,0.00022929646,0.00022827182,0.00041784393],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.007927431,0.00037986567,0.0015554668,0.0003222857,0.00012520241,0.000008642484,0.000497844,0.00039227298,0.00029266317],"category_scores_gemma":[0.00042176995,0.00026844183,0.0003333635,0.00035312522,0.0009132993,0.0001821058,0.00017314065,0.0023836957,0.000010893346],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24033174,0.01591721,0.05705198,0.0006734016,0.001574359,0.00053322973,0.0023398132,0.008420501,0.46311072,0.0002465379,0.012230462,0.19757006],"study_design_scores_gemma":[0.08664086,0.016367892,0.030173795,0.00015207137,0.0022909034,0.00042504095,0.00016703882,0.008513331,0.81070155,0.0009869704,0.04292091,0.00065961893],"about_ca_topic_score_codex":0.00017481521,"about_ca_topic_score_gemma":0.000030564002,"teacher_disagreement_score":0.34759086,"about_ca_system_score_codex":0.000046674457,"about_ca_system_score_gemma":0.00032430887,"threshold_uncertainty_score":0.99997675},"labels":[],"label_agreement":null},{"id":"W1987539558","doi":"10.1002/j.1552-4604.2002.tb06009.x","title":"Adolescents Prenatally Exposed to Marijuana: Examination of Facets of Complex Behaviors and Comparisons with the Influence of In Utero Cigarettes","year":2002,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Prenatal Substance Exposure Effects","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Carleton University","funders":"","keywords":"Psychology; Developmental psychology; Context (archaeology); Offspring; Cognition; In utero; Pregnancy; Clinical psychology; Psychiatry; Fetus","score_opus":0.11709426686251614,"score_gpt":0.4360151626969021,"score_spread":0.318920895834386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987539558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78016174,0.21816958,0.000027829563,0.0001979509,0.0001672088,0.0012348376,0.00002426972,0.0000030058225,0.000013594717],"genre_scores_gemma":[0.68214136,0.3175109,0.00009071848,0.00014620344,0.00007557271,0.000007365967,0.0000030009228,0.000017678118,0.0000072156536],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9944877,0.001973101,0.0026086743,0.00018378484,0.00052787334,0.00021887722],"domain_scores_gemma":[0.99273247,0.0029455558,0.0034824188,0.00029493115,0.00038906618,0.00015553673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031219139,0.0002796755,0.0030038,0.00024785454,0.00002412768,0.0000030023832,0.0006334398,0.0002334368,0.000033273333],"category_scores_gemma":[0.00047185225,0.0001428486,0.0002651609,0.00039949498,0.00071227667,0.000077963254,0.00016887108,0.0012961277,8.384923e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063472055,0.0042384793,0.027452944,0.022164084,0.0024163122,0.000374461,0.0023328934,0.00050814555,0.0057812263,0.0000076076526,0.005927265,0.92244935],"study_design_scores_gemma":[0.009390857,0.007816426,0.92263234,0.03757337,0.007389646,0.0005683177,0.00012564531,0.00006281216,0.0012081887,0.000003363301,0.012891491,0.00033755018],"about_ca_topic_score_codex":0.000008913563,"about_ca_topic_score_gemma":0.000018863542,"teacher_disagreement_score":0.9221118,"about_ca_system_score_codex":0.000051091323,"about_ca_system_score_gemma":0.00019625992,"threshold_uncertainty_score":0.5825197},"labels":[],"label_agreement":null},{"id":"W1991334257","doi":"10.1177/0091270004272670","title":"Differential Toxicity of Reactive Metabolites of Clindamycin and Sulfonamides in HIV‐Infected Cells: Influence of HIV Infection on Clindamycin Toxicity In Vitro","year":2005,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"","keywords":"Clindamycin; Toxicity; Microsome; Pharmacology; Population; Metabolite; Chemistry; Medicine; In vitro; Antibiotics; Immunology; Microbiology; Biology; Internal medicine; Biochemistry","score_opus":0.03873251600058317,"score_gpt":0.396321656709676,"score_spread":0.35758914070909287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991334257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980691,0.000069088506,0.00003958884,0.0007562856,0.0004050851,0.00038719352,0.000030158411,0.0000069022444,0.00023658008],"genre_scores_gemma":[0.99787235,0.0012383551,0.00019279604,0.00027133757,0.00038514126,0.0000026132134,0.000002532343,0.00001578052,0.000019120818],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99516064,0.0013052577,0.0027195564,0.00020058641,0.00035687353,0.00025705993],"domain_scores_gemma":[0.992408,0.0046385056,0.0021822955,0.00019406078,0.00041807757,0.00015906674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026835941,0.00020852083,0.001494299,0.0005263899,0.000025861887,0.0000023158054,0.00016351671,0.00027918137,0.00003683293],"category_scores_gemma":[0.0018360546,0.00014893008,0.00028840365,0.00042642627,0.00054719637,0.00021614188,0.00008110429,0.0016076645,0.0000030347392],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005229256,0.00330223,0.0611455,0.00006954768,0.0002467728,0.000011406472,0.0003149207,0.0030258463,0.919818,0.00001805852,0.00003158544,0.006786863],"study_design_scores_gemma":[0.0051896623,0.00040623313,0.4325477,0.00011611465,0.00035920797,0.00002983918,0.000050741684,0.00044047573,0.56061685,0.00006636185,0.00011437967,0.00006245022],"about_ca_topic_score_codex":0.00009824297,"about_ca_topic_score_gemma":0.000068801346,"teacher_disagreement_score":0.3714022,"about_ca_system_score_codex":0.00011522557,"about_ca_system_score_gemma":0.00031132024,"threshold_uncertainty_score":0.6984592},"labels":[],"label_agreement":null},{"id":"W1991774560","doi":"10.1177/0091270010382420","title":"Increased Risk of Myocardial Infarction Associated With Angiotensin-Converting Enzyme Gene Polymorphism Is Age Dependent","year":2010,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Renin-Angiotensin System Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Myocardial infarction; Angiotensin-converting enzyme; Genotype; Medicine; Internal medicine; Allele; Young adult; Coronary artery disease; Polymorphism (computer science); Gene polymorphism; Locus (genetics); Endocrinology; Genetics; Gene; Biology; Blood pressure","score_opus":0.03792610348517438,"score_gpt":0.3600109217731067,"score_spread":0.3220848182879323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991774560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99196136,0.00041592485,0.00008575724,0.0041313944,0.002881082,0.00032495186,0.000012959351,0.000018450492,0.00016812175],"genre_scores_gemma":[0.9935952,0.00037298552,0.0003633299,0.0028445506,0.0027050576,0.0000015206867,0.000002197508,0.000031486492,0.00008370947],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9956578,0.0013420415,0.0018949781,0.00017915407,0.00060502626,0.00032097966],"domain_scores_gemma":[0.99274755,0.0028660917,0.0028730496,0.00026208584,0.0010006877,0.00025053584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006262597,0.00021568868,0.0013839663,0.00015311239,0.00012719132,0.0000062940835,0.00022792353,0.00029594632,0.00013550046],"category_scores_gemma":[0.002660079,0.00012387474,0.00053195254,0.00021806362,0.0005544549,0.000073399046,0.00009762013,0.0017018158,0.000011311256],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007979366,0.000530682,0.47527552,0.0000080347345,0.008331987,0.00045235967,0.00072334206,0.000039025217,0.4856854,0.0000020766736,0.019252975,0.0017192493],"study_design_scores_gemma":[0.010410589,0.0018977714,0.9250272,0.00007713398,0.005801175,0.0011745,0.000049030365,0.0002267702,0.054416113,0.00004345628,0.00073287066,0.00014342174],"about_ca_topic_score_codex":0.00017867805,"about_ca_topic_score_gemma":0.000030635238,"teacher_disagreement_score":0.44975168,"about_ca_system_score_codex":0.00004980414,"about_ca_system_score_gemma":0.00031712634,"threshold_uncertainty_score":0.73936373},"labels":[],"label_agreement":null},{"id":"W1994093013","doi":"10.1177/00912700122010177","title":"Effect of Alosetron on the Pharmacokinetics of Fluoxetine","year":2001,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Anesthesia and Sedative Agents","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Fluoxetine; Medicine; Pharmacokinetics; Pharmacology; CYP2C9; Active metabolite; CYP2D6; CYP3A4; Metabolite; Irritable bowel syndrome; Crossover study; Drug interaction; Internal medicine; Cytochrome P450; Placebo; Serotonin; Metabolism; Receptor","score_opus":0.07725395056796786,"score_gpt":0.47573142917853245,"score_spread":0.3984774786105646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994093013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874644,0.00027658406,0.000045901987,0.010102458,0.0006100913,0.00027691064,0.0000014663473,0.0000030512904,0.0012191148],"genre_scores_gemma":[0.99296445,0.0018133441,0.000022348222,0.004031062,0.00089709106,0.0000011678268,6.6485154e-7,0.000011996037,0.00025790223],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99630755,0.0019306046,0.0011841728,0.000073572555,0.00034348035,0.0001606141],"domain_scores_gemma":[0.9910803,0.00736185,0.001048908,0.00016116601,0.00023448687,0.00011328268],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005467463,0.00012193114,0.00075533293,0.00006281282,0.000032966054,0.0000010171568,0.00032284838,0.000080197686,0.0010595473],"category_scores_gemma":[0.0008382631,0.000051092175,0.0003332874,0.00015453319,0.00044574574,0.000022166942,0.00003712427,0.00072792184,0.000020453703],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1421549,0.0045287055,0.19999772,0.0003202865,0.0036092557,0.00081320654,0.0006109977,0.00046263725,0.3805019,0.000191687,0.1977085,0.069100186],"study_design_scores_gemma":[0.03427916,0.06354257,0.17029424,0.00031162615,0.0076069916,0.0013628636,0.00013770824,0.0013670988,0.6114411,0.00020649415,0.10922528,0.00022487147],"about_ca_topic_score_codex":0.0000024254048,"about_ca_topic_score_gemma":1.08918854e-7,"teacher_disagreement_score":0.2309392,"about_ca_system_score_codex":0.000011753779,"about_ca_system_score_gemma":0.00007127595,"threshold_uncertainty_score":0.9998536},"labels":[],"label_agreement":null},{"id":"W1995558772","doi":"10.1177/00912700222011436","title":"Effects of Azimilide on Heart Rate and ECG Conduction Intervals during Sinus Rhythm in Patients with a History of Atrial Fibrillation","year":2002,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Atrial fibrillation; Cardiology; Atrial flutter; QT interval; Internal medicine; Placebo; Sinus rhythm; Anesthesia; Torsades de pointes; Heart rate; Population; Blood pressure","score_opus":0.027511190880355193,"score_gpt":0.33170404422967287,"score_spread":0.30419285334931767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995558772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973107,0.0011055025,0.0000022033892,0.00041506145,0.0008956452,0.00023683476,5.8877293e-7,0.000002291705,0.00003119029],"genre_scores_gemma":[0.99820554,0.00063854916,0.000022480937,0.00027914657,0.0007923805,3.7756627e-7,3.3875108e-7,0.000005944249,0.000055247787],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982269,0.00079033396,0.0006984737,0.00007995088,0.000104012106,0.00010032869],"domain_scores_gemma":[0.99772567,0.0014506222,0.00059322757,0.000061182946,0.00011790152,0.000051376217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073498534,0.000075715776,0.0006122184,0.00009327549,0.000013121672,4.073075e-7,0.000026459044,0.000083949635,0.000043216336],"category_scores_gemma":[0.00035902107,0.000046899982,0.00016241848,0.000055883556,0.00023500502,0.000049208724,0.0000151518825,0.0004057683,0.0000014273437],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2753321,0.0013769021,0.1783248,0.0010239009,0.0024844352,0.0005760826,0.0014256428,0.006732044,0.50182956,0.000012881954,0.011881357,0.019000292],"study_design_scores_gemma":[0.022680264,0.010726214,0.9474306,0.00021941272,0.0007237008,0.00034660526,0.0000071647696,0.00034893124,0.016980547,0.000035614637,0.00042460478,0.00007633605],"about_ca_topic_score_codex":0.00000314081,"about_ca_topic_score_gemma":4.3469325e-7,"teacher_disagreement_score":0.7691058,"about_ca_system_score_codex":0.00006233984,"about_ca_system_score_gemma":0.000045002984,"threshold_uncertainty_score":0.19125257},"labels":[],"label_agreement":null},{"id":"W1995726799","doi":"10.1177/0091270010378858","title":"Incidence and Contributors to Potential Drug‐Drug Interactions in Hospitalized Patients","year":2010,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; University of Ottawa; Ottawa Hospital","funders":"","keywords":"Drug; Incidence (geometry); Medicine; Intensive care medicine; Pharmacology","score_opus":0.07025344659038651,"score_gpt":0.5034002863795165,"score_spread":0.43314683978913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995726799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9682309,0.000060463837,0.000032022395,0.024676874,0.0064263344,0.00038027737,0.0000038916965,0.000005846047,0.00018338488],"genre_scores_gemma":[0.98848057,0.0002649593,0.00020592977,0.010122201,0.00076871214,0.0000026803043,9.59358e-7,0.000008957934,0.0001450123],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977641,0.00054175744,0.0011188184,0.0001145568,0.00024599195,0.00021477551],"domain_scores_gemma":[0.9958373,0.00282323,0.00055162417,0.000101275524,0.0002843387,0.00040224232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025991227,0.000109007495,0.0005057147,0.00011158406,0.00005843226,0.000010482294,0.00019145531,0.00004188682,0.00046090578],"category_scores_gemma":[0.0023624464,0.00006614428,0.00013522197,0.00013466505,0.00017701168,0.00021209336,0.000116858704,0.001775179,0.000027275844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008199579,0.0011425728,0.9605343,0.000017187309,0.00017408014,0.000090817666,0.00037293686,0.00002197855,0.0048584756,0.000015810381,0.018736087,0.005836224],"study_design_scores_gemma":[0.011564617,0.00061733735,0.9354018,0.000039355073,0.0006062798,0.00014445139,0.000074197706,0.0006679471,0.0008096156,0.0002120249,0.049751222,0.00011113893],"about_ca_topic_score_codex":0.000036066434,"about_ca_topic_score_gemma":0.000037781174,"teacher_disagreement_score":0.031015135,"about_ca_system_score_codex":0.000021242231,"about_ca_system_score_gemma":0.00009939527,"threshold_uncertainty_score":0.7712368},"labels":[],"label_agreement":null},{"id":"W1996277995","doi":"10.1177/0091270009347871","title":"Does Therapeutic Equivalence Follow Bioequivalence? A Randomized Trial to Assess Clinical Effects After Switching From Clozaril to Generic Clozapine (Gen‐Clozapine)","year":2010,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovation Initiatives Ontario North; Northeast Cancer Centre; University of Calgary","funders":"","keywords":"Clozapine; Bioequivalence; Medicine; Randomized controlled trial; Clinical trial; Rating scale; Brief Psychiatric Rating Scale; Internal medicine; Psychology; Schizophrenia (object-oriented programming); Psychosis; Psychiatry; Pharmacokinetics","score_opus":0.12305645854272743,"score_gpt":0.4881997655925069,"score_spread":0.3651433070497795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996277995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9463746,0.0013525051,0.0031450065,0.026331304,0.019376295,0.003337909,0.000012663117,0.000039809143,0.000029885694],"genre_scores_gemma":[0.95686865,0.003975698,0.008431484,0.01531174,0.014989511,0.00019115892,0.0000029391376,0.0000587698,0.00017002266],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9888276,0.0051300405,0.0035203672,0.0005902552,0.0011023206,0.00082942506],"domain_scores_gemma":[0.9723463,0.023496177,0.0010678505,0.0007167136,0.00056344416,0.0018094908],"candidate_categories":["metaresearch","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.016006667,0.00047494326,0.0030326317,0.00027981916,0.00016903593,0.000057274312,0.0010160451,0.00042102914,0.0012752354],"category_scores_gemma":[0.008397815,0.00020957144,0.0016637528,0.00042705605,0.00055469107,0.00014633888,0.00039772873,0.00303545,0.0002455543],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8916088,0.0016323676,0.0031621216,0.00003082946,0.0023954338,0.00065470056,0.00013252198,0.000006854657,0.027480803,0.00002165451,0.0019178705,0.070956066],"study_design_scores_gemma":[0.9385736,0.011062327,0.030220991,0.00016822922,0.004923733,0.0001426728,0.000025969122,0.00036324025,0.0052878475,0.0022363903,0.006643636,0.0003513552],"about_ca_topic_score_codex":0.00006321816,"about_ca_topic_score_gemma":0.00008130521,"teacher_disagreement_score":0.07060471,"about_ca_system_score_codex":0.00007408838,"about_ca_system_score_gemma":0.0011208503,"threshold_uncertainty_score":0.9999549},"labels":[],"label_agreement":null},{"id":"W2000782600","doi":"10.1177/0091270004269521","title":"Pharmacokinetics of Dextromethorphan After Single or Multiple Dosing in Combination With Quinidine in Extensive and Poor Metabolizers","year":2004,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Respiratory and Cough-Related Research","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Dextromethorphan; Dextrorphan; Dosing; Pharmacokinetics; Quinidine; Pharmacology; CYP2D6; Medicine; Urine; Oral administration; Debrisoquine; Bioequivalence; Internal medicine; Metabolism; Cytochrome P450","score_opus":0.09137928177373802,"score_gpt":0.44312241836992794,"score_spread":0.35174313659618994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000782600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99413073,0.0017030506,0.00019632665,0.00331791,0.00028542374,0.0003213218,0.0000012214268,0.0000028890752,0.000041136704],"genre_scores_gemma":[0.9957151,0.0016515696,0.00084352767,0.0015716783,0.00017774598,0.0000038545963,3.3678407e-7,0.00001391308,0.00002232044],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99742866,0.00083599053,0.0011098336,0.00011884136,0.0002887677,0.00021791364],"domain_scores_gemma":[0.99729437,0.0016948833,0.00044934187,0.0000788126,0.00033589933,0.00014671774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031147487,0.000112896945,0.000653193,0.00028134644,0.00002227615,0.000004440139,0.00011928648,0.00011616345,0.0000958597],"category_scores_gemma":[0.00076672476,0.00006140801,0.00007406227,0.00041754945,0.00041034786,0.000108182685,0.000044223798,0.0010193476,0.0000012650256],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17733017,0.005622139,0.09741598,0.00021573425,0.00076571817,0.0030208845,0.0015401373,0.0035233216,0.6767203,0.000022441198,0.00026606058,0.033557065],"study_design_scores_gemma":[0.16147402,0.024086876,0.54356813,0.0010559433,0.0019408514,0.0016911011,0.0014582536,0.0017626435,0.25906548,0.0007486519,0.002791826,0.00035621284],"about_ca_topic_score_codex":0.00001526544,"about_ca_topic_score_gemma":0.000021942353,"teacher_disagreement_score":0.44615218,"about_ca_system_score_codex":0.00004640406,"about_ca_system_score_gemma":0.000267112,"threshold_uncertainty_score":0.44286147},"labels":[],"label_agreement":null},{"id":"W2002629531","doi":"10.1177/0091270006288953","title":"Pharmacokinetics and Urinary Excretion of Vincristine Sulfate Liposomes Injection in Metastatic Melanoma Patients","year":2006,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Advancements in Transdermal Drug Delivery","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Inimex Pharmaceuticals (Canada)","funders":"","keywords":"Pharmacokinetics; Vincristine; Chemistry; Volume of distribution; Pharmacology; Urology; Distribution (mathematics); Medicine; Chemotherapy; Internal medicine","score_opus":0.10486971386985322,"score_gpt":0.4804081156616854,"score_spread":0.3755384017918322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002629531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922645,0.0018143778,0.00078665116,0.0008429174,0.0035077285,0.00040274492,0.000032832402,0.000011776661,0.0003364768],"genre_scores_gemma":[0.9944249,0.0033391523,0.00037862582,0.0010132905,0.0007016975,0.0000062749596,0.000009219338,0.000023142049,0.00010369634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941143,0.0027835865,0.002284371,0.00019033218,0.00027591834,0.00035151545],"domain_scores_gemma":[0.995019,0.0030049586,0.001388922,0.00010688918,0.0003377409,0.000142453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003648148,0.00023333613,0.0007218087,0.00024620674,0.00009788955,0.000004559834,0.00036162394,0.0001932886,0.0004919682],"category_scores_gemma":[0.00021384784,0.000176077,0.0001549155,0.00026908962,0.0007128399,0.00020758441,0.000113054375,0.0015046659,0.000008763835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03755516,0.013626458,0.6829901,0.0005396789,0.0018584429,0.0004895398,0.00092116196,0.064009994,0.09544492,0.0002657518,0.02146761,0.08083123],"study_design_scores_gemma":[0.060827617,0.0111589,0.7491772,0.00014698847,0.0054356316,0.000795917,0.00032487643,0.015363289,0.0633835,0.005442889,0.08701532,0.0009278471],"about_ca_topic_score_codex":0.000033075477,"about_ca_topic_score_gemma":0.0000075994985,"teacher_disagreement_score":0.07990338,"about_ca_system_score_codex":0.000053718693,"about_ca_system_score_gemma":0.0000905323,"threshold_uncertainty_score":0.7180211},"labels":[],"label_agreement":null},{"id":"W2004250367","doi":"10.1002/jcph.435","title":"The use of antidepressants and the risk of chronic atrial fibrillation","year":2014,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Cohort; Depression (economics); Internal medicine; Atrial fibrillation; Confidence interval; Logistic regression; Incidence (geometry); Cohort study; Anxiety; Relative risk; Psychiatry","score_opus":0.15135383200253413,"score_gpt":0.45432407537447794,"score_spread":0.3029702433719438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004250367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98527926,0.0015479808,0.0005060708,0.010561567,0.0016829888,0.00032607993,0.0000016106269,0.0000031111524,0.00009134676],"genre_scores_gemma":[0.9786422,0.015244234,0.00007303651,0.00020080348,0.005688428,6.250127e-8,2.88515e-7,0.0000061104274,0.00014482206],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99651843,0.0018090942,0.0012784388,0.000057133744,0.00023478849,0.000102126935],"domain_scores_gemma":[0.97975963,0.0180251,0.0018302976,0.00015174542,0.00018631303,0.000046926973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006862084,0.000071419956,0.00056044705,0.00003611591,0.00009989493,0.000006747452,0.00014044576,0.00006278688,0.000045965317],"category_scores_gemma":[0.0037423612,0.000027246906,0.00039875344,0.000083670195,0.0007033323,0.00006908003,0.000081884275,0.0002883873,0.0000018996742],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051526695,0.000021876638,0.7527225,0.000081026774,0.0033292272,0.0000025297406,0.00025532724,0.01304877,0.0016084083,0.0014181843,0.018547582,0.15743785],"study_design_scores_gemma":[0.03173785,0.0018118216,0.6859207,0.000055180033,0.0057823323,0.000039329785,0.00004607925,0.03583694,0.0007355129,0.0019197072,0.23603119,0.00008334231],"about_ca_topic_score_codex":0.000014621108,"about_ca_topic_score_gemma":0.0000034363275,"teacher_disagreement_score":0.21748361,"about_ca_system_score_codex":0.0000071567633,"about_ca_system_score_gemma":0.00006302337,"threshold_uncertainty_score":0.44802263},"labels":[],"label_agreement":null},{"id":"W2006239204","doi":"10.1177/0091270007303767","title":"Mesna as a Nonvitamin Intervention to Lower Plasma Total Homocysteine Concentration: Implications for Assessment of the Homocysteine Theory of Atherosclerosis","year":2007,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Lawson Health Research Institute","funders":"Canadian Institutes of Health Research; Lawson Health Research Institute","keywords":"Homocysteine; Plasma homocysteine; Medicine; Internal medicine","score_opus":0.10692436997708163,"score_gpt":0.5071067901197855,"score_spread":0.4001824201427039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006239204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98323,0.0001366184,0.006013971,0.00817823,0.0010327717,0.00093460735,0.000023242477,0.000004130927,0.0004464487],"genre_scores_gemma":[0.9973365,0.00010384375,0.0005376511,0.0006969879,0.00057836686,0.000012560232,0.000002308776,0.000015318032,0.0007164422],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99694604,0.00057930144,0.0017663505,0.00012358476,0.0003398754,0.00024485626],"domain_scores_gemma":[0.99471384,0.0030377589,0.0009553852,0.00027151007,0.00084336795,0.00017810633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007663785,0.00011672306,0.0005899241,0.000085971944,0.000077065066,0.0000049045625,0.00036941475,0.0001228602,0.00024324363],"category_scores_gemma":[0.00076866074,0.000063028136,0.0005525108,0.0002905535,0.00035810244,0.000064572145,0.00011270932,0.00048240708,0.0000038007631],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015736913,0.004848071,0.023041835,0.00027116376,0.0017005028,0.000009814828,0.0005329655,0.00017473604,0.90150046,0.0023366674,0.007588097,0.042258743],"study_design_scores_gemma":[0.018122902,0.018746002,0.8318408,0.00035266986,0.0017627539,0.00035254683,0.0005504561,0.0005159097,0.12428637,0.00065063004,0.0026707526,0.00014818863],"about_ca_topic_score_codex":0.000008198605,"about_ca_topic_score_gemma":0.000008215687,"teacher_disagreement_score":0.80879897,"about_ca_system_score_codex":0.000069462156,"about_ca_system_score_gemma":0.00029077823,"threshold_uncertainty_score":0.2663347},"labels":[],"label_agreement":null},{"id":"W2008330092","doi":"10.1177/0091270004268320","title":"Population Pharmacokinetics of Ibuprofen Enantiomers in Very Premature Neonates","year":2004,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Cardiovascular Conditions and Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"ASTER","funders":"","keywords":"Ibuprofen; Pharmacokinetics; Medicine; Gestational age; NONMEM; Population; Anesthesia; Placebo; Pharmacodynamics; Pharmacology; Pregnancy","score_opus":0.03818168804833455,"score_gpt":0.423713679316355,"score_spread":0.38553199126802046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008330092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994945,0.001440624,0.00006454492,0.0021099802,0.0010589224,0.0002176688,0.0000050490253,0.0000039849656,0.00015423683],"genre_scores_gemma":[0.9967162,0.0019784428,0.0003031201,0.00051489176,0.00044309348,0.0000014791619,0.0000067020796,0.000008961377,0.000027096206],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984111,0.00027112654,0.00090851844,0.000069507696,0.00021652585,0.00012319407],"domain_scores_gemma":[0.9988722,0.0003383899,0.00045039254,0.00010468413,0.00015439898,0.00007988648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012738896,0.00008307505,0.00054979185,0.00013547533,0.000022534914,0.0000017787871,0.00010102014,0.000095589996,0.00009800463],"category_scores_gemma":[0.0001326861,0.00004997771,0.0003628844,0.00019530916,0.000111546105,0.00006143534,0.000026499027,0.0004762682,0.000005131563],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026200108,0.010511882,0.7481288,0.00059832353,0.015122215,0.0049889907,0.0014935267,0.032050442,0.08125425,0.00036802617,0.010818028,0.06846544],"study_design_scores_gemma":[0.02439037,0.0011093861,0.95806086,0.00017637438,0.0027236543,0.001354902,0.00008181155,0.000079588375,0.009306426,0.0013622257,0.0012687288,0.00008567728],"about_ca_topic_score_codex":0.00002539527,"about_ca_topic_score_gemma":0.000004054342,"teacher_disagreement_score":0.20993209,"about_ca_system_score_codex":0.00004688525,"about_ca_system_score_gemma":0.00012246691,"threshold_uncertainty_score":0.20691748},"labels":[],"label_agreement":null},{"id":"W2008423993","doi":"10.1177/0091270003261078","title":"Effects of St. John's Wort (<i>Hypericum perforatum</i>) on Tacrolimus Pharmacokinetics in Healthy Volunteers","year":2003,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Center for Research Resources","keywords":"Pharmacokinetics; Hypericum perforatum; Tacrolimus; Pharmacology; CYP3A; Volume of distribution; Medicine; Pharmacokinetic interaction; Oral administration; Dosing; Drug interaction; Chemistry; Transplantation; Metabolism; Internal medicine; Cytochrome P450","score_opus":0.09962250996604795,"score_gpt":0.4859302468162513,"score_spread":0.38630773685020336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008423993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96792626,0.0077083693,0.00008217316,0.0023318504,0.01842721,0.0008276531,0.000029346795,0.000020651561,0.002646497],"genre_scores_gemma":[0.9563897,0.022112042,0.00019699444,0.019234253,0.001785718,0.000020818467,0.0000019953927,0.00006245154,0.00019597675],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.98722976,0.0075961733,0.003208016,0.00038896877,0.0005833754,0.0009937291],"domain_scores_gemma":[0.9887505,0.007982261,0.0017544997,0.00028437443,0.00048725883,0.0007411151],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.010565989,0.00050940615,0.0016184363,0.000439139,0.00019094156,0.00001116156,0.0011417877,0.00056687446,0.0012670975],"category_scores_gemma":[0.001187901,0.000369657,0.0005689119,0.0007719733,0.00085755694,0.00013123927,0.00013363353,0.004480775,0.000065606735],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07968273,0.021269156,0.04709026,0.0009936339,0.0045365496,0.0019805296,0.0029039506,0.05265424,0.49373904,0.0018336778,0.22834696,0.06496928],"study_design_scores_gemma":[0.037993655,0.0049438896,0.013688426,0.00008119456,0.002659868,0.00030815657,0.00020075336,0.00290845,0.23080823,0.00088850566,0.70481694,0.000701944],"about_ca_topic_score_codex":0.000009477145,"about_ca_topic_score_gemma":0.0000046595715,"teacher_disagreement_score":0.47646996,"about_ca_system_score_codex":0.00009048108,"about_ca_system_score_gemma":0.00068322255,"threshold_uncertainty_score":0.99987555},"labels":[],"label_agreement":null},{"id":"W2008486886","doi":"10.1177/0091270009337946","title":"Effect of Age, Weight, and CYP2C19 Genotype on Escitalopram Exposure","year":2009,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute of Mental Health","keywords":"Escitalopram; Body mass index; CYP2C19; Population; Internal medicine; Volume of distribution; Demography; Medicine; Pharmacokinetics; Antidepressant","score_opus":0.03755929623619485,"score_gpt":0.4499459992483756,"score_spread":0.4123867030121807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008486886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910719,0.002036483,0.000010552621,0.004645617,0.00095843733,0.00024307038,0.0000011395892,0.000009668115,0.0010231377],"genre_scores_gemma":[0.9953655,0.0019303926,0.00016418434,0.0014807653,0.00086745573,6.0505886e-7,7.106618e-7,0.000009381496,0.00018101037],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978401,0.0008293265,0.0008072742,0.00010366491,0.00026992807,0.0001497067],"domain_scores_gemma":[0.9964268,0.00259669,0.00056366174,0.00014808362,0.00008602077,0.00017873183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024122,0.00013014335,0.00070860726,0.000048126203,0.000036074623,0.000002712473,0.00014925777,0.00013937977,0.000126517],"category_scores_gemma":[0.00029735346,0.00006262202,0.0001890553,0.00007131761,0.00017852016,0.000043676046,0.000029082652,0.0006568584,0.00001265981],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10474007,0.0037801182,0.061885662,0.00020100143,0.0019078181,0.0025307357,0.000248387,0.00007169238,0.16709282,0.00007338188,0.052376654,0.60509163],"study_design_scores_gemma":[0.03592264,0.11547716,0.7449047,0.00039032448,0.0041888556,0.0009924355,0.000011613195,0.000058618974,0.08785057,0.00056426856,0.009483589,0.00015521953],"about_ca_topic_score_codex":8.387001e-7,"about_ca_topic_score_gemma":1.3982034e-7,"teacher_disagreement_score":0.68301904,"about_ca_system_score_codex":0.000016154605,"about_ca_system_score_gemma":0.00005216774,"threshold_uncertainty_score":0.28537595},"labels":[],"label_agreement":null},{"id":"W2008793637","doi":"10.1177/0091270010376973","title":"Risperidone‐Induced QT Prolongation Following Overdose Correlates With Serum Drug Concentration and Resolves Rapidly With No Evidence of Altered Pharmacokinetics","year":2010,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; SickKids Foundation; Centre for Addiction and Mental Health; University of Calgary","funders":"","keywords":"Medicine","score_opus":0.02700299677982943,"score_gpt":0.37827359297261937,"score_spread":0.35127059619278994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008793637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99392927,0.0006204477,0.00004842251,0.0033513142,0.0015852423,0.00040172128,0.0000013199614,0.000009361136,0.000052904285],"genre_scores_gemma":[0.9956264,0.0012080085,0.0004573067,0.0011192198,0.0015314949,0.0000030724157,0.0000010942337,0.000015204624,0.00003821255],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981095,0.0005327298,0.0007778604,0.00014660467,0.00023253959,0.00020075432],"domain_scores_gemma":[0.99651974,0.0019595367,0.0008710317,0.0001308477,0.00037436263,0.00014450449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017052704,0.00014451277,0.0006256825,0.00003535155,0.00008374504,0.0000061930327,0.00010779396,0.00011754485,0.00006121587],"category_scores_gemma":[0.00038081454,0.000078754696,0.00014242463,0.000119697164,0.0004261541,0.00018062427,0.000029534818,0.0013396646,0.0000025252268],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036047854,0.0001927121,0.034445163,0.000061139275,0.0008145904,0.0001797481,0.0003865277,0.0001509107,0.924584,0.000012732681,0.0012188335,0.0019057879],"study_design_scores_gemma":[0.041553777,0.030770767,0.4236578,0.0011265881,0.009280108,0.0052572223,0.00026023225,0.008284046,0.4780509,0.00025233405,0.0009680231,0.0005382113],"about_ca_topic_score_codex":0.0000041371945,"about_ca_topic_score_gemma":0.0000032650785,"teacher_disagreement_score":0.4465331,"about_ca_system_score_codex":0.000010654382,"about_ca_system_score_gemma":0.0002853645,"threshold_uncertainty_score":0.58202505},"labels":[],"label_agreement":null},{"id":"W2009236753","doi":"10.1177/00912700222011418","title":"Limited Sampling Strategy to Predict AUC of the CYP3A Phenotyping Probe Midazolam in Adults: Application to Various Assay Techniques","year":2002,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences North","funders":"","keywords":"Midazolam; Reproducibility; Mean squared error; CYP3A; Sampling (signal processing); Linear regression; Pharmacokinetics; Mathematics; Statistics; Medicine; Anesthesia; Pharmacology; Internal medicine; Computer science","score_opus":0.17446470495559757,"score_gpt":0.48976398802201493,"score_spread":0.31529928306641736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009236753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97415966,0.0014323831,0.008176035,0.009089692,0.0035437678,0.0020780356,0.000043880507,0.000044620043,0.001431929],"genre_scores_gemma":[0.9827401,0.0018242694,0.0014861642,0.012033715,0.0017288546,0.00005825935,0.0000013480275,0.000038742335,0.00008854621],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9931392,0.0030261949,0.0025333536,0.0003239664,0.00038088998,0.0005963799],"domain_scores_gemma":[0.9947375,0.002672703,0.0012971296,0.00033997142,0.00049274525,0.00045993514],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.008267464,0.00030997721,0.00085885805,0.00028089515,0.00018760828,0.000012957507,0.0015252626,0.00042766082,0.0004751277],"category_scores_gemma":[0.00082425354,0.00020272868,0.00030702306,0.00086534384,0.0003008307,0.00010419782,0.00034340643,0.0024573195,0.000042928867],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006333851,0.0031616653,0.017363897,0.00014052962,0.0007200886,0.000027352718,0.0032136282,0.031287357,0.41752282,0.0003151491,0.019278731,0.5006349],"study_design_scores_gemma":[0.015040762,0.0031944935,0.062192187,0.000434005,0.0025959117,0.0002582813,0.00043177302,0.055252112,0.29530948,0.0034555518,0.56067395,0.0011614988],"about_ca_topic_score_codex":0.000021374984,"about_ca_topic_score_gemma":0.000020203564,"teacher_disagreement_score":0.5413952,"about_ca_system_score_codex":0.00007765539,"about_ca_system_score_gemma":0.00017221525,"threshold_uncertainty_score":0.9998441},"labels":[],"label_agreement":null},{"id":"W2010278974","doi":"10.1177/0091270010382915","title":"Pharmacogenetics of Intravenous and Oral Busulfan in Hematopoietic Cell Transplant Recipients","year":2010,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal","funders":"National Center for Research Resources; National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Busulfan; Medicine; Dosing; Pharmacology; Population; Hematopoietic stem cell transplantation; Pharmacokinetics; Pharmacogenetics; Internal medicine; Gastroenterology; Oncology; Transplantation; Genotype; Chemistry","score_opus":0.04259470473159469,"score_gpt":0.3938264752781396,"score_spread":0.35123177054654486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010278974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99588686,0.00022919298,0.00021320287,0.0012280687,0.0017775818,0.00027810028,0.0000064436663,0.0000045134725,0.000376015],"genre_scores_gemma":[0.9954718,0.002726143,0.00079892663,0.0006388132,0.0003128359,0.0000014920607,0.0000014085672,0.000016998521,0.00003159478],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9972953,0.0004296143,0.0016616413,0.00011821143,0.00027472645,0.00022050463],"domain_scores_gemma":[0.9974777,0.0014297501,0.0005874733,0.00012250339,0.00015591421,0.0002266637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003011852,0.00013431773,0.0007267131,0.00012909638,0.000024905794,0.0000028678335,0.00020329139,0.00017420076,0.00028868418],"category_scores_gemma":[0.000073381496,0.000088579,0.00013003383,0.00014385553,0.00035220673,0.000038249833,0.000017990144,0.0011678268,0.000006015217],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069737113,0.0021319655,0.23990217,0.0004733331,0.00027523696,0.00054310804,0.0044625243,0.000060160466,0.7353033,0.000029040717,0.0008156094,0.009029825],"study_design_scores_gemma":[0.029417431,0.0035401853,0.5790031,0.00035167503,0.003218363,0.006293459,0.00032884226,0.0007089067,0.37454373,0.00050552824,0.0017992998,0.0002894768],"about_ca_topic_score_codex":0.000008376429,"about_ca_topic_score_gemma":0.000009301793,"teacher_disagreement_score":0.3607596,"about_ca_system_score_codex":0.000009015554,"about_ca_system_score_gemma":0.0001833286,"threshold_uncertainty_score":0.5073691},"labels":[],"label_agreement":null},{"id":"W2011296465","doi":"10.1177/0091270005284388","title":"The Effect of AST‐120 on the Single‐Dose Pharmacokinetics of Losartan and Losartan Acid (E‐3174) in Healthy Subjects","year":2006,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Analytical Methods in Pharmaceuticals","field":"Chemistry","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Supratek Pharma (Canada)","funders":"","keywords":"Losartan; Pharmacokinetics; Pharmacology; Medicine; Internal medicine; Angiotensin II; Receptor","score_opus":0.07835730691922209,"score_gpt":0.4704475623508394,"score_spread":0.3920902554316173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011296465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847507,0.0021265282,0.00006830242,0.009262046,0.0008701926,0.00027993997,0.000012017256,0.000008824091,0.0026214581],"genre_scores_gemma":[0.99543804,0.001632397,0.00018613567,0.0015168731,0.0011305732,0.0000049267032,4.8897346e-7,0.00003285187,0.00005771925],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99150574,0.0041956664,0.002915823,0.00023433921,0.00061274314,0.0005356832],"domain_scores_gemma":[0.95039535,0.04701822,0.0017997986,0.0003608019,0.00020637072,0.00021947778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012937322,0.00030418547,0.0011648671,0.00008441874,0.00013494527,0.000014728717,0.0010123281,0.00023842766,0.00038810016],"category_scores_gemma":[0.0037471568,0.00014421003,0.00036825283,0.00031685166,0.0019567572,0.00005678386,0.00020808585,0.0022646992,0.00000589388],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12997295,0.002622417,0.025225058,0.0005866582,0.001284642,0.00017248727,0.0002048154,0.00084464625,0.79300815,0.0015044041,0.013001554,0.03157222],"study_design_scores_gemma":[0.011404151,0.0095418235,0.0033303774,0.00019110843,0.0014448571,0.00010297394,0.000102512706,0.0024819358,0.9578378,0.005288756,0.008003028,0.0002706317],"about_ca_topic_score_codex":0.000009317694,"about_ca_topic_score_gemma":0.0000065716526,"teacher_disagreement_score":0.16482969,"about_ca_system_score_codex":0.00006292979,"about_ca_system_score_gemma":0.00012777136,"threshold_uncertainty_score":0.98391175},"labels":[],"label_agreement":null},{"id":"W2011560794","doi":"10.1177/0091270011400414","title":"In Vitro and In Vivo Assessment of Renal Drug Transporters in the Disposition of Mesna and Dimesna","year":2011,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"Canadian Institutes of Health Research","keywords":"Disposition; Mesna; Pharmacology; In vivo; In vitro; Drug; Transporter; Medicine; Chemistry; Pharmacokinetics; Internal medicine; Biology; Biochemistry; Psychology; Biotechnology","score_opus":0.0446273170396223,"score_gpt":0.40099197996210395,"score_spread":0.35636466292248165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011560794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99646086,0.000294623,0.00011650136,0.002443878,0.00022758087,0.0002021137,0.0000037135833,7.512785e-7,0.00025000473],"genre_scores_gemma":[0.9976053,0.0013816257,0.00028070164,0.0006356723,0.00007448008,0.0000018237565,5.187226e-7,0.0000049911177,0.00001488628],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99809355,0.00040290342,0.0011353589,0.00007604365,0.00017335381,0.000118820026],"domain_scores_gemma":[0.9989803,0.00046158532,0.00039842154,0.00006704072,0.000038247803,0.000054438377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003729948,0.00007774116,0.00054771604,0.00012124906,0.000010266955,7.697625e-7,0.00011786824,0.00006531199,0.000064445274],"category_scores_gemma":[0.000013370335,0.000040388783,0.00008334913,0.00011788798,0.0002608874,0.00006176638,0.000007446349,0.000531795,4.0427004e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031327467,0.0031050744,0.14007607,0.000291487,0.0002649489,0.0007753995,0.010056333,0.000051966,0.81097096,0.0002302788,0.00039850883,0.0024515246],"study_design_scores_gemma":[0.012277118,0.0010354728,0.89122534,0.00024550955,0.00061530527,0.0000993824,0.0014619486,0.00031636565,0.09115352,0.0013684034,0.000118053715,0.00008360414],"about_ca_topic_score_codex":0.000034946184,"about_ca_topic_score_gemma":0.00007796384,"teacher_disagreement_score":0.75114924,"about_ca_system_score_codex":0.000011355409,"about_ca_system_score_gemma":0.00008240386,"threshold_uncertainty_score":0.23104145},"labels":[],"label_agreement":null},{"id":"W2012919964","doi":"10.1177/0091270008328099","title":"Influence of Controlled Rheumatoid Arthritis on the Action and Disposition of Verapamil: Focus on Infliximab","year":2009,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Rheumatoid arthritis; Infliximab; Verapamil; Medicine; Disposition; Pharmacology; Internal medicine; Tumor necrosis factor alpha; Psychology; Calcium","score_opus":0.0576005643334588,"score_gpt":0.43407641104862316,"score_spread":0.3764758467151644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012919964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860025,0.0008451111,0.000018476076,0.01195291,0.0002648384,0.0005522391,0.0000021138376,0.0000045073552,0.0003573219],"genre_scores_gemma":[0.98712474,0.01116766,0.000010853465,0.0014160346,0.00024890274,0.0000036298381,2.1755382e-7,0.000007349515,0.000020623835],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9966018,0.0011973156,0.0014710149,0.00009116905,0.0004830486,0.00015564747],"domain_scores_gemma":[0.9919587,0.0062118038,0.0011626055,0.00017552535,0.00038604942,0.00010534976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043384973,0.00010651229,0.0009088835,0.000118263466,0.00005255519,0.0000036118136,0.00018538795,0.000113132024,0.000052903808],"category_scores_gemma":[0.0015045324,0.000051184586,0.0002020231,0.00012547617,0.0003468582,0.000059887632,0.000021794409,0.000747923,0.000005345148],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34454763,0.004639387,0.034661707,0.00028186126,0.002430239,0.0001642715,0.0022114236,0.0022739281,0.50953907,0.0021503004,0.015485306,0.08161486],"study_design_scores_gemma":[0.23329952,0.06994581,0.4134901,0.0069263196,0.0012523634,0.016055027,0.0013500764,0.002789005,0.2426946,0.010210024,0.0015552541,0.00043191918],"about_ca_topic_score_codex":0.0000063797643,"about_ca_topic_score_gemma":0.0000010897107,"teacher_disagreement_score":0.37882838,"about_ca_system_score_codex":0.00003230449,"about_ca_system_score_gemma":0.00014445781,"threshold_uncertainty_score":0.32493946},"labels":[],"label_agreement":null},{"id":"W2013594289","doi":"10.1177/0091270009347673","title":"Comparative Pharmacokinetics of a Once‐Daily Tramadol Extended‐Release Tablet and an Immediate‐Release Reference Product Following Single‐Dose and Multiple‐Dose Administration","year":2010,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Veterinary Pharmacology and Anesthesia","field":"Veterinary","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Tramadol; Pharmacokinetics; Bioequivalence; Medicine; Dosing; Anesthesia; Analgesic; Pharmacology; Plasma concentration","score_opus":0.17478328394214743,"score_gpt":0.4708381661928176,"score_spread":0.29605488225067017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013594289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956064,0.0005212537,0.000021462483,0.0014359037,0.0017427967,0.00050890824,0.000023653232,0.000024987698,0.00011460049],"genre_scores_gemma":[0.9961933,0.0006037584,0.0007734313,0.000940031,0.0014074675,0.000008272582,0.000007517603,0.000029215145,0.00003703633],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9951525,0.002013935,0.0017412886,0.0003852139,0.00029874002,0.00040832188],"domain_scores_gemma":[0.99496317,0.0026104874,0.00139526,0.00024884497,0.00027258802,0.0005096665],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003120214,0.00035070657,0.0010365463,0.00012722789,0.00020952808,0.000027541662,0.0005134902,0.00024178374,0.00025478413],"category_scores_gemma":[0.00039664726,0.0002572041,0.00018435824,0.00014913993,0.0010392241,0.000525856,0.00013084219,0.0019794179,0.0000078877465],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027454862,0.0026266137,0.0035816072,0.00006794525,0.00046232398,0.001215753,0.0009520057,0.000045344575,0.95298004,0.00001964084,0.0010674006,0.009526438],"study_design_scores_gemma":[0.068838924,0.09289753,0.5725909,0.0002799896,0.009683478,0.025581036,0.0023886822,0.033076353,0.16765667,0.0011667889,0.023564188,0.002275456],"about_ca_topic_score_codex":0.000010489145,"about_ca_topic_score_gemma":0.000008513202,"teacher_disagreement_score":0.7853234,"about_ca_system_score_codex":0.000015771117,"about_ca_system_score_gemma":0.00029331472,"threshold_uncertainty_score":0.999988},"labels":[],"label_agreement":null},{"id":"W2014643868","doi":"10.1177/0091270011399574","title":"Combined Administration of Quinidine and Propafenone for Atrial Fibrillation: The CAQ‐PAF Study","year":2011,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Université Laval; Centre Hospitalier de l’Université de Montréal; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Propafenone; Quinidine; Atrial fibrillation; Medicine; Cardiology; Internal medicine; Disposition; Anesthesia; Psychology","score_opus":0.11092955567430206,"score_gpt":0.44046418615151484,"score_spread":0.32953463047721276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014643868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99287385,0.00034973366,0.000058941587,0.004716356,0.0011351198,0.0007827955,0.0000022863753,0.0000037901134,0.00007710927],"genre_scores_gemma":[0.9954264,0.0003664068,0.00010715684,0.0004140593,0.003612404,0.000002040038,9.3646673e-7,0.000006771938,0.000063836706],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9981561,0.0006273121,0.000914225,0.000078523466,0.00011241298,0.000111440946],"domain_scores_gemma":[0.99698925,0.0018734792,0.0007026858,0.000106426705,0.000261519,0.000066643326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026229224,0.00007887944,0.00053820363,0.000029440693,0.00008158767,0.0000015949904,0.000086131564,0.000077162,0.00008815979],"category_scores_gemma":[0.00041955058,0.000038453512,0.00025648088,0.000066508976,0.00032465308,0.00003681601,0.00002979178,0.00034128764,0.0000016224662],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.77636325,0.0029883375,0.070217304,0.00021513179,0.009825106,0.000419276,0.006461326,0.00017256128,0.06970906,0.001040918,0.02710775,0.035479985],"study_design_scores_gemma":[0.06837216,0.18208589,0.70010793,0.00006697738,0.0130152395,0.0032831638,0.0013858567,0.00069773704,0.017928604,0.0049010264,0.007847337,0.00030808416],"about_ca_topic_score_codex":0.000002992169,"about_ca_topic_score_gemma":0.0000016050063,"teacher_disagreement_score":0.70799106,"about_ca_system_score_codex":0.000006399124,"about_ca_system_score_gemma":0.00021359643,"threshold_uncertainty_score":0.15680887},"labels":[],"label_agreement":null},{"id":"W2019890777","doi":"10.1002/j.1552-4604.2000.tb05982.x","title":"Drug Labeling and Risk Perceptions of Teratogenicity: A Survey of Pregnant Canadian Women and Their Health Professionals","year":2000,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pregnancy; Health professionals; Perception; Nausea; Vomiting; Risk perception; Family medicine; Drug; Drugs in pregnancy; Obstetrics; Pediatrics; Health care; Psychiatry; Fetus; Psychology; Anesthesia","score_opus":0.06532141854844371,"score_gpt":0.44941326886651645,"score_spread":0.38409185031807275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019890777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892217,0.004431006,0.000011006886,0.005793784,0.00018851741,0.00023394919,0.00007215736,0.0000021184565,0.000045777015],"genre_scores_gemma":[0.96637034,0.030386131,0.00006390159,0.0029165358,0.00011704338,0.0000021027943,0.000001942336,0.0000062241434,0.00013580397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99691665,0.0016220544,0.0010652166,0.000076351556,0.00012014767,0.00019956412],"domain_scores_gemma":[0.9967158,0.0017357063,0.00069961534,0.00010062175,0.00019568129,0.000552596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0072737816,0.00007844082,0.0006136147,0.000086578635,0.00008746764,0.0000015241237,0.0001024441,0.00006773009,0.0006397953],"category_scores_gemma":[0.00065057905,0.000041951145,0.00005734749,0.000104466875,0.00031230113,0.00004548367,0.000018710176,0.0005425702,0.0000011033222],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040527196,0.0012002224,0.6882321,0.000285671,0.0013151204,0.000011282887,0.02781168,0.000026441088,0.0029179782,0.0000057239704,0.017194048,0.25694698],"study_design_scores_gemma":[0.004001255,0.0011816213,0.9908384,0.0006472066,0.00017859184,0.00018492196,0.0009720906,0.00018779303,0.0003128724,0.0001477578,0.0012904911,0.00005697051],"about_ca_topic_score_codex":0.0033001893,"about_ca_topic_score_gemma":0.0018913045,"teacher_disagreement_score":0.30260628,"about_ca_system_score_codex":0.00003173167,"about_ca_system_score_gemma":0.0014985586,"threshold_uncertainty_score":0.700531},"labels":[],"label_agreement":null},{"id":"W2020477779","doi":"10.1177/009127000104100908","title":"Evaluating Possible Pharmacokinetic Interactions between Tobramycin, Piperacillin, and a Combination of Piperacillin and Tazobactam in Patients with Various Degrees of Renal Impairment","year":2001,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Piperacillin; Tobramycin; Piperacillin/tazobactam; Medicine; Pharmacokinetics; Tazobactam; Renal function; Crossover study; Pharmacology; Antibacterial agent; Anesthesia; Internal medicine; Antibiotics; Chemistry; Gentamicin; Pathology","score_opus":0.07063823566904713,"score_gpt":0.4405121916659936,"score_spread":0.36987395599694645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020477779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974009,0.0003083489,0.00028630035,0.0011985474,0.00025802723,0.0004662149,0.000007986465,0.000003932442,0.00006974298],"genre_scores_gemma":[0.99715686,0.0014615385,0.000842055,0.0002569878,0.00023011286,0.0000010711426,0.000004839397,0.000015685193,0.0000308469],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971642,0.00048600428,0.0016074778,0.00015370449,0.00037957876,0.00020906852],"domain_scores_gemma":[0.99645746,0.0014962077,0.0011079252,0.000103841405,0.00064787373,0.00018668237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022877748,0.00016277231,0.0007594501,0.00021771762,0.000052231084,0.000006694723,0.00013233439,0.000077605924,0.00012162697],"category_scores_gemma":[0.00025140756,0.00010296933,0.00009002349,0.00023773577,0.00032296745,0.00010369074,0.000077102304,0.0007277994,7.822944e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010099152,0.002896328,0.9316877,0.00011801732,0.00062853855,0.000027674723,0.0006394167,0.0027891141,0.01642759,0.000007968053,0.0003213663,0.034357112],"study_design_scores_gemma":[0.021275477,0.0076638474,0.95561624,0.00023063572,0.0014671088,0.00009589494,0.00007315317,0.0109442305,0.0023129259,0.000052738014,0.00016036638,0.00010738021],"about_ca_topic_score_codex":0.000024238887,"about_ca_topic_score_gemma":0.0000046924138,"teacher_disagreement_score":0.03424973,"about_ca_system_score_codex":0.00003218667,"about_ca_system_score_gemma":0.00013461735,"threshold_uncertainty_score":0.41989675},"labels":[],"label_agreement":null},{"id":"W2022326153","doi":"10.1177/0091270003261496","title":"Effect of St. John's Wort on the Pharmacokinetics of Theophylline in Healthy Volunteers","year":2003,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Natural Compound Pharmacology Studies","field":"Agricultural and Biological Sciences","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Theophylline; Pharmacokinetics; Urine; Crossover study; Hypericum perforatum; Pharmacology; Medicine; Oral administration; Plasma concentration; Internal medicine","score_opus":0.052939215698079654,"score_gpt":0.4047689388473475,"score_spread":0.35182972314926786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022326153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848695,0.0014010726,8.96456e-7,0.010668661,0.002154006,0.00039338897,0.000013079341,0.000004805544,0.0004946373],"genre_scores_gemma":[0.99343216,0.002454991,0.000014568458,0.0034686201,0.00058734283,0.0000041271524,7.085443e-7,0.000001990833,0.000035473622],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99209505,0.0055800914,0.0015436767,0.00014327685,0.00033189883,0.00030599086],"domain_scores_gemma":[0.9757343,0.022749368,0.0011239351,0.00006775051,0.00022711827,0.00009753381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010421781,0.00019275282,0.0008464079,0.00003704313,0.000100994475,0.000003243445,0.0007609174,0.00012603392,0.0006949846],"category_scores_gemma":[0.0010336466,0.00005125281,0.0003331815,0.0004709144,0.0006669237,0.000043581957,0.00008472761,0.0012882847,0.0000057037732],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.074607596,0.003363373,0.087756634,0.00016945532,0.0021327927,0.000108840526,0.000514397,0.0024795097,0.64288646,0.0011425334,0.11853063,0.06630778],"study_design_scores_gemma":[0.027770206,0.1064642,0.26224673,0.0002868678,0.002944624,0.00026513942,0.0008881751,0.0007809635,0.37616336,0.0049748984,0.2161568,0.0010580379],"about_ca_topic_score_codex":0.00001968639,"about_ca_topic_score_gemma":0.00002447706,"teacher_disagreement_score":0.2667231,"about_ca_system_score_codex":0.000023643246,"about_ca_system_score_gemma":0.00004155663,"threshold_uncertainty_score":0.7609594},"labels":[],"label_agreement":null},{"id":"W2022811284","doi":"10.1177/0091270004268910","title":"Lack of Weight‐Based Dose Dependency and Intraindividual Variability of Omeprazole for CYP2C19 Phenotyping","year":2004,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Omeprazole; CYP2C19; Proton-pump inhibitor; Medicine; Interquartile range; Coefficient of variation; Pharmacology; Internal medicine; Chemistry; Metabolism; Chromatography","score_opus":0.34318280028713016,"score_gpt":0.5652223211458592,"score_spread":0.22203952085872908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022811284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98343974,0.0018917787,0.005333475,0.0036928032,0.004418072,0.00064907596,0.0001339039,0.000011176543,0.00042994597],"genre_scores_gemma":[0.99046195,0.0021022682,0.002279024,0.0037369158,0.00136406,0.000010352039,0.000003503619,0.000026164946,0.000015784855],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9942903,0.0021534557,0.0025634046,0.00024697877,0.00029232173,0.0004535359],"domain_scores_gemma":[0.9893062,0.007418753,0.0020540995,0.00020874744,0.0006363536,0.00037582565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013923359,0.00026450097,0.0011540535,0.00016169666,0.00014917184,0.000005390026,0.00074887957,0.000412302,0.00056678656],"category_scores_gemma":[0.0010636925,0.00019013684,0.00041580122,0.00022227774,0.0011351844,0.00011308017,0.00016197591,0.0014094658,0.0000045149477],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037194833,0.009973965,0.039219532,0.0010868886,0.0051538944,0.000063681866,0.0032132831,0.033178035,0.6887027,0.007536034,0.0069359094,0.16774127],"study_design_scores_gemma":[0.08770753,0.0040086606,0.052149322,0.00011918783,0.010261725,0.00022477817,0.00028244327,0.0085097095,0.66288185,0.08247456,0.090461485,0.00091877324],"about_ca_topic_score_codex":0.0000069088524,"about_ca_topic_score_gemma":0.0000025612183,"teacher_disagreement_score":0.1668225,"about_ca_system_score_codex":0.00003026439,"about_ca_system_score_gemma":0.0007204206,"threshold_uncertainty_score":0.7753555},"labels":[],"label_agreement":null},{"id":"W2023040232","doi":"10.1177/0091270010390806","title":"Bias Toward the Null Hypothesis in Pregnancy Drug Studies That Do Not Include Data on Medical Terminations of Pregnancy: The Folic Acid Antagonists","year":2011,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pregnancy and preeclampsia studies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Pregnancy; Odds ratio; Medicine; Confidence interval; Obstetrics; Neural tube; Internal medicine; Biology","score_opus":0.48740391772190744,"score_gpt":0.4917224524585324,"score_spread":0.004318534736624968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023040232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7300119,0.081053995,0.000047586153,0.17865178,0.0044023534,0.0017073075,0.000074884236,0.00003244449,0.004017738],"genre_scores_gemma":[0.92784417,0.066554315,0.00012244037,0.0047749863,0.00054950896,0.000026190819,0.0000011667472,0.000020485679,0.00010674074],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9941549,0.0025648905,0.0018383366,0.00026318463,0.00080792414,0.0003708114],"domain_scores_gemma":[0.9805746,0.016715355,0.0014138325,0.00089309097,0.0002505887,0.00015250228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0070328196,0.0002590491,0.0011493489,0.00011751402,0.00022496788,0.0000070089054,0.0021145032,0.0001735958,0.00022098958],"category_scores_gemma":[0.0071639633,0.00010650915,0.00030113195,0.00025491076,0.001816793,0.00015892956,0.0009824993,0.0016928338,0.000014105485],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02057829,0.010304004,0.22820467,0.00133275,0.013877618,0.0021220178,0.14602819,0.000017259914,0.0010796798,0.0015544398,0.13753377,0.43736732],"study_design_scores_gemma":[0.027172966,0.0059030275,0.8493152,0.020181958,0.009584303,0.001684335,0.012491084,0.00032832025,0.0363812,0.019367484,0.016752314,0.0008377637],"about_ca_topic_score_codex":0.000019954785,"about_ca_topic_score_gemma":0.00007364226,"teacher_disagreement_score":0.62111056,"about_ca_system_score_codex":0.000037136884,"about_ca_system_score_gemma":0.00042209312,"threshold_uncertainty_score":0.85764503},"labels":[],"label_agreement":null},{"id":"W2030694526","doi":"10.1177/0091270007301799","title":"Pharmacological Risk Factors for Amphotericin B Nephrotoxicity in Children","year":2007,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation; University of British Columbia; University of Toronto; BC Children's Hospital","funders":"","keywords":"Emergency department; Medicine; Pediatric emergency medicine; Sick child; Columbia university; Family medicine; Pediatrics; Emergency physician; Psychiatry; Media studies","score_opus":0.07610468210957791,"score_gpt":0.4671582270183429,"score_spread":0.391053544908765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030694526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945237,0.00025848873,0.0024233877,0.000849425,0.0009552791,0.00084927207,0.000010547768,0.000011216584,0.00011865108],"genre_scores_gemma":[0.9937826,0.0008972347,0.00041578693,0.0033126376,0.0015107801,0.000002334294,0.0000018230924,0.000012683863,0.00006412348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967645,0.0006375816,0.001760141,0.00017186963,0.00025645486,0.00040945248],"domain_scores_gemma":[0.9929857,0.005534942,0.00085116806,0.00012540961,0.0002193565,0.00028341994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010729752,0.00016010333,0.0008405513,0.000099948025,0.000086783424,0.000004096039,0.00029370878,0.00021869308,0.00035860148],"category_scores_gemma":[0.0018736066,0.00008671543,0.0005855679,0.00019547432,0.00041230765,0.000071157854,0.000048333237,0.0013828523,0.0000068214363],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017396696,0.0010692932,0.9495981,0.000010795842,0.00042578133,0.000035416095,0.00010192188,0.00003006897,0.020777991,0.0000049055657,0.006784548,0.0037645157],"study_design_scores_gemma":[0.0074738003,0.002098546,0.97669107,0.000012475436,0.0008398159,0.000069454865,0.00011861229,0.00009175058,0.010728201,0.00021205966,0.0015767089,0.000087517015],"about_ca_topic_score_codex":0.000026893544,"about_ca_topic_score_gemma":0.000018914494,"teacher_disagreement_score":0.027092991,"about_ca_system_score_codex":0.000080932354,"about_ca_system_score_gemma":0.00019072837,"threshold_uncertainty_score":0.6007882},"labels":[],"label_agreement":null},{"id":"W2032322018","doi":"10.1177/0091270008319708","title":"Acyclovir Bioavailability in Patients With Acute Myelogenous Leukemia Treated With Daunorubicin and Cytarabine","year":2008,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"Wellcome Trust","keywords":"Medicine; Gerontology; Library science; Family medicine","score_opus":0.030747347746441875,"score_gpt":0.353929433316853,"score_spread":0.3231820855704111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032322018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972173,0.000107966334,0.000052441646,0.0017123113,0.000120824385,0.0005750486,0.000006320512,0.00001186898,0.00019592016],"genre_scores_gemma":[0.9963911,0.001048899,0.00045921103,0.0016017109,0.0002942879,0.000003829838,0.0000042028173,0.000027366446,0.00016937368],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969425,0.00073265063,0.0011433798,0.0002337771,0.0005296085,0.00041804125],"domain_scores_gemma":[0.9965637,0.0018086134,0.00052991405,0.00025021765,0.00047588654,0.00037172495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017641482,0.00021634268,0.0009762016,0.00016167619,0.00009593523,0.000004225227,0.00027201703,0.00017042483,0.00014782314],"category_scores_gemma":[0.00029218826,0.00010181469,0.000080887694,0.00038180692,0.0014742562,0.00011594856,0.00009618221,0.0012666036,0.000013628041],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07087676,0.0010356988,0.9176881,0.000024773299,0.0009090435,0.0018887279,0.00025977692,0.00007590245,0.001418984,7.6868474e-7,0.0037305108,0.0020909954],"study_design_scores_gemma":[0.041697465,0.011697853,0.94139373,0.00004836737,0.00082032505,0.0023202975,0.000032433214,0.00029077975,0.0009872521,0.000010164954,0.000578436,0.00012292169],"about_ca_topic_score_codex":0.000096183416,"about_ca_topic_score_gemma":0.000015957554,"teacher_disagreement_score":0.029179301,"about_ca_system_score_codex":0.00046800272,"about_ca_system_score_gemma":0.0017649252,"threshold_uncertainty_score":0.5502833},"labels":[],"label_agreement":null},{"id":"W2032426985","doi":"10.1177/0091270003254800","title":"From Bench to Bedside: Utilization of an In Vitro Model to Predict Potential Drug‐Drug Interactions in the Kidney: The Digoxin‐Mifepristone Example","year":2003,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Mifepristone; Digoxin; Pharmacology; P-glycoprotein; Drug; Medicine; Kidney; Drug interaction; Internal medicine; Biology; Drug resistance; Multiple drug resistance; Pregnancy","score_opus":0.08950686802518415,"score_gpt":0.4324385615157118,"score_spread":0.34293169349052766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032426985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9703929,0.000095467316,0.0076714302,0.019485753,0.0015232876,0.0005707676,0.00002326384,0.0000055561045,0.00023157177],"genre_scores_gemma":[0.98926175,0.00016024614,0.001198073,0.008621898,0.0005550139,0.000011603252,0.000010319971,0.000015571355,0.00016553697],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966772,0.0011174894,0.0014059904,0.00016772361,0.00039530007,0.00023627681],"domain_scores_gemma":[0.9979845,0.00092418527,0.00040014702,0.00027813407,0.00016673896,0.00024628144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004521571,0.00013574735,0.00054980983,0.00014986406,0.00007321215,0.000007381072,0.0004696773,0.00005542127,0.00019809858],"category_scores_gemma":[0.00039955435,0.000067940644,0.00017427006,0.00035425645,0.00012810627,0.000106389656,0.00003030537,0.0009434083,0.000004741237],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040769905,0.009056553,0.0072654285,0.00008144912,0.00074265315,0.00042702846,0.03866286,0.07323942,0.74194145,0.00041985538,0.07594401,0.011449368],"study_design_scores_gemma":[0.05970645,0.004325419,0.23968291,0.0010579613,0.007648713,0.0007132338,0.03193,0.11055674,0.41062003,0.038541105,0.09386586,0.0013515651],"about_ca_topic_score_codex":0.00023745338,"about_ca_topic_score_gemma":0.00032709874,"teacher_disagreement_score":0.33132142,"about_ca_system_score_codex":0.000044454035,"about_ca_system_score_gemma":0.0003243911,"threshold_uncertainty_score":0.4098692},"labels":[],"label_agreement":null},{"id":"W2037103488","doi":"10.1177/00912700222011526","title":"Valuing Knowledge and the Knowledge of Values: Understanding Guideline‐ Incongruent Prescribing","year":2002,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes","funders":"","keywords":"Guideline; Medicine; Psychology; Pathology","score_opus":0.7244596182812622,"score_gpt":0.6264683863405677,"score_spread":0.09799123194069448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037103488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81398886,0.06841153,0.0015739931,0.065192774,0.021867253,0.001822702,0.000040884643,0.0000769261,0.027025072],"genre_scores_gemma":[0.97693795,0.012553679,0.00008686259,0.00648079,0.003305939,0.000007691383,8.343338e-7,0.000029010082,0.0005972405],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98592824,0.009562904,0.0033661493,0.00025521748,0.00024535795,0.00064214336],"domain_scores_gemma":[0.97889346,0.018042661,0.0016166375,0.00024141542,0.0005918716,0.0006139603],"candidate_categories":["sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.023143813,0.00031748408,0.0011455688,0.0001530419,0.0006087126,0.000017302922,0.0009886492,0.0006473575,0.0021517205],"category_scores_gemma":[0.0017142855,0.00018016121,0.00041309354,0.0003627969,0.0028400742,0.00020250388,0.00039379697,0.005100779,0.000046467678],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021965507,0.005853743,0.0143409595,0.0008693045,0.0063241348,0.0001622172,0.031757776,0.0030623889,0.016761301,0.022647608,0.7843256,0.091929466],"study_design_scores_gemma":[0.053254873,0.0022469203,0.0016180092,0.00036814966,0.0076176114,0.0011396017,0.0066205394,0.16683593,0.009031418,0.02247534,0.7279127,0.00087888737],"about_ca_topic_score_codex":0.000012376478,"about_ca_topic_score_gemma":0.00000807322,"teacher_disagreement_score":0.16377355,"about_ca_system_score_codex":0.00012972187,"about_ca_system_score_gemma":0.00024712348,"threshold_uncertainty_score":0.99987364},"labels":[],"label_agreement":null},{"id":"W2037155442","doi":"10.1177/0091270010387604","title":"Population Pharmacokinetic Modeling of Ziprasidone in Patients With Schizophrenia From the CATIE Study","year":2011,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baycrest Hospital; Centre for Addiction and Mental Health; University of Toronto","funders":"National Institute of Mental Health; Canadian Institutes of Health Research","keywords":"Ziprasidone; Medicine; Population; Pollock; Family medicine; Library science; Psychiatry; Schizophrenia (object-oriented programming); Antipsychotic; Art; Art history","score_opus":0.10473143568896107,"score_gpt":0.4085082857155987,"score_spread":0.3037768500266377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037155442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99787104,0.00025089117,0.00004488523,0.00069576775,0.00037569995,0.00071859907,0.0000051109173,0.0000041788185,0.00003385338],"genre_scores_gemma":[0.99862623,0.0001301086,0.00056639593,0.00027324425,0.00037533714,0.0000061158,0.0000040250748,0.000014336712,0.0000041894855],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99703395,0.0010246539,0.00116269,0.000120506345,0.00046743292,0.0001907562],"domain_scores_gemma":[0.9977661,0.0010073881,0.00057075045,0.00019800918,0.00031064442,0.00014713306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017868674,0.00012542192,0.00056616287,0.00008928817,0.000046878347,0.000002893005,0.000284553,0.000052016418,0.00033173908],"category_scores_gemma":[0.00023061766,0.000054920893,0.00010686639,0.00019137072,0.00012577762,0.0000743778,0.00006174054,0.0007675226,0.000007723306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12875122,0.0039177975,0.85899425,0.000004857794,0.0007401494,0.000040720824,0.0004816006,0.00047016106,0.000048313243,0.0000035177743,0.00013126686,0.006416135],"study_design_scores_gemma":[0.036146674,0.004983078,0.95511836,0.00003854882,0.0010009691,0.0000069484317,0.00015281106,0.0020598604,0.000111416426,0.00032890722,0.000003361814,0.000049085145],"about_ca_topic_score_codex":0.0005513706,"about_ca_topic_score_gemma":0.00014347608,"teacher_disagreement_score":0.09612408,"about_ca_system_score_codex":0.000037005822,"about_ca_system_score_gemma":0.00019400215,"threshold_uncertainty_score":0.36323103},"labels":[],"label_agreement":null},{"id":"W2037845030","doi":"10.1177/0091270005280851","title":"Effect of a Triphasic Oral Contraceptive on Drug‐Metabolizing Enzyme Activity as Measured by the Validated Cooperstown 5+1 Cocktail","year":2005,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Pharmacology; CYP2C19; Dextromethorphan; Medicine; CYP3A; CYP1A2; Drug; CYP2C9; Bioequivalence; Pharmacokinetics; Crossover study; Drug metabolism; Dextrorphan; Mephenytoin; Paraxanthine; Active metabolite; Oral administration; Internal medicine; Cytochrome P450; Metabolism; Placebo","score_opus":0.14238138566770764,"score_gpt":0.5159168353209036,"score_spread":0.37353544965319596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037845030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9738362,0.007285194,0.0001327028,0.00951816,0.006535164,0.0010462173,0.0000944454,0.00003265966,0.0015192679],"genre_scores_gemma":[0.98041177,0.00472597,0.000029270097,0.011418335,0.0026180982,0.000024760067,0.000003564891,0.000052912328,0.00071530393],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9763479,0.019639885,0.0021650796,0.00035599462,0.0006992768,0.0007918312],"domain_scores_gemma":[0.9799019,0.016156683,0.0023917898,0.00034747444,0.00062750565,0.00057463226],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.025175871,0.000546935,0.0018361844,0.00017034705,0.0004496689,0.00002216637,0.0015533095,0.00048577238,0.0022198798],"category_scores_gemma":[0.0015926261,0.00030058387,0.0008108456,0.0004869397,0.0014431736,0.00020121004,0.00018903083,0.0043136664,0.0001654668],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041177414,0.0019790167,0.00033490983,0.000028835808,0.0024135343,0.000039184295,0.0008155364,0.0035116766,0.60115,0.00006587391,0.16009964,0.1883844],"study_design_scores_gemma":[0.016424863,0.0018697518,0.00028756796,0.00001502309,0.0031618024,0.00011284568,0.000057901576,0.0017083507,0.61835843,0.0000490542,0.3577215,0.00023288206],"about_ca_topic_score_codex":0.00002617079,"about_ca_topic_score_gemma":0.0000061406995,"teacher_disagreement_score":0.19762185,"about_ca_system_score_codex":0.0000809085,"about_ca_system_score_gemma":0.0004267223,"threshold_uncertainty_score":0.9999446},"labels":[],"label_agreement":null},{"id":"W2038572124","doi":"10.1177/0091270011422815","title":"Disposition of Atorvastatin, Rosuvastatin, and Simvastatin in Oatp1b2‐/‐ Mice and Intraindividual Variability in Human Subjects","year":2011,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Lawson Health Research Institute; London Health Sciences Centre","funders":"Canadian Institutes of Health Research","keywords":"Rosuvastatin; Simvastatin; Atorvastatin; Statin; Context (archaeology); Medicine; Pharmacokinetics; Pharmacology; Crossover study; Internal medicine; HMG-CoA reductase; Bioavailability; Endocrinology; Chemistry; Placebo; Biology; Biochemistry; Pathology; Reductase; Enzyme","score_opus":0.06669206091737347,"score_gpt":0.3963727576278466,"score_spread":0.3296806967104731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038572124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99821466,0.00013962547,0.00045342403,0.000495937,0.00025341017,0.00024993627,0.000007748312,0.0000034136735,0.00018186124],"genre_scores_gemma":[0.9976613,0.0003147396,0.0014792528,0.0004065486,0.00011339866,0.0000019979911,0.0000019850509,0.000010144492,0.000010659495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99721205,0.00087740534,0.0014164147,0.00013410003,0.00017146568,0.00018858032],"domain_scores_gemma":[0.9977773,0.0013239017,0.0005716823,0.00007634071,0.000113749695,0.00013703282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0069068675,0.00011367299,0.0006457018,0.00012231954,0.000028849901,0.0000023269833,0.00010294434,0.00010287394,0.000108407265],"category_scores_gemma":[0.00024495542,0.00007482708,0.00006723138,0.00013948565,0.00043183766,0.00008074616,0.000028532293,0.00064769894,3.3620253e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016132424,0.0036567014,0.73548996,0.00063272344,0.00037034607,0.0006158547,0.01678401,0.000020006903,0.20245908,0.0010659518,0.0003444442,0.022428505],"study_design_scores_gemma":[0.007932271,0.0016037134,0.97041315,0.00015027357,0.0003416629,0.000102018465,0.0007808705,0.000088064146,0.012947967,0.0055092205,0.00003799563,0.00009276673],"about_ca_topic_score_codex":0.00004460902,"about_ca_topic_score_gemma":0.0001017993,"teacher_disagreement_score":0.23492323,"about_ca_system_score_codex":0.000016808706,"about_ca_system_score_gemma":0.000113136106,"threshold_uncertainty_score":0.305136},"labels":[],"label_agreement":null},{"id":"W2039223287","doi":"10.1177/00912700122012751","title":"Pharmacokinetics of Gemtuzumab Ozogamicin, an Antibody‐Targeted Chemotherapy Agent for the Treatment of Patients with Acute Myeloid Leukemia in First Relapse","year":2001,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":156,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Gemtuzumab ozogamicin; Calicheamicin; Pharmacokinetics; CD33; Medicine; Pharmacology; Myeloid leukemia; Radioimmunotherapy; Chemotherapy; Antibody; Internal medicine; Monoclonal antibody; Immunology; Stem cell; CD34","score_opus":0.05835483957096098,"score_gpt":0.43984683313773504,"score_spread":0.38149199356677405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039223287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99299955,0.00086095626,0.000116,0.0045010406,0.00051734294,0.0009042794,0.00004179218,0.0000036506522,0.000055401462],"genre_scores_gemma":[0.9488037,0.048621725,0.00033406232,0.0012310308,0.0006432848,0.000007650415,0.000018422852,0.00002451732,0.000315591],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973991,0.00032023073,0.0013852187,0.00014788544,0.00042910414,0.00031844652],"domain_scores_gemma":[0.9961575,0.0021191458,0.00084268634,0.00020459891,0.00051450724,0.000161541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011347445,0.00019381677,0.00088286423,0.00012057094,0.000073972915,0.0000031153525,0.00036247665,0.00010493156,0.00031776252],"category_scores_gemma":[0.00006056163,0.00008640705,0.00030936956,0.00022992647,0.00050533167,0.000057906662,0.000029896766,0.00043739888,0.0000019417294],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.35900226,0.013153767,0.47602326,0.00024780977,0.0076212035,0.00037050442,0.002507439,0.0032967476,0.050026283,0.000022240501,0.011101341,0.076627135],"study_design_scores_gemma":[0.055523172,0.03968332,0.7638049,0.000110086934,0.0023609716,0.000158648,0.00013843396,0.005319877,0.0200431,0.00007593126,0.112586446,0.00019507822],"about_ca_topic_score_codex":0.000081640406,"about_ca_topic_score_gemma":0.000024508445,"teacher_disagreement_score":0.3034791,"about_ca_system_score_codex":0.0001408529,"about_ca_system_score_gemma":0.00039534326,"threshold_uncertainty_score":0.35235775},"labels":[],"label_agreement":null},{"id":"W2040768488","doi":"10.1177/0091270005282628","title":"A Comparative Study of Sirolimus Tablet Versus Oral Solution for Prophylaxis of Acute Renal Allograft Rejection","year":2006,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Sirolimus; Pharmacokinetics; Medicine; Pharmacology; Urology; Antibacterial agent; Internal medicine; Antibiotics; Chemistry","score_opus":0.13577547502566623,"score_gpt":0.4886153690682973,"score_spread":0.35283989404263105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040768488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964027,0.00007664519,0.0014496954,0.00032471056,0.00094540353,0.0006822574,0.000019549705,0.0000040218006,0.00009504935],"genre_scores_gemma":[0.9982591,0.00012657067,0.0011049156,0.000065472545,0.00033183667,0.0000068553695,0.000007947728,0.000006585359,0.00009070037],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99787873,0.000431653,0.001244412,0.00008569839,0.00023138258,0.00012813219],"domain_scores_gemma":[0.99718803,0.0011967333,0.001075982,0.0000759295,0.0004057212,0.00005759246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010412782,0.0000987729,0.0007551559,0.00009027459,0.000046667905,0.0000017371053,0.000095258554,0.00007391346,0.00003112444],"category_scores_gemma":[0.00003501626,0.00005631437,0.00025463154,0.00013631706,0.00014831898,0.00005518157,0.000011538409,0.0002667583,9.12092e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5509592,0.029515613,0.101813376,0.00041801535,0.024007786,0.00024240436,0.0022034827,0.0044681127,0.27203465,0.00007475381,0.009859838,0.0044027343],"study_design_scores_gemma":[0.1986575,0.18237057,0.53742343,0.00019322085,0.025365153,0.00039822637,0.0006936729,0.0024826182,0.050264157,0.0005065258,0.0014005998,0.00024432107],"about_ca_topic_score_codex":0.00007181572,"about_ca_topic_score_gemma":0.000024195175,"teacher_disagreement_score":0.43561006,"about_ca_system_score_codex":0.000026309208,"about_ca_system_score_gemma":0.00010183015,"threshold_uncertainty_score":0.22964333},"labels":[],"label_agreement":null},{"id":"W2041832372","doi":"10.1177/0091270010397730","title":"Estimation of Onset of Analgesia From Simulated Data","year":2011,"lang":"en","type":"letter","venue":"The Journal of Clinical Pharmacology","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Pharmacokinetics; Acetaminophen; Analgesic; Clinical trial; Covariate; Clinical pharmacology; Pain relief; Anesthesia; Pharmacology; Internal medicine; Statistics","score_opus":0.4859159350533638,"score_gpt":0.5559504315765739,"score_spread":0.07003449652321009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041832372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8497986,0.001564219,0.0010201627,0.122574985,0.021046923,0.0012168199,0.0018197342,0.0000416608,0.0009168738],"genre_scores_gemma":[0.8175978,0.002645275,0.0003828306,0.1716004,0.007188598,0.0000032644298,0.00033823325,0.00006164254,0.00018194997],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9863115,0.0084155705,0.004007552,0.00036128864,0.00046806692,0.00043602544],"domain_scores_gemma":[0.98057216,0.011320849,0.006623879,0.0007471824,0.0005511649,0.00018474208],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.009475679,0.0004128964,0.0019613865,0.00030752685,0.0001311874,0.000005995153,0.0026104385,0.0027982309,0.0034807012],"category_scores_gemma":[0.0012152235,0.0003028181,0.0004932785,0.0003159512,0.0010582707,0.00024425905,0.00042758312,0.010563719,0.00006544643],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056062615,0.00083282,0.0009814353,0.00022524728,0.0037897867,0.0002738008,0.00038293272,0.003932776,0.0044714897,0.0000046749687,0.95502704,0.02447172],"study_design_scores_gemma":[0.009621296,0.0023036078,0.003236343,0.00026988215,0.01276019,0.00029713128,0.000052662886,0.045520645,0.061398305,0.0051061176,0.85872144,0.00071237015],"about_ca_topic_score_codex":0.00021953716,"about_ca_topic_score_gemma":0.000010475964,"teacher_disagreement_score":0.0963056,"about_ca_system_score_codex":0.00004939851,"about_ca_system_score_gemma":0.0006556149,"threshold_uncertainty_score":0.9999424},"labels":[],"label_agreement":null},{"id":"W2042687713","doi":"10.1177/0091270007304777","title":"Lack of Effect of Antacids on Single‐Dose Pharmacokinetics of Etoricoxib","year":2007,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"ASTER","funders":"","keywords":"Library science; Philosophy; Medicine; Computer science","score_opus":0.09905219942831701,"score_gpt":0.4897158995093864,"score_spread":0.3906637000810694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042687713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941799,0.0004446629,0.000095693074,0.00035049886,0.0036918821,0.0003368038,0.00000393318,0.000005407952,0.00089121755],"genre_scores_gemma":[0.9965447,0.0005789271,0.0000888616,0.00071961235,0.0020022723,5.6146115e-7,6.16045e-7,0.000020822403,0.000043581105],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9957778,0.0010138068,0.0023180835,0.000101454956,0.00052487233,0.00026401886],"domain_scores_gemma":[0.9885882,0.008470502,0.0020931037,0.00019120182,0.00041592008,0.00024107308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010847754,0.00017591832,0.0013938932,0.00019256245,0.0000205462,8.358744e-7,0.00027593915,0.00019909647,0.00020271845],"category_scores_gemma":[0.0012541428,0.0001005505,0.0004639893,0.00023358467,0.0004974814,0.000036015972,0.000050441402,0.000888602,0.0000064852165],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048162054,0.0016739556,0.03753814,0.0006279698,0.00078432425,0.00022236472,0.0002314657,0.00011116935,0.8860291,0.000026188383,0.008562564,0.016030688],"study_design_scores_gemma":[0.013531958,0.022078354,0.033652153,0.00019167786,0.0016874231,0.000119728655,0.000022319795,0.000106828265,0.9259732,0.000026647665,0.0025299808,0.00007977951],"about_ca_topic_score_codex":0.000002552946,"about_ca_topic_score_gemma":3.8130824e-7,"teacher_disagreement_score":0.039944038,"about_ca_system_score_codex":0.000033444074,"about_ca_system_score_gemma":0.00014481465,"threshold_uncertainty_score":0.41003302},"labels":[],"label_agreement":null},{"id":"W2044991833","doi":"10.1177/0091270007307572","title":"Pharmacokinetics of Lamivudine, Zidovudine, and Nevirapine Administered as a Fixed‐Dose Combination Formulation Versus Coadministration of the Individual Products","year":2007,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nuvo Pharmaceuticals (Canada); Patheon (Canada); BioPhage Pharma (Canada); Quebec Rehabilitation Research Network","funders":"","keywords":"Nevirapine; Fixed-dose combination; Lamivudine; Zidovudine; Pharmacokinetics; Bioequivalence; Pharmacology; Medicine; Crossover study; Viral load; Human immunodeficiency virus (HIV); Virology; Antiretroviral therapy; Viral disease","score_opus":0.11958774544962152,"score_gpt":0.4448748509857567,"score_spread":0.32528710553613516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044991833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870693,0.00029001388,0.00006101698,0.0102029815,0.0013159063,0.00053688086,0.0000049841888,0.0000049080018,0.0005139963],"genre_scores_gemma":[0.9977846,0.00053216855,0.0004903661,0.0003659115,0.00041121102,0.0000016647571,0.000010088776,0.000010479485,0.00039351542],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975698,0.0002325274,0.0015055002,0.00010749937,0.00043024067,0.00015446015],"domain_scores_gemma":[0.9964486,0.0013073136,0.0014866823,0.000128204,0.00052530546,0.00010392009],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030916736,0.00013300325,0.00048386925,0.00011172569,0.000060637136,0.000004459596,0.00016575737,0.00010073959,0.00006964818],"category_scores_gemma":[0.0007344729,0.00007545854,0.00012256784,0.000266619,0.00025599392,0.00010108753,0.00006626223,0.0003631822,0.0000019446134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13887155,0.017369175,0.3050473,0.0012987935,0.010845598,0.00026721315,0.008166286,0.00016205345,0.30205598,0.003332427,0.067672476,0.14491114],"study_design_scores_gemma":[0.051748455,0.008568069,0.6201425,0.00017639353,0.0049434975,0.00031849078,0.0004037982,0.0003710804,0.30086175,0.00044110027,0.011831191,0.00019363762],"about_ca_topic_score_codex":0.0000018068732,"about_ca_topic_score_gemma":0.0000035576293,"teacher_disagreement_score":0.31509525,"about_ca_system_score_codex":0.000027839476,"about_ca_system_score_gemma":0.00034791487,"threshold_uncertainty_score":0.30771098},"labels":[],"label_agreement":null},{"id":"W2045228294","doi":"10.1177/0091270009343694","title":"Population Pharmacokinetics of Perphenazine in Schizophrenia Patients From CATIE: Impact of Race and Smoking","year":2009,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baycrest Hospital; University of Toronto","funders":"National Institute of Mental Health; National Institute on Aging","keywords":"Perphenazine; Pharmacokinetics; Population; Antipsychotic; Medicine; Internal medicine; Schizophrenia (object-oriented programming); Psychiatry","score_opus":0.04552524627873902,"score_gpt":0.45026336011851115,"score_spread":0.4047381138397721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045228294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99740285,0.0009819613,0.000010208502,0.0011087527,0.00022842051,0.00022772087,0.00001532046,0.0000023769499,0.000022377282],"genre_scores_gemma":[0.9972827,0.0016330847,0.0005908384,0.00015707692,0.00031496867,5.5954484e-7,0.000008738316,0.0000072953753,0.0000047402586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997753,0.00047881991,0.001203188,0.000092211834,0.00031089323,0.00016187868],"domain_scores_gemma":[0.99760264,0.0010703297,0.00077837636,0.00010661441,0.00026097405,0.0001810514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001104916,0.00011099921,0.0007148073,0.00014497331,0.000019061894,0.0000022896481,0.00012796417,0.00008005,0.00015505424],"category_scores_gemma":[0.0004732239,0.00006379619,0.00018075372,0.00016185545,0.00011831963,0.000064856715,0.0000335306,0.0005420409,8.127109e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07248882,0.0016617085,0.8501582,0.000015864232,0.0005379411,0.000032718784,0.00015721603,0.00023816817,0.008108781,0.000006428831,0.00078200817,0.06581214],"study_design_scores_gemma":[0.02526197,0.003974227,0.96701485,0.00006596198,0.0004688959,0.00001768836,0.000010307247,0.0006332141,0.0018614802,0.0006379645,0.000010529272,0.000042891366],"about_ca_topic_score_codex":0.00014224582,"about_ca_topic_score_gemma":0.00000957235,"teacher_disagreement_score":0.11685667,"about_ca_system_score_codex":0.000057521207,"about_ca_system_score_gemma":0.00018008822,"threshold_uncertainty_score":0.26015332},"labels":[],"label_agreement":null},{"id":"W2046257359","doi":"10.1177/0091270005280297","title":"Aging and Clinical Pharmacology: Implications for Antidepressants","year":2005,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baycrest Hospital","funders":"National Institute of Mental Health","keywords":"Antidepressant; Medicine; Clinical trial; Depression (economics); Polypharmacy; Adverse effect; Clinical pharmacology; Pharmacokinetics; Intensive care medicine; Psychiatry; Pharmacology; Internal medicine; Anxiety","score_opus":0.32260002734407256,"score_gpt":0.6227360357906193,"score_spread":0.30013600844654675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046257359","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001500901,0.98131925,0.00014667178,0.008715335,0.0059793903,0.0021069425,0.000056454923,0.000033247434,0.00014177842],"genre_scores_gemma":[0.0005236815,0.9790644,0.0012359727,0.0033623858,0.015320114,0.000047607944,0.000017112949,0.000084626634,0.00034409136],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99197495,0.002270247,0.004611535,0.0004406525,0.000233492,0.00046909918],"domain_scores_gemma":[0.9783322,0.016483832,0.0038577227,0.00037487005,0.0003762101,0.00057514897],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0066495375,0.00047262863,0.00441846,0.00023797073,0.00018309905,0.0000147079945,0.00065531145,0.0007576444,0.00021872754],"category_scores_gemma":[0.0009689684,0.0002623564,0.0018154436,0.00017108503,0.00068976387,0.000117025585,0.00026906183,0.0026183978,0.000029632323],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077861483,0.0010651188,0.0014401595,0.0011020273,0.0031258748,0.000042382748,0.0000074326435,0.0000010373851,0.00001325449,0.0000053546737,0.13571323,0.8567055],"study_design_scores_gemma":[0.008387942,0.0013618134,0.0048310333,0.0017562103,0.03667245,0.0018684346,0.0000034259403,0.000020780555,0.0000053810613,0.000060592985,0.94483536,0.00019654924],"about_ca_topic_score_codex":0.0000010012675,"about_ca_topic_score_gemma":6.7702405e-7,"teacher_disagreement_score":0.856509,"about_ca_system_score_codex":0.0000807439,"about_ca_system_score_gemma":0.00089942303,"threshold_uncertainty_score":0.9999829},"labels":[],"label_agreement":null},{"id":"W2046814818","doi":"10.1177/0091270006288733","title":"Time‐Dependent Interaction Between Lopinavir/Ritonavir and Fexofenadine","year":2006,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Genome Canada; Ottawa Hospital","funders":"","keywords":"Lopinavir; Ritonavir; Fexofenadine; Lopinavir/ritonavir; Pharmacology; Pharmacokinetics; Medicine; Bioavailability; Chemistry; Internal medicine; Immunology; Viral load; Human immunodeficiency virus (HIV); Coronavirus disease 2019 (COVID-19)","score_opus":0.07987383447987405,"score_gpt":0.4649334033480723,"score_spread":0.38505956886819825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046814818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797104,0.00077545387,0.00008648518,0.016580671,0.0011655875,0.00023683853,0.0000039772194,0.000015319069,0.0014252714],"genre_scores_gemma":[0.9899866,0.00089568074,0.000067426234,0.0035110041,0.004892823,0.0000017792777,0.0000016666035,0.00001027596,0.0006327282],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9977848,0.0006188526,0.0010306382,0.00012385522,0.00022368504,0.00021815994],"domain_scores_gemma":[0.9959293,0.0031001957,0.00055994187,0.000071129136,0.0001627597,0.0001766621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024777213,0.00014009958,0.0007473562,0.000066766435,0.00010617597,0.000007538844,0.00013774663,0.000120624194,0.00033001503],"category_scores_gemma":[0.00026711813,0.000075502205,0.00017627547,0.00008707516,0.00042348463,0.000091439404,0.00010385187,0.0010270945,0.000045274195],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019319728,0.0043402337,0.13472605,0.00024937204,0.0043329024,0.001510032,0.00020916447,0.00044956946,0.29986537,0.00008281271,0.41519237,0.119722426],"study_design_scores_gemma":[0.020720249,0.010797591,0.80756295,0.00015766418,0.0055519445,0.0019424901,0.0001142839,0.0010236189,0.01996461,0.0018088132,0.12997754,0.00037826484],"about_ca_topic_score_codex":0.000021027514,"about_ca_topic_score_gemma":0.0000019289614,"teacher_disagreement_score":0.6728369,"about_ca_system_score_codex":0.000040488612,"about_ca_system_score_gemma":0.000055671022,"threshold_uncertainty_score":0.44622716},"labels":[],"label_agreement":null},{"id":"W2048164325","doi":"10.1177/0091270006293752","title":"NXY‐059 Does Not Affect Bleeding Time in Healthy Volunteers: A Randomized, Double‐Blind, Placebo‐Controlled, 3‐Period Crossover Phase I Study","year":2007,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Placebo; Crossover study; Medicine; Hemostasis; Anesthesia; Modified Rankin Scale; Double blind; Bleeding time; Stroke (engine); Randomized controlled trial; Platelet; Platelet aggregation; Cardiology; Internal medicine; Ischemia; Ischemic stroke; Pathology","score_opus":0.060906010070268454,"score_gpt":0.47021777025445977,"score_spread":0.4093117601841913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048164325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97666895,0.00047097204,0.0004885557,0.011570071,0.0033677293,0.0052417554,0.0000032577666,0.000030121337,0.0021585827],"genre_scores_gemma":[0.9858977,0.00039692305,0.00022619842,0.00795786,0.0037860565,0.00004828389,0.0000013738004,0.00004384888,0.0016417361],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99192506,0.0017611396,0.0043475977,0.00035830738,0.00082968984,0.00077823317],"domain_scores_gemma":[0.9869913,0.009992795,0.0019048759,0.0003173171,0.0003206927,0.00047303064],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.043495845,0.0003799032,0.0034630075,0.00047933628,0.00012716184,0.00002977187,0.00057758566,0.00023854196,0.0014240898],"category_scores_gemma":[0.0021699641,0.00019719785,0.0008970796,0.00033229866,0.0005830299,0.0001819848,0.00024162773,0.0022103188,0.000119935314],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9638556,0.0044849664,0.0017184647,0.00003841082,0.00329454,0.00095326913,0.0010888799,0.00006980005,0.005009521,0.0000040756804,0.018414622,0.0010678391],"study_design_scores_gemma":[0.9821368,0.0062899524,0.00039950036,0.00007243034,0.0042389017,0.00028679328,0.001199207,0.0014860848,0.0010249759,0.0000107807,0.0026658466,0.00018873082],"about_ca_topic_score_codex":0.00003593044,"about_ca_topic_score_gemma":0.000017251645,"teacher_disagreement_score":0.04132588,"about_ca_system_score_codex":0.00022553306,"about_ca_system_score_gemma":0.00031692573,"threshold_uncertainty_score":0.9994888},"labels":[],"label_agreement":null},{"id":"W2050102690","doi":"10.1177/0091270007299930","title":"Nuclear Receptors and the Regulation of Drug‐Metabolizing Enzymes and Drug Transporters: Implications for Interindividual Variability in Response to Drugs","year":2007,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":377,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"National Institute of General Medical Sciences","keywords":"Drug; Pharmacology; Transporter; Drug response; Drug metabolism; Receptor; ATP-binding cassette transporter; Pharmacogenetics; Medicine; Biology; Internal medicine; Biochemistry; Gene","score_opus":0.0861631247075621,"score_gpt":0.4553976741284672,"score_spread":0.3692345494209051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050102690","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1104726,0.86745,0.0010786698,0.0151231885,0.002031945,0.003694177,0.000070691254,0.000014009434,0.00006470343],"genre_scores_gemma":[0.067090526,0.93045676,0.001143129,0.00063027936,0.0005176325,0.000020961419,0.0000061934074,0.000036713776,0.00009781157],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946471,0.002059763,0.0026743116,0.00022044161,0.00018032154,0.00021810553],"domain_scores_gemma":[0.98817277,0.009989582,0.0012556878,0.00021800422,0.00018437536,0.00017960109],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.029012917,0.00022527899,0.0022267257,0.00024385226,0.000076325385,0.0000067408987,0.00029834517,0.00020720206,0.00004273281],"category_scores_gemma":[0.0005506654,0.00011556789,0.00051928277,0.00025369445,0.0006018435,0.000055102013,0.000036848134,0.0008554319,5.112086e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046213746,0.0004709133,0.0002780109,0.0043193046,0.0010324821,0.000005145656,0.0056060283,0.000004140425,0.00029310392,0.0011313554,0.0021278642,0.9385179],"study_design_scores_gemma":[0.008440458,0.0004080266,0.009912665,0.0030085861,0.0074457577,0.00011038141,0.00058480294,0.000008915169,0.000047335474,0.001091347,0.9687467,0.00019497973],"about_ca_topic_score_codex":0.0000045006277,"about_ca_topic_score_gemma":0.000006917827,"teacher_disagreement_score":0.9666189,"about_ca_system_score_codex":0.000038652634,"about_ca_system_score_gemma":0.00027509025,"threshold_uncertainty_score":0.99983555},"labels":[],"label_agreement":null},{"id":"W2050487849","doi":"10.1177/0091270004264164","title":"Absence of a Pharmacokinetic Interaction between Etanercept and Warfarin","year":2004,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Etanercept; Medicine; Pharmacokinetics; Warfarin; Pharmacodynamics; Rheumatoid arthritis; Pharmacology; Arthritis; Internal medicine","score_opus":0.08921902864956445,"score_gpt":0.47234528397580794,"score_spread":0.3831262553262435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050487849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99011815,0.0020065233,0.00029216337,0.0066329218,0.0005044126,0.00014342462,0.0000017515508,0.000005059468,0.00029558755],"genre_scores_gemma":[0.9688755,0.029591158,0.00025425106,0.00064094213,0.00059808284,8.4911414e-7,4.17673e-7,0.0000079117235,0.00003085275],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982721,0.0003470171,0.0009160779,0.00007402171,0.0002339087,0.00015683906],"domain_scores_gemma":[0.9979657,0.00111721,0.0004463995,0.00007635838,0.00019822584,0.00019613291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018142139,0.00007860587,0.00048993476,0.00008446878,0.000038126396,0.0000042050383,0.0001463954,0.000057939855,0.0003176157],"category_scores_gemma":[0.00030309102,0.000046754092,0.00012653526,0.00008950622,0.00046989316,0.00009039595,0.00005079456,0.0007609881,0.000010942817],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016483065,0.0016175446,0.09939138,0.00019108845,0.0025867838,0.00037569474,0.0023593178,0.00035700167,0.33854374,0.00014924964,0.0077379923,0.53020716],"study_design_scores_gemma":[0.06786223,0.018773144,0.73185736,0.0009988399,0.00079572323,0.0062755165,0.0010427412,0.00055008224,0.09575546,0.008188339,0.06750094,0.0003996204],"about_ca_topic_score_codex":0.00001801238,"about_ca_topic_score_gemma":0.0000016576137,"teacher_disagreement_score":0.63246596,"about_ca_system_score_codex":0.000016553628,"about_ca_system_score_gemma":0.00014541473,"threshold_uncertainty_score":0.3477669},"labels":[],"label_agreement":null},{"id":"W2051140296","doi":"10.1177/0091270005277937","title":"An Evaluation of an Optimal Sampling Strategy for Meropenem in Febrile Neutropenics","year":2005,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; St. Boniface Hospital","funders":"","keywords":"Sampling (signal processing); Meropenem; Nonparametric statistics; Population; Sampling design; Statistics; Computer science; Mathematics; Medicine; Biology","score_opus":0.2952749834255073,"score_gpt":0.5682998057018513,"score_spread":0.27302482227634406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051140296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99549234,0.00037552477,0.0011269494,0.0017520495,0.00057711225,0.0004970495,0.0000048228867,0.0000039464685,0.00017022536],"genre_scores_gemma":[0.99133253,0.0005339744,0.004869628,0.0011015342,0.002123531,0.0000012979339,0.0000055937194,0.000019375073,0.000012513957],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99707454,0.0007457717,0.0014894949,0.00012863209,0.0003466103,0.00021493409],"domain_scores_gemma":[0.99739057,0.00075156946,0.00074505794,0.00015420835,0.0007510646,0.000207543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010095596,0.00010934365,0.0005714489,0.00009576744,0.000039679424,0.0000075081634,0.00030103035,0.000108685446,0.00037976098],"category_scores_gemma":[0.00025426014,0.00007310375,0.00015951652,0.00010658476,0.0001416162,0.00015422759,0.000029110459,0.00055157184,0.0000032409573],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015871437,0.0037078562,0.001443727,0.0000434673,0.00033578568,0.0000119660035,0.00029864654,0.60477996,0.13010392,0.00006649323,0.002062128,0.24127464],"study_design_scores_gemma":[0.030649861,0.010340689,0.07448242,0.000064439526,0.003337015,0.00018417985,0.0003203875,0.8360059,0.03821826,0.00020760638,0.005993641,0.00019554756],"about_ca_topic_score_codex":0.0000051222655,"about_ca_topic_score_gemma":0.0000075380276,"teacher_disagreement_score":0.24107909,"about_ca_system_score_codex":0.000038498285,"about_ca_system_score_gemma":0.00044749762,"threshold_uncertainty_score":0.41581166},"labels":[],"label_agreement":null},{"id":"W2056298376","doi":"10.1177/0091270004273320","title":"CYP3A and P‐Glycoprotein Activity Induction With St. John's Wort in Healthy Volunteers From 6 Ethnic Populations","year":2005,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Clinical pharmacology; Family medicine; Library science; Traditional medicine; Pharmacology","score_opus":0.11155049814062448,"score_gpt":0.4478634263768943,"score_spread":0.3363129282362698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056298376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9734172,0.00062911096,0.0008385941,0.02393222,0.00080191175,0.00028609438,0.0000039515376,0.000009002979,0.00008190837],"genre_scores_gemma":[0.9939267,0.0012524611,0.0014156619,0.0019563895,0.0013220429,0.0000031763077,0.0000022893312,0.000012833575,0.000108421336],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983881,0.00033405732,0.00073675276,0.0001277341,0.00022375894,0.0001895716],"domain_scores_gemma":[0.99894446,0.00027584296,0.00039840152,0.00010229762,0.000090546295,0.00018844633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017411204,0.0001080024,0.00050795113,0.000102935766,0.000058302827,0.0000030923875,0.00009382008,0.00014614446,0.00022992436],"category_scores_gemma":[0.000051885596,0.000062550556,0.00008350424,0.0001755292,0.00018189456,0.00013115027,0.000012576159,0.00124122,0.000004014453],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21573913,0.006646001,0.2224781,0.00018070542,0.0016307193,0.00079082325,0.0032604514,0.0036007538,0.093046784,0.00018554446,0.009393385,0.44304758],"study_design_scores_gemma":[0.011613419,0.0023926506,0.9752715,0.00012902613,0.000683887,0.00016785243,0.00023643754,0.00054272875,0.0015149987,0.00041946326,0.0068991045,0.00012889312],"about_ca_topic_score_codex":0.00010361314,"about_ca_topic_score_gemma":0.0009559876,"teacher_disagreement_score":0.75279343,"about_ca_system_score_codex":0.000059504575,"about_ca_system_score_gemma":0.0002181788,"threshold_uncertainty_score":0.53925526},"labels":[],"label_agreement":null},{"id":"W2056389297","doi":"10.1177/0091270008319794","title":"Same Drug, Different Dosing: Differences in Dosing for Drugs Approved in the United States, Europe, and Japan","year":2008,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nutrasource","funders":"","keywords":"Dosing; Medicine; Drug; Pharmacology","score_opus":0.207105375854416,"score_gpt":0.4668571482132321,"score_spread":0.2597517723588161,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056389297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94379616,0.0018158073,0.000040178165,0.05320051,0.0005382354,0.00041901993,0.000002931568,0.0000047539534,0.00018242896],"genre_scores_gemma":[0.9560344,0.026412629,0.000057629186,0.016831128,0.00058076245,0.000006626926,0.0000020872826,0.000010743153,0.00006394307],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99657744,0.0016196774,0.0011170898,0.00013777213,0.00023928672,0.00030872718],"domain_scores_gemma":[0.9864813,0.012614772,0.00053071097,0.000090809386,0.00013691052,0.00014546697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038188149,0.00015539487,0.00070253556,0.000107029795,0.00015413293,0.000012941256,0.0002740042,0.00006421284,0.000035015608],"category_scores_gemma":[0.00089263637,0.000070174065,0.00010389159,0.00029407573,0.0005117822,0.00007849813,0.0000874068,0.0012752924,0.0000012540334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07164665,0.008863864,0.7314096,0.00045093254,0.0019471565,0.0006279082,0.04156795,0.00013550761,0.00858456,0.0002754468,0.0782185,0.056271892],"study_design_scores_gemma":[0.026375808,0.0028231393,0.7503771,0.00018811377,0.0013370295,0.00061758346,0.004682064,0.008825041,0.0005040649,0.0008321921,0.20315416,0.00028366546],"about_ca_topic_score_codex":0.000084464504,"about_ca_topic_score_gemma":0.00002277792,"teacher_disagreement_score":0.124935664,"about_ca_system_score_codex":0.0000227865,"about_ca_system_score_gemma":0.00006562198,"threshold_uncertainty_score":0.55405813},"labels":[],"label_agreement":null},{"id":"W2057686207","doi":"10.1177/0091270009350483","title":"The Safety of H<sub>2</sub>‐Blockers Use During Pregnancy","year":2009,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Pregnancy; Odds ratio; Confidence interval; Apgar score; Obstetrics; Confounding; Pediatrics; Birth weight; Internal medicine","score_opus":0.06089951179241699,"score_gpt":0.4245510688326612,"score_spread":0.3636515570402442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057686207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9659939,0.0032737746,0.00011318409,0.028641999,0.001384345,0.00027453035,0.0000024056303,0.0000110430365,0.00030485558],"genre_scores_gemma":[0.9716907,0.025166,0.00006923788,0.002150074,0.0007590103,0.000001039052,4.41181e-7,0.000008530857,0.00015492903],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99714535,0.0006193996,0.0015656435,0.000086275286,0.00032572876,0.00025760834],"domain_scores_gemma":[0.99521875,0.0028190664,0.0011862799,0.00024512966,0.0002615424,0.000269221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020786647,0.000110943285,0.00051623513,0.000055564265,0.00013512753,0.0000044338453,0.00032293593,0.000118417614,0.00005014967],"category_scores_gemma":[0.00210141,0.00005423079,0.00030513632,0.00014735461,0.0003980905,0.000115415154,0.00003454791,0.00093711633,0.000009457292],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033882856,0.0022754858,0.018078167,0.00014997335,0.0021089355,0.00044360163,0.0011502971,0.00013469126,0.57836086,0.00023264255,0.069942154,0.29324034],"study_design_scores_gemma":[0.017867243,0.0037456506,0.71741754,0.0016897148,0.0021460252,0.0019567066,0.0001549159,0.00012299762,0.23540182,0.00082078186,0.018492233,0.00018434416],"about_ca_topic_score_codex":7.9420084e-7,"about_ca_topic_score_gemma":6.160622e-7,"teacher_disagreement_score":0.6993394,"about_ca_system_score_codex":0.000032823376,"about_ca_system_score_gemma":0.00034720902,"threshold_uncertainty_score":0.40713564},"labels":[],"label_agreement":null},{"id":"W2061293585","doi":"10.1177/0091270003262951","title":"Rheumatoid Arthritis Does Not Reduce the Pharmacodynamic Response to Valsartan","year":2004,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Receptor Mechanisms and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Rheumatoid arthritis; Valsartan; Medicine; Pharmacodynamics; Inflammation; Pharmacology; Internal medicine; Arthritis; Pharmacokinetics; Tumor necrosis factor alpha; Endocrinology; Blood pressure","score_opus":0.02884002884328935,"score_gpt":0.38890449552481066,"score_spread":0.3600644666815213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061293585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97345316,0.0008645671,0.0018555816,0.01954825,0.0039961464,0.00022128645,0.000009166954,0.0000058767237,0.00004597605],"genre_scores_gemma":[0.98218405,0.0075725215,0.00044866116,0.0077529363,0.0018241658,0.0000062070053,0.000001197861,0.000024094987,0.00018616201],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99676025,0.0014035774,0.0010987822,0.00018935281,0.00024351125,0.0003045061],"domain_scores_gemma":[0.9981536,0.0006301705,0.00054194836,0.00023710787,0.00022001883,0.00021710483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006589528,0.00016605819,0.0003949088,0.000045213877,0.00019607582,0.0000202306,0.0007612038,0.00014489685,0.00031898476],"category_scores_gemma":[0.00069233734,0.00008202962,0.0003070671,0.000102739454,0.00021339908,0.000007927248,0.0001593046,0.0005718,0.000031182648],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007579868,0.00013567788,0.000020904348,0.0000019908584,0.0001829549,0.000020240781,0.00012734829,0.0021529768,0.9809726,0.00002856992,0.004075572,0.0047013247],"study_design_scores_gemma":[0.0035409057,0.0017799345,0.00031741871,0.00003330383,0.000071421506,0.00032325304,0.00018240056,0.000040984967,0.91890377,0.00063764805,0.0740079,0.0001610613],"about_ca_topic_score_codex":0.00000744871,"about_ca_topic_score_gemma":0.0000065724194,"teacher_disagreement_score":0.06993233,"about_ca_system_score_codex":0.000020840756,"about_ca_system_score_gemma":0.00030549124,"threshold_uncertainty_score":0.34926596},"labels":[],"label_agreement":null},{"id":"W2062442341","doi":"10.1177/0091270011420253","title":"The Seduction of Biomarkers in the Practice of Medicine and the Tyranny of Power in the Drug Approval Process: Lessons From Niacin","year":2011,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Psychological intervention; Diligence; Medicine; Due diligence; Intensive care medicine; Psychology; Psychiatry; Business; Social psychology","score_opus":0.08051743857832007,"score_gpt":0.4551217575855924,"score_spread":0.37460431900727237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062442341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88128185,0.0070986706,0.00003651841,0.10888256,0.00061113166,0.0007917938,0.0000027944177,0.0000013984582,0.0012932537],"genre_scores_gemma":[0.9892681,0.0069487137,0.00006732858,0.003118538,0.00057195546,0.0000100115685,4.155751e-7,0.000008302723,0.000006588833],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.99179435,0.0056291027,0.0016508787,0.00011301345,0.000636801,0.00017586729],"domain_scores_gemma":[0.98943686,0.008221469,0.0015790467,0.00036846427,0.0003422225,0.00005194516],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.039112445,0.00011446257,0.00077638665,0.00006785903,0.00007489229,0.0000026504258,0.00054210884,0.000095231335,0.000041009956],"category_scores_gemma":[0.003100027,0.000035486482,0.00024412092,0.0003324092,0.0019739717,0.000080236314,0.00004493159,0.0011276148,4.3307912e-7],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29903722,0.010729376,0.023391526,0.0012231683,0.01842766,0.000344954,0.394559,0.00014044748,0.013507793,0.0050507775,0.046837214,0.18675087],"study_design_scores_gemma":[0.11214826,0.009699477,0.44324002,0.0013159855,0.015608983,0.0034638692,0.34569883,0.0006303404,0.007204026,0.021685863,0.03891347,0.0003908673],"about_ca_topic_score_codex":0.0009502766,"about_ca_topic_score_gemma":0.000053009117,"teacher_disagreement_score":0.4198485,"about_ca_system_score_codex":0.000013046012,"about_ca_system_score_gemma":0.00028720067,"threshold_uncertainty_score":0.989436},"labels":[],"label_agreement":null},{"id":"W2064041298","doi":"10.1177/0091270005281350","title":"Pharmacokinetics of Sirolimus (Rapamycin) in Subjects With Mild to Moderate Hepatic Impairment","year":2005,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Sirolimus; Medicine; Pharmacokinetics; Trough level; Renal transplant; Internal medicine; Urology; Gastroenterology; Oral administration; Kidney; Transplantation","score_opus":0.06198061023468587,"score_gpt":0.4355212086474842,"score_spread":0.37354059841279835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064041298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913799,0.00025762696,0.00025021544,0.0071659284,0.00031082224,0.00039018304,0.0000042747033,0.00000423762,0.00023678657],"genre_scores_gemma":[0.9902448,0.0018261373,0.0014559667,0.0059702117,0.00037334615,0.0000035794417,0.0000010339493,0.000013826052,0.00011110568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997885,0.00031869914,0.0012108852,0.00009580439,0.00028276612,0.00020685775],"domain_scores_gemma":[0.9982467,0.000807707,0.00045282964,0.000098082106,0.00016517322,0.00022950627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010351879,0.00013137297,0.0006671111,0.0001379875,0.000020901276,0.0000025771358,0.00014062354,0.00005417087,0.00016314391],"category_scores_gemma":[0.000031602292,0.00006897786,0.00014724076,0.00018254385,0.00008634598,0.000051517807,0.000015921169,0.00040920445,0.000013271439],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19685397,0.01383386,0.58786684,0.00082323543,0.0052227587,0.0019475387,0.004405383,0.11541786,0.04275814,0.000037809277,0.004536805,0.026295796],"study_design_scores_gemma":[0.09258757,0.021791358,0.7561343,0.00087109907,0.0048271357,0.0014404092,0.00015744791,0.009050972,0.109640256,0.00012714778,0.0030336382,0.00033867653],"about_ca_topic_score_codex":0.000012400679,"about_ca_topic_score_gemma":0.000014050543,"teacher_disagreement_score":0.16826744,"about_ca_system_score_codex":0.000042329382,"about_ca_system_score_gemma":0.00015628102,"threshold_uncertainty_score":0.28128356},"labels":[],"label_agreement":null},{"id":"W2065604666","doi":"10.1177/0091270004265643","title":"Influence of Omeprazole on Bioavailability of Bismuth following Administration of a Triple Capsule of Bismuth Biskalcitrate, Metronidazole, and Tetracycline","year":2004,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; BioPhage Pharma (Canada)","funders":"","keywords":"Omeprazole; Cmax; Metronidazole; Bioavailability; Capsule; Tetracycline; Toxicity; Pharmacology; Bismuth; Chemistry; Pharmacokinetics; Medicine; Gastroenterology; Internal medicine; Antibiotics; Biochemistry; Biology","score_opus":0.04307213297367731,"score_gpt":0.4060488820230471,"score_spread":0.36297674904936983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065604666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99575615,0.0005051292,0.00005014307,0.00275202,0.0005083929,0.0003474905,0.000029440622,0.0000053028743,0.00004596121],"genre_scores_gemma":[0.99814713,0.00086296623,0.00040631063,0.00042889506,0.00012478605,0.000002123983,0.0000016627314,0.000013405435,0.000012718999],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99553305,0.00055829674,0.003103723,0.00018220357,0.0003734636,0.0002492499],"domain_scores_gemma":[0.99532044,0.0010442212,0.002573784,0.0002495044,0.0006523901,0.00015966344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038581889,0.00019319824,0.0015195358,0.00027602783,0.000035929217,0.0000013209096,0.00024865117,0.0002115724,0.000022507282],"category_scores_gemma":[0.0017948668,0.000127625,0.0003533768,0.000421136,0.0011655896,0.00011620193,0.00007967042,0.0008316784,0.0000012884744],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020319693,0.0047279275,0.29074755,0.00039092303,0.0036615185,0.00007186244,0.0008475897,0.0020640616,0.67550576,0.000031657597,0.0003104271,0.0013210012],"study_design_scores_gemma":[0.015307096,0.016979715,0.6351338,0.00028306528,0.0020495134,0.00010246008,0.00026044296,0.000034308712,0.32951435,0.00017175202,0.00007788843,0.00008562479],"about_ca_topic_score_codex":0.000041162282,"about_ca_topic_score_gemma":0.000011491848,"teacher_disagreement_score":0.34599143,"about_ca_system_score_codex":0.00003878261,"about_ca_system_score_gemma":0.00041285143,"threshold_uncertainty_score":0.5204396},"labels":[],"label_agreement":null},{"id":"W2067571642","doi":"10.1177/0091270008326716","title":"The Effects of Desvenlafaxine and Paroxetine on the Pharmacokinetics of the Cytochrome P450 2D6 Substrate Desipramine in Healthy Adults","year":2008,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Desipramine; Paroxetine; Pharmacokinetics; CYP2D6; Pharmacology; Medicine; Cytochrome P450; Internal medicine; Antidepressant","score_opus":0.1405376604974933,"score_gpt":0.4776603833222849,"score_spread":0.3371227228247916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067571642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9719861,0.009622892,0.000012182974,0.012838518,0.004213319,0.0010615422,0.000024400588,0.0000078012035,0.00023325064],"genre_scores_gemma":[0.93532556,0.055780962,0.000029271905,0.007643787,0.0010847375,0.000021914204,7.420123e-7,0.0000321824,0.000080869955],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9891096,0.0067888484,0.0026772758,0.00025746317,0.00051707943,0.0006497716],"domain_scores_gemma":[0.97336495,0.0231592,0.0023486651,0.00038284695,0.00042704362,0.00031731982],"candidate_categories":["sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.008712397,0.00037417782,0.0010235296,0.00011978066,0.00050143595,0.0000071853037,0.0015427084,0.00030395496,0.00015658281],"category_scores_gemma":[0.0016045792,0.00016731405,0.00038737434,0.0005443612,0.0027742253,0.00006289076,0.00030231226,0.0031554862,0.0000072674175],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10573781,0.0072743935,0.05362223,0.000743751,0.0032932577,0.00043613891,0.0044317776,0.005668362,0.7348544,0.0011943512,0.03779846,0.044945087],"study_design_scores_gemma":[0.040455773,0.00707307,0.40596357,0.00023986462,0.0026213012,0.00078927324,0.00026733679,0.004993979,0.46255717,0.0015854738,0.07288358,0.0005695877],"about_ca_topic_score_codex":0.0000186425,"about_ca_topic_score_gemma":0.000013130548,"teacher_disagreement_score":0.35234135,"about_ca_system_score_codex":0.000031976215,"about_ca_system_score_gemma":0.00040188854,"threshold_uncertainty_score":0.9999397},"labels":[],"label_agreement":null},{"id":"W2067746663","doi":"10.1177/0091270004271403","title":"Paradoxical Cyclosporine A Requirements in Pediatric Renal Transplants Receiving High‐Dose Steroids","year":2005,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Izaak Walton Killam Health Centre; Queen's University; Capital District Health Authority","funders":"","keywords":"Medicine; Pharmacology; Intensive care medicine","score_opus":0.08958645473415587,"score_gpt":0.4495713655283556,"score_spread":0.3599849107941997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067746663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99162996,0.0003961427,0.00013830468,0.00623666,0.0010373758,0.0002392514,0.0000061014953,0.000009554511,0.0003066254],"genre_scores_gemma":[0.98440444,0.00993594,0.00086964085,0.002290127,0.0022315972,0.0000028069662,0.00000461204,0.000015937258,0.00024489977],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99681914,0.000512163,0.0018271257,0.00014832853,0.00039251157,0.00030073704],"domain_scores_gemma":[0.9978992,0.0010706142,0.0005538063,0.00012115673,0.00008905149,0.00026620852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002055784,0.00016597578,0.00072026654,0.00016110505,0.00004427338,0.0000054750426,0.00021736286,0.00012875845,0.0004146431],"category_scores_gemma":[0.00007446253,0.00009721575,0.00024821612,0.00020247005,0.00008707748,0.00014253883,0.000016949842,0.00083179324,0.00004611768],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022528552,0.003294973,0.94246787,0.00013022994,0.00079080637,0.0019495031,0.00040098117,0.0006581161,0.0029235783,0.000023032135,0.0016044789,0.023227885],"study_design_scores_gemma":[0.023412326,0.0015349891,0.97064567,0.00013373616,0.0013187383,0.0007084152,0.000009705834,0.0001255714,0.00085107685,0.00009119489,0.0010678782,0.000100719044],"about_ca_topic_score_codex":0.0000085499405,"about_ca_topic_score_gemma":0.000012731393,"teacher_disagreement_score":0.028177785,"about_ca_system_score_codex":0.00005881368,"about_ca_system_score_gemma":0.00014578324,"threshold_uncertainty_score":0.4540051},"labels":[],"label_agreement":null},{"id":"W2067858710","doi":"10.1002/jcph.480","title":"Comparing pyridoxine and doxylamine succinate‐pyridoxine HCl for nausea and vomiting of pregnancy: A matched, controlled cohort study","year":2015,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Pyridoxine; Medicine; Vomiting; Metoclopramide; Nausea; Internal medicine; Anesthesia; Gastroenterology; Pharmacology","score_opus":0.14887125824406683,"score_gpt":0.4708826012822895,"score_spread":0.32201134303822265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067858710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98782134,0.0048536994,0.00046764992,0.003957671,0.0007836767,0.0018425897,0.000003836315,0.000012042079,0.00025749017],"genre_scores_gemma":[0.9968984,0.0012959164,0.00027498274,0.0006263629,0.0007044955,0.000024255869,0.0000016164207,0.000018147004,0.00015580686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99684596,0.0005763861,0.0018614694,0.00015875685,0.00031181547,0.00024562408],"domain_scores_gemma":[0.9941659,0.0032157013,0.0014393659,0.00016431665,0.0005711795,0.00044352323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008157664,0.00016633395,0.0017401595,0.00011138744,0.000058809776,0.000006466488,0.00017047465,0.00010449832,0.000038534392],"category_scores_gemma":[0.003377984,0.00009639014,0.00014653307,0.000101510566,0.00032681075,0.00010210076,0.00008918502,0.00054678094,0.0000010781102],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03514538,0.0021244474,0.9447084,0.00025742353,0.0024873067,0.000070195245,0.0014355653,0.00004170498,0.005483521,0.000027462484,0.004384478,0.0038340967],"study_design_scores_gemma":[0.2101957,0.013010671,0.75736123,0.0009831267,0.006662263,0.0008589111,0.0011842755,0.0055832746,0.002809029,0.00036860528,0.00077153405,0.0002113955],"about_ca_topic_score_codex":0.00001160745,"about_ca_topic_score_gemma":0.000006115555,"teacher_disagreement_score":0.1873472,"about_ca_system_score_codex":0.000026339969,"about_ca_system_score_gemma":0.00028204912,"threshold_uncertainty_score":0.40440065},"labels":[],"label_agreement":null},{"id":"W2069942679","doi":"10.1177/0091270008327538","title":"The Effect of Reporting Methods for Dosing Times on the Estimation of Pharmacokinetic Parameters of Escitalopram","year":2009,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of Mental Health","keywords":"NONMEM; Dosing; Escitalopram; Pharmacokinetics; Population; Medicine; Volume of distribution; Elimination rate constant; Anesthesia; Pharmacology; Internal medicine","score_opus":0.12579272282585838,"score_gpt":0.5792357211528095,"score_spread":0.4534429983269511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069942679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864157,0.00083380286,0.002133433,0.0091272015,0.00042788323,0.0008191356,0.0000017484423,0.000003363871,0.00023772045],"genre_scores_gemma":[0.992669,0.00054451596,0.006220079,0.00035748477,0.0001677309,0.0000064413875,6.654301e-7,0.000007899825,0.000026184865],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.994856,0.0021657257,0.0023976772,0.00008444813,0.0002971108,0.00019902845],"domain_scores_gemma":[0.96084356,0.034785993,0.0038166516,0.0001857551,0.0002735081,0.000094550276],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.020297771,0.000108124106,0.00076137914,0.00006385704,0.00008205955,0.0000037737748,0.00023266046,0.00005932325,0.000029976525],"category_scores_gemma":[0.011569929,0.00004104881,0.0004552803,0.0001403327,0.00041308632,0.000031905645,0.0000251809,0.0004989058,6.7360287e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032926086,0.00082544883,0.0048476164,0.00020793435,0.0020852573,0.000025363088,0.00019861064,0.0026778243,0.13751021,0.00008411833,0.004353172,0.81425834],"study_design_scores_gemma":[0.00921602,0.033026956,0.019482138,0.0003082531,0.002948046,0.00014670534,0.000057643905,0.020298291,0.9119986,0.0021170932,0.00033397652,0.00006623089],"about_ca_topic_score_codex":0.0000033986157,"about_ca_topic_score_gemma":1.2920802e-7,"teacher_disagreement_score":0.8141921,"about_ca_system_score_codex":0.000022116194,"about_ca_system_score_gemma":0.00012332856,"threshold_uncertainty_score":0.996756},"labels":[],"label_agreement":null},{"id":"W2071271954","doi":"10.1177/00912700122010005","title":"The Influence of Food on the Bioavailability of a Twice‐Daily Controlled Release Carbamazepine Formulation","year":2001,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CARE Canada","funders":"","keywords":"Bioavailability; Crossover study; Carbamazepine; Bioequivalence; Meal; Pharmacology; Medicine; Absorption (acoustics); Capsule; Internal medicine; Biology; Placebo","score_opus":0.07858251866896701,"score_gpt":0.4285742120667621,"score_spread":0.3499916933977951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071271954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9680221,0.00078874984,0.000018964036,0.029307464,0.00046831914,0.00086520606,0.000004788122,0.0000065000977,0.00051792583],"genre_scores_gemma":[0.99041873,0.0034654448,0.0000129293785,0.0055104024,0.000521484,0.000009913982,2.0762602e-7,0.00000734774,0.000053557862],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9955913,0.0017378023,0.0019080427,0.00011310879,0.0004111861,0.00023857392],"domain_scores_gemma":[0.97464067,0.022518408,0.0017620012,0.00023213224,0.0007149794,0.00013180808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008109354,0.00015289069,0.0010610678,0.000045528366,0.00016760078,0.0000037951902,0.00038700813,0.000108996435,0.00011541919],"category_scores_gemma":[0.0074812467,0.000054173648,0.00048283715,0.00023353886,0.0009323684,0.0000513234,0.00009254841,0.00092972064,0.0000047605986],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4711862,0.008086296,0.03416465,0.0002631857,0.009152304,0.00012221347,0.0009648802,0.006300657,0.4146399,0.0018584739,0.024684902,0.028576357],"study_design_scores_gemma":[0.09070699,0.0679267,0.7592956,0.00031814037,0.006943936,0.00024812197,0.00042390308,0.007360967,0.041070383,0.0077889278,0.017571885,0.00034448522],"about_ca_topic_score_codex":0.000011280067,"about_ca_topic_score_gemma":0.000005559854,"teacher_disagreement_score":0.7251309,"about_ca_system_score_codex":0.00003136469,"about_ca_system_score_gemma":0.00015251119,"threshold_uncertainty_score":0.89562917},"labels":[],"label_agreement":null},{"id":"W2072077675","doi":"10.1177/00912700222011283","title":"Serum Concentrations, Efficacy, and Safety of a New, Intravenously Administered Varicella Zoster Immune Globulin in Pregnant Women","year":2002,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Université de Montréal; B.C. Women's Hospital & Health Centre; British Columbia Centre of Excellence for Women's Health; University of Winnipeg; SickKids Foundation; Centre Hospitalier Universitaire Sainte-Justine; Hospital for Sick Children","funders":"","keywords":"Medicine; Chickenpox; Varicella zoster virus; Antibody; Virus; Immunology; Internal medicine","score_opus":0.06420611288494987,"score_gpt":0.39132936446859873,"score_spread":0.32712325158364886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072077675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927964,0.0015285298,0.000052515436,0.0037421656,0.0005794246,0.00035690443,0.0000050256363,0.0000044582143,0.00093456695],"genre_scores_gemma":[0.9927758,0.0053078528,0.00015639143,0.0008705063,0.0002909705,0.0000021023618,4.8653743e-7,0.00000908217,0.000586836],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976638,0.00045926575,0.0014358904,0.00009678903,0.00013121919,0.0002130342],"domain_scores_gemma":[0.9980153,0.0009881934,0.0005664715,0.00012392846,0.000087469736,0.00021863772],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012260849,0.00010829509,0.0006326123,0.000068156754,0.000043263197,0.000004705194,0.00010171059,0.000112240974,0.0013673675],"category_scores_gemma":[0.00017173843,0.000066464,0.000095210235,0.00013937768,0.0001876629,0.000046658086,0.000040934236,0.00048616002,0.00001546854],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033971574,0.019551877,0.10173693,0.00019179494,0.0045543993,0.0011209123,0.011119472,0.0002415015,0.0076982877,0.000087815344,0.012739824,0.8069856],"study_design_scores_gemma":[0.11638704,0.02337412,0.671468,0.0007773201,0.0026517971,0.0028318493,0.0006914159,0.0013315929,0.005457465,0.00039102606,0.17425455,0.00038377143],"about_ca_topic_score_codex":0.000019152372,"about_ca_topic_score_gemma":0.0000063625494,"teacher_disagreement_score":0.8066018,"about_ca_system_score_codex":0.00006343024,"about_ca_system_score_gemma":0.0001798497,"threshold_uncertainty_score":0.9995455},"labels":[],"label_agreement":null},{"id":"W2076382338","doi":"10.1177/0091270011413588","title":"Current Understanding of Drug Disposition in Kidney Disease","year":2012,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Kidney disease; Drug; Pharmacology; Disposition; Drug metabolism; Renal function; Population; Kidney; Pharmacokinetics; Parathyroid hormone; Disease; Internal medicine; Calcium","score_opus":0.33834513803193345,"score_gpt":0.5491011623739794,"score_spread":0.210756024342046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076382338","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011590227,0.99174607,0.000068723566,0.0016208017,0.0044759344,0.00077551894,0.000028334205,0.000006202581,0.000119376884],"genre_scores_gemma":[0.033926763,0.9625128,0.000010740065,0.0009034017,0.002588531,0.000008920779,0.0000068181794,0.000020618023,0.000021414537],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942209,0.0024086046,0.0025560416,0.00014829314,0.00033670518,0.00032943193],"domain_scores_gemma":[0.9919047,0.004983862,0.0021968326,0.00013268959,0.00010773566,0.00067421544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051232846,0.00028827443,0.0031588685,0.00022186902,0.00005477246,0.000003343993,0.00031523535,0.00016074169,0.00027240152],"category_scores_gemma":[0.0008757587,0.00014194763,0.0011100014,0.00027504287,0.00047254286,0.000073680996,0.00016439173,0.002241006,0.000012407261],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006864736,0.0071284133,0.0019707584,0.04682105,0.0035143166,0.0004255944,0.00024279048,0.000009909871,0.000032880485,0.00025039556,0.057529014,0.87521017],"study_design_scores_gemma":[0.0044003413,0.00068812165,0.0013451742,0.0140724955,0.024784084,0.00010278767,0.000026593169,0.00002862964,0.000005040804,0.00041662986,0.9539184,0.00021170739],"about_ca_topic_score_codex":0.0000015053879,"about_ca_topic_score_gemma":4.7730396e-7,"teacher_disagreement_score":0.89638937,"about_ca_system_score_codex":0.0002214901,"about_ca_system_score_gemma":0.00063939905,"threshold_uncertainty_score":0.97361803},"labels":[],"label_agreement":null},{"id":"W2076424992","doi":"10.1177/009127002401102614","title":"Trends of Medication Errors in Hospitalized Children","year":2002,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Patient Safety and Medication Errors","field":"Health Professions","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medication error; Medicine; Emergency medicine; Patient safety; Pediatrics; Medical emergency; Health care","score_opus":0.16890927089005242,"score_gpt":0.5417259858060803,"score_spread":0.3728167149160279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076424992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9604543,0.00029231983,0.00010158321,0.03229705,0.0029550472,0.00018238784,0.0000039078636,0.0000067560427,0.0037066771],"genre_scores_gemma":[0.99322736,0.0021560823,0.00008573712,0.0033064755,0.0006901747,0.0000055581813,0.0000021479316,0.0000072898792,0.0005191903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952869,0.0018614013,0.0022825464,0.00007699318,0.0002805901,0.00021159562],"domain_scores_gemma":[0.9951671,0.0018814972,0.0025202916,0.0001151953,0.00016267346,0.00015326055],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005288012,0.00007536622,0.00047328358,0.0001983987,0.0000845828,1.17420726e-7,0.0003935334,0.00019286512,0.004346595],"category_scores_gemma":[0.0010482996,0.00004621306,0.00013602938,0.0002927685,0.00027689635,0.00008299219,0.000046129626,0.0012139038,0.000059645165],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001156428,0.0011998565,0.7559089,0.000032024414,0.00024051464,0.0000043150576,0.0051498488,0.00015594458,0.00029892055,0.0001615965,0.22061403,0.015077603],"study_design_scores_gemma":[0.0056600664,0.0004023989,0.9704166,0.000064171145,0.00014968116,0.000006551267,0.00021520867,0.0003669078,0.000031341136,0.00018631677,0.02245067,0.00005010589],"about_ca_topic_score_codex":0.000014016741,"about_ca_topic_score_gemma":0.0000062288473,"teacher_disagreement_score":0.21450767,"about_ca_system_score_codex":0.000033180513,"about_ca_system_score_gemma":0.000108345375,"threshold_uncertainty_score":0.99656355},"labels":[],"label_agreement":null},{"id":"W2077031675","doi":"10.1177/0091270006296763","title":"Pharmacokinetics of Saquinavir With Atazanavir or Low‐Dose Ritonavir Administered Once Daily (ASPIRE I) or Twice Daily (ASPIRE II) in Seronegative Volunteers","year":2007,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity Western University","funders":"","keywords":"Saquinavir; Cmin; Pharmacokinetics; Ritonavir; Atazanavir; Cmax; Dosing; Pharmacology; Medicine; Crossover study; Adverse effect; Human immunodeficiency virus (HIV); Viral load; Antiretroviral therapy; Virology","score_opus":0.07292333696626545,"score_gpt":0.4390793595960441,"score_spread":0.36615602262977864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077031675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98827094,0.00048824472,0.000097205004,0.0084507875,0.0009878254,0.0009059075,0.000020061863,0.000022498149,0.0007565278],"genre_scores_gemma":[0.9857744,0.0011662735,0.0023001703,0.0033388413,0.00083964516,0.000010764438,0.0000101364385,0.00005846803,0.0065012868],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99444354,0.00069671386,0.0030502437,0.00036168113,0.00077362556,0.00067419355],"domain_scores_gemma":[0.9938257,0.0030944252,0.0016600142,0.00032299184,0.00055085524,0.0005460651],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004211073,0.00045572827,0.0016410435,0.0002946746,0.00014021758,0.000009055523,0.0006141607,0.00025798075,0.0007417569],"category_scores_gemma":[0.0004888442,0.00024102848,0.000282914,0.0007593862,0.00086152105,0.00023485287,0.00020833666,0.0016104331,0.000029850167],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5868197,0.017651709,0.14668001,0.0008252373,0.0076039247,0.018098012,0.014740113,0.0004843376,0.050873946,0.000029337787,0.045673903,0.11051974],"study_design_scores_gemma":[0.21683279,0.06727467,0.45071352,0.0043071094,0.012077791,0.0057756053,0.009535761,0.0018243225,0.10823473,0.00009300538,0.12141362,0.0019170853],"about_ca_topic_score_codex":0.000030512248,"about_ca_topic_score_gemma":0.00021261627,"teacher_disagreement_score":0.36998692,"about_ca_system_score_codex":0.00021763235,"about_ca_system_score_gemma":0.0013496651,"threshold_uncertainty_score":0.9828856},"labels":[],"label_agreement":null},{"id":"W2077165819","doi":"10.1177/0091270011402500","title":"Optimizing Drug Development and Use in Patients With Kidney Disease","year":2011,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Kidney disease; Intensive care medicine; Population; Public health; Disease; Dosing; Drug development; Health care; Clearance; Drug; Internal medicine; Environmental health; Pharmacology; Pathology; Economic growth","score_opus":0.15558054303457677,"score_gpt":0.35719692523095314,"score_spread":0.20161638219637637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077165819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99672884,0.00026486814,0.00007335427,0.0013292991,0.0006295471,0.000118561795,0.000015233914,0.0000027774965,0.00083749363],"genre_scores_gemma":[0.9891392,0.00042074738,0.0012469144,0.008975036,0.00014956357,0.0000018986232,8.9298675e-7,0.000012158388,0.000053581334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830323,0.00009618587,0.0012411738,0.00012600243,0.000025327963,0.0002080707],"domain_scores_gemma":[0.9984085,0.00035093704,0.00069595705,0.00008822651,0.00003803373,0.00041834026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018301257,0.000100444864,0.00041673606,0.00011625799,0.000044957418,0.0000135988175,0.00023015606,0.00004070314,0.00031052355],"category_scores_gemma":[0.00021470398,0.00007213095,0.000058371308,0.000066900895,0.00015016526,0.00023321222,0.000080246595,0.0004048853,0.000033127253],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024136654,0.00056724134,0.9883336,0.000012434975,0.00016688777,0.000014469156,0.00091462774,0.0000633423,6.9025435e-7,0.002112572,0.0042323056,0.0011682104],"study_design_scores_gemma":[0.005481275,0.00015739346,0.92593676,0.000016629168,0.00004495912,0.0000021802418,0.000012396351,0.00046429934,0.00003215963,0.0026157945,0.06507865,0.00015748561],"about_ca_topic_score_codex":0.0000149681655,"about_ca_topic_score_gemma":0.0000046665773,"teacher_disagreement_score":0.062396783,"about_ca_system_score_codex":0.00003235199,"about_ca_system_score_gemma":0.00009973307,"threshold_uncertainty_score":0.3400015},"labels":[],"label_agreement":null},{"id":"W2077817920","doi":"10.1177/0091270008319792","title":"Pharmacokinetic Interaction Between Efavirenz and Carbamazepine After Multiple‐Dose Administration in Healthy Subjects","year":2008,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Carbamazepine; Efavirenz; Pharmacokinetics; Crossover study; Pharmacology; Confidence interval; Dosing; Pharmacokinetic interaction; Drug interaction; Active metabolite; Metabolite; Medicine; Chemistry; Internal medicine; Antiretroviral therapy; Epilepsy; Viral load; Human immunodeficiency virus (HIV); Immunology","score_opus":0.0899044327554101,"score_gpt":0.4442458723768858,"score_spread":0.3543414396214757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077817920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98253965,0.0007110841,0.000023094086,0.01550256,0.00077935477,0.00033051657,0.0000023271084,0.000008302201,0.00010310926],"genre_scores_gemma":[0.99343514,0.0030418716,0.00024642644,0.0018254158,0.0011722976,0.000008932756,0.000004940808,0.000012769143,0.00025221068],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99768186,0.0005494589,0.0012271703,0.00013373063,0.00020190807,0.00020588192],"domain_scores_gemma":[0.997684,0.0014373378,0.00045381798,0.000076131844,0.000108607186,0.0002401004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012300913,0.00014196569,0.00057611364,0.00015379876,0.0000525658,0.00000353616,0.00007779898,0.00009839354,0.00014201937],"category_scores_gemma":[0.0001989484,0.00009108133,0.00010692566,0.00013896069,0.00016969745,0.00010565665,0.00003305037,0.00074766314,0.000018282512],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0314624,0.0011161285,0.93716717,0.00005331863,0.00044955182,0.00128174,0.0009770597,0.000009510787,0.0016971604,6.457751e-7,0.0051756245,0.020609664],"study_design_scores_gemma":[0.018523807,0.0025350703,0.9646935,0.00006928067,0.00062327966,0.0011821948,0.000057030877,0.00031159937,0.0022056594,0.000019787967,0.009670054,0.00010872302],"about_ca_topic_score_codex":0.000007557799,"about_ca_topic_score_gemma":0.000017261831,"teacher_disagreement_score":0.027526317,"about_ca_system_score_codex":0.00006880665,"about_ca_system_score_gemma":0.00030345595,"threshold_uncertainty_score":0.3714189},"labels":[],"label_agreement":null},{"id":"W2078570464","doi":"10.1177/0091270010393344","title":"A Review of Psychophysiological Stressors on Pharmacokinetics","year":2011,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Defence Research and Development Canada","funders":"","keywords":"Pharmacokinetics; Stressor; Drug; Medicine; Pharmacology; Clinical psychology","score_opus":0.34768733622085984,"score_gpt":0.580390445315223,"score_spread":0.23270310909436315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078570464","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000105774205,0.9951944,0.000008901484,0.00036294703,0.0025267154,0.0008976537,0.000021247768,0.0000073309593,0.0008750581],"genre_scores_gemma":[0.000048133657,0.99005204,0.00021554947,0.007819106,0.0016834453,0.000011415969,0.0000073843044,0.000036666726,0.00012626145],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9931587,0.0026359318,0.0034323758,0.0002112757,0.00029686769,0.00026482533],"domain_scores_gemma":[0.9920939,0.002877994,0.0040759924,0.0003476931,0.00030816888,0.00029623136],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0036611254,0.00039082207,0.004911471,0.00012691291,0.000031446456,0.0000013538563,0.00061124837,0.00037098888,0.0017565705],"category_scores_gemma":[0.00062914577,0.00017319605,0.0020605617,0.00021844395,0.0002838159,0.000019345669,0.00008801506,0.0020340807,0.00009362871],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001386052,0.002359443,0.000002911491,0.039857205,0.003223667,0.00018096389,0.000007697903,2.8212594e-7,0.000010375726,0.00003409744,0.08351679,0.8694205],"study_design_scores_gemma":[0.0023407245,0.004732751,0.000022092372,0.072369374,0.018910285,0.0003599674,0.0000014840766,0.0000011524324,0.000015216698,0.00013243624,0.9009985,0.00011605999],"about_ca_topic_score_codex":0.0000011240008,"about_ca_topic_score_gemma":3.9371113e-8,"teacher_disagreement_score":0.8693045,"about_ca_system_score_codex":0.000035500492,"about_ca_system_score_gemma":0.00040024373,"threshold_uncertainty_score":0.99915594},"labels":[],"label_agreement":null},{"id":"W2079912339","doi":"10.1177/00912700122010735","title":"The Safety of Higher Than Standard Dose of Doxylamine‐Pyridoxine (Diclectin®) for Nausea and Vomiting of Pregnancy","year":2001,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Nausea; Vomiting; Pregnancy; Adverse effect; Incidence (geometry); Metoclopramide; Antiemetic; Birth weight; Obstetrics; Gestational age; Population; Hyperemesis gravidarum; Anesthesia; Internal medicine","score_opus":0.08021228769728539,"score_gpt":0.4714493809293559,"score_spread":0.3912370932320705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079912339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98050743,0.008206232,0.00069654227,0.008342671,0.0009807543,0.0004913393,0.000018908408,0.000004921424,0.00075117976],"genre_scores_gemma":[0.9866549,0.011663214,0.00025021093,0.00040387982,0.0005697579,0.000003045966,7.8443014e-7,0.000012156998,0.00044204528],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9971561,0.00041739497,0.0018452319,0.00008594801,0.00029075125,0.00020456643],"domain_scores_gemma":[0.9911478,0.006045795,0.001946259,0.00017757797,0.00052140845,0.00016113106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004211422,0.000104392406,0.0007607984,0.000059873022,0.0000745843,0.0000016240047,0.00022743325,0.000114118826,0.00011331116],"category_scores_gemma":[0.0021257089,0.00005208183,0.0002337545,0.0001451007,0.00072375697,0.00006073103,0.00003970761,0.0004698553,2.8821785e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18315583,0.0029005639,0.17280816,0.0015718895,0.005273912,0.00008825002,0.002718861,0.000086210544,0.21145724,0.0010574367,0.030712338,0.3881693],"study_design_scores_gemma":[0.071282856,0.018658517,0.6550939,0.0043252003,0.0048186397,0.0009624724,0.00056346203,0.0003804255,0.17925292,0.0031799825,0.061207466,0.00027414854],"about_ca_topic_score_codex":0.000003455509,"about_ca_topic_score_gemma":0.000002485291,"teacher_disagreement_score":0.48228574,"about_ca_system_score_codex":0.00001819775,"about_ca_system_score_gemma":0.00030175445,"threshold_uncertainty_score":0.26667127},"labels":[],"label_agreement":null},{"id":"W2081057141","doi":"10.1177/0091270009340417","title":"Toward Optimal Treatment in Women: The Effect of Sex on Metoprolol‐Diphenhydramine Interaction","year":2009,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Metoprolol; Diphenhydramine; Medicine; Placebo; Pharmacokinetics; CYP2D6; Internal medicine; Chronotropic; Pharmacology; Anesthesia; Blood pressure; Heart rate","score_opus":0.15756673208901237,"score_gpt":0.5327479104422379,"score_spread":0.3751811783532255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081057141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98115337,0.0013836176,0.000026859034,0.010308532,0.005186268,0.00061917346,0.000010542892,0.0000118110265,0.0012998233],"genre_scores_gemma":[0.98255026,0.004360911,0.000027962029,0.010888699,0.0019677277,0.000022349399,0.0000011943424,0.000017257975,0.00016363125],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9909558,0.0061245034,0.0018882157,0.00021495203,0.00028390795,0.000532601],"domain_scores_gemma":[0.9908016,0.007376573,0.0012096253,0.00021499228,0.000119584955,0.00027762508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009509871,0.00032979646,0.0011324894,0.00019204762,0.00011637613,0.000008836544,0.00076221256,0.0002967867,0.0007495539],"category_scores_gemma":[0.0003313494,0.00016422312,0.00042189797,0.00028185634,0.00040304978,0.00009259165,0.000067134664,0.0020838901,0.000033688182],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07740492,0.0043949224,0.0033373686,0.000041750656,0.0022432467,0.0003006798,0.005868436,0.064858064,0.1279162,0.00008271186,0.012523076,0.70102865],"study_design_scores_gemma":[0.034034953,0.035391677,0.01112281,0.000034815585,0.0023547958,0.00035282737,0.00054635137,0.01022062,0.5221941,0.0006809011,0.38263604,0.00043015464],"about_ca_topic_score_codex":0.0000068204945,"about_ca_topic_score_gemma":9.663408e-7,"teacher_disagreement_score":0.7005985,"about_ca_system_score_codex":0.00013318393,"about_ca_system_score_gemma":0.00014310845,"threshold_uncertainty_score":0.9053582},"labels":[],"label_agreement":null},{"id":"W2081854990","doi":"10.1177/0091270010391790","title":"N‐acetylcysteine as a Novel Prophylactic Treatment for Ifosfamide‐Induced Nephrotoxicity in Children: Translational Pharmacokinetics","year":2011,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Chemotherapy-induced organ toxicity mitigation","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Children's Hospital of Western Ontario; London Health Sciences Centre; McMaster University; Royal College of Physicians and Surgeons of Canada; Hospital for Sick Children; Lawson Health Research Institute; University of Waterloo; Western University","funders":"Canadian Institutes of Health Research","keywords":"Nephrotoxicity; Acetylcysteine; Medicine; Ifosfamide; Antidote; Pharmacokinetics; Acetaminophen; acetaminophen overdose; Pharmacology; Chemotherapy; Cisplatin; Toxicity; Internal medicine; Chemistry","score_opus":0.15785577206162577,"score_gpt":0.43801656532004907,"score_spread":0.2801607932584233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081854990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902661,0.000114358634,0.0008131775,0.0059489165,0.0006465112,0.001963511,0.000010826659,0.000017293514,0.00021931303],"genre_scores_gemma":[0.9919282,0.00020675121,0.0018891547,0.003891608,0.0019424479,0.00002559739,0.000004967518,0.00004065871,0.00007057318],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971757,0.00035176854,0.0016437423,0.00020876274,0.00030904223,0.00031100292],"domain_scores_gemma":[0.99745953,0.0009694325,0.000864465,0.00017012382,0.00029188313,0.00024459278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018794634,0.0002385749,0.0007906635,0.00017633254,0.00006321736,0.0000054153243,0.00023801324,0.00022078706,0.00046620192],"category_scores_gemma":[0.00030708066,0.00015746898,0.00038777877,0.00023883449,0.0001855238,0.0001158264,0.000017908833,0.0007306687,0.000013745838],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013209082,0.0047421614,0.012876044,0.00004013261,0.00094361603,0.000025342595,0.0011764149,0.000045057288,0.955583,0.00003344835,0.0003797766,0.010945925],"study_design_scores_gemma":[0.051063012,0.009155719,0.1241321,0.000048060552,0.001503118,0.0012526002,0.000062375526,0.0009951307,0.81048703,0.00048658816,0.0005994879,0.00021480196],"about_ca_topic_score_codex":0.000043574993,"about_ca_topic_score_gemma":0.000009353659,"teacher_disagreement_score":0.14509599,"about_ca_system_score_codex":0.0001359277,"about_ca_system_score_gemma":0.00061453856,"threshold_uncertainty_score":0.64213985},"labels":[],"label_agreement":null},{"id":"W2082095891","doi":"10.1002/jcph.235","title":"Abuse potential, pharmacokinetics, pharmacodynamics, and safety of intranasally administered crushed oxycodone HCl abuse‐deterrent controlled‐release tablets in recreational opioid users","year":2013,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Purdue Pharma (Canada)","funders":"Purdue Pharma; Purdue University","keywords":"Oxycodone; Nasal administration; Medicine; Pharmacodynamics; Pharmacokinetics; Pharmacology; Placebo; Tolerability; Opioid; Cmax; Anesthesia; Crossover study; Adverse effect; Internal medicine","score_opus":0.026369272544800797,"score_gpt":0.366351148035836,"score_spread":0.3399818754910352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082095891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98650396,0.003409061,0.0002576786,0.005666719,0.0020223379,0.0019362129,0.00003632335,0.000016716705,0.00015097522],"genre_scores_gemma":[0.94823,0.047137864,0.0007779048,0.0029407253,0.00066304154,0.000033632256,0.000020990425,0.000046821264,0.00014898827],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9939525,0.0012035075,0.0034923588,0.0003112008,0.0005608015,0.00047962772],"domain_scores_gemma":[0.9947742,0.0020436263,0.0017036494,0.0002597063,0.00066683674,0.00055197655],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022189226,0.00037822197,0.001848548,0.00031714627,0.000074686446,0.00001941813,0.00040063512,0.00020636541,0.0019108274],"category_scores_gemma":[0.00031104765,0.00025617232,0.0004388878,0.00022433123,0.0005736317,0.00021515021,0.00007402097,0.0011146618,0.000023167719],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34706387,0.028783062,0.124688484,0.0011698466,0.01722579,0.001567697,0.008904499,0.006631988,0.34462777,0.00007705861,0.045602918,0.073657006],"study_design_scores_gemma":[0.3972211,0.010457662,0.4950649,0.0010821844,0.013027067,0.0010758188,0.0014242899,0.058235865,0.0112752225,0.0004755973,0.009639046,0.0010212386],"about_ca_topic_score_codex":0.00008105703,"about_ca_topic_score_gemma":0.00001270008,"teacher_disagreement_score":0.37037644,"about_ca_system_score_codex":0.000116776384,"about_ca_system_score_gemma":0.0005109675,"threshold_uncertainty_score":0.99998903},"labels":[],"label_agreement":null},{"id":"W2085955843","doi":"10.1177/0091270008325148","title":"Pharmacokinetics of Novel Atrial‐Selective Antiarrhythmic Agent Vernakalant Hydrochloride Injection (RSD1235): Influence of CYP2D6 Expression and Other Factors","year":2008,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cardiome (Canada)","funders":"","keywords":"Pharmacology; Pharmacokinetics; CYP2D6; Antiarrhythmic agent; Medicine; Hydrochloride; Cardiology; Internal medicine; Chemistry; Heart disease; Cytochrome P450; Metabolism","score_opus":0.14086357352761503,"score_gpt":0.4407561802247087,"score_spread":0.29989260669709367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085955843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972627,0.00029035093,0.00045285188,0.00044826276,0.0011326155,0.00033153407,0.0000057028187,0.000007009408,0.00006898381],"genre_scores_gemma":[0.9955541,0.002172491,0.00016186669,0.0003342993,0.0016909604,2.1667802e-7,6.170446e-7,0.000013430422,0.00007205091],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977188,0.00028237439,0.0014163313,0.000110708024,0.0003307066,0.00014108936],"domain_scores_gemma":[0.9963718,0.0014919904,0.0016563856,0.00009789472,0.00027034557,0.00011158282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012174464,0.00013376171,0.00071868976,0.00014508703,0.00006265721,0.0000016492696,0.00012239895,0.00010363457,0.00006969589],"category_scores_gemma":[0.00055301137,0.00008114173,0.0003025658,0.0001765496,0.00034568904,0.000094678035,0.00007550279,0.00038979296,0.0000013425914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012389516,0.0001316583,0.50815606,0.0000751899,0.0008296504,0.00002350928,0.0009398298,0.010164989,0.46494904,0.000014562767,0.0018588067,0.00046719512],"study_design_scores_gemma":[0.019352557,0.0030125687,0.7151998,0.00014322727,0.0021231663,0.00042516648,0.00017153814,0.0015918938,0.25099343,0.00007302885,0.006734828,0.00017872298],"about_ca_topic_score_codex":0.00002518544,"about_ca_topic_score_gemma":5.9679024e-7,"teacher_disagreement_score":0.21395558,"about_ca_system_score_codex":0.00002365142,"about_ca_system_score_gemma":0.00011134022,"threshold_uncertainty_score":0.33088636},"labels":[],"label_agreement":null},{"id":"W2086227412","doi":"10.1177/0091270009360979","title":"Dose Proportionality of Once‐Daily Trazodone Extended‐Release Caplets Under Fasting Conditions","year":2010,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Bioequivalence; Confidence interval; Trazodone; Pharmacokinetics; Crossover study; Chemistry; Pharmacology; Medicine; Internal medicine; Placebo","score_opus":0.09624446245214258,"score_gpt":0.4861058692314061,"score_spread":0.3898614067792635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086227412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834702,0.00013728965,0.000149308,0.013444773,0.001845501,0.00029201995,0.000014654249,0.000015513064,0.0006307505],"genre_scores_gemma":[0.9958385,0.00014372362,0.0008015538,0.0015340487,0.0013880761,0.0000036674244,0.000005924214,0.00001575194,0.00026874733],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99707913,0.0005171229,0.0016118335,0.00013778602,0.00044583232,0.00020828693],"domain_scores_gemma":[0.99540555,0.0022074361,0.001401894,0.00021268116,0.00046444146,0.0003080071],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026652892,0.00013719777,0.00064666045,0.000081940496,0.00009331133,0.0000035201417,0.00022203322,0.00017319073,0.0020813965],"category_scores_gemma":[0.0010238846,0.00007943542,0.00032296797,0.00011028954,0.00066081004,0.00010607178,0.000056069817,0.0014366481,0.000023383975],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009763791,0.008481638,0.042793248,0.00010323347,0.0014592024,0.00045896485,0.0002007145,0.00030033107,0.88214904,0.00047842038,0.029751189,0.024060205],"study_design_scores_gemma":[0.014477175,0.0020239216,0.95382255,0.00008716975,0.002126436,0.0013713471,0.000098826386,0.0003088922,0.0207831,0.0022997868,0.0024863512,0.00011443109],"about_ca_topic_score_codex":0.000012799701,"about_ca_topic_score_gemma":0.0000071810014,"teacher_disagreement_score":0.91102934,"about_ca_system_score_codex":0.000025892352,"about_ca_system_score_gemma":0.0005022997,"threshold_uncertainty_score":0.99883085},"labels":[],"label_agreement":null},{"id":"W2086291342","doi":"10.1002/jcph.510","title":"Pharmacokinetic (PK) drug interaction studies of cabozantinib: Effect of CYP3A inducer rifampin and inhibitor ketoconazole on cabozantinib plasma PK and effect of cabozantinib on CYP2C8 probe substrate rosiglitazone plasma PK","year":2015,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celerion (Canada)","funders":"Exelixis","keywords":"Cabozantinib; Pharmacology; Ketoconazole; CYP3A4; Pharmacokinetics; CYP3A; Drug interaction; Tyrosine-kinase inhibitor; Chemistry; Medicine; Cytochrome P450; Internal medicine; Cancer; Metabolism","score_opus":0.09779140068654354,"score_gpt":0.4436915727444264,"score_spread":0.3459001720578828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086291342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923281,0.0016982695,0.0000016402639,0.001016248,0.0024531027,0.0020332881,0.000030922944,0.000018007293,0.0004204096],"genre_scores_gemma":[0.99672335,0.0019329742,0.000053822423,0.0001988893,0.0009172202,0.000028509865,0.000005338361,0.000060248498,0.0000796681],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99205154,0.0032915405,0.0029380503,0.00044191998,0.0008117684,0.00046516187],"domain_scores_gemma":[0.98489815,0.011101005,0.0025124038,0.0003161011,0.0007056701,0.00046666156],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0072661135,0.00059521303,0.0029701602,0.0004087783,0.000075780146,0.000010712231,0.00027451757,0.00027005805,0.00004404892],"category_scores_gemma":[0.0015661201,0.00034418146,0.0004315442,0.0003015018,0.0010953497,0.00017027037,0.00017909081,0.0015906147,0.000009738132],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22024682,0.003142046,0.10370699,0.0025586984,0.0054805116,0.0005725791,0.003044272,0.00066741806,0.6411369,0.000020070238,0.0063648657,0.013058803],"study_design_scores_gemma":[0.045463927,0.038565323,0.035940442,0.0010834087,0.0037092413,0.0006069409,0.00035620312,0.00036176035,0.8732323,0.00001752911,0.0004257319,0.00023721065],"about_ca_topic_score_codex":0.000050198178,"about_ca_topic_score_gemma":0.0000076203573,"teacher_disagreement_score":0.23209536,"about_ca_system_score_codex":0.00007396884,"about_ca_system_score_gemma":0.00025671217,"threshold_uncertainty_score":0.999901},"labels":[],"label_agreement":null},{"id":"W2088345106","doi":"10.1177/0091270011408425","title":"Population Pharmacokinetics of Vernakalant Hydrochloride Injection (RSD1235) in Patients With Atrial Fibrillation or Atrial Flutter","year":2011,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cardiome (Canada)","funders":"","keywords":"Atrial fibrillation; Atrial flutter; Medicine; Pharmacokinetics; Cardiology; Internal medicine; Anesthesia; Population pharmacokinetics; Population; Pharmacology","score_opus":0.11597592399445847,"score_gpt":0.4155165467127693,"score_spread":0.29954062271831083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088345106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951899,0.00005731745,0.00016850082,0.0006717243,0.0032776059,0.00052524917,0.0000022823401,0.000008836784,0.00009857348],"genre_scores_gemma":[0.9922763,0.00029817334,0.00026091607,0.00025180323,0.006810825,1.0066049e-7,0.00000731234,0.000015880101,0.000078705474],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99719477,0.00045710313,0.0016769548,0.00011205647,0.00039710168,0.00016201993],"domain_scores_gemma":[0.99733615,0.0007686397,0.0014591787,0.00010597253,0.00024138139,0.000088662084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017433,0.0001323183,0.000657002,0.00020674407,0.000036949634,0.000003444537,0.00011744142,0.0001157797,0.00045959145],"category_scores_gemma":[0.00035919299,0.00007307676,0.0003381064,0.00023163353,0.000092927745,0.00016978536,0.000044052034,0.0003433404,0.0000068072077],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09461212,0.000032352327,0.895412,0.000023119246,0.00039736222,0.00000917191,0.00016173469,0.002379168,0.0001185361,0.000008348852,0.000539339,0.0063066953],"study_design_scores_gemma":[0.023521561,0.0035670332,0.96828705,0.0000390427,0.0014853419,0.000016448788,0.000017659262,0.0007871327,0.00034123976,0.00009114076,0.0017574204,0.00008892952],"about_ca_topic_score_codex":0.000042414435,"about_ca_topic_score_gemma":0.000007420069,"teacher_disagreement_score":0.072875,"about_ca_system_score_codex":0.00004965333,"about_ca_system_score_gemma":0.000087835564,"threshold_uncertainty_score":0.5032204},"labels":[],"label_agreement":null},{"id":"W2088355176","doi":"10.1177/0091270011407195","title":"Semagacestat Pharmacokinetics Are Not Significantly Affected by Formulation, Food, or Time of Dosing in Healthy Participants","year":2011,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Pharmacokinetics; Bioavailability; Dosing; Confidence interval; Morning; Medicine; Evening; Crossover study; Pharmacodynamics; Bioequivalence; Cmax; Half-life; Area under the curve; Pharmacology; Internal medicine; Animal science; Placebo","score_opus":0.2351494950380212,"score_gpt":0.48090644255593323,"score_spread":0.24575694751791202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088355176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962756,0.0013486238,0.000033510776,0.0013829019,0.00027568362,0.00055566203,0.000034527548,0.000009031617,0.00008442985],"genre_scores_gemma":[0.99670684,0.0014380331,0.00014609592,0.0014238332,0.00023228565,0.0000057167126,0.0000044335798,0.000020691372,0.00002204613],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99646854,0.0010540122,0.0015005582,0.00013774598,0.00039597964,0.00044316115],"domain_scores_gemma":[0.9963303,0.0015815488,0.001049669,0.00013834334,0.00035216787,0.00054794725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002109168,0.00015260866,0.00078464,0.0001280988,0.000049256447,0.0000033065658,0.00020269108,0.00010133325,0.00082489004],"category_scores_gemma":[0.00047793973,0.00008701454,0.00016847737,0.00025960396,0.0002331246,0.00010573053,0.000049242477,0.00059639174,0.000026777103],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44835868,0.03365859,0.33434254,0.0006647167,0.029526858,0.002300485,0.0031226394,0.00014735872,0.07260511,0.00001133509,0.063209146,0.012052548],"study_design_scores_gemma":[0.07784148,0.04199181,0.72522706,0.000466807,0.009219462,0.00032009307,0.00046776165,0.004770275,0.13824324,0.000332364,0.0006969921,0.0004226576],"about_ca_topic_score_codex":0.000013804675,"about_ca_topic_score_gemma":0.000007272142,"teacher_disagreement_score":0.39088452,"about_ca_system_score_codex":0.000047356985,"about_ca_system_score_gemma":0.00048582393,"threshold_uncertainty_score":0.90319675},"labels":[],"label_agreement":null},{"id":"W2090079955","doi":"10.1177/009127002401102830","title":"Efficacy and Tolerability of Nonprescription Ibuprofen versus Celecoxib for Dental Pain","year":2002,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Ibuprofen; Medicine; Analgesic; Celecoxib; Tolerability; Placebo; Anesthesia; Etodolac; Cancer pain; Adverse effect; Internal medicine; Pharmacology; Cancer","score_opus":0.11944502214446621,"score_gpt":0.43596552186026,"score_spread":0.31652049971579377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090079955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944993,0.0005583032,0.00022900214,0.0014005222,0.0026248898,0.0005970291,0.0000026334624,0.0000051402517,0.000083168066],"genre_scores_gemma":[0.9969166,0.0004132965,0.0002115544,0.00077993906,0.0016197062,0.0000054625107,7.372513e-7,0.000009007144,0.000043712338],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977929,0.0008460617,0.00096294354,0.0000845129,0.00015427351,0.00015928644],"domain_scores_gemma":[0.9934718,0.0055628824,0.0005368206,0.00009822278,0.00016788818,0.00016238895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061402246,0.00008735896,0.0005497859,0.000042621417,0.00004615883,0.0000021594478,0.00010980765,0.00011725103,0.0002472938],"category_scores_gemma":[0.0018513877,0.00005369882,0.0001765403,0.00005023683,0.0002511577,0.00004934115,0.000028187596,0.0004302764,0.0000042573265],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19096576,0.0059012393,0.12634704,0.0011534804,0.002244343,0.0001427398,0.0018291887,0.0001036734,0.18651451,0.0000703806,0.21510378,0.26962388],"study_design_scores_gemma":[0.24239711,0.07161449,0.49405673,0.00039644595,0.007631719,0.000598073,0.0006780227,0.03422575,0.06919083,0.00043848954,0.07813533,0.00063700316],"about_ca_topic_score_codex":0.00000174656,"about_ca_topic_score_gemma":0.0000015719379,"teacher_disagreement_score":0.36770973,"about_ca_system_score_codex":0.000023041817,"about_ca_system_score_gemma":0.000045260018,"threshold_uncertainty_score":0.27076936},"labels":[],"label_agreement":null},{"id":"W2092729209","doi":"10.1177/0091270007306957","title":"Pharmacokinetic Profile of Temsirolimus With Concomitant Administration of Cytochrome P450‐Inducing Medications<sup>1</sup>","year":2007,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Temsirolimus; Pharmacology; Sirolimus; CYP3A4; Pharmacokinetics; CYP3A; Concomitant; Medicine; Cytochrome P450; Internal medicine; Chemistry; Discovery and development of mTOR inhibitors; PI3K/AKT/mTOR pathway; Biochemistry; Metabolism","score_opus":0.03752277635510766,"score_gpt":0.40245016355153684,"score_spread":0.3649273871964292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092729209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923104,0.00062858977,0.0053630117,0.0006558502,0.00031835656,0.0002588506,0.000014075404,0.0000025301763,0.00044832932],"genre_scores_gemma":[0.996453,0.0009344034,0.000751679,0.00073091884,0.0010197315,0.0000032920698,0.0000061569644,0.000016442484,0.00008436357],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978424,0.0002634244,0.0013124662,0.0001317759,0.0002524751,0.00019746152],"domain_scores_gemma":[0.9976014,0.00035950597,0.0013120989,0.00018400754,0.00040812787,0.00013485471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030891914,0.00012483113,0.0004202883,0.000062891864,0.000040333594,0.0000026470857,0.00034769252,0.00014394772,0.00012743572],"category_scores_gemma":[0.00008044672,0.0000811953,0.00014813938,0.000119261524,0.00034023542,0.000006151963,0.000048840913,0.00032553056,0.0000011948409],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051511996,0.00033317404,0.00019671036,0.000030626838,0.00051543396,0.00001281796,0.00011914867,0.00035420954,0.9864183,0.00005329046,0.000792114,0.0060229837],"study_design_scores_gemma":[0.0047855377,0.005878036,0.004746932,0.000042574007,0.00070995983,0.0003106357,0.00024351326,0.00046333089,0.972598,0.000117141295,0.009977727,0.00012658733],"about_ca_topic_score_codex":0.00000459095,"about_ca_topic_score_gemma":0.0000038145706,"teacher_disagreement_score":0.013820265,"about_ca_system_score_codex":0.000013523739,"about_ca_system_score_gemma":0.00047303623,"threshold_uncertainty_score":0.33110484},"labels":[],"label_agreement":null},{"id":"W2093981065","doi":"10.1177/0091270001417011","title":"Monitoring Disease Progression in Parkinson's Disease","year":2001,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pavilion; Library science; Medicine; Glioblastoma; Neurology; Family medicine; History; Psychiatry; Computer science","score_opus":0.10340023488546343,"score_gpt":0.486644437889344,"score_spread":0.3832442030038805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093981065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97691965,0.0027424302,0.000010400649,0.018747492,0.001144783,0.00023270184,8.37399e-7,0.00000851859,0.00019316391],"genre_scores_gemma":[0.9871996,0.008193188,0.000043295608,0.0034550384,0.0009961386,0.000005538283,3.8898733e-7,0.000008979782,0.0000978276],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832,0.00046832912,0.00067714,0.00011115304,0.00021877576,0.00020460217],"domain_scores_gemma":[0.9983629,0.000644818,0.00029617533,0.00010747648,0.00006609916,0.00052253244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008000998,0.000098681114,0.0003579023,0.00005421147,0.000043023505,0.0000039157107,0.00014389925,0.000048997306,0.00018617795],"category_scores_gemma":[0.00043639384,0.000050085746,0.00019001125,0.00011909109,0.00014143655,0.000055179506,0.000048297985,0.0005678288,0.000017558146],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018907866,0.0019891092,0.9402403,0.000010589985,0.00006386423,0.004407395,0.000011948801,0.00004044143,0.00014165693,0.0000021790142,0.0016847653,0.032499854],"study_design_scores_gemma":[0.005981011,0.0009371703,0.97650325,0.000071503186,0.00042599492,0.0000281048,0.000009476887,0.00013282977,0.00003760251,0.0012706247,0.014556286,0.0000461558],"about_ca_topic_score_codex":0.0000012068718,"about_ca_topic_score_gemma":2.3004242e-7,"teacher_disagreement_score":0.036262907,"about_ca_system_score_codex":0.00001749068,"about_ca_system_score_gemma":0.000115264105,"threshold_uncertainty_score":0.24669655},"labels":[],"label_agreement":null},{"id":"W2094323797","doi":"10.1002/jcph.339","title":"Biosimilar monoclonal antibodies: A Canadian regulatory perspective on the assessment of clinically relevant differences and indication extrapolation","year":2014,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Canada","funders":"","keywords":"Biosimilar; Monoclonal antibody; Perspective (graphical); Medicine; Extrapolation; Pharmacology; Antibody; Internal medicine; Immunology; Computer science; Mathematics; Statistics; Artificial intelligence","score_opus":0.1412695353166486,"score_gpt":0.5070305994950575,"score_spread":0.36576106417840887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094323797","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005482782,0.97818804,0.00014607016,0.011449867,0.003035783,0.0007895792,0.00008242099,0.000007348765,0.00081809174],"genre_scores_gemma":[0.034725778,0.96248215,0.00029789403,0.0018943552,0.00049368455,0.000005807334,0.0000039648567,0.000018414556,0.000077936704],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98773277,0.008390196,0.0031430698,0.00028888672,0.00013179024,0.0003132697],"domain_scores_gemma":[0.97772014,0.017562602,0.0039253403,0.00030858073,0.00035686433,0.00012645817],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.013325244,0.00032854083,0.0024419646,0.00024675153,0.00022291312,0.000011742962,0.0007965656,0.000948249,0.00040719696],"category_scores_gemma":[0.001889001,0.0001462632,0.00073550374,0.00018242712,0.0018856486,0.000035603312,0.00010181106,0.0026927786,0.000008153429],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016843446,0.0012801897,0.0042792014,0.0016677344,0.011936996,0.000023252387,0.00043074714,0.0000027465135,0.0003511398,0.015990738,0.048274506,0.9140784],"study_design_scores_gemma":[0.0016044657,0.0039667026,0.020549294,0.0024160186,0.007981744,0.00025642585,0.00024207217,0.000057869674,0.00003661818,0.0027020562,0.9597843,0.00040241203],"about_ca_topic_score_codex":0.00013640778,"about_ca_topic_score_gemma":0.00011923459,"teacher_disagreement_score":0.91367596,"about_ca_system_score_codex":0.000115685216,"about_ca_system_score_gemma":0.0013275222,"threshold_uncertainty_score":0.99960804},"labels":[],"label_agreement":null},{"id":"W2094409037","doi":"10.1177/0091270005283285","title":"Challenges and Opportunities for Pharmacoepidemiology in Drug‐Therapy Decision Making","year":2006,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Queen's University; Centre for Advancing Health Outcomes; Royal Victoria Hospital","funders":"","keywords":"Pharmacoepidemiology; Medicine; Adverse effect; Drug; Intensive care medicine; Population; Drug reaction; MEDLINE; Alternative medicine; Randomized controlled trial; Clinical study design; Adverse drug reaction; Clinical trial; Pharmacology; Internal medicine; Pathology; Environmental health","score_opus":0.5675048479289339,"score_gpt":0.5966121160322262,"score_spread":0.02910726810329234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094409037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9390576,0.02964981,0.00028536507,0.020304104,0.006964148,0.0006211915,0.000024618204,0.000031691627,0.0030614696],"genre_scores_gemma":[0.8385141,0.145838,0.00027164546,0.012139817,0.0029956212,0.000031216783,0.0000024053415,0.000027160031,0.00018003494],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939929,0.0029149344,0.0020810352,0.00027340293,0.00016281333,0.0005748874],"domain_scores_gemma":[0.9781121,0.02015585,0.0011580708,0.00013162423,0.00023868414,0.00020367836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01262021,0.00028811922,0.00096188794,0.00028225326,0.0002132609,0.000008201832,0.0005301152,0.00032566002,0.00025658033],"category_scores_gemma":[0.00038371774,0.00020328308,0.00030630632,0.00011101164,0.0006472468,0.00027162276,0.000096031705,0.0017640926,0.000009420706],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016337212,0.0016841645,0.0056310343,0.0000761646,0.0006124335,0.00027626642,0.0005906637,0.0045695463,0.016462013,0.0023452318,0.19723982,0.7541754],"study_design_scores_gemma":[0.012628661,0.00050399615,0.013568069,0.00006082297,0.00049462717,0.0004409911,0.0006041063,0.0030957432,0.0035272448,0.013383204,0.95135915,0.00033335533],"about_ca_topic_score_codex":0.000008957485,"about_ca_topic_score_gemma":0.000030629297,"teacher_disagreement_score":0.75411934,"about_ca_system_score_codex":0.000050369577,"about_ca_system_score_gemma":0.00019691985,"threshold_uncertainty_score":0.82896435},"labels":[],"label_agreement":null},{"id":"W2094518494","doi":"10.1177/0091270003251388","title":"Pharmacokinetics of an Immediate‐Release Oral Formulation of Fampridine (4‐Aminopyridine) in Normal Subjects and Patients with Spinal Cord Injury","year":2003,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care; Lawson Health Research Institute; Western University","funders":"","keywords":"Cmax; Pharmacokinetics; 4-Aminopyridine; Spinal cord injury; High-performance liquid chromatography; Oral administration; Medicine; Plasma concentration; Spinal cord; Anesthesia; Chemistry; Pharmacology; Chromatography; Internal medicine; Potassium channel","score_opus":0.056258487578764935,"score_gpt":0.42508783929785565,"score_spread":0.3688293517190907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094518494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989091,0.00020517237,0.000030154803,0.00018119629,0.00036071325,0.00027429865,0.000015821066,0.0000023039695,0.000021221624],"genre_scores_gemma":[0.9982394,0.00050234934,0.00016905084,0.0008144448,0.0002469107,0.000001286845,0.0000071197655,0.000013245813,0.0000062076383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977588,0.0005565751,0.0011502212,0.000111697525,0.0002606768,0.00016203613],"domain_scores_gemma":[0.9980022,0.00039724488,0.0008167755,0.00009840664,0.00047127908,0.00021412704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090347696,0.00013607417,0.0006053123,0.00014594557,0.000021859445,0.0000022233892,0.00009508786,0.00006200322,0.00006703137],"category_scores_gemma":[0.00033301502,0.00008279219,0.00008717221,0.0001813329,0.00020364774,0.00015444713,0.00002429399,0.00038618408,4.1733824e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14974962,0.004398871,0.7403671,0.00016094957,0.00023544446,0.000095194875,0.000112509784,0.0002520402,0.09237287,0.00001793748,0.0004984813,0.011738985],"study_design_scores_gemma":[0.020902786,0.020150067,0.80008125,0.00007187031,0.00083704037,0.0000617483,0.000037862268,0.00050609163,0.15701942,0.000026986205,0.00020095431,0.000103890605],"about_ca_topic_score_codex":0.0000052271794,"about_ca_topic_score_gemma":0.0000033277954,"teacher_disagreement_score":0.12884684,"about_ca_system_score_codex":0.000012039765,"about_ca_system_score_gemma":0.00019225448,"threshold_uncertainty_score":0.33761677},"labels":[],"label_agreement":null},{"id":"W2095984197","doi":"10.1177/0091270009341182","title":"Acute Hemodynamic Effects of Single‐Dose Sildenafil When Added to Established Bosentan Therapy in Patients With Pulmonary Arterial Hypertension: Results of the COMPASS‐1 Study","year":2009,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital","funders":"Actelion Pharmaceuticals; Universität Leipzig; Universität zu Köln","keywords":"Sildenafil; Bosentan; Medicine; Pulmonary hypertension; Ambrisentan; Hemodynamics; Internal medicine; Vascular resistance; Cardiology; Pharmacodynamics; Confidence interval; Anesthesia; Pharmacokinetics; Endothelin receptor","score_opus":0.03882880036594852,"score_gpt":0.3676106898940989,"score_spread":0.32878188952815035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095984197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99165446,0.00009354166,0.000001770887,0.00568514,0.0007722708,0.0017094269,0.000014093376,0.0000054660813,0.000063811276],"genre_scores_gemma":[0.997102,0.00011182832,0.00009284816,0.0024072903,0.00021800773,0.0000043108184,0.000005092058,0.000015712123,0.00004286728],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99571025,0.0014654453,0.0014950447,0.00021341842,0.00079863466,0.0003172202],"domain_scores_gemma":[0.99641585,0.0015155377,0.0008042219,0.00039437806,0.00058493955,0.00028508602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012413631,0.00021100858,0.0011794298,0.00017248202,0.00005933619,0.000005311821,0.00045694836,0.00009925028,0.000035083245],"category_scores_gemma":[0.00043242256,0.00009465472,0.00021872985,0.00034295695,0.00022868457,0.00010102958,0.000097419594,0.0006240928,0.000002804692],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.46255687,0.07507965,0.19769137,0.000035441954,0.0024153797,0.004901976,0.0005260725,0.00007858085,0.22692752,6.657033e-7,0.010883547,0.01890296],"study_design_scores_gemma":[0.0525382,0.03502962,0.9072591,0.00016110475,0.00061295356,0.00017679694,0.00007864436,0.00009941382,0.0038208957,0.00005168828,0.00008829362,0.000083278406],"about_ca_topic_score_codex":0.000023972365,"about_ca_topic_score_gemma":0.000006625288,"teacher_disagreement_score":0.7095677,"about_ca_system_score_codex":0.00005610606,"about_ca_system_score_gemma":0.00023406695,"threshold_uncertainty_score":0.38599074},"labels":[],"label_agreement":null},{"id":"W2099178340","doi":"10.1177/0091270002239824","title":"The Pharmacokinetics and Pharmacodynamics of Zoledronic Acid in Cancer Patients with Varying Degrees of Renal Function","year":2003,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Bone health and treatments","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Pharmacokinetics; Pharmacodynamics; Zoledronic acid; Medicine; Cancer; Renal function; Pharmacology; Impaired renal function; Oncology; Internal medicine","score_opus":0.045790833849402864,"score_gpt":0.41797851588960183,"score_spread":0.372187682040199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099178340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99453366,0.0033742487,0.000064223044,0.0007333603,0.00084176095,0.00031366735,0.0000052209457,0.000002187936,0.00013167366],"genre_scores_gemma":[0.9900093,0.009163886,0.00013488569,0.0005496975,0.00009885457,0.0000041197786,8.3132994e-7,0.000012055183,0.000026354894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99772316,0.0005417786,0.0011768563,0.000086426306,0.0002540187,0.00021774322],"domain_scores_gemma":[0.9974642,0.00097261945,0.001034232,0.00008078969,0.00029880376,0.00014937787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015589533,0.00011428821,0.0004969039,0.000070037226,0.00006016852,0.0000017872038,0.0000985538,0.000068040856,0.000066319524],"category_scores_gemma":[0.00012096853,0.000055519835,0.00007910554,0.00016428076,0.00031322255,0.00005406879,0.000021637406,0.0006233231,5.132429e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038203377,0.002574428,0.9075193,0.00018460823,0.0016536579,0.000031078973,0.00023002687,0.002348498,0.00894902,0.000032639677,0.0010311201,0.037242256],"study_design_scores_gemma":[0.07268022,0.01008367,0.88908917,0.00031153174,0.00533324,0.0001456963,0.00006988012,0.004162424,0.013168025,0.00017537408,0.004596827,0.00018397183],"about_ca_topic_score_codex":0.000025309697,"about_ca_topic_score_gemma":0.000024188206,"teacher_disagreement_score":0.037058286,"about_ca_system_score_codex":0.000042287815,"about_ca_system_score_gemma":0.00036732567,"threshold_uncertainty_score":0.27080634},"labels":[],"label_agreement":null},{"id":"W2099744961","doi":"10.1177/00912700122010663","title":"Population Pharmacokinetics of Fentanyl in Healthy Volunteers","year":2001,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; St. Boniface Hospital","funders":"","keywords":"Pharmacokinetics; Fentanyl; Volume of distribution; Population pharmacokinetics; Population; Medicine; Distribution (mathematics); Anesthesia; Nonparametric statistics; Pharmacology; Mathematics; Statistics","score_opus":0.23344573158738122,"score_gpt":0.5612801435504464,"score_spread":0.3278344119630652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099744961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97717094,0.0043595703,0.0001428368,0.0050322674,0.011563117,0.0004267588,0.000019301135,0.000015051959,0.00127015],"genre_scores_gemma":[0.96306074,0.024719298,0.00017586509,0.009452925,0.0024115976,0.0000057418833,0.0000041288727,0.00003303345,0.00013665868],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99157387,0.0038031451,0.0033544428,0.00023087105,0.00042157428,0.0006160776],"domain_scores_gemma":[0.9943628,0.00283814,0.0017453588,0.00020380375,0.00039920904,0.00045072744],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.009517344,0.00028922904,0.0011296612,0.00035457872,0.00011529905,0.000006121964,0.000946484,0.00038204514,0.0020119676],"category_scores_gemma":[0.0003986745,0.00021451544,0.00039352447,0.00062649784,0.000498417,0.00015424451,0.00015056386,0.002473903,0.000039003087],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053548276,0.006082398,0.54139787,0.00015775878,0.0016226759,0.00048397193,0.0015771803,0.043534808,0.14383385,0.0003983665,0.050654814,0.15670802],"study_design_scores_gemma":[0.04227785,0.003064966,0.27513272,0.00006397023,0.002887404,0.0008618133,0.0004320029,0.023960792,0.024711376,0.0023645198,0.6234844,0.0007582098],"about_ca_topic_score_codex":0.000066702014,"about_ca_topic_score_gemma":0.000026795558,"teacher_disagreement_score":0.57282954,"about_ca_system_score_codex":0.00006916329,"about_ca_system_score_gemma":0.0002476841,"threshold_uncertainty_score":0.99982744},"labels":[],"label_agreement":null},{"id":"W2102128538","doi":"10.1177/0091270008329550","title":"Lopinavir/Ritonavir Pharmacokinetics in a Substitution of High‐Dose Soft‐Gelatin Capsule to Tablet Formulation","year":2009,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; HIV Legal Network; AIDS Vancouver","funders":"","keywords":"Pharmacokinetics; Lopinavir; Ritonavir; Capsule; Lopinavir/ritonavir; Pharmacology; Gelatin; Medicine; Bioequivalence; Chemistry; Virology; Human immunodeficiency virus (HIV); Antiretroviral therapy; Viral load","score_opus":0.05661761758653071,"score_gpt":0.43117385757911747,"score_spread":0.37455623999258675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102128538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98000056,0.00027245324,0.0007764153,0.017458806,0.00078358897,0.00043984086,0.000003504817,0.000008366905,0.00025649456],"genre_scores_gemma":[0.9944529,0.0005340923,0.0017221358,0.0022130483,0.00059904536,0.0000028549841,0.000006755898,0.000008901448,0.00046024824],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974622,0.0003075876,0.00156181,0.0001200862,0.00031053624,0.00023775316],"domain_scores_gemma":[0.99840933,0.00045069627,0.0005938005,0.00011164006,0.00024233217,0.0001921782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00188785,0.00014496087,0.000665353,0.00019786443,0.000039692102,0.0000035168068,0.00016462913,0.000114425726,0.00021690172],"category_scores_gemma":[0.0002470518,0.000094854884,0.0001447797,0.00032953662,0.00007580002,0.00010668734,0.000030219358,0.0005246421,0.000029088744],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049066693,0.015714506,0.11374613,0.0002617262,0.0020721944,0.0015073116,0.0043034307,0.019455723,0.44164136,0.0018331138,0.093609266,0.25678855],"study_design_scores_gemma":[0.05361166,0.0066451817,0.769799,0.0005317789,0.0025778024,0.00068499806,0.00013877262,0.0039452408,0.1198817,0.0035382758,0.038185213,0.00046036072],"about_ca_topic_score_codex":0.000010274919,"about_ca_topic_score_gemma":0.000003972413,"teacher_disagreement_score":0.6560529,"about_ca_system_score_codex":0.00010020763,"about_ca_system_score_gemma":0.00027520605,"threshold_uncertainty_score":0.386807},"labels":[],"label_agreement":null},{"id":"W2103407911","doi":"10.1002/jcph.564","title":"Food effects on abiraterone pharmacokinetics in healthy subjects and patients with metastatic castration‐resistant prostate cancer","year":2015,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Astellas Pharma; Pfizer","keywords":"Abiraterone acetate; Pharmacokinetics; Prostate cancer; Medicine; Meal; Prednisone; Endocrinology; Internal medicine; Adverse effect; Cancer; Androgen deprivation therapy","score_opus":0.09995530838740403,"score_gpt":0.4608467841323652,"score_spread":0.36089147574496117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103407911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887092,0.0019946299,0.0000038729454,0.0077146585,0.0006431681,0.0008699388,0.000010986731,0.000004796094,0.000048712503],"genre_scores_gemma":[0.994802,0.0021958994,0.000094687064,0.0024899067,0.0003263832,0.00001961522,0.000003113328,0.000017212384,0.000051171675],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9977567,0.00073836907,0.0006899574,0.00013316302,0.00039987915,0.00028192092],"domain_scores_gemma":[0.9979026,0.00088836486,0.00038725894,0.000080859085,0.00035800601,0.0003829211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015334446,0.00014103181,0.00052927836,0.00011712055,0.000040780797,0.0000087702365,0.00009070396,0.000042435157,0.0000213848],"category_scores_gemma":[0.00013229555,0.0000698016,0.00004250585,0.00017622049,0.00020061553,0.00007373383,0.000027549724,0.00065758004,0.0000029902808],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.527475,0.0046600807,0.41251495,0.00066689664,0.002037388,0.0010274432,0.0019572047,0.0007752044,0.0044807056,0.0000111182735,0.01064682,0.033747155],"study_design_scores_gemma":[0.16999131,0.14718673,0.6657205,0.0004443104,0.0017467388,0.00010290612,0.0002041651,0.00024973063,0.011263317,0.0002446766,0.0025963683,0.00024920964],"about_ca_topic_score_codex":0.000018429646,"about_ca_topic_score_gemma":0.000032770666,"teacher_disagreement_score":0.3574837,"about_ca_system_score_codex":0.00012060667,"about_ca_system_score_gemma":0.0006730133,"threshold_uncertainty_score":0.28568947},"labels":[],"label_agreement":null},{"id":"W2105461052","doi":"10.1177/00912700022009549","title":"The Future of Clinical Trials in Chronic Renal Disease: Outcome of an NIH/FDA/Physician Specialist Conference","year":2000,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"Medicine; Renal function; Dialysis; Kidney disease; Proteinuria; Transplantation; Internal medicine; Clinical trial; Disease; Creatinine; End stage renal disease; Intensive care medicine; Urology; Kidney","score_opus":0.1717190249127503,"score_gpt":0.5421633479599028,"score_spread":0.3704443230471526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105461052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98050344,0.004580221,0.0000059004924,0.011719377,0.0019180399,0.00044714456,0.000050991446,0.0000065291183,0.0007683513],"genre_scores_gemma":[0.9736166,0.009060618,0.000035130834,0.0035315808,0.013497399,0.0000034981733,0.000007185241,0.000018030596,0.00022996841],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9863595,0.0060751117,0.0064833257,0.00020314292,0.0005222305,0.0003567352],"domain_scores_gemma":[0.98507327,0.010507556,0.00290651,0.00045272242,0.00035302993,0.00070688885],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.021824753,0.00020259505,0.0024796682,0.00007227172,0.00007191939,0.000009613955,0.00067052356,0.00020390164,0.0022262891],"category_scores_gemma":[0.0035583742,0.00010230802,0.0011708048,0.00020558012,0.0011739797,0.00012177487,0.000061740844,0.0013423723,0.000017135628],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.098871194,0.0073945494,0.12487817,0.00040654893,0.0022992338,0.00039749948,0.00025049853,0.000385005,0.0064173327,0.00070823246,0.0801767,0.677815],"study_design_scores_gemma":[0.035426058,0.005659405,0.80617094,0.00040751733,0.004702989,0.000028016835,0.00025459248,0.0020422875,0.0013446436,0.0038403913,0.13984582,0.00027732068],"about_ca_topic_score_codex":0.000011967406,"about_ca_topic_score_gemma":0.00003270932,"teacher_disagreement_score":0.6812928,"about_ca_system_score_codex":0.000066385575,"about_ca_system_score_gemma":0.0027729312,"threshold_uncertainty_score":0.99868584},"labels":[],"label_agreement":null},{"id":"W2107017366","doi":"10.1177/0091270009333017","title":"Trigeminal Neuralgia Treated With Pregabalin in Family Medicine Settings: Its Effect on Pain Alleviation and Cost Reduction","year":2009,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Trigeminal Neuralgia and Treatments","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pregabalin; Trigeminal neuralgia; Observational study; Neuropathic pain; Health care; Neuralgia; Physical therapy; Emergency medicine; Anesthesia; Internal medicine","score_opus":0.05855088445694896,"score_gpt":0.43263845140783014,"score_spread":0.3740875669508812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107017366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826246,0.00060722564,0.000011416244,0.015513625,0.00028790045,0.00070310966,0.000001152957,0.0000136150275,0.00023734912],"genre_scores_gemma":[0.9949702,0.0008929514,0.000030067593,0.0032210364,0.0006651535,0.0000046830082,0.000004761571,0.000011206334,0.00019994767],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99682367,0.0015769602,0.00094050687,0.00017213987,0.00027852293,0.00020818117],"domain_scores_gemma":[0.99666625,0.0022687982,0.00064680143,0.000094640025,0.0001364801,0.0001870436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036204509,0.0001878563,0.0007358394,0.00017125018,0.00005359236,0.0000042982474,0.00009286156,0.000119972996,0.0000373468],"category_scores_gemma":[0.0006233931,0.00009051032,0.00008151748,0.00023086357,0.0001503352,0.00008297005,0.000008068267,0.0007814519,0.00000498213],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18289237,0.0031767434,0.084020644,0.00018377254,0.0009956168,0.0028740512,0.0006161278,0.00016309053,0.15622944,0.000026415602,0.035178345,0.53364336],"study_design_scores_gemma":[0.047936104,0.12631795,0.80410343,0.0010133577,0.002637636,0.0030155964,0.00013025578,0.00074122706,0.011735414,0.0000747932,0.0020998747,0.00019436683],"about_ca_topic_score_codex":0.0000062226277,"about_ca_topic_score_gemma":6.411258e-7,"teacher_disagreement_score":0.72008276,"about_ca_system_score_codex":0.000058243248,"about_ca_system_score_gemma":0.00005994676,"threshold_uncertainty_score":0.36909038},"labels":[],"label_agreement":null},{"id":"W2108043165","doi":"10.1177/0091270007310385","title":"Sex, Race, and Smoking Impact Olanzapine Exposure","year":2008,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":180,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of Mental Health; National Institutes of Health","keywords":"Olanzapine; Antipsychotic; Clearance; Medicine; Population; Pharmacokinetics; Volume of distribution; Internal medicine; Atypical antipsychotic; Schizophrenia (object-oriented programming); Psychiatry; Urology; Environmental health","score_opus":0.10352528642345275,"score_gpt":0.47661050049044423,"score_spread":0.37308521406699147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108043165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883599,0.0033390168,0.000023711245,0.0074677547,0.00041833395,0.00014932145,0.0000020352084,0.000007206275,0.0002326942],"genre_scores_gemma":[0.98727953,0.009239029,0.0002765841,0.0012662796,0.0016407555,0.0000011764764,7.75921e-7,0.0000102102385,0.00028562883],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982417,0.00050983217,0.0006675336,0.00008453661,0.00027231855,0.0002240832],"domain_scores_gemma":[0.99747056,0.0015850975,0.00029496817,0.00010819126,0.00014347717,0.00039770736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001969822,0.00010279833,0.00059749826,0.0000756327,0.00009949244,0.0000036902622,0.00011735957,0.00008360591,0.00051690673],"category_scores_gemma":[0.0003916553,0.000049475027,0.00021027637,0.000090406575,0.0003019669,0.00005548724,0.00005329836,0.0008617752,0.000011882017],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0821268,0.0013864926,0.77206093,0.00002728431,0.0033806558,0.00443473,0.00039097483,0.000037474972,0.0047499402,0.000014788476,0.08211478,0.049275123],"study_design_scores_gemma":[0.025166094,0.0072677396,0.94968385,0.000027898774,0.00069474493,0.01168593,0.000034200653,0.0001348638,0.0017405318,0.00029333032,0.0031967685,0.000074043564],"about_ca_topic_score_codex":0.0000075366975,"about_ca_topic_score_gemma":0.00000144418,"teacher_disagreement_score":0.1776229,"about_ca_system_score_codex":0.00003225529,"about_ca_system_score_gemma":0.00039104445,"threshold_uncertainty_score":0.5659766},"labels":[],"label_agreement":null},{"id":"W2109748368","doi":"10.1002/jcph.139","title":"Exposure to Nitrofurantoin During the First Trimester of Pregnancy and the Risk for Major Malformations","year":2013,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Nitrofurantoin; Pregnancy; Medicine; Obstetrics; Congenital malformations; First trimester; Retrospective cohort study; Gestation; Cohort study; Medical record; Pediatrics; Gynecology; Antibiotics; Surgery; Internal medicine","score_opus":0.03719027354448589,"score_gpt":0.3958296222977215,"score_spread":0.3586393487532356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109748368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9245712,0.002752876,0.0006404122,0.06992867,0.0005857165,0.0013195979,0.000008117972,0.000004612156,0.00018876906],"genre_scores_gemma":[0.9912934,0.002792242,0.00018029132,0.004698643,0.000553457,0.000051946383,3.413379e-7,0.000007976717,0.0004217116],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9980949,0.00043810564,0.0010858073,0.0000590747,0.00015875962,0.00016330821],"domain_scores_gemma":[0.9943681,0.004220416,0.00083255477,0.00018726624,0.00024770512,0.0001440061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025701302,0.00008460183,0.0004263394,0.000047258294,0.00017764446,0.00000650738,0.00026235756,0.00006792147,0.0001629485],"category_scores_gemma":[0.0016015533,0.000031417894,0.0002124194,0.00008882166,0.0003852309,0.00010825706,0.000050537077,0.0005004785,0.000010856251],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0784186,0.0040332843,0.20311151,0.0021426333,0.009091179,0.00003103924,0.03357999,0.00056545914,0.018189453,0.00071528036,0.47073027,0.1793913],"study_design_scores_gemma":[0.041775893,0.0028409096,0.9296672,0.0008637074,0.002849301,0.00054920063,0.00070735044,0.0004018893,0.003779713,0.001538606,0.014910168,0.000116090196],"about_ca_topic_score_codex":0.000010631782,"about_ca_topic_score_gemma":0.0000030637302,"teacher_disagreement_score":0.72655565,"about_ca_system_score_codex":0.000009796921,"about_ca_system_score_gemma":0.00011966082,"threshold_uncertainty_score":0.21743578},"labels":[],"label_agreement":null},{"id":"W2109918996","doi":"10.1002/j.1552-4604.2002.tb05998.x","title":"Cannabidiol: An Overview of Some Pharmacological Aspects","year":2002,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":506,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Wilfrid Laurier University","funders":"","keywords":"Cannabidiol; Cannabinoid; Pharmacology; Cannabis; Endocannabinoid system; Cannabinoid receptor; Antipsychotic; Anandamide; Mechanism of action; Chemistry; Tetrahydrocannabinol; Mechanism (biology); Medicine; Receptor; Schizophrenia (object-oriented programming); Psychiatry; Biochemistry","score_opus":0.43935877927221867,"score_gpt":0.5887265220845699,"score_spread":0.1493677428123512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109918996","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014907088,0.98868597,0.000001492225,0.004709995,0.0033715689,0.0011109061,0.00003087123,0.000016206266,0.0005822823],"genre_scores_gemma":[0.00022919991,0.98664975,0.000026355108,0.0024570287,0.008099289,0.000021957618,0.000006774922,0.00007444545,0.0024351717],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98899996,0.004429283,0.0045835567,0.00035931717,0.0009788251,0.0006490257],"domain_scores_gemma":[0.993438,0.0009929367,0.0033734934,0.0004705059,0.00076843565,0.00095664285],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.007841162,0.0005149425,0.0060800835,0.00036894175,0.00008918829,0.000013000813,0.0012940957,0.00077432266,0.004810943],"category_scores_gemma":[0.00081548584,0.0002653645,0.0026327185,0.0005189182,0.001014097,0.00014259777,0.00028702742,0.00461794,0.00007535836],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091763085,0.0019954662,0.000008111644,0.006426545,0.0021399965,0.0007917351,0.00003724386,0.0000034014847,0.000067816574,0.00011183273,0.35922527,0.6282749],"study_design_scores_gemma":[0.0028942525,0.004948062,0.00009456357,0.0019058217,0.011494459,0.0025278826,0.000014696057,0.000025529516,0.000039316954,0.00014047672,0.9756888,0.00022612313],"about_ca_topic_score_codex":0.000013129363,"about_ca_topic_score_gemma":0.0000015980665,"teacher_disagreement_score":0.62804884,"about_ca_system_score_codex":0.00016786666,"about_ca_system_score_gemma":0.002418881,"threshold_uncertainty_score":0.99997985},"labels":[],"label_agreement":null},{"id":"W2112914725","doi":"10.1177/0091270006297226","title":"Pharmacokinetics and Pharmacodynamics of Once‐Daily Controlled‐Release Oxybutynin and Immediate‐Release Oxybutynin","year":2007,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Purdue Pharma (Canada)","funders":"","keywords":"Oxybutynin; Pharmacokinetics; Pharmacodynamics; Crossover study; Medicine; Anesthesia; Pharmacology; Urology; Chemistry; Overactive bladder","score_opus":0.05100878752085448,"score_gpt":0.45186913944050794,"score_spread":0.40086035191965347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112914725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983902,0.0067610727,0.00036924574,0.006226861,0.0011112918,0.00073544064,0.000024334544,0.000013433441,0.00085635565],"genre_scores_gemma":[0.9564316,0.03841595,0.00033639275,0.0026907537,0.001658439,0.0000033794663,0.0000037054683,0.000035991394,0.00042375998],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9950629,0.0010600272,0.0024165467,0.00024164197,0.0006242019,0.00059466896],"domain_scores_gemma":[0.9905905,0.006486189,0.0011072694,0.0001832343,0.0006481808,0.0009846414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009932011,0.0002870909,0.001469013,0.00027829522,0.00011335581,0.000012516301,0.00031159207,0.00021079574,0.00046829137],"category_scores_gemma":[0.00083707215,0.00018282727,0.00031127952,0.00025907528,0.0012195958,0.00013309233,0.00019569391,0.001973668,0.000008691869],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.31294665,0.0055999923,0.059553146,0.00086819864,0.00544306,0.0040555834,0.0017339241,0.0002403593,0.3621376,0.000101286874,0.04362531,0.20369491],"study_design_scores_gemma":[0.46849683,0.04011726,0.19280827,0.0005196206,0.020020707,0.012572266,0.0024528252,0.057163943,0.11440963,0.0015139652,0.088387534,0.0015371554],"about_ca_topic_score_codex":0.000017532222,"about_ca_topic_score_gemma":0.0000026007203,"teacher_disagreement_score":0.24772795,"about_ca_system_score_codex":0.000036822614,"about_ca_system_score_gemma":0.0004512627,"threshold_uncertainty_score":0.8574716},"labels":[],"label_agreement":null},{"id":"W2114457800","doi":"10.1177/00912700222011193","title":"Multiple‐Dose, Safety, Pharmacokinetics, and Pharmacodynamics of a New Selective Estrogen Receptor Modulator, ERA‐923, in Healthy Postmenopausal Women","year":2002,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Pharmacokinetics; Medicine; Pharmacodynamics; Tolerability; Placebo; Adverse effect; Selective estrogen receptor modulator; Internal medicine; Estrogen; Tamoxifen; Pharmacology; Breast cancer; Oncology; Cancer","score_opus":0.022099064252359652,"score_gpt":0.3476892674425801,"score_spread":0.3255902031902205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114457800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98878044,0.007915972,0.000068125984,0.0015956408,0.0011139343,0.00038421372,0.000018137367,0.0000057305238,0.00011783006],"genre_scores_gemma":[0.9693664,0.027508587,0.00042719982,0.0015000945,0.0010367342,0.000003949787,0.0000056632834,0.000033672517,0.0001177059],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966486,0.0010032548,0.0014262162,0.00025538096,0.00020850151,0.0004580605],"domain_scores_gemma":[0.9978526,0.000525059,0.0008632461,0.00015292733,0.00018559021,0.00042058196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017684848,0.0002468987,0.0006630876,0.00011348728,0.000065479566,0.000006123958,0.00039415335,0.0003036243,0.00011484782],"category_scores_gemma":[0.00022139009,0.00018260384,0.00015447858,0.00021093716,0.00031400248,0.0000142070285,0.00015876433,0.0010759847,0.0000071023032],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02527077,0.0014766747,0.010542476,0.000048953014,0.0013997483,0.000042902568,0.0007435226,0.0021589173,0.9067359,0.000012741392,0.020733058,0.030834317],"study_design_scores_gemma":[0.17324908,0.083567955,0.04389524,0.00021858535,0.0026899506,0.0023824323,0.0007992426,0.055224407,0.5229263,0.0008360238,0.111763805,0.0024470338],"about_ca_topic_score_codex":0.000016654003,"about_ca_topic_score_gemma":0.0000027229712,"teacher_disagreement_score":0.3838097,"about_ca_system_score_codex":0.000055244684,"about_ca_system_score_gemma":0.00023406094,"threshold_uncertainty_score":0.74463683},"labels":[],"label_agreement":null},{"id":"W2115198007","doi":"10.1002/jcph.335","title":"An evaluation of oral dabigatran etexilate pharmacokinetics and pharmacodynamics in hemodialysis","year":2014,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Capital District Health Authority; Nova Scotia Health Authority; Dalhousie University","funders":"","keywords":"Dabigatran; Medicine; Hemodialysis; Cmax; Pharmacokinetics; Pharmacodynamics; Direct thrombin inhibitor; Warfarin; Anesthesia; Pharmacology; Atrial fibrillation; Anticoagulant; Internal medicine","score_opus":0.20264000342271588,"score_gpt":0.5325608484467391,"score_spread":0.32992084502402325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115198007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99286807,0.0002026885,0.0005168233,0.0048022084,0.0010117437,0.0002896451,0.0000012396471,0.0000057206294,0.0003018942],"genre_scores_gemma":[0.9957979,0.0012892559,0.0005174884,0.0011491153,0.0012096002,4.244737e-7,0.0000025682157,0.000011516963,0.000022143216],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9960807,0.0018376794,0.0013866845,0.00010712013,0.00044420583,0.00014360205],"domain_scores_gemma":[0.9975254,0.0010408247,0.0007994964,0.00011587016,0.00037413428,0.00014425618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01347195,0.00010921431,0.000662635,0.00017846923,0.000028970639,0.0000050554736,0.00015823153,0.00008315681,0.00024643852],"category_scores_gemma":[0.000439554,0.000071658,0.00017334074,0.00020535321,0.00019903858,0.00012114249,0.000036047564,0.00039772352,0.0000022454278],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0093183555,0.00036385012,0.46782902,0.00012386646,0.0009516633,0.00001657001,0.0005597511,0.03151891,0.12954016,0.00013241348,0.0015104067,0.35813504],"study_design_scores_gemma":[0.02832653,0.0015946231,0.36943832,0.000033781846,0.008315824,0.000056008765,0.000094504874,0.57850325,0.006072151,0.0012598679,0.006152617,0.00015250695],"about_ca_topic_score_codex":0.0000061544815,"about_ca_topic_score_gemma":0.000004568007,"teacher_disagreement_score":0.5469844,"about_ca_system_score_codex":0.000023904478,"about_ca_system_score_gemma":0.00009445644,"threshold_uncertainty_score":0.46691358},"labels":[],"label_agreement":null},{"id":"W2117179744","doi":"10.1177/0091270006296421","title":"Potential Interactions Between Pharmaceuticals and Natural Health Products in Canada","year":2007,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Complementary and Alternative Medicine Studies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; Ontario Clinical Oncology Group","funders":"","keywords":"Medicine; Population; Environmental health; Drug; Family medicine; Pharmacology","score_opus":0.15330381352389033,"score_gpt":0.5394708613179644,"score_spread":0.38616704779407407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117179744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.936712,0.0017733388,0.000105145824,0.05762572,0.0035137369,0.00020064041,0.00000257515,0.0000021294145,0.00006471171],"genre_scores_gemma":[0.98821265,0.0010423267,0.00013448541,0.006719943,0.0038297924,3.9093962e-7,0.0000012047351,0.000004737481,0.00005447159],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99792004,0.000368405,0.0011693767,0.000089435656,0.00021295248,0.00023982029],"domain_scores_gemma":[0.99711907,0.002059045,0.00042469826,0.000051401257,0.00014616699,0.00019961817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034874529,0.0000856456,0.00053790084,0.000077408666,0.00006537904,0.0000014538398,0.00009947813,0.0000057652237,0.00011541517],"category_scores_gemma":[0.00038075578,0.000049694463,0.00004769107,0.00011683453,0.00017267339,0.000046368103,0.00006773879,0.0010676407,8.1381114e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035634188,0.00027938775,0.8134957,0.00007606398,0.00083493243,0.00051253114,0.00035247835,0.000008758137,0.0021739933,0.000013778118,0.03115311,0.14753588],"study_design_scores_gemma":[0.0048612566,0.0006991454,0.95845884,0.00004670991,0.0003027986,0.00042784598,0.00063512864,0.000047251382,0.0010576445,0.000055141383,0.03335701,0.000051220046],"about_ca_topic_score_codex":0.025693405,"about_ca_topic_score_gemma":0.05460987,"teacher_disagreement_score":0.14748466,"about_ca_system_score_codex":0.00014301234,"about_ca_system_score_gemma":0.00076351274,"threshold_uncertainty_score":0.9807946},"labels":[],"label_agreement":null},{"id":"W2118216302","doi":"10.1177/0091270011403740","title":"Effects of Alcohol on the Pharmacokinetics of Morphine Sulfate and Naltrexone Hydrochloride Extended Release Capsules","year":2011,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celerion (Canada)","funders":"","keywords":"Naltrexone; Pharmacokinetics; Pharmacology; Morphine; Bioavailability; Crossover study; Alcohol; Opioid; Narcotic antagonist; Drug; Medicine; Anesthesia; Chemistry; Internal medicine; Biochemistry","score_opus":0.07106933015080256,"score_gpt":0.38791553595837497,"score_spread":0.3168462058075724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118216302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919188,0.002226623,0.00002186183,0.0041161077,0.00079613633,0.00054072187,0.0000062763525,0.000006737091,0.0003667118],"genre_scores_gemma":[0.98766154,0.009816824,0.00018517474,0.0018395346,0.0003924799,0.0000060054936,7.566421e-7,0.000022674207,0.0000750227],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99723923,0.000685421,0.0013885358,0.00013507255,0.00033492278,0.00021680482],"domain_scores_gemma":[0.9945341,0.0035094258,0.0012614344,0.00022056616,0.00026660514,0.0002078798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017525398,0.00019337662,0.0008731616,0.000100305515,0.000043515443,0.0000015492385,0.00027862386,0.00009394911,0.00025035546],"category_scores_gemma":[0.00072812225,0.000094373165,0.00026481057,0.00013907994,0.0005912173,0.00003743735,0.00008072738,0.00070579146,0.0000074187783],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0748977,0.016599081,0.013601263,0.0010940777,0.008043613,0.0011744495,0.003956527,0.00011362305,0.8405022,0.00051421847,0.021958925,0.017544335],"study_design_scores_gemma":[0.02080811,0.0077316863,0.19659105,0.0002464686,0.0058586155,0.00026246515,0.00015878913,0.00036840505,0.76590365,0.0013505289,0.00058808277,0.00013212045],"about_ca_topic_score_codex":0.000029387425,"about_ca_topic_score_gemma":7.694919e-7,"teacher_disagreement_score":0.18298979,"about_ca_system_score_codex":0.000016953314,"about_ca_system_score_gemma":0.00013676328,"threshold_uncertainty_score":0.38484257},"labels":[],"label_agreement":null},{"id":"W2118693119","doi":"10.1177/0091270006292163","title":"Drug‐Disease Interactions: Losartan Effect Is Not Downregulated by Rheumatoid Arthritis","year":2006,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Receptor Mechanisms and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Losartan; Rheumatoid arthritis; Active metabolite; Pharmacology; Metabolite; Medicine; Arthritis; Inflammation; Pharmacokinetics; Internal medicine; Endocrinology; Angiotensin II; Chemistry; Receptor","score_opus":0.012671496766233704,"score_gpt":0.3470690022118119,"score_spread":0.3343975054455782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118693119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901515,0.00414653,0.0006302721,0.0026489373,0.0021259373,0.000152242,0.000020903868,0.00000656199,0.00011711866],"genre_scores_gemma":[0.99066,0.0046005514,0.00008028477,0.002613517,0.0014823306,0.0000040283107,0.000017331446,0.000020290428,0.0005216263],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99754125,0.0008479534,0.001034877,0.00017172059,0.00017701424,0.00022716532],"domain_scores_gemma":[0.998476,0.0003929272,0.0006245124,0.00016184073,0.00016488969,0.00017978015],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018496542,0.00016007297,0.00038620277,0.00003737313,0.00011038632,0.000017713888,0.00031436284,0.00010880664,0.00114642],"category_scores_gemma":[0.00014790035,0.00010812274,0.00035278438,0.00006447473,0.00015012307,0.000009971402,0.00006879133,0.0004242971,0.000028567643],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034227697,0.00017101124,0.00041696412,0.000005073185,0.00016420691,0.00001422004,0.00000996844,0.00015160342,0.6756532,0.0000075146986,0.31705645,0.002927019],"study_design_scores_gemma":[0.0033129533,0.0011401488,0.00049956696,0.000039768765,0.00011678573,0.000094308554,0.000015337782,0.00023661944,0.7846802,0.0002717848,0.20942494,0.00016759367],"about_ca_topic_score_codex":0.000015820053,"about_ca_topic_score_gemma":0.000004532245,"teacher_disagreement_score":0.10902698,"about_ca_system_score_codex":0.000010964958,"about_ca_system_score_gemma":0.000093059825,"threshold_uncertainty_score":0.99976665},"labels":[],"label_agreement":null},{"id":"W2120703255","doi":"10.1002/jcph.436","title":"Interactions of the hepatitis C virus protease inhibitor faldaprevir with cytochrome P450 enzymes: In vitro and in vivo correlation","year":2014,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Hepatitis C virus research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"CYP3A; CYP2B6; CYP2C9; Pharmacology; Midazolam; CYP3A4; In vivo; Pharmacokinetics; In vitro; CYP2D6; Protease inhibitor (pharmacology); Chemistry; Cytochrome P450; Biology; Virology; Microsome; Enzyme; Virus; Biochemistry; Viral load","score_opus":0.04768740136658928,"score_gpt":0.4200101933250173,"score_spread":0.37232279195842805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120703255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944525,0.0001504069,0.00017399495,0.0038632583,0.00031431287,0.00065734354,0.0000065440063,0.0000031809952,0.00037850428],"genre_scores_gemma":[0.9975486,0.0007620657,0.0001538576,0.0009872372,0.00042867672,0.000014444755,4.075232e-7,0.000012762462,0.000091944166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99641436,0.0018119208,0.0011653074,0.00010905955,0.0003178172,0.0001815269],"domain_scores_gemma":[0.9965276,0.0023969484,0.00059272,0.00015470228,0.00019444719,0.00013357133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003149145,0.00010028904,0.0005461971,0.00017089807,0.000039472194,0.0000051537513,0.000179354,0.000091504255,0.00023827926],"category_scores_gemma":[0.0016978546,0.000052348623,0.00008996,0.00027340648,0.0004032726,0.0001305908,0.00008254464,0.0014003514,0.000005170784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018213445,0.0013381983,0.49278003,0.00014161268,0.00021384991,0.0001151734,0.00074022386,0.00041859248,0.46443442,0.000026769854,0.0042031677,0.017374502],"study_design_scores_gemma":[0.0138914995,0.003039233,0.8351113,0.0006498151,0.00034196483,0.00035649727,0.000077625686,0.012129012,0.12329027,0.00019543341,0.0107694315,0.00014787003],"about_ca_topic_score_codex":0.00034601163,"about_ca_topic_score_gemma":0.0006715663,"teacher_disagreement_score":0.3423313,"about_ca_system_score_codex":0.000073835756,"about_ca_system_score_gemma":0.00028771648,"threshold_uncertainty_score":0.6083908},"labels":[],"label_agreement":null},{"id":"W2123329990","doi":"10.1002/jcph.281","title":"Implications of serum creatinine measurements on GFR estimation and vancomycin dosing in children","year":2014,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Dosing; Renal function; Creatinine; Vancomycin; Pharmacokinetics; Urology; Medicine; Chemistry; Pharmacology; Internal medicine","score_opus":0.06810537494621932,"score_gpt":0.4423548053465175,"score_spread":0.3742494304002982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123329990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930959,0.00024511645,0.00011503902,0.005450488,0.00016546319,0.0001624035,0.0000036871152,0.0000034513541,0.00075849134],"genre_scores_gemma":[0.99657977,0.00017986388,0.00026421298,0.0026199927,0.00033694605,0.0000012343578,0.0000016402942,0.000006095017,0.000010275336],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857306,0.00034240956,0.00077317725,0.00006935324,0.00013569438,0.00010632624],"domain_scores_gemma":[0.9981765,0.0010184901,0.00045973563,0.00009951644,0.00010426319,0.00014146177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002083939,0.00006585851,0.00036980485,0.00007388472,0.000027892525,0.0000021298754,0.00008397323,0.000050994222,0.00011596128],"category_scores_gemma":[0.0009361243,0.000041589403,0.00007282593,0.000080874845,0.00011220269,0.000041609805,0.000022950779,0.00027720645,0.0000029682328],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087779615,0.0006785082,0.9290419,0.00003289449,0.0002117344,6.701481e-7,0.00005297473,0.00039205927,0.0051139644,0.00004086888,0.0034366357,0.06011997],"study_design_scores_gemma":[0.0065101446,0.0009344992,0.9868296,0.00010654351,0.00046612602,0.000024940133,0.000006649638,0.0012430445,0.0029757388,0.00074290065,0.0001245349,0.000035327375],"about_ca_topic_score_codex":0.0000042428082,"about_ca_topic_score_gemma":0.0000012745066,"teacher_disagreement_score":0.060084645,"about_ca_system_score_codex":0.000023353337,"about_ca_system_score_gemma":0.00013581153,"threshold_uncertainty_score":0.16959667},"labels":[],"label_agreement":null},{"id":"W2126315888","doi":"10.1177/0091270009335766","title":"Iatrogenic Severe Depression of High‐Density Lipoprotein Cholesterol","year":2009,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Health Sciences Centre","funders":"","keywords":"Fibrate; Fenofibrate; Medicine; Cholesterol; Internal medicine; Drug; Depression (economics); Statin; Endocrinology; Pharmacology","score_opus":0.035605492307966544,"score_gpt":0.3924006890397838,"score_spread":0.35679519673181725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126315888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98991203,0.0019038032,0.00038695842,0.0061973147,0.0010108956,0.00040257614,0.0000015235482,0.000009900397,0.00017499585],"genre_scores_gemma":[0.98943585,0.001477666,0.0004337491,0.005622405,0.0029567417,0.0000010460341,6.916105e-7,0.000010793329,0.00006106394],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99681056,0.0009356851,0.0013884602,0.00012805137,0.00050810154,0.0002291345],"domain_scores_gemma":[0.99779826,0.0002989264,0.00094090507,0.00033675024,0.00035075902,0.0002743847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049625477,0.00012768082,0.0010063645,0.000065332875,0.000060665156,0.0000030143106,0.00025909624,0.00019241213,0.00015428055],"category_scores_gemma":[0.00028697576,0.0000718638,0.0009136919,0.00012638875,0.00013477293,0.000068232875,0.000052198673,0.0010393899,0.000012710779],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018564548,0.002324667,0.0100520635,0.00019281526,0.0027394646,0.00033318953,0.000218345,0.00025577054,0.04591349,0.000034824905,0.024318596,0.8950522],"study_design_scores_gemma":[0.018201854,0.0059426716,0.8977279,0.00019472378,0.0033925902,0.005173297,0.000048047783,0.00006110335,0.06312701,0.0012292637,0.004736165,0.0001653807],"about_ca_topic_score_codex":0.00008781034,"about_ca_topic_score_gemma":0.0000049035953,"teacher_disagreement_score":0.89488685,"about_ca_system_score_codex":0.000029872248,"about_ca_system_score_gemma":0.0002909475,"threshold_uncertainty_score":0.45156893},"labels":[],"label_agreement":null},{"id":"W2126980140","doi":"10.1177/0091270007299759","title":"Single‐Dose Pharmacokinetics of Multilayer‐Release Methylphenidate and Immediate‐Release Methylphenidate in Children With Attention‐Deficit/Hyperactivity Disorder","year":2007,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Purdue Pharma (Canada); Royal University Hospital","funders":"","keywords":"Methylphenidate; Pharmacokinetics; Attention deficit hyperactivity disorder; Controlled release; Medicine; Immediate release; Attention deficit disorder; Pharmacology; Anesthesia; Pediatrics; Psychiatry","score_opus":0.05213842800743826,"score_gpt":0.4118467299516465,"score_spread":0.3597083019442082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126980140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99289894,0.0011416351,0.0019080051,0.002635053,0.0005666057,0.00075542287,0.000016908043,0.00001927075,0.00005813958],"genre_scores_gemma":[0.99592793,0.0015475452,0.0009903995,0.00087844,0.0005053968,0.0000041797457,0.000010316391,0.000060510574,0.00007527915],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99492997,0.0012179046,0.0022855792,0.00035417947,0.0006620855,0.0005503025],"domain_scores_gemma":[0.9938801,0.0028534662,0.001919879,0.00030656077,0.00058089325,0.00045913074],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0055407733,0.00037556505,0.0014049906,0.00039140263,0.00009123983,0.000012398082,0.0003124429,0.00024189342,0.0003452358],"category_scores_gemma":[0.0008804878,0.00024927605,0.00033744515,0.0005503884,0.0007363973,0.00034305386,0.00015551319,0.0019561297,0.0000141443115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011733503,0.0046593947,0.80632704,0.000049567694,0.0011250129,0.00013765242,0.000100458994,0.0006046663,0.14723061,0.0000045679503,0.00011438621,0.027913123],"study_design_scores_gemma":[0.025684938,0.0019489452,0.96117616,0.00006753819,0.0028659257,0.0009110966,0.00060676155,0.0010045547,0.00503225,0.00002356244,0.00038975934,0.00028848276],"about_ca_topic_score_codex":0.00007790582,"about_ca_topic_score_gemma":0.000040132254,"teacher_disagreement_score":0.15484914,"about_ca_system_score_codex":0.000058490306,"about_ca_system_score_gemma":0.00022832694,"threshold_uncertainty_score":0.99999595},"labels":[],"label_agreement":null},{"id":"W2128897405","doi":"10.1177/0091270011415528","title":"Evaluation of Exposure Change of Nonrenally Eliminated Drugs in Patients With Chronic Kidney Disease Using Physiologically Based Pharmacokinetic Modeling and Simulation","year":2012,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Physiologically based pharmacokinetic modelling; Pharmacokinetics; Pharmacology; Telithromycin; Repaglinide; Renal function; Bioavailability; Medicine; Bioequivalence; In vivo; Chemistry; Internal medicine; Antibacterial agent; Antibiotics; Biology","score_opus":0.16298244757660132,"score_gpt":0.45662863504824647,"score_spread":0.29364618747164517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128897405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969459,0.0012599046,0.00023354091,0.0004465227,0.00028520744,0.00080802705,0.000007808015,0.0000039506413,0.000009114439],"genre_scores_gemma":[0.99806,0.00021972861,0.00012153887,0.0011019418,0.00047566197,0.0000067888645,0.0000036659762,0.0000101687165,5.4398e-7],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9964792,0.0015492275,0.0010233893,0.00011235177,0.0006064535,0.00022934703],"domain_scores_gemma":[0.9966186,0.0011527487,0.00086926925,0.00007655428,0.0010044298,0.00027836315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005350392,0.00014879632,0.00068457983,0.00011429711,0.00003811834,0.0000015227658,0.00010209626,0.00008167577,0.0001212701],"category_scores_gemma":[0.0009738291,0.00007990796,0.00011269452,0.000182363,0.00024037079,0.00013831355,0.000055165096,0.00041555165,2.9546752e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035638135,0.005522075,0.29536554,0.00047054412,0.00081607053,0.00000636679,0.0005095357,0.6020742,0.04174305,0.0000013650695,0.000053552743,0.01779958],"study_design_scores_gemma":[0.013521521,0.0021053015,0.4606667,0.00015735558,0.002505446,6.9187894e-7,0.000010701159,0.5204219,0.0005289664,0.00001618083,0.000005202916,0.00006001097],"about_ca_topic_score_codex":0.0000051043967,"about_ca_topic_score_gemma":3.1656765e-7,"teacher_disagreement_score":0.16530114,"about_ca_system_score_codex":0.000075393116,"about_ca_system_score_gemma":0.00027295537,"threshold_uncertainty_score":0.3258552},"labels":[],"label_agreement":null},{"id":"W2131499894","doi":"10.1177/00912700122012706","title":"Pharmacokinetics and Tolerability of GW420867X, a Nonnucleoside Reverse Transcriptase Inhibitor, following Single Escalating Doses in Healthy Male Volunteers","year":2001,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Smiths Detection (Canada)","funders":"","keywords":"Pharmacokinetics; Cmax; Pharmacology; Dosing; Tolerability; Medicine; Reverse-transcriptase inhibitor; Adverse effect; Placebo; Human immunodeficiency virus (HIV); Viral load; Immunology; Antiretroviral therapy","score_opus":0.06472534940166322,"score_gpt":0.4050944900719915,"score_spread":0.3403691406703283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131499894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98380375,0.0009331137,0.000050096918,0.013328671,0.001093755,0.00035355872,0.000002901622,0.000007707764,0.00042646652],"genre_scores_gemma":[0.9946693,0.0013951935,0.0013115697,0.0018059947,0.00042268483,0.0000025578024,0.0000013239459,0.000016023674,0.00037533973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967157,0.0006168584,0.0019289711,0.00016606193,0.0002811798,0.00029122946],"domain_scores_gemma":[0.9976257,0.0013514985,0.0005204074,0.000112775495,0.00012921783,0.00026038056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030301635,0.00016909985,0.0009171354,0.00017709752,0.000059221235,0.000004720226,0.0001252099,0.000109043096,0.0002822779],"category_scores_gemma":[0.0004228231,0.00011502824,0.00026985456,0.00029487157,0.00023993988,0.00010912345,0.00004274785,0.0006908534,0.000003599376],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022221694,0.004741897,0.83205944,0.00021492851,0.0009178925,0.0014168146,0.0033578204,0.00015722054,0.10246548,0.000004710892,0.013539514,0.01890261],"study_design_scores_gemma":[0.25218725,0.026643684,0.43011862,0.0029282267,0.014340848,0.0070011015,0.0082585355,0.008018612,0.07383946,0.00064038584,0.17434339,0.0016798835],"about_ca_topic_score_codex":0.000023484672,"about_ca_topic_score_gemma":0.000016617507,"teacher_disagreement_score":0.4019408,"about_ca_system_score_codex":0.00008600711,"about_ca_system_score_gemma":0.00021667489,"threshold_uncertainty_score":0.46907154},"labels":[],"label_agreement":null},{"id":"W2134568577","doi":"10.1177/0091270003262106","title":"Teaching Application of Clinical Pharmacology Skills Using Unusual Observations from Clozapine Overdoses","year":2004,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Clozapine; Medicine; Pharmacokinetics; Dosing; Drug; Pharmacology; Absorption (acoustics); Clinical pharmacology; Toxicity; Intensive care medicine; Schizophrenia (object-oriented programming); Psychiatry; Internal medicine","score_opus":0.3675259103323184,"score_gpt":0.5928112687652362,"score_spread":0.22528535843291775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134568577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96754956,0.0007044679,0.0067583146,0.01845819,0.005795599,0.00053407013,0.000023116976,0.000020559055,0.00015611145],"genre_scores_gemma":[0.9655674,0.0020794934,0.0056215664,0.019818584,0.006816577,0.0000033030835,0.000010786367,0.000029714874,0.000052561823],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99306107,0.0019804903,0.0038947656,0.00025158457,0.00048125882,0.00033086215],"domain_scores_gemma":[0.985286,0.010383175,0.0032060917,0.00024440538,0.00044857882,0.0004317485],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0062118936,0.00022715116,0.0014006345,0.00011983772,0.00015349689,0.00000694287,0.0004742455,0.00030141472,0.00028065266],"category_scores_gemma":[0.0021173009,0.0001498698,0.000622199,0.00022838234,0.00059101894,0.0003062775,0.00016268372,0.0026102692,0.000022492273],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027838469,0.018402303,0.6212727,0.0002268133,0.0064168526,0.00023415437,0.0009495435,0.010064886,0.24382828,0.00076429854,0.015147937,0.054853767],"study_design_scores_gemma":[0.072560646,0.0069712573,0.5703884,0.00028210029,0.017327027,0.0005975523,0.00037917154,0.029197522,0.019341698,0.0055192714,0.27677724,0.0006581205],"about_ca_topic_score_codex":0.00018170656,"about_ca_topic_score_gemma":0.0000046135137,"teacher_disagreement_score":0.2616293,"about_ca_system_score_codex":0.00007348853,"about_ca_system_score_gemma":0.00063492527,"threshold_uncertainty_score":0.9996908},"labels":[],"label_agreement":null},{"id":"W2135186116","doi":"10.1177/00912700122010168","title":"Effect of Alosetron on the Pharmacokinetics of Alprazolam","year":2001,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Anesthesia and Sedative Agents","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Alprazolam; Medicine; Pharmacokinetics; CYP3A4; Pharmacology; Crossover study; Irritable bowel syndrome; Internal medicine; Gastroenterology; Placebo; Cytochrome P450; Anxiety","score_opus":0.07925662576691779,"score_gpt":0.47852998843760375,"score_spread":0.39927336267068597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135186116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98853844,0.00026080562,0.000046770154,0.008830738,0.0006628654,0.00028550474,0.0000013308459,0.0000030619879,0.0013705015],"genre_scores_gemma":[0.99253166,0.002039594,0.000018425766,0.004355163,0.0008206505,0.0000012197261,5.5158245e-7,0.000012060534,0.00022066543],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963936,0.0018525228,0.0011612895,0.0000747791,0.0003537098,0.00016405084],"domain_scores_gemma":[0.99056673,0.007861557,0.00107538,0.00016542505,0.00021997569,0.00011092585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053727147,0.00012258768,0.00075252197,0.00006317926,0.000034627094,0.0000011501443,0.00033842825,0.00008663361,0.0008479454],"category_scores_gemma":[0.0007468928,0.000051688945,0.00034729956,0.00014968438,0.00044655704,0.000026763488,0.000036736106,0.0007682002,0.00002049125],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12748332,0.0046571568,0.24208947,0.00029956078,0.0043354738,0.00080952107,0.00078552176,0.00049400685,0.32617432,0.00028477484,0.21807292,0.07451395],"study_design_scores_gemma":[0.032683037,0.064546764,0.23319557,0.00030715973,0.008248526,0.0014910498,0.00017254427,0.0013002901,0.53065675,0.000291025,0.12686501,0.00024228296],"about_ca_topic_score_codex":0.0000024365268,"about_ca_topic_score_gemma":1.392143e-7,"teacher_disagreement_score":0.20448242,"about_ca_system_score_codex":0.000012972213,"about_ca_system_score_gemma":0.000080571284,"threshold_uncertainty_score":0.92844075},"labels":[],"label_agreement":null},{"id":"W2138758167","doi":"10.1177/00912700222011210","title":"Multiple‐Dose, Linear, Dose‐Proportional Pharmacokinetics of Retigabine in Healthy Volunteers","year":2002,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Pharmacokinetics; Medicine; Evening; Placebo; Population; Morning; Volume of distribution; Pharmacology; Oral administration; Anesthesia; Internal medicine","score_opus":0.13995706701739158,"score_gpt":0.478575900618726,"score_spread":0.33861883360133443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138758167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9706127,0.0016768471,0.00003270685,0.025648532,0.0010044908,0.0004395755,0.000008890704,0.0000074242585,0.0005688207],"genre_scores_gemma":[0.9838027,0.01077955,0.00071588426,0.0029805016,0.0013189431,0.000004931646,0.0000035898206,0.000018269084,0.00037564308],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99599576,0.0007651015,0.0021274348,0.00014865301,0.0005830555,0.00037999862],"domain_scores_gemma":[0.9960716,0.0020945787,0.00075392413,0.00016898301,0.00046835025,0.00044257968],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0031536655,0.0001529668,0.0008302507,0.00019761075,0.000041486303,0.0000021195942,0.00026171026,0.00013245289,0.002291782],"category_scores_gemma":[0.0010824883,0.00009190454,0.000307435,0.00029205688,0.0005183389,0.000056806573,0.000066222965,0.0014204698,0.000050202252],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06157863,0.014150194,0.7492907,0.00027635772,0.0018187001,0.001258763,0.00053463486,0.0012380198,0.021095116,0.000027471802,0.1220655,0.026665889],"study_design_scores_gemma":[0.109613195,0.032284103,0.7548966,0.00025864737,0.001557737,0.0013086917,0.00022390345,0.042696208,0.009087715,0.00021888291,0.04753069,0.00032366777],"about_ca_topic_score_codex":0.000025131072,"about_ca_topic_score_gemma":0.00000936624,"teacher_disagreement_score":0.07453481,"about_ca_system_score_codex":0.00007634987,"about_ca_system_score_gemma":0.00027605647,"threshold_uncertainty_score":0.9986203},"labels":[],"label_agreement":null},{"id":"W2138799068","doi":"10.1177/0091270007307571","title":"A Randomized Study of the Bioavailability of Different Formulations of Coenzyme Q<sub>10</sub> (Ubiquinone)","year":2007,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Coenzyme Q10 studies and effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Biostatistics; Medicine; Library science; Family medicine; Internal medicine; Computer science","score_opus":0.041513446203637554,"score_gpt":0.3941344114753074,"score_spread":0.35262096527166986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138799068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971323,0.00055077416,0.00038303112,0.00036537353,0.00081520353,0.0006812051,0.0000064628366,0.0000013523721,0.0000643166],"genre_scores_gemma":[0.9989027,0.0004927011,0.000020082543,0.00014963746,0.00040005162,0.000003612299,7.859454e-7,0.00000881804,0.000021660275],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99611473,0.0013251785,0.00199567,0.00012459655,0.00024957833,0.00019024457],"domain_scores_gemma":[0.9948917,0.0024547223,0.0017883222,0.0003005014,0.000491704,0.00007305255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0064037996,0.00014012033,0.0009902247,0.000042435477,0.0000664189,0.0000013801554,0.00042873115,0.00012179479,0.000038894395],"category_scores_gemma":[0.0011964038,0.00006931573,0.000593091,0.000129694,0.00069569086,0.000003425238,0.00028641036,0.00029014077,5.416447e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12738547,0.003418544,0.011297351,0.000061809835,0.0016482109,0.0000021355372,0.00041489935,0.00014181665,0.8354152,0.000029745543,0.019508159,0.00067669136],"study_design_scores_gemma":[0.108106166,0.0046093822,0.059982963,0.00002781341,0.0013241197,0.000015277565,0.00033752553,0.00009558457,0.8246971,0.00019878928,0.0004914333,0.00011389883],"about_ca_topic_score_codex":0.000016268756,"about_ca_topic_score_gemma":0.00007686763,"teacher_disagreement_score":0.04868561,"about_ca_system_score_codex":0.000009698469,"about_ca_system_score_gemma":0.00008347828,"threshold_uncertainty_score":0.28266132},"labels":[],"label_agreement":null},{"id":"W2138869278","doi":"10.1177/0091270005279799","title":"FTY720, a Novel Immunomodulator in de Novo Kidney Transplant Patients: Pharmacokinetics and Exposure‐Response Relationship","year":2005,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Pharmacokinetics; Volume of distribution; Medicine; Population; Pharmacology; Urology; Renal function; Distribution (mathematics); Internal medicine","score_opus":0.029964187003614383,"score_gpt":0.35836579525568396,"score_spread":0.3284016082520696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138869278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99470794,0.0012931345,0.0010592112,0.0019864053,0.0007829443,0.00012506326,0.000016688608,0.000002866079,0.00002572311],"genre_scores_gemma":[0.99087167,0.0013837866,0.0008434522,0.005361521,0.0014752627,0.0000023828911,0.0000044338603,0.000016289283,0.000041221032],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99771047,0.0008063113,0.0009831486,0.0001330905,0.00012810262,0.00023888536],"domain_scores_gemma":[0.9985594,0.0006270973,0.00036613495,0.000113993694,0.00012228296,0.0002110515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003951617,0.00013036725,0.00029720052,0.0000733413,0.00005954132,0.0000087928265,0.0002746068,0.00016423395,0.00003811185],"category_scores_gemma":[0.00094318145,0.000095101874,0.00012091989,0.0000800024,0.00015263473,0.000012427015,0.000050884413,0.00050986576,0.0000022343916],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0154454885,0.00068809127,0.12791772,0.000012291818,0.00016344419,0.000010019872,0.00049077184,0.0016980944,0.8487827,0.000014616703,0.0023403165,0.002436405],"study_design_scores_gemma":[0.03858988,0.0018827701,0.7107938,0.000062819694,0.000651958,0.0004531856,0.00008254909,0.0013555206,0.09029298,0.00007994778,0.1553415,0.0004130775],"about_ca_topic_score_codex":0.0000027014287,"about_ca_topic_score_gemma":0.0000020897385,"teacher_disagreement_score":0.7584897,"about_ca_system_score_codex":0.000014634203,"about_ca_system_score_gemma":0.00023444605,"threshold_uncertainty_score":0.38781416},"labels":[],"label_agreement":null},{"id":"W2139025099","doi":"10.1177/0091270010365554","title":"The In Vitro Platelet Toxicity Assay (iPTA): A Novel Approach for Assessment of Drug Hypersensitivity Syndrome","year":2010,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Drug; Toxicity; In vitro; Medicine; Pharmacology; Platelet; Hypersensitivity reaction; Immunology; Chemistry; Internal medicine","score_opus":0.08553915562320197,"score_gpt":0.44641309873995777,"score_spread":0.3608739431167558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139025099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98501277,0.000019212557,0.0022355232,0.0067436667,0.0026750749,0.00063740264,0.000021602591,0.0000071244053,0.0026476157],"genre_scores_gemma":[0.9932323,0.00008603365,0.0049338485,0.0008814718,0.0007120443,0.000009762798,0.0000025508564,0.000018354749,0.00012361977],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9971979,0.00065056776,0.0013649252,0.00014773679,0.00033294613,0.00030587448],"domain_scores_gemma":[0.9894688,0.008753378,0.0010277578,0.00024282884,0.00031478703,0.00019243069],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0125064105,0.00014525397,0.0008480752,0.00010285418,0.000114080656,0.0000061930737,0.00028926812,0.00017706967,0.000008482058],"category_scores_gemma":[0.001440397,0.000078824254,0.00040250758,0.000171822,0.0004706911,0.0000907103,0.000075968455,0.0024911948,0.0000017237246],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001430374,0.003039684,0.0005414175,0.00004062246,0.00062081614,0.00007268486,0.00012234632,0.0002558084,0.9778338,0.000099498015,0.00067097216,0.015271962],"study_design_scores_gemma":[0.067814484,0.0021802695,0.52318555,0.0001481981,0.005047726,0.0209998,0.0034805639,0.10633075,0.20283805,0.0008450365,0.06632719,0.0008023601],"about_ca_topic_score_codex":0.000018323799,"about_ca_topic_score_gemma":0.00001493978,"teacher_disagreement_score":0.77499574,"about_ca_system_score_codex":0.00007191706,"about_ca_system_score_gemma":0.00058703317,"threshold_uncertainty_score":0.9998101},"labels":[],"label_agreement":null},{"id":"W2139517640","doi":"10.1177/00912700122009953","title":"Pharmacodynamic Modeling of Pantoprazole's Irreversible Effect on Gastric Acid Secretion in Humans and Rats","year":2001,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Pantoprazole; Gastric acid; Pharmacodynamics; Pharmacokinetics; Pentagastrin; Proton-pump inhibitor; Oral administration; Secretion; Chemistry; Stimulation; Internal medicine; Pharmacology; Placebo; Dose–response relationship; Endocrinology; Medicine; Omeprazole","score_opus":0.0560408509565002,"score_gpt":0.4287510628516842,"score_spread":0.372710211895184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139517640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99776566,0.00036179813,0.000235098,0.00047670968,0.0005640068,0.00025698263,0.0000017199816,0.000005266748,0.00033276068],"genre_scores_gemma":[0.9969339,0.00202747,0.000086405904,0.0005625942,0.00033074396,0.000001856125,0.0000019010345,0.000011571023,0.00004358219],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978979,0.0006112729,0.0009188191,0.00012115952,0.00022957842,0.00022126973],"domain_scores_gemma":[0.99849373,0.00071844837,0.00043951222,0.00009175519,0.00009382261,0.0001627155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021776776,0.00013814434,0.0006486943,0.0001953106,0.00003953759,0.0000026685889,0.00011912564,0.000091397866,0.00012735614],"category_scores_gemma":[0.00014376189,0.00008246488,0.00016294535,0.0001702892,0.00011067811,0.000075247845,0.000035053166,0.0007348258,0.000008416946],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02866535,0.002656294,0.7773392,0.00016520859,0.0011096128,0.0030149478,0.00028839888,0.0066828127,0.13764001,0.000010973941,0.00062591303,0.041801225],"study_design_scores_gemma":[0.10141648,0.048941907,0.6857093,0.0006567553,0.006696866,0.0029928251,0.00013296666,0.12728335,0.024762416,0.0008101116,0.0002861808,0.00031086017],"about_ca_topic_score_codex":0.0000054309703,"about_ca_topic_score_gemma":0.0000013459926,"teacher_disagreement_score":0.120600544,"about_ca_system_score_codex":0.000046739347,"about_ca_system_score_gemma":0.00007546704,"threshold_uncertainty_score":0.336282},"labels":[],"label_agreement":null},{"id":"W2140742930","doi":"10.1002/jcph.479","title":"Proton pump inhibitor use is not associated with cardiac arrhythmia in critically ill patients","year":2015,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Magnesium in Health and Disease","field":"Nursing","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"National Institute of Biomedical Imaging and Bioengineering; National Institute of General Medical Sciences","keywords":"Medicine; Cardiac arrhythmia; Hypomagnesemia; Internal medicine; Cardiology; Proton-pump inhibitor; Critically ill; Sudden cardiac death; Cohort; Cohort study; Heart failure; Atrial fibrillation","score_opus":0.09731841499499422,"score_gpt":0.4276299999289619,"score_spread":0.3303115849339677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140742930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96830285,0.00007101294,0.0000044923504,0.02503027,0.0055347723,0.0008228045,0.000025336933,0.00001420785,0.0001942423],"genre_scores_gemma":[0.9490807,0.000015828577,0.000070279195,0.048686128,0.0020581472,0.000016197055,0.0000025455088,0.000022680735,0.000047469828],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950802,0.0021606814,0.0015785184,0.00016773796,0.00055074017,0.0004621428],"domain_scores_gemma":[0.9926971,0.0029812648,0.0007516613,0.00015895088,0.0026140248,0.0007969936],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.004105081,0.00017223641,0.0006763958,0.0000987534,0.00006682719,0.000021740892,0.0002538368,0.00019871914,0.00011706195],"category_scores_gemma":[0.012699416,0.00010389802,0.00016607349,0.00020175382,0.00027088082,0.0002648111,0.0000545474,0.001084416,0.000027646436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06899673,0.0021488771,0.84761083,0.00014425235,0.000114769944,0.0002040278,0.00089278526,0.00012872322,0.00019964304,0.000005154501,0.07363329,0.0059209038],"study_design_scores_gemma":[0.03917796,0.015046271,0.884766,0.00017682604,0.0015498424,0.00003508121,0.00026959874,0.0010392797,0.0038034017,0.0007186015,0.05282931,0.00058781484],"about_ca_topic_score_codex":0.0000421318,"about_ca_topic_score_gemma":0.000007797706,"teacher_disagreement_score":0.037155166,"about_ca_system_score_codex":0.0001353779,"about_ca_system_score_gemma":0.00043985702,"threshold_uncertainty_score":0.99561703},"labels":[],"label_agreement":null},{"id":"W2141387431","doi":"10.1002/jcph.582","title":"Pharmacodynamics and tolerability of repository corticotropin injection in healthy human subjects: A comparison with intravenous methylprednisolone","year":2015,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals","keywords":"Tolerability; Medicine; Pharmacodynamics; Adverse effect; Methylprednisolone; Rheumatoid arthritis; Crossover study; Adrenocorticotropic hormone; Anesthesia; Hydrocortisone; Internal medicine; Pharmacology; Pharmacokinetics; Hormone; Placebo","score_opus":0.16443226951735881,"score_gpt":0.4961834245506466,"score_spread":0.3317511550332878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141387431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954294,0.0011671899,0.00020684752,0.0020898937,0.00051869155,0.00045088513,0.0000016782697,0.0000073396204,0.00012806569],"genre_scores_gemma":[0.9974187,0.0013348177,0.0004044905,0.00038044652,0.00043463745,0.0000049259697,6.959655e-7,0.0000112285525,0.000010033308],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995471,0.0018148486,0.0019023394,0.00015154385,0.00041536684,0.00024488586],"domain_scores_gemma":[0.9962602,0.0015757928,0.0010914021,0.00014728913,0.0006200996,0.00030519374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037220647,0.00012568038,0.0011346131,0.00014160012,0.00006692529,0.000004539957,0.0001550338,0.000096363714,0.000010769435],"category_scores_gemma":[0.00087146176,0.00007536976,0.00008321207,0.0002112922,0.00085616554,0.00007109553,0.00009144773,0.0012247703,4.969517e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07358735,0.0041450136,0.8298562,0.00028778653,0.00090936635,0.00010842258,0.0035717015,0.0015805978,0.07461673,0.0000071666873,0.001841395,0.009488246],"study_design_scores_gemma":[0.02598675,0.0344907,0.92259926,0.00014021748,0.00072454964,0.00058549613,0.0015864315,0.007986913,0.0054018083,0.00009292678,0.00027263735,0.00013229217],"about_ca_topic_score_codex":0.00025683525,"about_ca_topic_score_gemma":0.000122036734,"teacher_disagreement_score":0.092743054,"about_ca_system_score_codex":0.00014845816,"about_ca_system_score_gemma":0.00044757046,"threshold_uncertainty_score":0.53210855},"labels":[],"label_agreement":null},{"id":"W2143746873","doi":"10.1177/0091270009355814","title":"Role of Orally Available Antagonists of Factor Xa in the Treatment and Prevention of Thromboembolic Disease: Focus on Rivaroxaban","year":2010,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute","keywords":"Rivaroxaban; Apixaban; Medicine; Warfarin; Atrial fibrillation; Dabigatran; Clinical trial; Stroke (engine); Pharmacodynamics; Intensive care medicine; Internal medicine; Pharmacology; Pharmacokinetics","score_opus":0.11246280484235874,"score_gpt":0.46424650051919475,"score_spread":0.351783695676836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143746873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99531496,0.00027384303,0.0000046860446,0.003310951,0.00034013615,0.00034892673,0.0000056919566,0.0000017060737,0.0003990872],"genre_scores_gemma":[0.9976347,0.0015299415,0.000073462616,0.000119952805,0.00048831716,5.0336337e-7,9.944879e-7,0.000005279299,0.00014681926],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835694,0.00038209965,0.00092893635,0.000065002554,0.00017906426,0.00008793403],"domain_scores_gemma":[0.99772173,0.0011557405,0.00084388006,0.00013094496,0.00008472952,0.000063002226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012139471,0.000078794365,0.000553294,0.00007597446,0.000019514895,0.0000019705158,0.00012668702,0.00005565945,0.00037322042],"category_scores_gemma":[0.00019062862,0.000038033133,0.00020696707,0.00008586327,0.0001946227,0.000042977565,0.0000225316,0.00022175164,0.000002785857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012275929,0.0012245476,0.78122014,0.000110452995,0.00087365863,0.000012610126,0.00089448114,0.000048567807,0.17030592,0.00076798646,0.0019633474,0.030302359],"study_design_scores_gemma":[0.0060524857,0.003597242,0.9692521,0.00003741187,0.00089914154,0.0000068040595,0.000084943735,0.0000753212,0.012230557,0.0020485395,0.0056736674,0.00004179552],"about_ca_topic_score_codex":0.000013930563,"about_ca_topic_score_gemma":0.000009912318,"teacher_disagreement_score":0.18803196,"about_ca_system_score_codex":0.0000085506035,"about_ca_system_score_gemma":0.00009911792,"threshold_uncertainty_score":0.4086502},"labels":[],"label_agreement":null},{"id":"W2146447716","doi":"10.1177/0091270008317589","title":"Population Pharmacokinetic and Pharmacodynamic Analysis of Pegloticase in Subjects With Hyperuricemia and Treatment‐Failure Gout","year":2008,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Hyperuricemia; Gout; Pharmacodynamics; Medicine; Pharmacokinetics; Uric acid; Dosing; Pharmacology; Population; Internal medicine; Volume of distribution","score_opus":0.04565843014041542,"score_gpt":0.3927535771106155,"score_spread":0.34709514697020005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146447716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99642396,0.0010244763,0.000034506887,0.0018540632,0.00018858955,0.00035312324,0.000007671137,0.000009533473,0.000104084305],"genre_scores_gemma":[0.9928109,0.0055967276,0.00043563163,0.0007360537,0.0003149911,0.0000035109933,0.0000057893403,0.000021675072,0.00007468817],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99717003,0.00065892795,0.0013501089,0.0002225507,0.00032864846,0.0002697341],"domain_scores_gemma":[0.9968774,0.0016379122,0.00085947016,0.00016221411,0.00017513496,0.00028788712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011739809,0.00022926163,0.0013630309,0.00051392964,0.000067581524,0.0000035152339,0.00013218097,0.00013948903,0.00014790613],"category_scores_gemma":[0.00016518467,0.0001339589,0.00019189568,0.0008350971,0.00048134595,0.000120307195,0.000047422454,0.0006778019,0.0000016935131],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008779782,0.001097523,0.95210385,0.000057231602,0.005153199,0.0011096373,0.0008640951,0.0014168584,0.023316657,0.0000030220092,0.00029322217,0.0058049257],"study_design_scores_gemma":[0.018066013,0.002766609,0.93736386,0.000040543422,0.022916058,0.0036770608,0.00015350567,0.01353862,0.0009866408,0.000011993571,0.00032217376,0.00015691451],"about_ca_topic_score_codex":0.000106990534,"about_ca_topic_score_gemma":0.000046912864,"teacher_disagreement_score":0.022330016,"about_ca_system_score_codex":0.0000835967,"about_ca_system_score_gemma":0.0001763734,"threshold_uncertainty_score":0.5462685},"labels":[],"label_agreement":null},{"id":"W2150253814","doi":"10.1002/jcph.418","title":"Effect of faldaprevir on raltegravir pharmacokinetics in healthy volunteers","year":2014,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Hepatitis C virus research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"Boehringer Ingelheim","keywords":"Raltegravir; Pharmacology; Pharmacokinetics; Medicine; Integrase inhibitor; Adverse effect; Virology; Human immunodeficiency virus (HIV); Viral load; Antiretroviral therapy","score_opus":0.07340238251602631,"score_gpt":0.5299250640556625,"score_spread":0.4565226815396362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150253814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877147,0.00033409693,0.000063837804,0.0077797067,0.0014372685,0.00048774626,0.0000026586763,0.0000063542966,0.0021736238],"genre_scores_gemma":[0.9890596,0.0034155843,0.0000647382,0.0060393577,0.0013059501,0.0000038865887,7.3197555e-7,0.000022545331,0.00008757606],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99173146,0.00544106,0.0017871459,0.00013528418,0.00055052515,0.00035450057],"domain_scores_gemma":[0.9891579,0.009465471,0.0006063138,0.00021336942,0.00022156158,0.00033536213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015740048,0.00015397527,0.0011414993,0.00024447372,0.00002956607,0.0000027423084,0.00040396219,0.0001482059,0.0004387736],"category_scores_gemma":[0.0031707226,0.000087173015,0.00029726437,0.0002686076,0.0003910625,0.00004102263,0.000066866174,0.002054489,0.00007226839],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14402045,0.0023565744,0.18491738,0.0008168819,0.00077802036,0.00027845197,0.00030376404,0.0013191886,0.03393943,0.00006885879,0.0847931,0.5464079],"study_design_scores_gemma":[0.12840962,0.23649828,0.14893058,0.0009916985,0.0026180488,0.00038077106,0.000052144842,0.028845577,0.09748215,0.00030496102,0.3549351,0.0005510552],"about_ca_topic_score_codex":0.0000345448,"about_ca_topic_score_gemma":0.0000062406207,"teacher_disagreement_score":0.54585683,"about_ca_system_score_codex":0.00006657345,"about_ca_system_score_gemma":0.00024217421,"threshold_uncertainty_score":0.8925847},"labels":[],"label_agreement":null},{"id":"W2150276412","doi":"10.1177/0091270004265642","title":"The Influence of St. John's Wort on CYP2C19 Activity with Respect to Genotype","year":2004,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Genotype; CYP2C19; Medicine; Traditional medicine; Pharmacology; Genetics; Biology; Gene","score_opus":0.14819380871095922,"score_gpt":0.5163174603508064,"score_spread":0.36812365163984717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150276412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779232,0.00072932703,0.0001263653,0.015851725,0.0035378367,0.00053993444,0.000027556778,0.000016509905,0.00124751],"genre_scores_gemma":[0.9806641,0.004033407,0.00016094638,0.013311536,0.0016232051,0.000011216047,4.1976764e-7,0.000033120537,0.00016206998],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.99455774,0.0025525382,0.0014817119,0.00025975727,0.0005319157,0.00061633426],"domain_scores_gemma":[0.9914161,0.00563294,0.0013928948,0.00035952398,0.00063213316,0.0005664172],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.008633412,0.00031081578,0.00081720034,0.00014694055,0.00041775688,0.000015482825,0.0014210831,0.00027122657,0.00026741993],"category_scores_gemma":[0.00067676,0.00016159315,0.0002884436,0.0004913696,0.0010056115,0.00010777042,0.00020810662,0.0028026095,0.00007941072],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09248932,0.0037305856,0.006727504,0.00004727743,0.0032684884,0.00040400936,0.0013618998,0.45725945,0.33735245,0.0015092988,0.031087667,0.06476203],"study_design_scores_gemma":[0.017080443,0.008087569,0.1380798,0.0000700835,0.0022929388,0.00031177874,0.00011356207,0.00016850038,0.24142678,0.0034306946,0.5883823,0.0005555328],"about_ca_topic_score_codex":0.00001703245,"about_ca_topic_score_gemma":0.000026953234,"teacher_disagreement_score":0.55729467,"about_ca_system_score_codex":0.000072192044,"about_ca_system_score_gemma":0.0007349928,"threshold_uncertainty_score":0.99949795},"labels":[],"label_agreement":null},{"id":"W2150283025","doi":"10.1177/0091270008319465","title":"Pharmacokinetics of High‐Dose Abetimus Sodium in Normal Subjects With Specific Assessment of Effect on Coagulation","year":2008,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; St. Joseph's Hospital","funders":"","keywords":"Partial thromboplastin time; Pharmacokinetics; Medicine; Pharmacology; Prothrombin time; Adverse effect; Placebo; Thromboplastin; Dose; Dose–response relationship; Coagulation; Internal medicine","score_opus":0.07607168347934419,"score_gpt":0.4454504800145086,"score_spread":0.3693787965351644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150283025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961896,0.00025849708,0.00010594783,0.0009831403,0.0009973103,0.0006791459,0.0000030315693,0.000005299612,0.00077805284],"genre_scores_gemma":[0.99735343,0.0012419285,0.00030203277,0.00021153284,0.0007740572,0.000004413082,0.0000017345086,0.000023462177,0.00008739466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99495316,0.0017806182,0.0019315194,0.00014580235,0.0009016195,0.00028728406],"domain_scores_gemma":[0.99346274,0.0043329187,0.0013177866,0.00022901266,0.00047758414,0.00017994316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005451455,0.0001690911,0.0012550696,0.00030232512,0.000033555818,0.0000017483842,0.0002999774,0.00013471945,0.0002581989],"category_scores_gemma":[0.00022552017,0.0000946596,0.00019181236,0.00034564,0.00055021484,0.000055643275,0.000057057827,0.0011399069,0.0000067112132],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050878294,0.0026816379,0.7894247,0.00063416205,0.00077809696,0.00091006124,0.0005238959,0.0035583181,0.13962649,0.000030648374,0.008635183,0.0023185257],"study_design_scores_gemma":[0.057582755,0.026639542,0.7805068,0.00073560706,0.0006838565,0.008422717,0.00010098452,0.0020168768,0.12245954,0.00003277078,0.0006434284,0.00017514927],"about_ca_topic_score_codex":0.000014784007,"about_ca_topic_score_gemma":0.000002033798,"teacher_disagreement_score":0.023957903,"about_ca_system_score_codex":0.00009666961,"about_ca_system_score_gemma":0.0005172466,"threshold_uncertainty_score":0.4952392},"labels":[],"label_agreement":null},{"id":"W2153132143","doi":"10.1002/jcph.526","title":"Evaluation of the effect of food and gastric pH on the single‐dose pharmacokinetics of cabozantinib in healthy adult subjects","year":2015,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celerion (Canada)","funders":"Exelixis","keywords":"Cabozantinib; Pharmacokinetics; Esomeprazole; Bioavailability; Tyrosine-kinase inhibitor; Medicine; Pharmacology; Medullary thyroid cancer; Gastroenterology; Concomitant; Drug interaction; Internal medicine; Drug; Cancer; Thyroid cancer","score_opus":0.12958508742111535,"score_gpt":0.44994349247232857,"score_spread":0.3203584050512132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153132143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927823,0.0013056459,0.0000029066666,0.0036995185,0.00095624034,0.0009373694,0.000006363934,0.0000020622622,0.00030758357],"genre_scores_gemma":[0.9981553,0.0006596905,0.00002180136,0.0008031139,0.0003342797,0.0000051362595,5.205317e-7,0.000013321198,0.0000068644745],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9926406,0.004597454,0.0015228837,0.00011295263,0.0009303235,0.0001957864],"domain_scores_gemma":[0.9911876,0.0058616903,0.001787333,0.00023300195,0.00079619803,0.00013422815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013254119,0.00014628851,0.0007922614,0.00010782339,0.00002381279,0.0000014328974,0.00027452526,0.00010479026,0.000049548267],"category_scores_gemma":[0.0048287525,0.000063993924,0.00018248019,0.00032020695,0.00043335633,0.000030641273,0.00007916867,0.0007574206,0.0000012175868],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20509219,0.010684793,0.2760863,0.0012001282,0.0061124195,0.000075083524,0.004697,0.007036682,0.2835727,0.00010064611,0.021989629,0.18335244],"study_design_scores_gemma":[0.19954167,0.09735869,0.19928692,0.0009034323,0.01236779,0.000586804,0.00038071748,0.0073851733,0.48104262,0.00055747695,0.00039039797,0.00019830235],"about_ca_topic_score_codex":0.00002214836,"about_ca_topic_score_gemma":0.000011571219,"teacher_disagreement_score":0.19746992,"about_ca_system_score_codex":0.00018730522,"about_ca_system_score_gemma":0.0010543743,"threshold_uncertainty_score":0.57808167},"labels":[],"label_agreement":null},{"id":"W2153400265","doi":"10.1177/0091270011405524","title":"Pregnancy Outcomes Following Use of Escitalopram: A Prospective Comparative Cohort Study","year":2011,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Escitalopram; Medicine; Prospective cohort study; Pregnancy; Cohort study; Cohort; Obstetrics; Internal medicine; Psychiatry; Anxiety; Antidepressant","score_opus":0.2805889978629389,"score_gpt":0.49912108651699827,"score_spread":0.21853208865405938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153400265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946094,0.00040977602,0.000028610855,0.0002043158,0.0027292143,0.0014386253,0.0000034550233,0.000010311919,0.0005662628],"genre_scores_gemma":[0.99847394,0.00013034859,0.0003349962,0.0005360245,0.000119885495,0.000010225061,3.0035545e-7,0.000012029212,0.00038225128],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99664897,0.0009163914,0.0017260732,0.00013556599,0.0003471546,0.00022587564],"domain_scores_gemma":[0.9967307,0.0014762452,0.001162193,0.00018528245,0.00024255391,0.00020303726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001991005,0.0001541253,0.0011829658,0.000076267475,0.00006876598,0.000003493437,0.00022661773,0.00007750402,0.00023432016],"category_scores_gemma":[0.00024723835,0.000085470114,0.00033771142,0.00010636003,0.00020327112,0.00016956206,0.00008249541,0.0007302822,0.000018499608],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037358068,0.0029454788,0.9872509,0.00012030105,0.0015159351,0.00023326495,0.003847957,0.000002881196,0.00006369173,0.000017600241,0.00014093485,0.00012520862],"study_design_scores_gemma":[0.0051141237,0.0058441292,0.9836737,0.000789203,0.0014151633,0.000064466854,0.00034389977,0.000009746993,0.002489506,0.00014357502,0.000040780676,0.000071739356],"about_ca_topic_score_codex":0.000049115424,"about_ca_topic_score_gemma":0.000006265355,"teacher_disagreement_score":0.0038645111,"about_ca_system_score_codex":0.00003279581,"about_ca_system_score_gemma":0.0001476742,"threshold_uncertainty_score":0.348537},"labels":[],"label_agreement":null},{"id":"W2153778965","doi":"10.1002/jcph.570","title":"Pharmacokinetics and pharmacodynamics of a human monoclonal anti‐FGF23 antibody (KRN23) in the first multiple ascending‐dose trial treating adults with X‐linked hypophosphatemia","year":2015,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Shriners Hospitals for Children - Canada","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Kyowa Hakko Kirin; University of California, San Francisco; Shriners Hospitals for Children; Yale University","keywords":"Pharmacokinetics; Pharmacodynamics; Hypophosphatemia; Medicine; Pharmacology; Monoclonal antibody; Antibody; Internal medicine; Immunology","score_opus":0.08344190394491893,"score_gpt":0.4537382079247536,"score_spread":0.3702963039798347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153778965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937773,0.002533734,0.00002242228,0.0017386711,0.00066531735,0.0009957791,0.0000126978775,0.000009091902,0.00024499247],"genre_scores_gemma":[0.99573034,0.0023136311,0.00023041312,0.0008923342,0.00075990695,0.0000105320205,0.000010702869,0.000026715783,0.00002543419],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99664325,0.00065485685,0.0016678402,0.00021120747,0.00048104164,0.00034183296],"domain_scores_gemma":[0.99619156,0.0017921849,0.0012949127,0.00017673393,0.000282589,0.0002620221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029699588,0.0002691965,0.0010245814,0.00013800617,0.00011723654,0.000012836628,0.00035285443,0.00013642367,0.00001711022],"category_scores_gemma":[0.0003209642,0.0001370031,0.00019854556,0.0002930158,0.00046963274,0.00011453345,0.00007321904,0.00095647946,0.0000027688545],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.35129246,0.009421346,0.6031581,0.00009553461,0.0018468159,0.0012444603,0.004629317,0.0009352021,0.01425559,0.00001733441,0.010187613,0.002916175],"study_design_scores_gemma":[0.7301775,0.021278413,0.21829677,0.00021289587,0.0041920473,0.0010476167,0.0020448542,0.018134013,0.0021862003,0.00014651606,0.0019092961,0.00037385846],"about_ca_topic_score_codex":0.000076999946,"about_ca_topic_score_gemma":0.000026106094,"teacher_disagreement_score":0.38486138,"about_ca_system_score_codex":0.00004599594,"about_ca_system_score_gemma":0.000265205,"threshold_uncertainty_score":0.55868244},"labels":[],"label_agreement":null},{"id":"W2155235311","doi":"10.1177/0091270009355155","title":"Operating Characteristics of a Partial‐Block Randomized Crossover Bioequivalence Study for Dutasteride, a Drug with a Long Half‐Life: Investigation Through Simulation and Comparison with Final Results","year":2010,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Bioequivalence; Crossover study; Dutasteride; Crossover; Medicine; Randomized controlled trial; Block (permutation group theory); Sample size determination; Mathematics; Computer science; Pharmacology; Statistics; Pharmacokinetics; Surgery; Internal medicine; Machine learning; Placebo","score_opus":0.5556653165397538,"score_gpt":0.6166235713161934,"score_spread":0.06095825477643957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155235311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9131724,0.000016565069,0.082695425,0.0013094951,0.0008869759,0.0018598419,0.000036454487,0.0000111467325,0.000011704843],"genre_scores_gemma":[0.8254018,0.000018091852,0.17335582,0.0003348039,0.0008265625,0.000023910303,7.8997635e-7,0.000023285054,0.000014933165],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9900211,0.0043892968,0.0046082553,0.00026626256,0.000461996,0.00025307687],"domain_scores_gemma":[0.7896844,0.20352508,0.0053081065,0.00027220693,0.0009996842,0.00021048919],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0246826,0.00023498923,0.002234624,0.0000467669,0.00014939296,0.000043431995,0.00031983617,0.00014389619,0.00003182161],"category_scores_gemma":[0.1082863,0.00012391794,0.00015808162,0.000148242,0.0015364903,0.00017685589,0.00009466806,0.0010540329,6.2361903e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94413704,0.003453296,0.03120411,0.0004974963,0.002428699,0.000048105314,0.006466128,0.003156459,0.0033291036,0.0014305977,0.000940642,0.0029083195],"study_design_scores_gemma":[0.75352776,0.015438302,0.028272329,0.00066459156,0.01146119,0.00013750556,0.0008360814,0.120654166,0.0055980035,0.062512696,0.00016305548,0.0007343303],"about_ca_topic_score_codex":0.00001326157,"about_ca_topic_score_gemma":0.000016462129,"teacher_disagreement_score":0.20033668,"about_ca_system_score_codex":0.000009877831,"about_ca_system_score_gemma":0.0002600566,"threshold_uncertainty_score":0.899225},"labels":[],"label_agreement":null},{"id":"W2157210369","doi":"10.1002/jcph.387","title":"Pregnancy-induced changes in the long-term pharmacokinetics of 1.1 mg vs. 5 mg folic acid: A randomized clinical trial","year":2014,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Canadian Nutrition Society; University of Toronto; Hospital for Sick Children","funders":"Duchesnay","keywords":"Pharmacokinetics; Medicine; Pregnancy; Randomized controlled trial; Folic acid; Gestation; Gestational age; Internal medicine; Folic acid supplementation; Gastroenterology; Endocrinology; Biology","score_opus":0.18560481331910206,"score_gpt":0.5281143321011844,"score_spread":0.34250951878208236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157210369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9752924,0.0011339559,0.00009299663,0.017982084,0.0032003724,0.0018035471,0.000002327383,0.000008786591,0.00048355295],"genre_scores_gemma":[0.97715974,0.01190153,0.000055546854,0.0051262868,0.0055575464,0.000027431503,0.0000020804696,0.000027164491,0.00014267895],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9825558,0.012294681,0.003588574,0.00023400511,0.0008190372,0.00050791394],"domain_scores_gemma":[0.97606987,0.020981457,0.0017661365,0.00042468306,0.00045409027,0.00030375936],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.036630724,0.0002440143,0.0024865689,0.00023941862,0.000065462445,0.000013181322,0.0010220159,0.00035699047,0.0004478758],"category_scores_gemma":[0.006833237,0.00011525109,0.0009474481,0.00035368116,0.0009440914,0.000069369155,0.00017305455,0.0027776712,0.000025537434],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9058138,0.003196885,0.005174481,0.00012304177,0.0012011374,0.00021984828,0.00043917852,0.0000032888813,0.016908726,0.000022483227,0.0057183905,0.061178748],"study_design_scores_gemma":[0.9460156,0.013837084,0.025414597,0.00030932066,0.0029462862,0.00028336898,0.00004984168,0.0010085669,0.0075086798,0.00018934588,0.0022735414,0.00016377955],"about_ca_topic_score_codex":0.0000112183625,"about_ca_topic_score_gemma":0.000021524358,"teacher_disagreement_score":0.06101497,"about_ca_system_score_codex":0.00002414486,"about_ca_system_score_gemma":0.00038137758,"threshold_uncertainty_score":0.999523},"labels":[],"label_agreement":null},{"id":"W2157932545","doi":"10.1177/00912700022009558","title":"Who Needs Individual Bioequivalence Studies for Narrow Therapeutic Index Drugs? A Case for Warfarin","year":2000,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cegep de Sainte Foy","funders":"","keywords":"Bioequivalence; Warfarin; Medicine; Pharmacokinetics; Crossover study; Pharmacology; Therapeutic index; Replicate; CYP2C9; Internal medicine; Drug; Statistics; Mathematics; Placebo","score_opus":0.421124098491936,"score_gpt":0.5880239667940168,"score_spread":0.1668998683020808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157932545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95296407,0.02396154,0.00049193745,0.01045074,0.0099080475,0.0015557198,0.0002248271,0.000038328264,0.00040482086],"genre_scores_gemma":[0.95246047,0.013685669,0.00032224943,0.026165683,0.005625824,0.00011888119,0.0000043895498,0.000062916515,0.0015539271],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9932654,0.0026400182,0.0025165847,0.0003218655,0.00033762518,0.00091852696],"domain_scores_gemma":[0.9845149,0.01265185,0.0012639601,0.00025305228,0.000789224,0.0005270317],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.011560675,0.00045472174,0.0013809794,0.00025940622,0.0006662938,0.000027662649,0.001262336,0.00052829727,0.0015189149],"category_scores_gemma":[0.00047408824,0.00030945273,0.0008156457,0.00039012593,0.0012247084,0.0001966038,0.00014637999,0.0019035278,0.000031615753],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03144833,0.0024309678,0.0018404482,0.00032206296,0.009836498,0.00044637374,0.010813419,0.008350524,0.013964014,0.00056752126,0.2306054,0.68937445],"study_design_scores_gemma":[0.022960665,0.0022764516,0.00053448067,0.000025507152,0.0076781088,0.0020848496,0.0016333398,0.008402975,0.013497857,0.0070613325,0.9332677,0.0005767379],"about_ca_topic_score_codex":0.0000046447135,"about_ca_topic_score_gemma":0.0000033628237,"teacher_disagreement_score":0.7026623,"about_ca_system_score_codex":0.000047587884,"about_ca_system_score_gemma":0.00038821693,"threshold_uncertainty_score":0.99993575},"labels":[],"label_agreement":null},{"id":"W2160527274","doi":"10.1177/0091270010377503","title":"Response to “Role of Orally Available Antagonists of Factor Xa in the Treatment and Prevention of Thromboembolic Disease: Focus on Rivaroxaban”","year":2011,"lang":"en","type":"letter","venue":"The Journal of Clinical Pharmacology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Dosing; Rivaroxaban; Medicine; Regimen; Knee replacement; Surgery; Anesthesia; Internal medicine; Arthroplasty; Warfarin; Atrial fibrillation","score_opus":0.08548956022768175,"score_gpt":0.4107141093005324,"score_spread":0.3252245490728507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160527274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87180096,0.0011125075,0.0000046623413,0.12488456,0.0005550968,0.0012017895,0.000057594563,0.0000031619668,0.00037964704],"genre_scores_gemma":[0.92894274,0.010043113,0.000100311205,0.059348863,0.0011301696,0.000024137411,0.0000065138956,0.00003674224,0.00036739113],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9948175,0.0023032452,0.0019487635,0.00021456426,0.0004440397,0.00027191915],"domain_scores_gemma":[0.9948073,0.0025515368,0.0018743718,0.00042359348,0.00020862973,0.00013457818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029774457,0.0002655398,0.0019460695,0.00028556417,0.000032256805,0.000004283191,0.0004603219,0.00026598555,0.0005927948],"category_scores_gemma":[0.00030053005,0.00013891335,0.00046550293,0.0001569437,0.0003374133,0.000040908788,0.000086735905,0.00090923894,0.000011757262],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036919307,0.010787072,0.005414929,0.0005692196,0.0031627712,0.00038584278,0.0029833128,0.00002377693,0.011067315,0.000058245514,0.917655,0.010973193],"study_design_scores_gemma":[0.011714955,0.044348564,0.47209677,0.0011478615,0.0074134367,0.000056940735,0.00020106645,0.000009752104,0.0098386565,0.0021140538,0.4507601,0.00029783315],"about_ca_topic_score_codex":0.00009169763,"about_ca_topic_score_gemma":0.000008862214,"teacher_disagreement_score":0.46689492,"about_ca_system_score_codex":0.00006372997,"about_ca_system_score_gemma":0.0003900083,"threshold_uncertainty_score":0.6490688},"labels":[],"label_agreement":null},{"id":"W2162908443","doi":"10.1177/0091270007308615","title":"Assessment of Pharmacokinetics and Pharmacodynamic Effects Related to Abuse Potential of a Unique Oral Osmotic‐Controlled Extended‐Release Methylphenidate Formulation in Humans","year":2007,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Methylphenidate; Placebo; Stimulant; Crossover study; Pharmacodynamics; Pharmacokinetics; Pharmacology; Anesthesia; Controlled release; Medicine; Attention deficit hyperactivity disorder; Psychiatry","score_opus":0.03448215947735757,"score_gpt":0.4752178458980692,"score_spread":0.44073568642071165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162908443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98640716,0.00023613886,0.010047339,0.0011609356,0.00084183825,0.0011867579,0.000003921584,0.000009500538,0.00010640209],"genre_scores_gemma":[0.99671227,0.000708481,0.0015612011,0.00079678744,0.0001294277,0.0000042663632,0.0000030279418,0.000027001122,0.000057540146],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.995027,0.0013735521,0.0026680855,0.00018027975,0.00045105244,0.0003000326],"domain_scores_gemma":[0.9944559,0.0029917513,0.0016233622,0.00015561545,0.000513524,0.00025990017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0077432203,0.00020372972,0.0013978182,0.0004529466,0.000038114238,0.0000038138844,0.00019387392,0.00017199047,0.00019206743],"category_scores_gemma":[0.0005719549,0.00014396122,0.0003334252,0.00037805023,0.00019076988,0.00014476222,0.00006861955,0.0011236125,0.0000016232233],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024887698,0.0037422467,0.03872112,0.00023797338,0.0014918348,0.0003145793,0.00045807744,0.008842551,0.90806943,0.00010860362,0.00011989275,0.013006015],"study_design_scores_gemma":[0.08505164,0.0038597265,0.8513093,0.0001803994,0.004935091,0.00022325541,0.00030048643,0.04192168,0.011504498,0.00038813488,0.00011363399,0.00021215767],"about_ca_topic_score_codex":0.000014756587,"about_ca_topic_score_gemma":0.000008585008,"teacher_disagreement_score":0.8965649,"about_ca_system_score_codex":0.00006346982,"about_ca_system_score_gemma":0.00019157707,"threshold_uncertainty_score":0.5870569},"labels":[],"label_agreement":null},{"id":"W2164900475","doi":"10.1177/0091270007305504","title":"Ciprofloxacin Prolonged‐Release Tablets Do Not Affect Warfarin Pharmacokinetics and Pharmacodynamics","year":2007,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baker Hughes (Canada)","funders":"","keywords":"Pharmacokinetics; Warfarin; Pharmacodynamics; Ciprofloxacin; Crossover study; Medicine; Pharmacology; Prothrombin time; Drug interaction; Partial thromboplastin time; Anticoagulant; Antibiotics; Internal medicine; Chemistry; Atrial fibrillation; Coagulation; Placebo","score_opus":0.16523373510749947,"score_gpt":0.5281118326839626,"score_spread":0.36287809757646305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164900475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9655806,0.008510392,0.0012227845,0.00497965,0.016337888,0.001044393,0.00006883794,0.00007227773,0.0021831868],"genre_scores_gemma":[0.95002264,0.02143918,0.0005140363,0.020866549,0.0065654535,0.000014148195,0.000005553014,0.00009793557,0.00047450248],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9896214,0.0040247007,0.0035618152,0.00057676726,0.00075247616,0.0014628123],"domain_scores_gemma":[0.9872296,0.007828686,0.0022514465,0.00036939743,0.0007547343,0.0015661333],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.026733158,0.00071428996,0.0015292417,0.00043408727,0.0005327641,0.000048612976,0.0015047806,0.00074980926,0.0015653118],"category_scores_gemma":[0.00079654885,0.00051846635,0.0005625559,0.0006236869,0.0014882195,0.00029635473,0.0005590667,0.0055498057,0.00010500291],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023611495,0.002491904,0.014822937,0.0001790069,0.0027857139,0.001127872,0.0013194056,0.0029069283,0.6360517,0.00039816755,0.05440171,0.25990316],"study_design_scores_gemma":[0.025388302,0.0015044431,0.019115992,0.00004037321,0.006062386,0.001208619,0.0002763597,0.012308439,0.26668352,0.0008119255,0.6655609,0.0010387263],"about_ca_topic_score_codex":0.000010160911,"about_ca_topic_score_gemma":0.00000595155,"teacher_disagreement_score":0.6111592,"about_ca_system_score_codex":0.00009732119,"about_ca_system_score_gemma":0.00045768864,"threshold_uncertainty_score":0.9997267},"labels":[],"label_agreement":null},{"id":"W2172198715","doi":"10.1177/0091270011407196","title":"Low‐Density Lipoprotein Cholesterol and High‐Sensitivity C‐Reactive Protein Lowering With Atorvastatin in Patients of South Asian Compared With European Origin: Insights From the Achieve Cholesterol Targets Fast With Atorvastatin Stratified Titration (ACTFAST) Study","year":2011,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Heart Research Centre; Université Laval; Canadian Respiratory Research Network; McMaster University; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Atorvastatin; Internal medicine; Body mass index; Medicine; Cholesterol; C-reactive protein; Simvastatin; Endocrinology; Gastroenterology; Inflammation","score_opus":0.03404934312411262,"score_gpt":0.3015063388714265,"score_spread":0.2674569957473139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2172198715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99518156,0.000018559642,0.0014790555,0.00022210382,0.00012521393,0.0028714084,0.00001862514,0.000013389995,0.0000700574],"genre_scores_gemma":[0.99870056,0.000006555722,0.00057252817,0.00031366802,0.0003319028,0.000017390303,0.00000744194,0.000046088215,0.0000038721964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99408597,0.0032572204,0.0012470277,0.00035872243,0.0007516681,0.00029942225],"domain_scores_gemma":[0.99696195,0.00028647218,0.0015512999,0.00041270952,0.000521993,0.00026559486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003037056,0.00033587374,0.0011694329,0.00008845166,0.00013345186,0.00002220208,0.00020312906,0.00008437712,0.000016555603],"category_scores_gemma":[0.000081102,0.00016113537,0.00010625474,0.0002166375,0.00047180548,0.00024904992,0.00007532367,0.0013703009,0.0000027020183],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13350102,0.010568392,0.75091785,0.00025238557,0.0053326613,0.0012011421,0.05082451,0.00025679852,0.010254622,0.000010313497,0.000026783746,0.036853537],"study_design_scores_gemma":[0.020343387,0.011839484,0.95458764,0.00038808648,0.00068899256,0.000058314687,0.0030228405,0.00004212342,0.008836704,0.000013711934,0.000005424093,0.00017326501],"about_ca_topic_score_codex":0.0012460466,"about_ca_topic_score_gemma":0.002393727,"teacher_disagreement_score":0.20366983,"about_ca_system_score_codex":0.000059267506,"about_ca_system_score_gemma":0.00033140372,"threshold_uncertainty_score":0.6570909},"labels":[],"label_agreement":null},{"id":"W2172262068","doi":"10.1002/jcph.552","title":"Intranasal administration of crushed ALO‐02 (extended‐release oxycodone with sequestered naltrexone): A randomized, controlled abuse‐potential study in nondependent recreational opioid users","year":2015,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vale (Canada)","funders":"Pfizer","keywords":"Oxycodone; Naltrexone; Medicine; Opioid; Nasal administration; Anesthesia; Randomized controlled trial; Pharmacology; Surgery; Internal medicine","score_opus":0.04970508110535511,"score_gpt":0.40881595491288547,"score_spread":0.3591108738075304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2172262068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99096674,0.0006548971,0.0005595616,0.0030081058,0.0010176955,0.0035859093,0.000008373676,0.000012925067,0.00018580513],"genre_scores_gemma":[0.9969466,0.0009912277,0.00057500065,0.00062323257,0.00061550015,0.00007859005,0.000013282295,0.00002892557,0.00012765291],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9914295,0.0036259661,0.00341779,0.00024731565,0.0009824842,0.0002969389],"domain_scores_gemma":[0.99370164,0.0026128849,0.0021139325,0.0002470399,0.0008973443,0.0004271828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008160874,0.00029840597,0.0029713437,0.00027320374,0.000043202646,0.000014141128,0.0002786851,0.00016448468,0.00025469836],"category_scores_gemma":[0.0009361084,0.00016338626,0.00050938205,0.0002203406,0.00043864793,0.00015866716,0.000035345463,0.0008694957,0.000008049469],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96817887,0.010271317,0.011111382,0.000033957385,0.003909628,0.0010526547,0.0021639222,0.0012741827,0.00078361254,0.000015101717,0.0006742348,0.000531148],"study_design_scores_gemma":[0.93383145,0.015476131,0.03668325,0.0001449408,0.007408314,0.0006953084,0.002360347,0.0022451228,0.0006991598,0.00022086661,0.00005402095,0.00018109333],"about_ca_topic_score_codex":0.00009588823,"about_ca_topic_score_gemma":0.00011567685,"teacher_disagreement_score":0.03434741,"about_ca_system_score_codex":0.00014267115,"about_ca_system_score_gemma":0.0020880103,"threshold_uncertainty_score":0.6662698},"labels":[],"label_agreement":null},{"id":"W2188542029","doi":"10.1002/jcph.688","title":"Increased Risk of Adverse Renal Outcome Following Polyethylene Glycol Bowel Preparation Compared to Sodium Picosulfate","year":2015,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Potassium and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Western University","funders":"","keywords":"Medicine; Bowel preparation; Polyethylene glycol; Adverse effect; Sodium; Bisacodyl; Gastroenterology; Internal medicine; Urology; Colonoscopy; Colorectal cancer; Chemistry; Cancer","score_opus":0.08141559703530282,"score_gpt":0.44902245659959833,"score_spread":0.3676068595642955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2188542029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912954,0.00035551217,0.00044296574,0.0038460726,0.0026580768,0.00042892215,0.0000064526257,0.000015633768,0.00095094513],"genre_scores_gemma":[0.9959244,0.000173882,0.0004474077,0.002573963,0.0006646062,0.0000029208495,0.0000027838032,0.000015851328,0.00019417849],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99596506,0.0012137023,0.0019979076,0.00013073141,0.00043445057,0.00025817324],"domain_scores_gemma":[0.9965192,0.001054629,0.0012976215,0.00019390542,0.00033694,0.000597701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005312896,0.00015366256,0.0008879502,0.00014777642,0.0000626373,0.000002418897,0.0002696139,0.00019795769,0.00009734328],"category_scores_gemma":[0.0016958776,0.00009251728,0.0004878261,0.00020138657,0.00016914713,0.00009238647,0.00007491399,0.00090760586,0.000045347388],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15566503,0.0044930326,0.5616847,0.00008868288,0.0062803286,0.000540264,0.0032548204,0.013055231,0.12427839,0.000014798538,0.12853956,0.0021051364],"study_design_scores_gemma":[0.16160557,0.020500798,0.7062158,0.00039538296,0.024088677,0.0007914792,0.0023525942,0.011560617,0.03656778,0.00110119,0.033985913,0.0008341779],"about_ca_topic_score_codex":0.00008647729,"about_ca_topic_score_gemma":0.000009995678,"teacher_disagreement_score":0.14453109,"about_ca_system_score_codex":0.000057187834,"about_ca_system_score_gemma":0.00049758086,"threshold_uncertainty_score":0.39431465},"labels":[],"label_agreement":null},{"id":"W2260994960","doi":"10.1002/jcph.710","title":"Early Improvements in Individual Symptoms to Predict Later Remission in Major Depressive Disorder Treated With Mirtazapine","year":2016,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Japan Society for the Promotion of Science; Astellas Pharma; Meiji Seika Pharma; Kyowa Hakko Kirin; Dainippon Sumitomo Pharma","keywords":"Mirtazapine; Major depressive disorder; Placebo; Hamilton Rating Scale for Depression; Internal medicine; Depressive symptoms; Insomnia; Psychology; Depression (economics); Logistic regression; Rating scale; Psychiatry; Antidepressant; Medicine; Anxiety; Cognition","score_opus":0.034127921085280365,"score_gpt":0.3922577559557528,"score_spread":0.35812983487047245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2260994960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902584,0.00020106754,0.000031602194,0.008268643,0.0003971211,0.0007296223,0.000008557494,0.000013274442,0.00009173989],"genre_scores_gemma":[0.99735785,0.00021625709,0.0001750478,0.0012919841,0.00041308795,0.000018936718,0.000001967598,0.000028294873,0.0004965808],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99709487,0.00062022905,0.0012636436,0.00023271267,0.0004352364,0.00035328252],"domain_scores_gemma":[0.99768656,0.0010226237,0.00055494835,0.0002629419,0.00015808338,0.00031483127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013844641,0.00020410425,0.0006930337,0.00026206276,0.00003185573,0.000005837256,0.00038399428,0.00018188238,0.0003002133],"category_scores_gemma":[0.0005086613,0.00008341345,0.0001042073,0.000222193,0.0001372441,0.00015219777,0.00017479446,0.00058892026,0.000023755201],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021380091,0.0012619937,0.90686494,0.000011671978,0.0003479518,0.00040304847,0.00015824888,0.00001721221,0.03544017,3.5270767e-7,0.0033266894,0.03078763],"study_design_scores_gemma":[0.045399647,0.006206275,0.93552953,0.0005758791,0.00052995107,0.00008406688,0.000016462287,0.000012993127,0.010378505,0.00004350785,0.0011203131,0.00010285433],"about_ca_topic_score_codex":0.000041832944,"about_ca_topic_score_gemma":0.000026773838,"teacher_disagreement_score":0.030684777,"about_ca_system_score_codex":0.00008592894,"about_ca_system_score_gemma":0.00013218784,"threshold_uncertainty_score":0.34015018},"labels":[],"label_agreement":null},{"id":"W2280682835","doi":"10.1002/jcph.714","title":"Effect of Renal and Hepatic Impairment on the Pharmacokinetics of Cabozantinib","year":2016,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celerion (Canada)","funders":"Exelixis","keywords":"Cabozantinib; Pharmacokinetics; Medicine; Tyrosine-kinase inhibitor; Internal medicine; Adverse effect; Renal function; Gastroenterology; Dosing; Body mass index; Toxicity; Urology; Oncology; Cancer; Pharmacology","score_opus":0.06468027082223873,"score_gpt":0.4890645115591757,"score_spread":0.4243842407369369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2280682835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98471147,0.00035181438,0.00007575444,0.013383002,0.00041351566,0.0004307793,0.0000046706564,0.0000024514056,0.0006265152],"genre_scores_gemma":[0.9939449,0.004253501,0.00004730242,0.0009900719,0.00053261133,0.0000038663893,1.228391e-7,0.000009037817,0.00021860308],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.995713,0.0023918562,0.0012423503,0.00008597371,0.00036325192,0.0002035928],"domain_scores_gemma":[0.97654366,0.02203824,0.0008618043,0.00016325242,0.00023509157,0.00015795438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009930084,0.00011305636,0.0009667566,0.00007380556,0.000039380295,0.0000011218298,0.00023836145,0.00009425452,0.000647497],"category_scores_gemma":[0.0017643359,0.00003814513,0.00020113109,0.00009248527,0.0010769055,0.000020752499,0.00007935729,0.0005280168,0.000007907399],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07841066,0.0021137914,0.4254188,0.0004372978,0.0036115563,0.0001880595,0.00042843082,0.000012018443,0.37972525,0.00018800102,0.047460016,0.062006116],"study_design_scores_gemma":[0.06747324,0.124487914,0.35886693,0.001177567,0.010864044,0.001163877,0.00009883956,0.0012913389,0.42345488,0.0006997877,0.010190459,0.0002311443],"about_ca_topic_score_codex":0.0000046760897,"about_ca_topic_score_gemma":4.168654e-7,"teacher_disagreement_score":0.122374125,"about_ca_system_score_codex":0.000017220895,"about_ca_system_score_gemma":0.00022815642,"threshold_uncertainty_score":0.7089638},"labels":[],"label_agreement":null},{"id":"W2474151176","doi":"10.1002/jcph.797","title":"Metronidazole Metabolism in Neonates and the Interplay Between Ontogeny and Genetic Variation","year":2016,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Center for Advancing Translational Sciences; National Institute of Allergy and Infectious Diseases; National Institute of Mental Health; National Institute of Child Health and Human Development; Canadian Institutes of Health Research; U.S. Food and Drug Administration; Biomedical Advanced Research and Development Authority; National Institutes of Health","keywords":"Clinical pharmacology; Medicine; Pharmacy; Library science; Family medicine; Gerontology; Pharmacology","score_opus":0.07831174594227665,"score_gpt":0.4836225283893333,"score_spread":0.40531078244705665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2474151176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9059985,0.009811915,0.0002754662,0.0830484,0.00051415444,0.00016770442,0.0000016657823,0.0000033176163,0.00017886877],"genre_scores_gemma":[0.96985936,0.02487493,0.0001398119,0.003982541,0.0011019633,0.0000020720584,5.5691952e-8,0.000005562288,0.00003368295],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976916,0.001145474,0.00077936985,0.00008513651,0.00013898672,0.0001594613],"domain_scores_gemma":[0.9881715,0.01112955,0.0004314844,0.00006240791,0.00007988993,0.00012514032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043092854,0.000085222455,0.00052792474,0.00004093933,0.00005984915,0.000007148184,0.00012464916,0.00006317326,0.00012301537],"category_scores_gemma":[0.0011327239,0.00003052508,0.000077093944,0.000067921916,0.0004889885,0.0000885795,0.00011293448,0.0005086358,0.000004402125],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032763463,0.0004383441,0.32548708,0.000057542133,0.0038408635,0.00012068118,0.0019085552,0.000008936776,0.01688065,0.00061357406,0.006841002,0.6110393],"study_design_scores_gemma":[0.01631719,0.00037483743,0.9226679,0.00002813335,0.0019998767,0.00018761725,0.000063685504,0.0001837482,0.00048761335,0.002156898,0.05547504,0.000057457215],"about_ca_topic_score_codex":0.000027781392,"about_ca_topic_score_gemma":0.000007907044,"teacher_disagreement_score":0.6109818,"about_ca_system_score_codex":0.000014217082,"about_ca_system_score_gemma":0.00004388263,"threshold_uncertainty_score":0.22097978},"labels":[],"label_agreement":null},{"id":"W2476580486","doi":"10.1002/jcph.805","title":"Proton Pump Inhibitors Are Not Associated With Acute Kidney Injury in Critical Illness","year":2016,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"National Institute of Biomedical Imaging and Bioengineering; National Institute of General Medical Sciences","keywords":"Medicine; Acute kidney injury; Internal medicine; Kidney disease; Hypomagnesemia; Proton-pump inhibitor; Demographics; Cohort; Nephrology; Intensive care medicine","score_opus":0.05646454235980046,"score_gpt":0.4564304335668288,"score_spread":0.3999658912070283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2476580486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97608954,0.000010447417,0.000036605077,0.022115802,0.0011221408,0.00046232532,0.000027295415,0.000012474711,0.0001233787],"genre_scores_gemma":[0.9930018,0.00014793126,0.000046523866,0.0057950444,0.0007433715,0.000016837184,0.00000130367,0.00002152707,0.00022563923],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971865,0.00082003465,0.0011012271,0.00015412887,0.00037936948,0.0003587412],"domain_scores_gemma":[0.99685633,0.0015744339,0.0006144664,0.00013320924,0.00033076515,0.0004908233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020930837,0.00016891453,0.0007785549,0.00010871582,0.000055191984,0.000005171592,0.00018870286,0.00017732782,0.0002890725],"category_scores_gemma":[0.0029529573,0.00006970241,0.00017735155,0.00016214229,0.0004644626,0.00012604542,0.00005606113,0.0007964048,0.000033318065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026060091,0.004496393,0.9208272,0.000047662383,0.0021067634,0.01041403,0.00013471844,8.347725e-7,0.011216623,0.000018044007,0.015208861,0.00946878],"study_design_scores_gemma":[0.03601435,0.012037801,0.8841733,0.0008431606,0.002913456,0.0009202125,0.000027603897,0.000016975171,0.060065236,0.00049928605,0.0023188635,0.00016976222],"about_ca_topic_score_codex":0.0000016241705,"about_ca_topic_score_gemma":5.993837e-7,"teacher_disagreement_score":0.04884861,"about_ca_system_score_codex":0.000108342414,"about_ca_system_score_gemma":0.000404335,"threshold_uncertainty_score":0.3535179},"labels":[],"label_agreement":null},{"id":"W2496244196","doi":"10.1002/jcph.691","title":"Impact of Transporter Polymorphisms on Drug Development: Is It Clinically Significant?","year":2016,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Transporter; Drug; Drug development; Pharmacology; Efflux; Computational biology; ATP-binding cassette transporter; Personalized medicine; Drug discovery; Biology; Medicine; Bioinformatics; Genetics; Gene","score_opus":0.1425352898254683,"score_gpt":0.5002124890627286,"score_spread":0.3576771992372604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2496244196","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011224089,0.9762943,0.00030424347,0.0035230457,0.0055207876,0.0014705437,0.00013611904,0.000022608996,0.0015043002],"genre_scores_gemma":[0.0062940805,0.9864528,0.00023873102,0.0020279055,0.002286617,0.0000072270427,0.0000111449035,0.00008932733,0.0025921636],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98963314,0.0010079468,0.007700154,0.00036271385,0.0007656051,0.0005304411],"domain_scores_gemma":[0.98948246,0.0038685764,0.0051852874,0.00045787162,0.0004094032,0.0005963735],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.007111706,0.00062383397,0.0059481487,0.00031631134,0.00007157176,0.000004957654,0.00097254984,0.0006987499,0.004595172],"category_scores_gemma":[0.00014156265,0.00026274152,0.004466683,0.00025383732,0.00059422466,0.000058506273,0.00003122775,0.002430617,0.00018943058],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00990945,0.002361274,0.00041776954,0.0031225726,0.008548658,0.0006853417,0.00042888572,9.769349e-7,0.00011858707,0.000010627457,0.052215304,0.92218053],"study_design_scores_gemma":[0.0054291035,0.0031331782,0.0012073616,0.014391782,0.009781802,0.00019134427,0.0000151591275,5.045369e-7,0.00012629978,0.000058234324,0.9653057,0.00035956892],"about_ca_topic_score_codex":0.0000021345684,"about_ca_topic_score_gemma":6.398492e-7,"teacher_disagreement_score":0.921821,"about_ca_system_score_codex":0.00011640943,"about_ca_system_score_gemma":0.0038479525,"threshold_uncertainty_score":0.9999825},"labels":[],"label_agreement":null},{"id":"W2520297993","doi":"10.1002/jcph.828","title":"Safety and Tolerability of Neladenoson Bialanate, a Novel Oral Partial Adenosine A1 Receptor Agonist, in Patients With Chronic Heart Failure","year":2016,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Cardiac Arrhythmias and Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Bayer","keywords":"Tolerability; Medicine; Placebo; Agonist; Ejection fraction; Partial agonist; Heart failure; Adenosine; Anesthesia; Cardiology; Heart rate; Internal medicine; Blood pressure; Adverse effect; Receptor","score_opus":0.024958583913106833,"score_gpt":0.3546411885409498,"score_spread":0.32968260462784293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2520297993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848807,0.00020695657,0.000055110067,0.013809592,0.0006242254,0.000361254,0.00003643059,0.0000041534986,0.000021589754],"genre_scores_gemma":[0.99841434,0.00024615828,0.00022959258,0.00038790784,0.0006697941,0.0000019868871,0.0000025767752,0.000012843154,0.000034799694],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783874,0.000395292,0.0011501199,0.00015108712,0.00024440902,0.00022037353],"domain_scores_gemma":[0.99802613,0.00086200057,0.0005572498,0.00014493802,0.00022270772,0.00018696827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012845279,0.0001371835,0.00094010634,0.00005717038,0.000036258138,0.0000027796618,0.00008010039,0.00011939312,0.00027131214],"category_scores_gemma":[0.00020321543,0.00006215698,0.0001626678,0.000111531954,0.000408856,0.000088344044,0.000054911092,0.00039484742,0.0000047174517],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03367262,0.0013998237,0.9504349,0.000032211137,0.00055442663,0.000019520001,0.000060764614,0.000020870133,0.002744312,0.0000062961635,0.0046004076,0.006453804],"study_design_scores_gemma":[0.03411194,0.0052946317,0.94492286,0.00014157919,0.00054023333,0.00007167802,0.000008438128,0.000011693539,0.0011855118,0.000012511251,0.013622522,0.000076401135],"about_ca_topic_score_codex":0.000025850151,"about_ca_topic_score_gemma":0.000027893226,"teacher_disagreement_score":0.013533653,"about_ca_system_score_codex":0.00011052663,"about_ca_system_score_gemma":0.0002855777,"threshold_uncertainty_score":0.29706776},"labels":[],"label_agreement":null},{"id":"W2526766920","doi":"10.1002/jcph.833","title":"Oral Human Abuse Potential of Oxycodone DETERx<sup>®</sup>(Xtampza<sup>®</sup>ER)","year":2016,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Global Health Research; University of Toronto","funders":"","keywords":"Oxycodone; Oxymorphone; Medicine; Morphine; Placebo; Pharmacology; Anesthesia; Pharmacokinetics; Opioid; Internal medicine","score_opus":0.05726826766494194,"score_gpt":0.41920358808748787,"score_spread":0.36193532042254595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2526766920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988148,0.0006471298,0.000341229,0.008941553,0.0010065356,0.000567371,0.00002633215,0.000035329165,0.0002865292],"genre_scores_gemma":[0.990959,0.0024619363,0.0005526271,0.0026821645,0.0024238983,0.000008812734,0.0000046491223,0.00006885584,0.0008380436],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9937066,0.0014780024,0.003077663,0.0003386704,0.000746673,0.0006524129],"domain_scores_gemma":[0.9948049,0.0019197065,0.0015506656,0.00054753764,0.00061680935,0.0005603699],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0033301928,0.00039877184,0.0017382712,0.00024757654,0.00014111809,0.000011059119,0.0007245589,0.000352154,0.0027828524],"category_scores_gemma":[0.0004951618,0.00021028443,0.00090688356,0.00021719268,0.0008602071,0.00020541616,0.0001745343,0.0010639026,0.00019567406],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07538036,0.033193875,0.21095188,0.0007439015,0.020604862,0.005006495,0.01206038,0.006985369,0.27173844,0.00026857443,0.24558245,0.11748344],"study_design_scores_gemma":[0.2934325,0.06411142,0.39832076,0.0021441502,0.039473724,0.0076646064,0.0040507433,0.00788187,0.06076738,0.006273391,0.11323319,0.002646276],"about_ca_topic_score_codex":0.000031683703,"about_ca_topic_score_gemma":0.0000030790584,"teacher_disagreement_score":0.21805213,"about_ca_system_score_codex":0.00011930015,"about_ca_system_score_gemma":0.00041657776,"threshold_uncertainty_score":0.9981287},"labels":[],"label_agreement":null},{"id":"W2582949731","doi":"10.1002/jcph.868","title":"Preliminary Evidence for the Off-Label Treatment of Bulimia Nervosa With Psychostimulants: Six Case Reports","year":2017,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Eating Disorders and Behaviors","field":"Psychology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Health Authority; Dalhousie University","funders":"","keywords":"Bulimia nervosa; Binge eating; Psychiatry; Anorexia nervosa; Body mass index; Psychology; Eating disorders; Appetite; Binge-eating disorder; Medicine; Internal medicine","score_opus":0.2813980952795472,"score_gpt":0.5564495400787205,"score_spread":0.2750514447991733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582949731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828766,0.003849581,0.00019308852,0.007629026,0.004600651,0.00067572127,0.000006944801,0.0000066445323,0.00016171556],"genre_scores_gemma":[0.99574775,0.0015121319,0.0003413797,0.00062244607,0.0011194521,0.000031034848,4.6874877e-7,0.00002167756,0.00060367427],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973767,0.0005424505,0.0014231853,0.00020310709,0.00018180237,0.00027276808],"domain_scores_gemma":[0.9878953,0.0077379006,0.0032172462,0.00072104915,0.0003090427,0.000119452125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026978748,0.00018012829,0.0006247217,0.000037036523,0.0004193615,0.00001759885,0.0004947788,0.00014317298,0.00031618317],"category_scores_gemma":[0.00056823355,0.00007953511,0.00027372816,0.000043098986,0.00075630244,0.00010443865,0.000052244384,0.00037073385,0.0000058377636],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.085985675,0.014137154,0.32406047,0.00007156969,0.0041266875,0.026481528,0.004562772,0.0006888241,0.0016013427,0.000043646865,0.16208318,0.37615713],"study_design_scores_gemma":[0.046353944,0.15163717,0.63301975,0.0005559877,0.018916132,0.1037452,0.0028151157,0.0013973432,0.00064118556,0.0007611971,0.039365835,0.00079114136],"about_ca_topic_score_codex":0.00017959795,"about_ca_topic_score_gemma":0.00004571874,"teacher_disagreement_score":0.375366,"about_ca_system_score_codex":0.000019324445,"about_ca_system_score_gemma":0.00014345169,"threshold_uncertainty_score":0.3461984},"labels":[],"label_agreement":null},{"id":"W2614817248","doi":"10.1002/jcph.931","title":"Effect of Steady‐State Faldaprevir on Pharmacokinetics of Atorvastatin or Rosuvastatin in Healthy Volunteers: A Prospective Open‐Label, Fixed‐Sequence Crossover Study","year":2017,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Hepatitis C virus research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"Boehringer Ingelheim","keywords":"Rosuvastatin; Atorvastatin; Crossover study; Pharmacokinetics; Crossover; Pharmacology; Medicine; Mathematics; Computer science; Artificial intelligence","score_opus":0.25938220810295654,"score_gpt":0.6031953930390901,"score_spread":0.34381318493613355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2614817248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937103,0.00013826207,0.000020762867,0.001497245,0.0008186464,0.0032870665,0.00006689592,0.0000054052357,0.00045544462],"genre_scores_gemma":[0.99694407,0.0013753151,0.00020971938,0.00079746376,0.0002888785,0.0000377554,7.6540607e-7,0.00004048785,0.00030553847],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99058324,0.0047258902,0.002932752,0.000316202,0.00093357,0.0005083245],"domain_scores_gemma":[0.9878394,0.007719277,0.0027184437,0.00058098027,0.00079249777,0.00034940324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016098378,0.00027675924,0.001992006,0.00021745822,0.00014937404,0.000034816123,0.0015649868,0.00011509353,0.0005363178],"category_scores_gemma":[0.0076250583,0.00016000752,0.00017643855,0.0002483527,0.00113085,0.00027134287,0.0005417567,0.0020478382,0.000028539158],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.38764182,0.0085128695,0.49947482,0.000714861,0.0012774733,0.0012406732,0.0026067093,0.00019096019,0.026612282,0.000008519376,0.004922068,0.06679695],"study_design_scores_gemma":[0.19392988,0.32053825,0.42881358,0.0012404973,0.0014487228,0.00014081725,0.00047859974,0.0033284845,0.04779488,0.0001597365,0.0016937006,0.00043286194],"about_ca_topic_score_codex":0.00047405504,"about_ca_topic_score_gemma":0.00018021403,"teacher_disagreement_score":0.3120254,"about_ca_system_score_codex":0.000164973,"about_ca_system_score_gemma":0.0012247588,"threshold_uncertainty_score":0.91284573},"labels":[],"label_agreement":null},{"id":"W2740384019","doi":"10.1002/jcph.979","title":"Pharmacokinetics and Safety of Brexpiprazole Following Multiple‐Dose Administration to Japanese Patients With Schizophrenia","year":2017,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Otsuka Pharmaceutical","keywords":"Pharmacokinetics; Medicine; Pharmacology; Adverse effect; CYP2D6; Internal medicine; Cytochrome P450","score_opus":0.04972760625445495,"score_gpt":0.4251193734943682,"score_spread":0.37539176723991324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740384019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932677,0.00013544226,0.00002045221,0.0053258124,0.00060257025,0.0005286826,0.000011267799,0.0000045905144,0.000103482336],"genre_scores_gemma":[0.9972341,0.00030364908,0.001407594,0.00047751394,0.0005115433,0.000003689956,0.000002868906,0.000014880881,0.00004414227],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99805635,0.0002753122,0.00088406226,0.00013354719,0.0004327514,0.00021796675],"domain_scores_gemma":[0.99707466,0.0010809139,0.0007705039,0.00025846486,0.0003523191,0.0004631222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014145635,0.0001404439,0.0005848591,0.00007734127,0.00018663042,0.000016648513,0.00028638786,0.00007163414,0.000065573186],"category_scores_gemma":[0.0009975379,0.00007693437,0.00015913422,0.00005853103,0.00027505157,0.00012682674,0.00011477578,0.0004967721,0.00000674141],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.49670807,0.0023177876,0.43428227,0.000060113573,0.0019729426,0.00034502265,0.00030589034,0.00005086578,0.005835851,0.000009383929,0.0018916958,0.056220118],"study_design_scores_gemma":[0.051728785,0.0067859935,0.9346027,0.000091594826,0.0010242206,0.00008082052,0.000044469325,0.0001545762,0.004790567,0.000029763438,0.00058203266,0.00008447289],"about_ca_topic_score_codex":0.000011270898,"about_ca_topic_score_gemma":0.000019536224,"teacher_disagreement_score":0.50032043,"about_ca_system_score_codex":0.000024081446,"about_ca_system_score_gemma":0.0003274274,"threshold_uncertainty_score":0.31372926},"labels":[],"label_agreement":null},{"id":"W2761037621","doi":"10.1002/jcph.1024","title":"Improving Therapeutics to Better Care for Older Adults and the Young: Report From the American College of Clinical Pharmacology Workshop","year":2017,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Baby boom; Life expectancy; Context (archaeology); Medicine; Population; Pediatrics; Population ageing; Gerontology; Environmental health; Geography","score_opus":0.15446826702004562,"score_gpt":0.5421725688643844,"score_spread":0.38770430184433874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761037621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7759245,0.0028753038,0.00024922926,0.21407509,0.0054622116,0.0011790375,0.00005292063,0.000006349154,0.00017536504],"genre_scores_gemma":[0.9247894,0.006319871,0.0006489053,0.0601846,0.007913111,0.000024945182,0.0000015159054,0.000026395759,0.00009120282],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9946857,0.0017688068,0.0024946313,0.00029608974,0.00036069145,0.00039406607],"domain_scores_gemma":[0.9635894,0.030513056,0.0043395213,0.0004924516,0.00076552184,0.00030010557],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.009287722,0.00023384514,0.001635506,0.000027884587,0.0006408286,0.00002349076,0.00094352604,0.00015464825,0.000108644366],"category_scores_gemma":[0.0044456683,0.0000998479,0.0005908749,0.00008852934,0.0028125837,0.00010690557,0.00047532088,0.0017967601,0.0000035262733],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20859046,0.0012158807,0.15863341,0.00013745317,0.009080499,0.0007015008,0.0038373906,0.000011588425,0.0018949823,0.000030031953,0.19329382,0.42257297],"study_design_scores_gemma":[0.05041449,0.003100031,0.46141165,0.00015780012,0.015083104,0.00087065087,0.0061583263,0.0015893744,0.0012525187,0.00030714055,0.45933586,0.00031903814],"about_ca_topic_score_codex":0.00013381107,"about_ca_topic_score_gemma":0.00005996838,"teacher_disagreement_score":0.42225394,"about_ca_system_score_codex":0.000022967402,"about_ca_system_score_gemma":0.00025671918,"threshold_uncertainty_score":0.9999012},"labels":[],"label_agreement":null},{"id":"W2767708353","doi":"10.1002/jcph.1029","title":"Pharmacokinetics, Immunogenicity, and Efficacy of Etanercept in Pediatric Patients With Moderate to Severe Plaque Psoriasis","year":2017,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"U.S. Food and Drug Administration; Wyeth; Pfizer","keywords":"Etanercept; Medicine; Psoriasis; Psoriasis Area and Severity Index; Dosing; Pharmacokinetics; Pharmacodynamics; Immunogenicity; Internal medicine; Arthritis; Body mass index; Gastroenterology; Immunology; Antibody; Rheumatoid arthritis","score_opus":0.049130363699124276,"score_gpt":0.41819186797543706,"score_spread":0.3690615042763128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767708353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99503165,0.00039573142,0.000021069869,0.0033431014,0.00041174947,0.0004282716,0.0000036231359,0.0000029843204,0.00036180983],"genre_scores_gemma":[0.9951415,0.0035567717,0.00010229707,0.0006988192,0.0003947679,0.000002034985,8.038251e-7,0.000016326398,0.00008670238],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976512,0.0004223978,0.0012098553,0.00012745973,0.00034616177,0.00024292884],"domain_scores_gemma":[0.9975049,0.0007579883,0.0008891931,0.00025583062,0.0004068253,0.0001852689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002083868,0.00013159133,0.0007648924,0.00015048224,0.000111096495,0.000012396446,0.00045026903,0.00010461177,0.0001850385],"category_scores_gemma":[0.00067306636,0.00007773759,0.00011112587,0.00009318734,0.00030234604,0.00012223283,0.0002151057,0.0008865588,0.000008331329],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06422557,0.001981559,0.8937106,0.00013747733,0.0006456933,0.00010364234,0.00074194494,0.00086666405,0.002078855,0.0000064063815,0.007829879,0.027671691],"study_design_scores_gemma":[0.027393986,0.0022549776,0.96755165,0.000041962165,0.0005278472,0.000030530704,0.000037393904,0.00021252959,0.0008157943,0.000031491134,0.0010087423,0.000093093986],"about_ca_topic_score_codex":0.000018447705,"about_ca_topic_score_gemma":0.0000052510923,"teacher_disagreement_score":0.073841035,"about_ca_system_score_codex":0.000019957444,"about_ca_system_score_gemma":0.00030025342,"threshold_uncertainty_score":0.3851706},"labels":[],"label_agreement":null},{"id":"W2778907143","doi":"10.1002/jcph.1051","title":"Population Pharmacokinetic– Pharmacodynamic Analysis to Characterize the Effect of Empagliflozin on Renal Glucose Threshold in Patients With Type 1 Diabetes Mellitus","year":2017,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Empagliflozin; Medicine; Pharmacodynamics; Renal glucose reabsorption; Placebo; Internal medicine; Diabetes mellitus; Population; Endocrinology; Renal function; Type 2 Diabetes Mellitus; Pharmacokinetics; Type 2 diabetes; Pharmacology; Urology","score_opus":0.026713679420603053,"score_gpt":0.3810745709882775,"score_spread":0.3543608915676745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2778907143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955603,0.00011082031,0.0000043140194,0.002362441,0.00094022683,0.0008379739,0.0000074342074,0.0000060937227,0.00017038386],"genre_scores_gemma":[0.9977677,0.0003208555,0.000025380124,0.0013998395,0.00038227974,0.000009733898,0.000016490716,0.000017509314,0.00006023305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99749637,0.0006257972,0.000992468,0.00017130557,0.00043423977,0.00027982303],"domain_scores_gemma":[0.99708575,0.0009941598,0.0011813429,0.00037434828,0.00020146777,0.00016290238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027926986,0.0002061448,0.0009977522,0.0002619961,0.000104272214,0.000017574517,0.0004957145,0.00006195633,0.00019084055],"category_scores_gemma":[0.00026148258,0.00009367582,0.000260375,0.00034436368,0.00017411084,0.000107745385,0.00010834649,0.00049905706,0.000013040397],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021879531,0.00084118225,0.94172966,0.000032932752,0.00462409,0.00002134676,0.000051518666,0.0011264116,0.0031748884,0.0000024948163,0.0010657782,0.025450172],"study_design_scores_gemma":[0.011890995,0.009371518,0.9616001,0.00006767859,0.010064579,5.371684e-7,0.000002574458,0.0012010925,0.005206288,0.00000865142,0.0004979081,0.00008804712],"about_ca_topic_score_codex":0.000012011039,"about_ca_topic_score_gemma":0.0000074300237,"teacher_disagreement_score":0.025362125,"about_ca_system_score_codex":0.000054261167,"about_ca_system_score_gemma":0.000030589898,"threshold_uncertainty_score":0.3819989},"labels":[],"label_agreement":null},{"id":"W2790919647","doi":"10.1002/jcph.1094","title":"Pharmacokinetics and Tolerability of Letermovir Coadministered With Azole Antifungals (Posaconazole or Voriconazole) in Healthy Subjects","year":2018,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pharma Medica Research (Canada)","funders":"Merck","keywords":"Posaconazole; Voriconazole; Tolerability; Medicine; Pharmacokinetics; Pharmacology; Azole; Internal medicine; Antifungal; Adverse effect; Dermatology","score_opus":0.13227700090648814,"score_gpt":0.48705294376907643,"score_spread":0.3547759428625883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790919647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919144,0.0006524973,0.000034834284,0.005831593,0.0005932613,0.0004995844,0.000012466417,0.000006583095,0.00045476807],"genre_scores_gemma":[0.9919861,0.0022460737,0.00023711861,0.004309487,0.0010982984,0.0000031851573,7.811695e-7,0.000020562158,0.0000983809],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99616575,0.00090567156,0.0018811636,0.00021039008,0.0004353833,0.00040166362],"domain_scores_gemma":[0.9955617,0.002391245,0.0008397078,0.0002262365,0.00059067726,0.00039044363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004498963,0.00018063119,0.0011823359,0.00018948072,0.00007434128,0.000009821013,0.00029590467,0.00014884636,0.00067670183],"category_scores_gemma":[0.00038151667,0.00009736647,0.000122794,0.00034038606,0.0013341323,0.00009661761,0.00012708262,0.0011233365,0.000010009854],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37071815,0.0043954165,0.42855966,0.0006670747,0.0009261426,0.00076042843,0.001517178,0.000015721049,0.1416761,0.000029505234,0.0106056575,0.040128957],"study_design_scores_gemma":[0.054652438,0.04842943,0.7603574,0.0003195556,0.00102834,0.0019713866,0.00041164644,0.0013292662,0.087075576,0.00016160753,0.043891855,0.00037150696],"about_ca_topic_score_codex":0.000047249185,"about_ca_topic_score_gemma":0.000094676645,"teacher_disagreement_score":0.33179775,"about_ca_system_score_codex":0.000045428438,"about_ca_system_score_gemma":0.00093291875,"threshold_uncertainty_score":0.74094105},"labels":[],"label_agreement":null},{"id":"W2791625572","doi":"10.1002/jcph.1073","title":"The Drug–Drug Interaction Profile of Presatovir","year":2018,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Respiratory viral infections research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Gilead Sciences (Canada)","funders":"Gilead Sciences","keywords":"CYP3A; Pharmacology; Organic anion-transporting polypeptide; CYP3A4; Pharmacokinetics; Abcg2; P-glycoprotein; Chemistry; Drug interaction; Cobicistat; Medicine; ATP-binding cassette transporter; Transporter; Cytochrome P450; Internal medicine; Multiple drug resistance; Metabolism; Antibiotics; Immunology; Viral load; Biochemistry; Virus","score_opus":0.14830321942755476,"score_gpt":0.5645011660159464,"score_spread":0.4161979465883916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791625572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828181,0.0003428017,0.000067892404,0.00850446,0.003082197,0.00032394697,0.0000011993575,0.000007659259,0.0048517026],"genre_scores_gemma":[0.9920912,0.0006331415,0.00005727862,0.0014348954,0.00372756,0.000004394473,1.9243706e-7,0.000011826616,0.0020395217],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964109,0.0016521241,0.0013071019,0.00008264753,0.00034844028,0.0001988079],"domain_scores_gemma":[0.99403673,0.0038143392,0.00084858976,0.00021891983,0.0009381994,0.00014324734],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0070829047,0.0000817801,0.0003740477,0.000091911956,0.0001716574,0.000008750974,0.00034174218,0.000060848368,0.0010388615],"category_scores_gemma":[0.0015553455,0.000037671583,0.00022128821,0.00020902419,0.0010847645,0.000116561954,0.00010465993,0.0012117767,0.00013418873],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018348586,0.0010291608,0.015379101,0.000052394145,0.0010398501,0.000034382978,0.0004036666,0.000041966217,0.094434865,0.000086275744,0.8184139,0.050735824],"study_design_scores_gemma":[0.0061438433,0.0062011904,0.053108823,0.00009875366,0.00076205534,0.00056036614,0.00046009765,0.0015135767,0.20681487,0.0005492556,0.7236738,0.00011333485],"about_ca_topic_score_codex":0.000014848961,"about_ca_topic_score_gemma":0.000010948542,"teacher_disagreement_score":0.11238,"about_ca_system_score_codex":0.00003954948,"about_ca_system_score_gemma":0.00034741947,"threshold_uncertainty_score":0.99987435},"labels":[],"label_agreement":null},{"id":"W2800224917","doi":"10.1002/jcph.1103","title":"Multiple Doses of Rifabutin Reduce Exposure of Doravirine in Healthy Subjects","year":2018,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pharma Medica Research (Canada)","funders":"Merck","keywords":"Rifabutin; Pharmacokinetics; Pharmacology; Drug interaction; Rifamycin; Reverse-transcriptase inhibitor; Antibacterial agent; Medicine; Chemistry; Antibiotics; Sida; Human immunodeficiency virus (HIV); Immunology; Clarithromycin","score_opus":0.08523358754433018,"score_gpt":0.4618648557188534,"score_spread":0.3766312681745232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800224917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877817,0.00059990125,0.000012721201,0.009978258,0.0009893824,0.0002524257,0.000003016299,0.000003972046,0.00037864418],"genre_scores_gemma":[0.9961401,0.0011131595,0.0007941331,0.0007821584,0.0008028118,0.000001610157,0.0000013018,0.000010425258,0.00035429682],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970424,0.00060163275,0.0017983097,0.00010213123,0.0002441887,0.00021131733],"domain_scores_gemma":[0.99650866,0.00181169,0.0010272551,0.00013938974,0.00036020056,0.00015278735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029629834,0.00011372694,0.0008472302,0.00014494041,0.000027582208,9.347451e-7,0.0001918396,0.000106265354,0.00028837513],"category_scores_gemma":[0.00069627096,0.00006630701,0.00016425783,0.00022844752,0.00044101718,0.00004008689,0.0000550061,0.00047294673,0.000014464821],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07492271,0.0059624887,0.7902489,0.00020130588,0.0011599804,0.00025034972,0.0027405631,0.000021266183,0.0721905,0.000029817851,0.03412393,0.01814824],"study_design_scores_gemma":[0.05789005,0.017434515,0.65841144,0.00040655799,0.0011613029,0.0003965091,0.00065087207,0.00014474629,0.24461667,0.00033383406,0.01835188,0.0002016126],"about_ca_topic_score_codex":0.000018337409,"about_ca_topic_score_gemma":0.00003064215,"teacher_disagreement_score":0.17242618,"about_ca_system_score_codex":0.00003494096,"about_ca_system_score_gemma":0.00047579836,"threshold_uncertainty_score":0.31575054},"labels":[],"label_agreement":null},{"id":"W2801880426","doi":"10.1002/jcph.1129","title":"Drug‐induced Proarrhythmia and Torsade de Pointes: A Primer for Students and Practitioners of Medicine and Pharmacy","year":2018,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Canada","funders":"","keywords":"Proarrhythmia; Pharmacy; Drug; Medicine; Pharmacology; Business; Family medicine","score_opus":0.16029762925276814,"score_gpt":0.552479589150734,"score_spread":0.3921819598979659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801880426","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13227884,0.86107504,0.000015103271,0.0043122964,0.0010141117,0.001246401,0.00000891703,0.0000058680694,0.000043426648],"genre_scores_gemma":[0.0074607925,0.98491037,0.00020674574,0.0018052033,0.005440366,0.000021277598,0.0000039228016,0.000032058204,0.000119243996],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99634737,0.0012583277,0.001690922,0.00023377017,0.00020462617,0.00026501526],"domain_scores_gemma":[0.991709,0.0055812635,0.0019989195,0.00013226166,0.00029111406,0.00028745324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004711447,0.00028094204,0.002779887,0.00016046279,0.00008422235,0.0000045108554,0.00014657446,0.00022677031,0.000050676455],"category_scores_gemma":[0.0012954681,0.00015401404,0.0003645513,0.00010269699,0.0012166183,0.00006986306,0.00011892718,0.0012048272,0.0000011542604],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027776001,0.0010742998,0.00074402953,0.025412634,0.018248038,0.0006655759,0.002015722,6.9455467e-7,0.0036674393,0.00009285278,0.14223348,0.77806926],"study_design_scores_gemma":[0.016494092,0.0065128393,0.0006155983,0.006285841,0.028649708,0.015578846,0.00013380153,0.000015515783,0.00016994085,0.00040587995,0.92486364,0.000274309],"about_ca_topic_score_codex":0.0000070926153,"about_ca_topic_score_gemma":6.836396e-7,"teacher_disagreement_score":0.78263015,"about_ca_system_score_codex":0.000036387904,"about_ca_system_score_gemma":0.0005814491,"threshold_uncertainty_score":0.62805104},"labels":[],"label_agreement":null},{"id":"W2805642491","doi":"10.1002/jcph.1133","title":"Development of a Physiologically Based Pharmacokinetic Model of Ethionamide in the Pediatric Population by Integrating Flavin‐Containing Monooxygenase 3 Maturational Changes Over Time","year":2018,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Korea Health Industry Development Institute","keywords":"Ethionamide; Physiologically based pharmacokinetic modelling; Flavin-containing monooxygenase; Pharmacology; Pharmacokinetics; Population; Drug metabolism; Chemistry; Drug; Medicine; Monooxygenase; Metabolism; Biochemistry; Cytochrome P450; Antibiotics; Rifampicin","score_opus":0.061538689732225385,"score_gpt":0.40239794198755285,"score_spread":0.3408592522553275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805642491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948459,0.00013175492,0.0028117406,0.0016377721,0.00025610594,0.0002477064,0.000006820218,0.0000044807925,0.000057718764],"genre_scores_gemma":[0.99109864,0.00010834077,0.0061041503,0.0020675203,0.0005686751,0.0000047291187,0.000011723186,0.000009156063,0.000027042948],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99756634,0.00041798566,0.0013737484,0.00010601947,0.00037382095,0.00016208869],"domain_scores_gemma":[0.99763584,0.0009178895,0.0010249977,0.000083345716,0.00027480882,0.000063088046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035089843,0.00012362695,0.0005163415,0.000102534854,0.000057199613,0.0000022873141,0.00024925702,0.000114993076,0.00019624575],"category_scores_gemma":[0.00015936015,0.00006159394,0.00013325305,0.00017980792,0.0001383786,0.00004348184,0.000019548783,0.00056330644,0.0000018789397],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008328804,0.0008665305,0.0041318494,0.00010201062,0.00014941249,0.000011860617,0.0014963573,0.0020336886,0.9782082,0.000046436053,0.001474296,0.0031505707],"study_design_scores_gemma":[0.024073234,0.0058733965,0.43703723,0.00051368633,0.002554765,0.00006128966,0.0008899467,0.425213,0.100917265,0.001712141,0.00060796365,0.0005460858],"about_ca_topic_score_codex":0.0000034600032,"about_ca_topic_score_gemma":0.0000082604565,"teacher_disagreement_score":0.8772909,"about_ca_system_score_codex":0.000026055086,"about_ca_system_score_gemma":0.00027106496,"threshold_uncertainty_score":0.2511728},"labels":[],"label_agreement":null},{"id":"W2883546793","doi":"10.1002/jcph.1107","title":"Cardiovascular Safety of the β<sub>3</sub>‐Adrenoceptor Agonist Mirabegron and the Antimuscarinic Agent Solifenacin in the SYNERGY Trial","year":2018,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Allergan; Astellas Pharma Global Development; Astellas Foundation for Research on Metabolic Disorders; Ipsen; Pfizer","keywords":"Mirabegron; Solifenacin; Medicine; Placebo; Overactive bladder; Combination therapy; Urology; Internal medicine; Pharmacology; Anesthesia","score_opus":0.063444621870896,"score_gpt":0.4039625429456552,"score_spread":0.3405179210747592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883546793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9724117,0.003268928,0.000029290728,0.020344723,0.0019758705,0.0010587231,0.0000058133155,0.0000035297344,0.00090144627],"genre_scores_gemma":[0.9826451,0.0114793815,0.000008969575,0.0025165572,0.0032645492,0.000008325781,7.7533286e-7,0.000016153628,0.00006021259],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9908768,0.006341489,0.0015212302,0.00017027091,0.0007335366,0.00035665763],"domain_scores_gemma":[0.9938361,0.004707364,0.00055815734,0.00049558125,0.00027188053,0.00013088685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019892275,0.00016832793,0.000972306,0.000066798304,0.00025413383,0.000014969798,0.0007622288,0.00014560291,0.00012922024],"category_scores_gemma":[0.00089689624,0.00006034247,0.0008534778,0.00029589792,0.002670803,0.000051672323,0.0002643139,0.001611463,0.000010078593],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.793128,0.0032740529,0.005946549,0.0002549882,0.010063401,0.00038227922,0.0074746734,0.00025268065,0.023267305,0.00031056805,0.069114365,0.08653113],"study_design_scores_gemma":[0.4964798,0.025495434,0.20725031,0.0003824357,0.011260121,0.0037447985,0.0024441562,0.0012861983,0.044002883,0.0023962252,0.20471852,0.00053913],"about_ca_topic_score_codex":0.000045977562,"about_ca_topic_score_gemma":0.00001806746,"teacher_disagreement_score":0.2966482,"about_ca_system_score_codex":0.000033761196,"about_ca_system_score_gemma":0.000473208,"threshold_uncertainty_score":0.9840686},"labels":[],"label_agreement":null},{"id":"W2884326257","doi":"10.1002/jcph.1282","title":"Pharmacokinetic and Pharmacodynamic Evaluation of Intravenous Levetiracetam in Children With Epilepsy","year":2018,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"First Quantum Minerals (Canada)","funders":"Ministry of Food and Drug Safety","keywords":"Levetiracetam; Medicine; Tolerability; Irritability; Epilepsy; Anesthesia; Pharmacokinetics; Pediatrics; Dosing; Somnolence; Adverse effect; Internal medicine","score_opus":0.08013198252937535,"score_gpt":0.4743202451600297,"score_spread":0.3941882626306543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884326257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952101,0.0011914651,0.000039727533,0.0020466954,0.00029786266,0.0007312621,0.000003960482,0.0000041810354,0.00047475766],"genre_scores_gemma":[0.9958248,0.0024186745,0.00018037963,0.0006237792,0.0008995281,0.000006675738,0.0000018503364,0.000014610501,0.000029668672],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966737,0.00133322,0.001004588,0.00013926503,0.0005924743,0.00025675577],"domain_scores_gemma":[0.99771637,0.0006714476,0.0005729408,0.0001239004,0.000687812,0.00022756038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0065736687,0.00013182712,0.0006007612,0.00017249233,0.000041276136,0.000003284776,0.0001694034,0.00007006485,0.0006249571],"category_scores_gemma":[0.00023964245,0.000071974464,0.00008879859,0.0002179068,0.00079090835,0.0000677704,0.000047993763,0.0006924903,0.000010109197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013565173,0.0021052272,0.7859682,0.000032400327,0.0018508531,0.00006013098,0.0003575127,0.00012829162,0.018579124,0.0000061999185,0.0013143423,0.17603256],"study_design_scores_gemma":[0.02799872,0.008989118,0.946867,0.00006933733,0.0028092144,0.0012281552,0.00004690395,0.0039291927,0.0076521668,0.00016461499,0.00016937063,0.00007621029],"about_ca_topic_score_codex":0.000022879873,"about_ca_topic_score_gemma":0.000011809256,"teacher_disagreement_score":0.17595634,"about_ca_system_score_codex":0.000056711608,"about_ca_system_score_gemma":0.00048552116,"threshold_uncertainty_score":0.6842842},"labels":[],"label_agreement":null},{"id":"W2886245611","doi":"10.1002/jcph.1280","title":"Abuse Potential of Buprenorphine/Samidorphan Combination Compared to Buprenorphine and Placebo: A Phase 1 Randomized Controlled Trial","year":2018,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Buprenorphine; Placebo; Medicine; Opioid; Crossover study; Anesthesia; Pharmacology; Adverse effect; Partial agonist; Opioid use disorder; Antagonist; Internal medicine; Receptor","score_opus":0.034133645984824976,"score_gpt":0.4165368754345509,"score_spread":0.38240322944972593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886245611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831012,0.0004605125,0.00084994506,0.0068323975,0.003605934,0.0049557816,0.000011706406,0.000015848918,0.00016668838],"genre_scores_gemma":[0.99489254,0.00085750275,0.0004597654,0.0014997215,0.002066764,0.000051560437,0.00000620233,0.000023287872,0.00014264768],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99389243,0.0021812064,0.003015912,0.00018997917,0.00046245032,0.000258027],"domain_scores_gemma":[0.992176,0.004435611,0.0019298748,0.00022070215,0.00087218045,0.0003656392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006733156,0.00024620307,0.003354628,0.00024405192,0.00008642062,0.000010861359,0.00026065085,0.00014437959,0.00064322905],"category_scores_gemma":[0.0018181525,0.00013659317,0.00065307255,0.00018085606,0.00083213905,0.0000792954,0.000069842274,0.00047759726,0.000036432928],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9730212,0.005342182,0.000105041916,0.000024024617,0.0024920495,0.000043189542,0.0008603809,0.00003590443,0.011014715,0.000016598,0.0061533023,0.00089139433],"study_design_scores_gemma":[0.9731082,0.013347512,0.000467631,0.00005892916,0.006559351,0.00012056933,0.000110248024,0.0034206507,0.0018549173,0.00029322616,0.0005535271,0.00010527826],"about_ca_topic_score_codex":0.000020573723,"about_ca_topic_score_gemma":0.000004170021,"teacher_disagreement_score":0.011791362,"about_ca_system_score_codex":0.00003849097,"about_ca_system_score_gemma":0.00028390725,"threshold_uncertainty_score":0.7042907},"labels":[],"label_agreement":null},{"id":"W2893109079","doi":"10.1002/jcph.1113","title":"Opioids in Breast Milk: Pharmacokinetic Principles and Clinical Implications","year":2018,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Prenatal Substance Exposure Effects","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Oxycodone; Methadone; Breastfeeding; Opioid; Pharmacokinetics; Buprenorphine; Tramadol; Breast milk; Adverse effect; Drug; CYP2D6; Pharmacology; Anesthesia; Pediatrics; Internal medicine; Analgesic","score_opus":0.17171856197060484,"score_gpt":0.5239676029081161,"score_spread":0.3522490409375112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2893109079","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00942014,0.9817843,0.000026396101,0.0031948509,0.00397515,0.0012766938,0.000030616033,0.000018650868,0.00027323255],"genre_scores_gemma":[0.0030243313,0.9876387,0.00025669578,0.0014826974,0.0073924037,0.00002034206,0.000008513372,0.000060278184,0.000116034884],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98982936,0.0038234326,0.0051926817,0.00039377523,0.0003139463,0.00044679493],"domain_scores_gemma":[0.9855205,0.010259757,0.0028808704,0.00043905535,0.00032669536,0.00057312654],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.010541219,0.00042987615,0.0040051998,0.00026348376,0.00006525797,0.000012108747,0.0008082899,0.0006608014,0.00019622299],"category_scores_gemma":[0.0012939911,0.00024620676,0.0010564048,0.00042283974,0.0011654726,0.00009159548,0.0003258882,0.0037391076,0.00007453999],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015353842,0.0012087168,0.0050594043,0.00337282,0.0018705095,0.0002773752,0.00003334139,8.902271e-7,0.000021940969,0.000026709622,0.033354253,0.95323867],"study_design_scores_gemma":[0.0052857124,0.0013590341,0.022881653,0.0045948424,0.008163517,0.0059940824,0.0000038427133,0.000028737051,0.000003604425,0.00008185178,0.95136523,0.00023787317],"about_ca_topic_score_codex":0.0000030141864,"about_ca_topic_score_gemma":0.0000047210897,"teacher_disagreement_score":0.9530008,"about_ca_system_score_codex":0.00010686101,"about_ca_system_score_gemma":0.001145286,"threshold_uncertainty_score":0.99999905},"labels":[],"label_agreement":null},{"id":"W2893167959","doi":"10.1002/jcph.1115","title":"Adverse Drug Reactions Across the Age Continuum: Epidemiology, Diagnostic Challenges, Prevention, and Treatments","year":2018,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Pharmacogenomics; Dosing; Drug reaction; Epidemiology; Drug; Intensive care medicine; Pharmacotherapy; Pediatrics; Pharmacovigilance; Adverse effect; Pharmacology; Internal medicine","score_opus":0.4827540263646637,"score_gpt":0.6264753641667427,"score_spread":0.14372133780207896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2893167959","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000972974,0.9749389,0.000004756663,0.018497802,0.0038082788,0.0010572007,0.00001893684,0.000011496547,0.000689604],"genre_scores_gemma":[0.0002903458,0.9897263,0.000045917135,0.0030252724,0.0052853264,0.000037728656,0.000005339129,0.000029719666,0.0015540294],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9885585,0.0074882554,0.0030213797,0.00027939834,0.00019135342,0.00046115564],"domain_scores_gemma":[0.91362005,0.08204185,0.0034944066,0.00029341376,0.00023590343,0.00031434436],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.016662965,0.00036452358,0.00314795,0.000042236737,0.00038191766,0.000006587719,0.00043356756,0.00033951004,0.00026750876],"category_scores_gemma":[0.012153473,0.0001535512,0.0010525705,0.00012645264,0.00158333,0.00009805353,0.00028823607,0.002579955,0.00008643052],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008745298,0.0009123762,0.0002095172,0.002121608,0.008260786,0.00027470975,0.00026068627,2.3859877e-7,4.5559236e-7,0.000019501398,0.15022805,0.83683753],"study_design_scores_gemma":[0.0023512186,0.0010232244,0.0019383231,0.0018859257,0.021604773,0.0015949941,0.00013896362,0.0000016220811,3.942289e-7,0.00037796894,0.96896094,0.00012163017],"about_ca_topic_score_codex":0.0000140520415,"about_ca_topic_score_gemma":0.000027528613,"teacher_disagreement_score":0.8367159,"about_ca_system_score_codex":0.00006631572,"about_ca_system_score_gemma":0.00023736125,"threshold_uncertainty_score":0.9997211},"labels":[],"label_agreement":null},{"id":"W2893858554","doi":"10.1002/jcph.1316","title":"Pharmacometric Modeling and Simulation Is Essential to Pediatric Clinical Pharmacology","year":2018,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Child Health and Human Development; National Institute of General Medical Sciences","keywords":"Clinical pharmacology; Medicine; Subspecialty; Pharmacology; Broad spectrum; Specialty; Drug development; Intensive care medicine; Drug; Medical physics; Family medicine","score_opus":0.44415338444241576,"score_gpt":0.6476140339209964,"score_spread":0.2034606494785806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2893858554","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009625845,0.9650505,0.00084136304,0.005418813,0.017340628,0.0014815683,0.000024975741,0.000029063971,0.00018720428],"genre_scores_gemma":[0.0051141577,0.93326384,0.000310723,0.015857453,0.045240782,0.000013775502,0.0000036269616,0.00008024358,0.00011537883],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98730546,0.004462673,0.006171186,0.0006227467,0.00070639973,0.00073151395],"domain_scores_gemma":[0.9726089,0.021248389,0.00361735,0.0002821358,0.0009472689,0.0012959554],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.014018338,0.0006540645,0.0050637666,0.0006963149,0.00029368038,0.000034946206,0.0008046157,0.0007880249,0.0017214661],"category_scores_gemma":[0.0025701113,0.0003902992,0.0016627202,0.0012972433,0.00049397006,0.0002075378,0.000710256,0.004665613,0.00029234987],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007336644,0.0015150952,0.00030219028,0.004314713,0.006110926,0.00026067588,0.000106295476,0.00046840287,0.0000046375276,0.0000011922277,0.18320528,0.79637396],"study_design_scores_gemma":[0.004599522,0.002761069,0.000036685193,0.0003789153,0.046093,0.00047927088,0.000012420942,0.014465284,0.0000026513999,0.000026812828,0.9308029,0.0003414831],"about_ca_topic_score_codex":0.0000044314565,"about_ca_topic_score_gemma":3.1198735e-7,"teacher_disagreement_score":0.7960325,"about_ca_system_score_codex":0.00009421835,"about_ca_system_score_gemma":0.0008663191,"threshold_uncertainty_score":0.99985486},"labels":[],"label_agreement":null},{"id":"W2900478530","doi":"10.1002/jcph.1336","title":"Analyses of Adverse Drug Reactions–Nationwide Active Surveillance Network: Canadian Pharmacogenomics Network for Drug Safety Database","year":2018,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"University of British Columbia; Western University; Provincial Health Services Authority; Child and Family Research Institute; Genome British Columbia; Pfizer Canada; Société Canadienne de Pédiatrie; Michael Smith Health Research BC; Canadian Institutes of Health Research; Genome Canada","keywords":"Medicine; Pharmacogenomics; Pharmacovigilance; Database; MedDRA; Drug reaction; Drug; Adverse drug reaction; Cardiotoxicity; Pharmacology; Internal medicine; Toxicity","score_opus":0.22913844339583006,"score_gpt":0.5357776064072207,"score_spread":0.30663916301139066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900478530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9312909,0.005610425,0.0026287162,0.0101601295,0.0426156,0.0019058582,0.0016639989,0.000048454254,0.004075878],"genre_scores_gemma":[0.9535595,0.012851662,0.0020630604,0.011428173,0.019363763,0.000022653021,0.00006195406,0.00006704887,0.0005821498],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9902551,0.004685934,0.003210761,0.00038826923,0.00034470693,0.0011152026],"domain_scores_gemma":[0.9840509,0.009791069,0.0030000452,0.0003588097,0.0017725326,0.0010265972],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.016838377,0.00042939233,0.0013089456,0.00025187616,0.0008500683,0.000008781083,0.0013248087,0.00031256385,0.0021355979],"category_scores_gemma":[0.0008687686,0.0003367395,0.0006890222,0.00069661875,0.0012725382,0.0002614695,0.00020129926,0.001982305,0.00005123294],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029282087,0.0010516796,0.013242319,0.00010635387,0.006750873,0.00006858237,0.0009099638,0.12060311,0.06999655,0.0005156834,0.73388225,0.02359056],"study_design_scores_gemma":[0.009078386,0.00029258497,0.008580488,0.000027830522,0.003001859,0.00008468883,0.00015344619,0.013519553,0.04768303,0.001123971,0.91602546,0.00042867864],"about_ca_topic_score_codex":0.0012069284,"about_ca_topic_score_gemma":0.004004436,"teacher_disagreement_score":0.18214324,"about_ca_system_score_codex":0.00012942817,"about_ca_system_score_gemma":0.0015828308,"threshold_uncertainty_score":0.99990845},"labels":[],"label_agreement":null},{"id":"W2902782985","doi":"10.1002/jcph.1343","title":"Abuse Potential of Samidorphan: A Phase I, Oxycodone‐, Pentazocine‐, Naltrexone‐, and Placebo‐Controlled Study","year":2018,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Oxycodone; Placebo; Naltrexone; Opioid; Medicine; Visual analogue scale; Anesthesia; Pharmacology; Psychology; Internal medicine","score_opus":0.06326979985406189,"score_gpt":0.47798855935209056,"score_spread":0.41471875949802867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902782985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931216,0.0009581211,0.00010777846,0.0023025265,0.0020087438,0.0012748175,0.0000060313287,0.000015366215,0.00020501953],"genre_scores_gemma":[0.99425733,0.0011868748,0.00028823415,0.0010771087,0.0029148508,0.0000074685763,9.838795e-7,0.000025214054,0.00024191855],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9953774,0.0015148043,0.0020928099,0.00020793834,0.0005314968,0.0002755529],"domain_scores_gemma":[0.9950359,0.0022087437,0.0016615287,0.00026180866,0.00049126596,0.00034078522],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004337134,0.00022785395,0.0015932835,0.00017926915,0.000110764755,0.000007904734,0.0002903873,0.000139268,0.0011886195],"category_scores_gemma":[0.0005837524,0.000123244,0.00036304694,0.00013653832,0.00067016983,0.00011544174,0.00010698956,0.0006900152,0.000056871195],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.65053105,0.027946828,0.04012344,0.00007530384,0.0073413537,0.0012412907,0.0019513421,0.000022583235,0.2031533,0.000003675579,0.050523482,0.017086355],"study_design_scores_gemma":[0.77705854,0.079846404,0.09900752,0.00020234795,0.01866063,0.002606356,0.0014245478,0.0014012558,0.0150077185,0.00015572557,0.004333393,0.00029558325],"about_ca_topic_score_codex":0.000008814344,"about_ca_topic_score_gemma":0.0000052733835,"teacher_disagreement_score":0.18814558,"about_ca_system_score_codex":0.000027911226,"about_ca_system_score_gemma":0.00017974176,"threshold_uncertainty_score":0.99972445},"labels":[],"label_agreement":null},{"id":"W2905418559","doi":"10.1002/jcph.1349","title":"Population Pharmacokinetic Study and Individual Dose Adjustments of High‐Dose Methotrexate in Chinese Pediatric Patients With Acute Lymphoblastic Leukemia or Osteosarcoma","year":2018,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Emergent BioSolutions (Canada)","funders":"Research Grants Council, University Grants Committee","keywords":"NONMEM; Medicine; Pharmacokinetics; Osteosarcoma; Population; Methotrexate; Oncology; Pharmacology; Internal medicine; Cancer research","score_opus":0.042200890842123376,"score_gpt":0.4145748417704224,"score_spread":0.37237395092829906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905418559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974262,0.00009699812,0.000038699487,0.0003044086,0.00086021266,0.0012210467,0.00002101644,0.000010328501,0.000021063988],"genre_scores_gemma":[0.9970856,0.00034465393,0.00058949273,0.000613154,0.0012519811,0.000010863311,0.000008734549,0.000041387637,0.000054141645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946332,0.0017368424,0.0018803653,0.00029383466,0.0010103303,0.00044540502],"domain_scores_gemma":[0.99387896,0.0034908594,0.0013762364,0.00024300691,0.0006318704,0.000379049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032694133,0.00030253158,0.0012534687,0.00049866166,0.00007867376,0.000010824269,0.0004658775,0.00015945187,0.0002511919],"category_scores_gemma":[0.0009517377,0.00015234204,0.0001051828,0.00084419164,0.0004651145,0.0001977643,0.0003114448,0.0008347631,0.00001097272],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.076983236,0.002979938,0.9052575,0.00008376073,0.0015001561,0.0005737545,0.00072590815,0.000087587505,0.0004410111,7.859706e-7,0.0009840518,0.010382278],"study_design_scores_gemma":[0.073701605,0.016358878,0.90463686,0.00004221432,0.0037042,0.00023306822,0.000070162576,0.00097345567,0.00009033465,0.000043424843,0.000015616448,0.00013019612],"about_ca_topic_score_codex":0.00009152522,"about_ca_topic_score_gemma":0.000029596298,"teacher_disagreement_score":0.0133789405,"about_ca_system_score_codex":0.00031613675,"about_ca_system_score_gemma":0.0010938476,"threshold_uncertainty_score":0.6212328},"labels":[],"label_agreement":null},{"id":"W2906557460","doi":"10.1002/jcph.1361","title":"Pharmacokinetics, Pharmacodynamics, and Safety of E6011, a Novel Humanized Antifractalkine (CX3CL1) Monoclonal Antibody: A Randomized, Double‐Blind, Placebo‐Controlled Single‐Ascending‐Dose Study","year":2018,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eisai Canada; Eisai","keywords":"Medicine; Pharmacokinetics; Pharmacodynamics; Rheumatoid arthritis; Placebo; Adverse effect; Pharmacology; Internal medicine; Potency; Gastroenterology; Pathology","score_opus":0.081837816035069,"score_gpt":0.4485786332011374,"score_spread":0.3667408171660684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906557460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98750323,0.0011346778,0.0017888681,0.0022393276,0.003506481,0.0032573836,0.000014406727,0.0000286514,0.00052700157],"genre_scores_gemma":[0.9893781,0.0028513228,0.00077079615,0.0011282723,0.005564137,0.000013499853,0.0000079559495,0.00006677893,0.00021913764],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99208057,0.001503786,0.0047079856,0.00040623886,0.0007637981,0.00053761253],"domain_scores_gemma":[0.9885876,0.005941803,0.003415452,0.00027432368,0.0012948676,0.00048595935],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.014012729,0.0004937246,0.004195638,0.0003821896,0.00021374668,0.000028770532,0.000510173,0.00023300068,0.0016297615],"category_scores_gemma":[0.0011045719,0.00030275912,0.0009981144,0.00035035214,0.0016142381,0.00016819873,0.0002699857,0.0015581724,0.000009985706],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6949101,0.0044267625,0.001678124,0.000060303348,0.00428572,0.000061556806,0.00054019,0.00003334807,0.29150224,0.000014270599,0.0010065271,0.001480859],"study_design_scores_gemma":[0.94915915,0.0042217276,0.0006442559,0.00014330995,0.010333068,0.00058876514,0.00027013934,0.012780625,0.019662505,0.000041655363,0.0018628289,0.00029197524],"about_ca_topic_score_codex":0.000026954678,"about_ca_topic_score_gemma":0.0000051263705,"teacher_disagreement_score":0.27183974,"about_ca_system_score_codex":0.00007047284,"about_ca_system_score_gemma":0.00033989636,"threshold_uncertainty_score":0.9999425},"labels":[],"label_agreement":null},{"id":"W2909891606","doi":"10.1002/jcph.1372","title":"Comparison of Cognitive Impairments After Intensive Care Unit Sedation Using Dexmedetomidine and Propofol Among Older Patients","year":2019,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Intensive Care Unit Cognitive Disorders","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dexmedetomidine; Propofol; Medicine; Sedation; Intensive care unit; Anesthesia; Cognition; Montreal Cognitive Assessment; Intensive care; Cognitive impairment; Intensive care medicine; Psychiatry","score_opus":0.06279359722470408,"score_gpt":0.4685922046614829,"score_spread":0.4057986074367788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909891606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99698865,0.00027565417,0.00006468678,0.00035866952,0.0011691974,0.0010056652,0.0000149626085,0.0000042659954,0.000118236625],"genre_scores_gemma":[0.99053323,0.00007034187,0.000035867644,0.009119139,0.00017721724,0.0000027650592,0.00001547516,0.00002177864,0.000024160669],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99754614,0.0006450972,0.0011656751,0.00014163052,0.00029888802,0.00020258367],"domain_scores_gemma":[0.9729839,0.0014248418,0.0011707068,0.000080430334,0.024196766,0.00014334724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006223306,0.00016359535,0.0008270872,0.00016503704,0.000038899685,0.0000042003126,0.00009478399,0.00014139415,0.00029309947],"category_scores_gemma":[0.00417044,0.000107150874,0.0001799791,0.00013282736,0.0005359345,0.00012408689,0.00009756205,0.0007588555,0.000009525855],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008185588,0.0003348149,0.9825294,0.00009940104,0.00056396896,0.000024457457,0.0037010524,0.000010157249,0.0020547486,3.1489563e-7,0.0006674811,0.0018286374],"study_design_scores_gemma":[0.0104782935,0.0043087373,0.9257913,0.0006895683,0.00215709,0.000049905215,0.046974055,0.00065719115,0.00872542,0.000009906928,0.0000393289,0.00011918856],"about_ca_topic_score_codex":0.000010617017,"about_ca_topic_score_gemma":0.0000037553723,"teacher_disagreement_score":0.056738064,"about_ca_system_score_codex":0.000044306413,"about_ca_system_score_gemma":0.00017892002,"threshold_uncertainty_score":0.49927077},"labels":[],"label_agreement":null},{"id":"W2913866147","doi":"10.1002/jcph.1391","title":"4β‐Hydroxycholesterol as an Endogenous Biomarker for CYP3A Activity: Literature Review and Critical Evaluation","year":2019,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Waterloo CFD Engineering Consulting","funders":"","keywords":"CYP3A; Biomarker; Pharmacology; Midazolam; Endogeny; Metabolite; Biology; Cholesterol; Cytochrome P450; Medicine; Endocrinology; Metabolism; Biochemistry","score_opus":0.6130139562391858,"score_gpt":0.6623758551971944,"score_spread":0.04936189895800869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913866147","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010688656,0.97858405,0.0000565543,0.0022641125,0.012917013,0.0042484473,0.00032308444,0.00002074827,0.00051712146],"genre_scores_gemma":[0.0011063948,0.9775659,0.0000791045,0.016439712,0.0042185844,0.0001835166,0.000049889826,0.00011548875,0.00024142745],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9780873,0.016618207,0.0032828166,0.00066828245,0.00054716313,0.00079622597],"domain_scores_gemma":[0.98114735,0.013334933,0.00285962,0.0005138384,0.0012471009,0.00089718634],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.02567608,0.0008359266,0.0046725646,0.00031264176,0.00032014202,0.0000798265,0.0013667255,0.0015494927,0.0010065429],"category_scores_gemma":[0.0023821634,0.00053536403,0.0014448086,0.0004075499,0.0007389967,0.00045290738,0.00027230597,0.0047838395,0.0001059966],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011184248,0.0010135552,0.0000039502606,0.019380415,0.0024218524,0.000084360254,0.000101658356,0.0000068993304,0.0004460514,0.00007063485,0.01722005,0.95813215],"study_design_scores_gemma":[0.0040307795,0.00099408,0.000010614352,0.003302092,0.06573028,0.0030110176,0.0000055713763,0.00034945834,0.0000711884,0.00044089562,0.9215742,0.0004798194],"about_ca_topic_score_codex":0.000001109359,"about_ca_topic_score_gemma":5.322194e-7,"teacher_disagreement_score":0.95765233,"about_ca_system_score_codex":0.000086269,"about_ca_system_score_gemma":0.0013896013,"threshold_uncertainty_score":0.99990666},"labels":[],"label_agreement":null},{"id":"W2920650314","doi":"10.1002/jcph.1399","title":"A Study to Evaluate Doravirine Pharmacokinetics When Coadministered With Acid‐Reducing Agents","year":2019,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pharma Medica Research (Canada)","funders":"","keywords":"Pharmacokinetics; Antacid; Pharmacology; Drug interaction; Zidovudine; Chemistry; Reverse-transcriptase inhibitor; Medicine; Internal medicine; Human immunodeficiency virus (HIV); Sida; Virology","score_opus":0.11937628668729905,"score_gpt":0.47735217306619193,"score_spread":0.3579758863788929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2920650314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97930634,0.000102775775,0.000043990887,0.016607543,0.0014848064,0.00144287,0.0000021928745,0.000014944898,0.0009945158],"genre_scores_gemma":[0.98575515,0.00011906671,0.001096537,0.004699134,0.0007851387,0.000009310413,0.0000019395534,0.00003174555,0.0075019863],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966514,0.00079558836,0.0013730492,0.00022558784,0.0006222018,0.00033214802],"domain_scores_gemma":[0.99761754,0.00064981513,0.0006482598,0.0002541333,0.0003852153,0.000445058],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0034487937,0.00023500374,0.0009435494,0.00014806559,0.00006353309,0.000013053831,0.00034129331,0.0000529356,0.0019130406],"category_scores_gemma":[0.00012419016,0.00012333221,0.00016472295,0.00019515959,0.00008980602,0.000067503046,0.00014551857,0.0006854407,0.00042178694],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0788387,0.019249646,0.5820746,0.00012742447,0.013235267,0.0040575825,0.017886272,0.0008887177,0.026078163,0.0000040705895,0.23041978,0.027139813],"study_design_scores_gemma":[0.22504227,0.080815256,0.41560543,0.0007417686,0.028157583,0.004333768,0.006732433,0.0014134255,0.043567285,0.00012406398,0.19216995,0.0012967937],"about_ca_topic_score_codex":0.000003130219,"about_ca_topic_score_gemma":0.000002857097,"teacher_disagreement_score":0.16646914,"about_ca_system_score_codex":0.00007384362,"about_ca_system_score_gemma":0.000418294,"threshold_uncertainty_score":0.99899936},"labels":[],"label_agreement":null},{"id":"W2945068176","doi":"10.1002/jcph.1446","title":"Membrane‐Spanning Protein Genetic Polymorphisms Related to Methotrexate Therapeutic Outcomes in a Chinese Rheumatoid Arthritis Population","year":2019,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Natural Science Foundation of China","keywords":"Odds ratio; Methotrexate; Single-nucleotide polymorphism; Rheumatoid arthritis; SNP; Medicine; Internal medicine; Pharmacology; Adverse effect; Confidence interval; Arthritis; Genotype; Bioinformatics; Genetics; Gene; Biology","score_opus":0.038734896236194846,"score_gpt":0.4362140282801865,"score_spread":0.39747913204399166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945068176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892949,0.0012235829,0.000041349664,0.0069322027,0.0010847818,0.001219301,0.0000011010444,0.000017992445,0.00018479631],"genre_scores_gemma":[0.995286,0.0010344418,0.00053320767,0.0022893886,0.0001898698,0.000012681821,0.0000012744166,0.000039529692,0.00061358965],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950484,0.0016081507,0.0020989839,0.00022278768,0.0005756179,0.0004460375],"domain_scores_gemma":[0.996366,0.0021951087,0.000662188,0.00030568024,0.00017087624,0.00030012263],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0051183505,0.00020674108,0.0012127896,0.00031122405,0.000044985067,0.000011399096,0.00038731738,0.00020845633,0.00093336345],"category_scores_gemma":[0.0010237197,0.00012118035,0.00029705244,0.00048968726,0.000119450655,0.00010085524,0.00012120377,0.0012593932,0.00019400907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018754445,0.00148144,0.67974466,0.00015920174,0.0019399279,0.0014214551,0.0019854235,0.0069842963,0.2304382,0.00007282493,0.0005560892,0.056462053],"study_design_scores_gemma":[0.07154604,0.0030839713,0.90156406,0.0005384206,0.00018681126,0.002617899,0.00010558177,0.014515387,0.003776267,0.0010471743,0.00071040285,0.00030799911],"about_ca_topic_score_codex":0.00023231219,"about_ca_topic_score_gemma":0.0000186725,"teacher_disagreement_score":0.22666194,"about_ca_system_score_codex":0.0009381586,"about_ca_system_score_gemma":0.0014296572,"threshold_uncertainty_score":0.9999799},"labels":[],"label_agreement":null},{"id":"W2970013275","doi":"10.1002/jcph.1508","title":"Randomized Population Pharmacokinetic Analysis and Safety of Intravenous Acetaminophen for Acute Postoperative Pain in Neonates and Infants","year":2019,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pediatric Pain Management Techniques","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals","keywords":"Medicine; Acetaminophen; Placebo; Anesthesia; Pharmacokinetics; Population; Adverse effect; Randomized controlled trial; Pharmacodynamics; Mallinckrodt; Surgery; Internal medicine","score_opus":0.02126594272878669,"score_gpt":0.4057640991048461,"score_spread":0.38449815637605944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970013275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99158823,0.0006874083,0.0033382927,0.002820165,0.00014868523,0.0013371281,0.0000050626045,0.0000067424107,0.00006830986],"genre_scores_gemma":[0.9854624,0.011007982,0.0017000351,0.0016300058,0.00013666536,0.000008188864,0.0000049716336,0.00000792227,0.000041794305],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9964227,0.0018005548,0.00137077,0.00012001339,0.00014679285,0.00013914438],"domain_scores_gemma":[0.9924437,0.0064104525,0.00082903984,0.00008262311,0.0001577197,0.00007648289],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012542186,0.00010988214,0.0013841166,0.00047603046,0.000020748788,0.0000036285699,0.00011252366,0.00008745183,0.000064917775],"category_scores_gemma":[0.00092426373,0.00006823966,0.0001983141,0.00035499808,0.000176256,0.0000734962,0.00005725893,0.00033312145,3.0264107e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5098999,0.0005346232,0.38932544,0.00018888006,0.011649497,0.000040632927,0.0008353444,0.00038959787,0.013395757,0.000049542843,0.0017440028,0.0719468],"study_design_scores_gemma":[0.33381987,0.0034100716,0.59294474,0.000073427116,0.025879068,0.00005234324,0.00011532443,0.04047311,0.00092123816,0.0017681882,0.0003550723,0.00018752967],"about_ca_topic_score_codex":0.000027682621,"about_ca_topic_score_gemma":0.0000034132586,"teacher_disagreement_score":0.20361933,"about_ca_system_score_codex":0.00001733551,"about_ca_system_score_gemma":0.00003422133,"threshold_uncertainty_score":0.43468967},"labels":[],"label_agreement":null},{"id":"W2972367557","doi":"10.1002/jcph.1493","title":"Characterization of the Ontogeny of Hepatic UDP‐Glucuronosyltransferase Enzymes Based on Glucuronidation Activity Measured in Human Liver Microsomes","year":2019,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"F. Hoffmann-La Roche","keywords":"UGT2B7; Glucuronidation; Microsome; Gene isoform; Glucuronosyltransferase; Isozyme; In vivo; Enzyme; Internal medicine; Endocrinology; Pharmacokinetics; Ontogeny; In vitro; Chemistry; Pharmacology; Biology; Biochemistry; Medicine; Gene; Genetics","score_opus":0.12747881036509193,"score_gpt":0.4600267149257834,"score_spread":0.3325479045606915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972367557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99227107,0.00038155835,0.000112069225,0.0013087884,0.0048786392,0.0007439518,0.000058559,0.00000645149,0.00023892682],"genre_scores_gemma":[0.9957872,0.0010943555,0.000019992443,0.0024828215,0.0005019391,0.000006719943,0.0000047161802,0.000024459252,0.00007779988],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9920684,0.0052027223,0.0018012777,0.0002068823,0.00039508307,0.00032564],"domain_scores_gemma":[0.9950046,0.002298324,0.0018282463,0.00028274488,0.00043965055,0.00014642265],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0057768617,0.0002492488,0.0008908158,0.00019690154,0.000113850525,0.00000545421,0.00082818215,0.000310125,0.0011131546],"category_scores_gemma":[0.00029845547,0.00016034913,0.00042570563,0.00033215107,0.0004940753,0.00013010498,0.00007969934,0.0014584975,0.000012937916],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004034677,0.0016981668,0.041721705,0.00008709119,0.00023565085,0.000005299847,0.00033114242,0.0038425885,0.9424114,0.00006132502,0.00022879402,0.0053421524],"study_design_scores_gemma":[0.0065185134,0.0005902722,0.17610912,0.00004405475,0.0005884338,0.000005808798,0.000013138082,0.0055951807,0.8061316,0.00007660505,0.0041926918,0.0001345798],"about_ca_topic_score_codex":0.000020916197,"about_ca_topic_score_gemma":0.000014032933,"teacher_disagreement_score":0.1362798,"about_ca_system_score_codex":0.000050440805,"about_ca_system_score_gemma":0.0003646668,"threshold_uncertainty_score":0.99979997},"labels":[],"label_agreement":null},{"id":"W2984226240","doi":"10.1002/jcph.1540","title":"Integration of Ontogeny Into a Physiologically Based Pharmacokinetic Model for Monoclonal Antibodies in Premature Infants","year":2019,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Canadian Institutes of Health Research","keywords":"Ontogeny; Monoclonal antibody; Antibody; Pharmacokinetics; Population; Medicine; Immunology; Biology; Pharmacology; Internal medicine","score_opus":0.15478821319222888,"score_gpt":0.5134345119709951,"score_spread":0.3586462987787662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984226240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98736256,0.0012018195,0.0016938136,0.007912794,0.00079091545,0.00071453437,0.000007826645,0.00000592878,0.00030981287],"genre_scores_gemma":[0.9871576,0.0021840748,0.0038158176,0.006300676,0.00045205106,0.000007987356,0.0000024738451,0.000010851148,0.00006847023],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.997514,0.0004888761,0.0013787578,0.00014412146,0.00024675528,0.00022749543],"domain_scores_gemma":[0.9942483,0.004152534,0.00096113107,0.00010843863,0.00040580978,0.00012378892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029791305,0.0001541564,0.0009069471,0.00008095212,0.000037385526,0.0000038382386,0.00026313393,0.00014662286,0.0002488002],"category_scores_gemma":[0.0009584407,0.000082674924,0.0003200309,0.00013512112,0.00021006337,0.0001173079,0.000068090274,0.0009260642,0.0000051445327],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.074436024,0.0022188798,0.016005129,0.00045113135,0.0008991756,0.000021275655,0.0006965593,0.020817094,0.85541105,0.00006240593,0.008720769,0.020260502],"study_design_scores_gemma":[0.020908076,0.0045357095,0.08510734,0.0002650496,0.0016096041,0.000044077886,0.00014377345,0.8546412,0.023974214,0.002112467,0.006451839,0.00020662657],"about_ca_topic_score_codex":0.0000069626217,"about_ca_topic_score_gemma":0.000005837295,"teacher_disagreement_score":0.83382416,"about_ca_system_score_codex":0.000030238898,"about_ca_system_score_gemma":0.00020793796,"threshold_uncertainty_score":0.40233397},"labels":[],"label_agreement":null},{"id":"W2985012075","doi":"10.1002/jcph.1535","title":"Role of Oxidative Stress in Hypersensitivity Reactions to Sulfonamides","year":2019,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pesticide Exposure and Toxicity","field":"Agricultural and Biological Sciences","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Oxidative stress; Chemistry; Biochemistry","score_opus":0.04869333413966463,"score_gpt":0.3626578290051098,"score_spread":0.31396449486544514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985012075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959907,0.00004695603,0.0000020904674,0.0024791933,0.00041578338,0.00011126052,0.00001324915,0.0000028899954,0.00093790196],"genre_scores_gemma":[0.9987389,0.00007916756,0.000044448807,0.000657166,0.00042666012,4.9274524e-7,6.471768e-7,4.5787405e-7,0.000052054365],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983176,0.0006802849,0.0006590916,0.000077989964,0.00013201308,0.00013301932],"domain_scores_gemma":[0.995595,0.0037513094,0.00040684655,0.000031277203,0.00013110707,0.00008449621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018650871,0.000062282204,0.00033847685,0.000016754,0.000025494024,0.0000029597716,0.00021839413,0.00006834113,0.00029608447],"category_scores_gemma":[0.00036626705,0.00002042919,0.000111963775,0.00018431623,0.00008108218,0.000074809104,0.000056685723,0.00036332593,0.00002613901],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005660485,0.00031684866,0.051295295,0.0000018281579,0.00003451514,0.000004969572,0.0000910298,0.00034087262,0.9342834,0.000039137067,0.00028831238,0.012737786],"study_design_scores_gemma":[0.00042673477,0.0013352381,0.9229253,0.000022481527,0.00004293233,0.000021745236,0.00049713213,0.000078609126,0.068928465,0.0007931776,0.0048632156,0.00006500613],"about_ca_topic_score_codex":0.00015231276,"about_ca_topic_score_gemma":0.00027357045,"teacher_disagreement_score":0.87162995,"about_ca_system_score_codex":0.0000110186,"about_ca_system_score_gemma":0.000022434057,"threshold_uncertainty_score":0.32419172},"labels":[],"label_agreement":null},{"id":"W2990457166","doi":"10.1002/jcph.1543","title":"Abuse Potential of Lasmiditan: A Phase 1 Randomized, Placebo‐ and Alprazolam‐Controlled Crossover Study","year":2019,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"De Beers (Canada)","funders":"Eli Lilly and Company","keywords":"Alprazolam; Placebo; Medicine; Adverse effect; Tolerability; Anesthesia; Internal medicine; Psychiatry; Anxiety","score_opus":0.03858354255254871,"score_gpt":0.45940601735817826,"score_spread":0.42082247480562956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990457166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99176985,0.0017737088,0.00004374765,0.0032654356,0.000689679,0.0017954719,0.0000030609206,0.0000057482057,0.00065328093],"genre_scores_gemma":[0.9920812,0.0033213247,0.00006149658,0.001643167,0.0012026358,0.000007920596,3.1742974e-7,0.000013209326,0.00166871],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99586606,0.0013976239,0.0020539935,0.0001324492,0.00034063615,0.00020924014],"domain_scores_gemma":[0.99234337,0.0057056705,0.0012482771,0.00015526424,0.00039058857,0.0001568611],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008839274,0.000162913,0.0026836735,0.00009586787,0.000058800346,0.0000057200573,0.00015879313,0.000099456585,0.0009726979],"category_scores_gemma":[0.0011077806,0.000081661194,0.0006355609,0.00007829372,0.00049014034,0.000066433364,0.000070761256,0.00076834916,0.000022419626],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9476918,0.00311991,0.0033442916,0.000042896016,0.0047081956,0.00011236454,0.0017469227,0.000023323464,0.006262844,0.000013290495,0.03257405,0.00036010696],"study_design_scores_gemma":[0.97815776,0.006298935,0.0031990805,0.000032973017,0.006358513,0.0002474607,0.0011528936,0.0007070492,0.00026078764,0.00010319692,0.0033957164,0.00008560642],"about_ca_topic_score_codex":0.000009533372,"about_ca_topic_score_gemma":0.000004282401,"teacher_disagreement_score":0.030465983,"about_ca_system_score_codex":0.000010368894,"about_ca_system_score_gemma":0.00015616337,"threshold_uncertainty_score":0.9999406},"labels":[],"label_agreement":null},{"id":"W2998100580","doi":"10.1002/jcph.1571","title":"Coexpression of Human Hepatic Uridine Diphosphate Glucuronosyltransferase Proteins: Implications for Ontogenetic Mechanisms and Isoform Coregulation","year":2019,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Gene isoform; Ontogeny; Biology; Glucuronosyltransferase; Internal medicine; Endocrinology; Western blot; Blot; Uridine; Glucuronidation; Microsome; Genetics; Biochemistry; Medicine; Gene; Enzyme; RNA","score_opus":0.1620544192543954,"score_gpt":0.5110713937836602,"score_spread":0.3490169745292648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998100580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867937,0.002479168,0.0034189054,0.0026615795,0.0026585297,0.0017139983,0.000086773005,0.000013995828,0.00017334476],"genre_scores_gemma":[0.9933092,0.0031677892,0.000740446,0.0019491656,0.00060975685,0.000045998993,0.000010874863,0.000032948607,0.00013380747],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962957,0.0010527966,0.0018653576,0.00023193574,0.000179216,0.0003749904],"domain_scores_gemma":[0.9954346,0.0022554754,0.0013201042,0.00021401345,0.00045911432,0.00031670625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004431346,0.0002448565,0.0008205269,0.0001226757,0.0002253341,0.000008615517,0.0005257572,0.0002898381,0.00059615105],"category_scores_gemma":[0.00014988775,0.00017235501,0.0002912085,0.00014714168,0.00035756998,0.00012099835,0.000082217106,0.00075524586,0.000008681526],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026975535,0.0006588965,0.006666827,0.00012214089,0.00043078436,0.000001675788,0.0002656774,0.0011045103,0.9672751,0.0018809794,0.0013878524,0.017507993],"study_design_scores_gemma":[0.019485792,0.0037852563,0.061808053,0.00006601952,0.0029366403,0.000081579004,0.0000798451,0.0065209437,0.8536559,0.025223447,0.025952557,0.00040400008],"about_ca_topic_score_codex":0.000006984315,"about_ca_topic_score_gemma":0.0000035300966,"teacher_disagreement_score":0.113619246,"about_ca_system_score_codex":0.000023172423,"about_ca_system_score_gemma":0.00019142333,"threshold_uncertainty_score":0.7028433},"labels":[],"label_agreement":null},{"id":"W3003468346","doi":"10.1002/jcph.1567","title":"Reversing the Effects of 0.5% Bupivacaine Using Phentolamine Mesylate: A Preliminary Randomized Controlled Clinical Trial","year":2020,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Dental Anxiety and Anesthesia Techniques","field":"Dentistry","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Phentolamine; Medicine; Anesthesia; Mesylate; Randomized controlled trial; Saline; Bupivacaine; Surgery; Chemistry; Propranolol","score_opus":0.08814747455870142,"score_gpt":0.44690200914843603,"score_spread":0.3587545345897346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003468346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98252946,0.0018261652,0.0012873249,0.0070162085,0.0049688453,0.0021982256,0.0000015055115,0.000029731253,0.00014254964],"genre_scores_gemma":[0.98716766,0.0025206076,0.0004208596,0.005228708,0.0045185625,0.000010538252,6.485932e-7,0.00002391384,0.000108482374],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9839144,0.010391337,0.0047386237,0.0001942741,0.00049323763,0.00026812978],"domain_scores_gemma":[0.956833,0.038314905,0.0041564475,0.00020847467,0.00027148586,0.0002156904],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01800971,0.00024114142,0.0034881802,0.000047064535,0.00015299067,0.000018862022,0.00095368404,0.00028046625,0.00022002477],"category_scores_gemma":[0.012359785,0.00011342621,0.0024827665,0.00020159292,0.0010963461,0.00013893537,0.00021679273,0.0015943241,0.000013584685],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.978943,0.0007776455,0.00020978821,0.000075577256,0.0015368108,0.00034407477,0.00016183186,0.000026356234,0.0048311986,0.000039449762,0.010882657,0.0021716082],"study_design_scores_gemma":[0.9765784,0.0057991506,0.00043851312,0.00016084117,0.005074168,0.000506881,0.00008718185,0.004222076,0.0038798822,0.0005163665,0.0025815256,0.00015497931],"about_ca_topic_score_codex":0.0000080205655,"about_ca_topic_score_gemma":3.8158072e-7,"teacher_disagreement_score":0.02792357,"about_ca_system_score_codex":0.000017437993,"about_ca_system_score_gemma":0.00015040782,"threshold_uncertainty_score":0.9959595},"labels":[],"label_agreement":null},{"id":"W3006385761","doi":"10.1002/jcph.1575","title":"Pharmacokinetics, Safety, and Tolerability of Orally Administered Ursodeoxycholic Acid in Patients With Parkinson's Disease—A Pilot Study","year":2020,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute of Biomedical Imaging and Bioengineering; National Institutes of Health","keywords":"Tolerability; Ursodeoxycholic acid; Medicine; Pharmacokinetics; Internal medicine; Parkinson's disease; Gastroenterology; Adverse effect; Pharmacology; Disease","score_opus":0.05089371776168045,"score_gpt":0.36159830008939864,"score_spread":0.3107045823277182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006385761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99625677,0.0010057894,0.00011444743,0.0020435578,0.00021567296,0.00032574226,0.00001355853,0.0000020531681,0.000022426992],"genre_scores_gemma":[0.9968131,0.00042861493,0.000069596295,0.002146315,0.0005156105,0.0000017203682,0.000004215405,0.000013568195,0.0000072138373],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976373,0.00078277296,0.0010379816,0.00019275202,0.00018986371,0.00015934758],"domain_scores_gemma":[0.9986316,0.00017673978,0.0006039762,0.00013065344,0.00021449155,0.00024253287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010388574,0.00014037779,0.0004718552,0.00002706294,0.00003061188,0.0000048744305,0.0003226798,0.00004321998,0.000071213755],"category_scores_gemma":[0.0002597591,0.00008945399,0.00006405955,0.00009391024,0.00021595419,0.000007601486,0.0001493982,0.0003470412,8.5249e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.071760334,0.0029076089,0.91070193,0.000036009536,0.00035195655,0.000026492506,0.00018465884,0.0005768797,0.00785047,0.0000010646835,0.004550246,0.0010523553],"study_design_scores_gemma":[0.015387941,0.025634855,0.9486169,0.000016440728,0.00042020634,0.000004836924,0.00007030375,0.000088800734,0.0021225556,0.00001540782,0.0074649313,0.00015682795],"about_ca_topic_score_codex":0.0000034861598,"about_ca_topic_score_gemma":0.0000016651674,"teacher_disagreement_score":0.05637239,"about_ca_system_score_codex":0.000005042497,"about_ca_system_score_gemma":0.00012819264,"threshold_uncertainty_score":0.36478278},"labels":[],"label_agreement":null},{"id":"W3027201765","doi":"10.1002/jcph.1645","title":"Can Colchicine as an Old Anti‐Inflammatory Agent Be Effective in COVID‐19?","year":2020,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Iran University of Medical Sciences","keywords":"Colchicine; Medicine; Pneumonia; Immunology; Tumor necrosis factor alpha; Cytokine storm; Cytokine; Inflammation; Interferon; Internal medicine; Coronavirus disease 2019 (COVID-19); Disease; Infectious disease (medical specialty)","score_opus":0.1528156422679541,"score_gpt":0.5651303726928837,"score_spread":0.4123147304249296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027201765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72304136,0.00022960354,0.000044842585,0.275123,0.0006323709,0.00078164606,0.000006342634,0.000019324681,0.00012147906],"genre_scores_gemma":[0.8203101,0.0037223666,0.00003312907,0.17351839,0.0023105547,0.000011401689,0.0000015843798,0.000021251493,0.00007122347],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9930387,0.0033468606,0.002111658,0.0003127106,0.0007154911,0.00047456063],"domain_scores_gemma":[0.95772797,0.038471386,0.0009308217,0.0002822658,0.0004701941,0.0021173535],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.010379275,0.00022434579,0.001473311,0.00014165325,0.000114480434,0.000009581544,0.0005581339,0.00020190238,0.0008044808],"category_scores_gemma":[0.08040268,0.00013619433,0.00037897535,0.0003731798,0.00092179654,0.000100913705,0.00031501945,0.0029342445,0.000044345485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14328761,0.007906048,0.5452617,0.0022994827,0.005600727,0.02115494,0.010898985,0.0073706377,0.057339672,0.000359591,0.15602082,0.042499833],"study_design_scores_gemma":[0.0653357,0.04137222,0.6503031,0.0003079285,0.002497413,0.00021493716,0.0011437748,0.004590763,0.002713465,0.0019745382,0.22901562,0.00053052726],"about_ca_topic_score_codex":0.00010883742,"about_ca_topic_score_gemma":0.000048812937,"teacher_disagreement_score":0.105041444,"about_ca_system_score_codex":0.00022590808,"about_ca_system_score_gemma":0.0017694541,"threshold_uncertainty_score":0.99936604},"labels":[],"label_agreement":null},{"id":"W3032901080","doi":"10.1002/jcph.1684","title":"Colchicine and COVID‐19","year":2020,"lang":"en","type":"letter","venue":"The Journal of Clinical Pharmacology","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Medicine; Placebo; Family medicine; Clinical trial; Colchicine; Population; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Internal medicine; Alternative medicine; Environmental health; Pathology","score_opus":0.25126387426054914,"score_gpt":0.5924996591163878,"score_spread":0.34123578485583866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032901080","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017164246,0.0016128079,0.0002581296,0.9932494,0.0021357515,0.00063192606,0.000023164928,0.000024772984,0.000347605],"genre_scores_gemma":[0.009606916,0.025217796,0.00010240826,0.9284387,0.03474637,0.000005420861,0.0000064368637,0.00004535777,0.001830578],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9925284,0.0027507073,0.002867781,0.00035763718,0.000979032,0.0005164455],"domain_scores_gemma":[0.8800976,0.115471914,0.0020642367,0.0003703321,0.00069239223,0.0013034901],"candidate_categories":["metaresearch","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0069309114,0.00034355972,0.002617172,0.00016659754,0.00016420316,0.000012854598,0.00068159925,0.0007107176,0.0012174904],"category_scores_gemma":[0.10778274,0.00018754617,0.0006734106,0.00023747991,0.0021905787,0.00004427028,0.0006046,0.013456772,0.000076275624],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004901232,0.000140257,0.001072718,0.0009401788,0.0016815267,0.0068140873,0.00008084116,0.000010396428,0.00010695522,0.0000019829354,0.9822642,0.001985579],"study_design_scores_gemma":[0.007588571,0.004791559,0.0012834937,0.000092766,0.003089021,0.00028255148,0.000016798753,0.00018107836,0.000011596536,0.0008038475,0.9817087,0.00015000928],"about_ca_topic_score_codex":0.000016387154,"about_ca_topic_score_gemma":0.0000011335716,"teacher_disagreement_score":0.11272121,"about_ca_system_score_codex":0.00012351008,"about_ca_system_score_gemma":0.0027470265,"threshold_uncertainty_score":0.99969554},"labels":[],"label_agreement":null},{"id":"W3088185875","doi":"10.1002/jcph.1743","title":"Population Pharmacokinetics of Phenobarbital in Neonates and Infants on Extracorporeal Membrane Oxygenation and the Influence of Concomitant Renal Replacement Therapy","year":2020,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"National Institute of Neurological Disorders and Stroke; National Science Foundation","keywords":"Medicine; Extracorporeal membrane oxygenation; Pharmacokinetics; Dosing; Volume of distribution; Renal replacement therapy; Concomitant; Anesthesia; Population; Phenobarbital; Loading dose; Pharmacology; Internal medicine","score_opus":0.04983872761312437,"score_gpt":0.3892984059846899,"score_spread":0.33945967837156554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088185875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98895,0.00076586416,0.000025481804,0.009599056,0.00017437592,0.00040368745,0.0000052697465,0.0000027768613,0.00007348765],"genre_scores_gemma":[0.98473614,0.011538162,0.000111127636,0.0033127046,0.00028568442,6.3596184e-7,0.0000017315755,0.0000100016805,0.000003782529],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974801,0.0005005535,0.001479518,0.00011891431,0.0002973127,0.00012362254],"domain_scores_gemma":[0.996589,0.0018817547,0.0011117636,0.000079926525,0.00021058375,0.00012698329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025342242,0.00012216442,0.0006382215,0.00006920104,0.000028303579,0.0000038582684,0.00014296775,0.000071385504,0.000036413905],"category_scores_gemma":[0.00044930892,0.000065287146,0.00008851851,0.00014098952,0.000516857,0.000048440255,0.000055066073,0.0005688537,3.2566567e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18965542,0.0013550802,0.13584773,0.00025528797,0.0011671771,0.00007661769,0.0030535804,0.018068306,0.6196418,0.0006506351,0.0011732535,0.029055124],"study_design_scores_gemma":[0.054180995,0.004943527,0.87293625,0.00015373077,0.0007097162,0.000112324844,0.00011776436,0.022370549,0.043416303,0.00042656684,0.000503722,0.00012856886],"about_ca_topic_score_codex":0.000016882186,"about_ca_topic_score_gemma":8.9853904e-7,"teacher_disagreement_score":0.7370885,"about_ca_system_score_codex":0.000009419732,"about_ca_system_score_gemma":0.00006284873,"threshold_uncertainty_score":0.26623327},"labels":[],"label_agreement":null},{"id":"W3100206030","doi":"10.1002/jcph.1713","title":"A Physiological Approach to Pharmacokinetics in Chronic Kidney Disease","year":2020,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Canadian Institutes of Health Research","keywords":"Kidney disease; Renal function; Pharmacokinetics; Medicine; Hematocrit; Population; Intensive care medicine; Clinical trial; Internal medicine; Pharmacology; Urology","score_opus":0.11503815945997459,"score_gpt":0.42454581783916673,"score_spread":0.30950765837919214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3100206030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9227015,0.0007944097,0.0028049827,0.07087882,0.0013118667,0.00061782857,0.000009673542,0.000022328524,0.00085860904],"genre_scores_gemma":[0.94040173,0.0010277824,0.00060537196,0.054456048,0.0034062227,0.000004917478,0.000003061478,0.000015338688,0.000079506906],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99779236,0.0003829745,0.001097656,0.00017233,0.00027303927,0.00028162592],"domain_scores_gemma":[0.9980071,0.00022686705,0.0002725676,0.000103930644,0.00010399524,0.0012855062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011978009,0.00014375341,0.00070323166,0.00005414097,0.000030453859,0.0000033572046,0.00035927957,0.00008723716,0.00036173224],"category_scores_gemma":[0.00032978895,0.00007871022,0.0002868501,0.00027408235,0.0001637031,0.000034808785,0.000052841744,0.0010775322,0.00003634679],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07233429,0.0050885845,0.0074655185,0.00074522215,0.00094993087,0.002023852,0.00119956,0.0115288105,0.49726605,0.00028473334,0.39340842,0.0077050263],"study_design_scores_gemma":[0.074807175,0.015509555,0.29277706,0.00047047445,0.0062917033,0.0002559003,0.00042620272,0.036977876,0.017633118,0.0012085709,0.55261475,0.0010276075],"about_ca_topic_score_codex":6.749403e-7,"about_ca_topic_score_gemma":1.7735033e-7,"teacher_disagreement_score":0.47963294,"about_ca_system_score_codex":0.000046578443,"about_ca_system_score_gemma":0.00061737763,"threshold_uncertainty_score":0.4681401},"labels":[],"label_agreement":null},{"id":"W3118172129","doi":"10.1002/jcph.1807","title":"Phase 1 Renal Impairment Trial Results Supports Targeted Individualized Dosing of ELX‐02 in Patients With Nephropathic Cystinosis","year":2020,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Biomedical Research and Pathophysiology","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Dosing; Medicine; Renal function; Cystinosis; Pharmacokinetics; Urology; Area under the curve; Internal medicine; Urinary system; Population; Urine; Endocrinology; Chemistry; Cystine","score_opus":0.08037499124568052,"score_gpt":0.45048855609374333,"score_spread":0.3701135648480628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118172129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880462,0.0001104263,0.00005589847,0.010319851,0.0005863386,0.0007747152,0.000050510604,0.000007194758,0.000048860307],"genre_scores_gemma":[0.9932761,0.00025477377,0.0004153585,0.004672573,0.0013257492,0.0000042004986,0.00002928296,0.00001470638,0.000007257489],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9937574,0.0023292853,0.0025116873,0.00020587262,0.0007838214,0.00041189298],"domain_scores_gemma":[0.99485797,0.0024657054,0.0014286499,0.00014858758,0.0003866511,0.0007124334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054204916,0.00016717415,0.0011834784,0.00015043044,0.000042575382,0.0000039710626,0.0003096757,0.00021745889,0.00044617523],"category_scores_gemma":[0.0036891785,0.00008858013,0.00024424124,0.00042596596,0.0006437898,0.00006579343,0.00011184788,0.0016408341,0.0000070747433],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9437164,0.0064363657,0.0047939415,0.000067738685,0.00044905915,0.00040541065,0.00045451245,0.000012804958,0.015589624,8.847439e-7,0.016702348,0.011370902],"study_design_scores_gemma":[0.73074895,0.1838106,0.07425786,0.00020426334,0.00084956567,0.000042636864,0.00006175125,0.00033780647,0.004805741,0.00007263563,0.0046506105,0.00015756334],"about_ca_topic_score_codex":0.000008978715,"about_ca_topic_score_gemma":0.0000010261807,"teacher_disagreement_score":0.21296744,"about_ca_system_score_codex":0.00003542414,"about_ca_system_score_gemma":0.0008610216,"threshold_uncertainty_score":0.71286994},"labels":[],"label_agreement":null},{"id":"W3129612282","doi":"10.1002/jcph.1839","title":"Association of Urine Platinum With Acute Kidney Injury in Children Treated With Cisplatin for Cancer","year":2021,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Chemotherapy-induced organ toxicity mitigation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hamilton Regional Laboratory Medicine Program; Western University; McGill University Health Centre; BC Children's Hospital; University of Toronto; SickKids Foundation; University of British Columbia; Hospital for Sick Children; Montreal Children's Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Canadian Institutes of Health Research","keywords":"Acute kidney injury; Medicine; Urine; Cisplatin; Urology; Creatinine; Lipocalin; Urinary system; Interquartile range; Internal medicine; Gastroenterology; Chemotherapy","score_opus":0.024114753455638818,"score_gpt":0.4001321020540021,"score_spread":0.37601734859836333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129612282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984482,0.00003337937,0.00011738305,0.014768377,0.00012509878,0.00037276736,0.000046731093,0.000005866907,0.000048434238],"genre_scores_gemma":[0.9941921,0.00044718242,0.00086204574,0.0033833846,0.00066584634,0.0000059802524,0.000016882324,0.000023014629,0.00040356987],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998293,0.00028933169,0.00089774426,0.00011014716,0.00024528088,0.00016451556],"domain_scores_gemma":[0.9973635,0.0006665878,0.0012314193,0.00009423229,0.00051688106,0.00012736877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012211412,0.000109731474,0.0006391012,0.00007348194,0.00002502209,0.0000030913523,0.00009302026,0.0001377704,0.00028874897],"category_scores_gemma":[0.00040559153,0.00006473097,0.00009890532,0.00027099418,0.000078772806,0.00006535444,0.0000148654835,0.0005708475,7.964612e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015703093,0.0006549679,0.6360849,0.000029770987,0.0027995566,0.000032455344,0.00019563176,0.00007410428,0.32976705,0.0000020111265,0.012322631,0.002333797],"study_design_scores_gemma":[0.01940689,0.0024816256,0.3973036,0.00014326606,0.0019099477,0.0002358658,0.00001919684,0.00016349767,0.57782114,0.0000439441,0.0003894258,0.000081566126],"about_ca_topic_score_codex":0.000022891092,"about_ca_topic_score_gemma":0.000021691654,"teacher_disagreement_score":0.2480541,"about_ca_system_score_codex":0.00013174808,"about_ca_system_score_gemma":0.00078010844,"threshold_uncertainty_score":0.31615987},"labels":[],"label_agreement":null},{"id":"W3139458708","doi":"10.1002/jcph.1850","title":"<i>The Journal of Clinical Pharmacology</i> Adds 2 Associate Editors","year":2021,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Clinical pharmacology; Pharmacy; Medicine; Associate editor; Family medicine; Library science; Medical education; Pharmacology","score_opus":0.17579865130730293,"score_gpt":0.5619432494937948,"score_spread":0.3861445981864919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3139458708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.65585566,0.017614964,0.00011135297,0.19615988,0.12706228,0.0003082417,0.000011700596,0.000015620262,0.0028603047],"genre_scores_gemma":[0.64570093,0.15264466,0.00034822072,0.05760398,0.1423731,0.0000025641255,0.0000013381249,0.000050932584,0.0012742938],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9849525,0.007878894,0.00539108,0.00018618668,0.00095604395,0.0006352736],"domain_scores_gemma":[0.9433593,0.047229778,0.005724008,0.00023581156,0.0025837352,0.0008673413],"candidate_categories":["metaresearch","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.03492929,0.0002705663,0.0019199356,0.00006183759,0.0004337249,0.000026191557,0.00084907096,0.00038403642,0.0015119802],"category_scores_gemma":[0.011790441,0.00013803564,0.0012551852,0.00036709057,0.0011798308,0.00023465391,0.00035052618,0.0057626357,0.000060025246],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015333659,0.0015966957,0.010545607,0.00003121669,0.0049360106,0.0009801835,0.00011199219,0.000032022894,0.0035997266,0.0000075093067,0.93467313,0.028152255],"study_design_scores_gemma":[0.012444661,0.0028868665,0.013670483,0.000050373466,0.0074594547,0.0019718162,0.0003553316,0.00013420948,0.004030903,0.00022034874,0.95663685,0.00013872217],"about_ca_topic_score_codex":0.000003900031,"about_ca_topic_score_gemma":0.000004161627,"teacher_disagreement_score":0.13855591,"about_ca_system_score_codex":0.00007512756,"about_ca_system_score_gemma":0.001568937,"threshold_uncertainty_score":0.9994008},"labels":[],"label_agreement":null},{"id":"W3157957845","doi":"10.1002/jcph.1876","title":"Longitudinal Impact of Acute Spinal Cord Injury on Clinical Pharmacokinetics of Riluzole, a Potential Neuroprotective Agent","year":2021,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Riluzole; Medicine; Pharmacokinetics; Neuroprotection; Pharmacology; Spinal cord injury; Amyotrophic lateral sclerosis; Population; Anesthesia; Spinal cord; Internal medicine","score_opus":0.17296837871998935,"score_gpt":0.5555047025165303,"score_spread":0.3825363237965409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157957845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926863,0.00024052623,0.00047206713,0.0037812006,0.002236899,0.0004243197,0.00003892403,0.000007435294,0.00011232943],"genre_scores_gemma":[0.99044555,0.0054242406,0.00027276584,0.0011644706,0.0025714622,0.0000026013156,0.0000022432757,0.000032382846,0.000084272666],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99213207,0.00290984,0.0032549978,0.00028835627,0.00096542214,0.0004493368],"domain_scores_gemma":[0.9941305,0.0012729687,0.0020087026,0.0003578205,0.0016864557,0.0005435635],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004349681,0.000255067,0.0016408791,0.00016231135,0.00006142857,0.0000073123015,0.000538873,0.00024781894,0.0015029071],"category_scores_gemma":[0.0010416172,0.0001503534,0.0015433566,0.0004216443,0.0010737509,0.00007692175,0.00033320874,0.0029527766,0.000024004052],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3454249,0.0068527767,0.039904263,0.000115529256,0.010275789,0.0032853894,0.00004685308,0.00061748875,0.5197977,0.000014208828,0.021689896,0.051975194],"study_design_scores_gemma":[0.01127322,0.07328528,0.8882481,0.00016283171,0.0033143037,0.0012127596,0.00001271337,0.0007110602,0.021013973,0.00014955435,0.00047701361,0.00013919132],"about_ca_topic_score_codex":0.000019486433,"about_ca_topic_score_gemma":4.281162e-7,"teacher_disagreement_score":0.84834385,"about_ca_system_score_codex":0.000093333336,"about_ca_system_score_gemma":0.0011751454,"threshold_uncertainty_score":0.99940985},"labels":[],"label_agreement":null},{"id":"W3165414811","doi":"10.1002/jcph.1914","title":"Influence of Prednisone on Inflammatory Biomarkers in Community‐Acquired Pneumonia: Secondary Analysis of a Randomized Trial","year":2021,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Sepsis Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"Gottfried und Julia Bangerter-Rhyner-Stiftung; Inselspital, Universitätsspital Bern; Universität Basel; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Helmut Horten Stiftung; National Science Foundation; Nora van Meeuwen Häfliger Stiftung","keywords":"Prednisone; Medicine; Procalcitonin; Placebo; Internal medicine; Pneumonia; Community-acquired pneumonia; Gastroenterology; Randomized controlled trial; Glucocorticoid; Corticosteroid; Absolute neutrophil count; Immunology; Pathology; Chemotherapy; Neutropenia; Sepsis","score_opus":0.10357982708112005,"score_gpt":0.4627796006136836,"score_spread":0.35919977353256355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165414811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99539274,0.0010254944,0.0000026788969,0.0024546608,0.000387101,0.00051001005,0.0000085913225,0.0000030851031,0.00021561592],"genre_scores_gemma":[0.9956742,0.0025940211,0.00005095678,0.0015197973,0.0001241586,0.000012548881,0.0000042518423,0.000008634034,0.000011440675],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9899844,0.0063303974,0.0031029435,0.00009896513,0.0003324907,0.00015081222],"domain_scores_gemma":[0.9790404,0.018143877,0.0019521171,0.00029882236,0.00043922523,0.0001255603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009797795,0.0001355676,0.002772882,0.0003903081,0.000034531095,0.000002503338,0.00023226542,0.00014711371,0.0003142009],"category_scores_gemma":[0.003357961,0.00008170666,0.0011432926,0.0006130214,0.0005804592,0.000049273833,0.000078357545,0.00068050245,0.0000016963405],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91486454,0.00578648,0.033452984,0.00006366528,0.02697507,0.00020344337,0.0006521401,0.0032028118,0.012919344,0.000013522932,0.00048525791,0.0013807241],"study_design_scores_gemma":[0.7023724,0.0025677986,0.26742896,0.0001498125,0.015743935,0.000028531691,0.00021036441,0.0002846572,0.010976921,0.00009869691,0.000078611876,0.000059344162],"about_ca_topic_score_codex":0.000048969825,"about_ca_topic_score_gemma":0.000031873486,"teacher_disagreement_score":0.23397598,"about_ca_system_score_codex":0.00004876637,"about_ca_system_score_gemma":0.00055027544,"threshold_uncertainty_score":0.40200356},"labels":[],"label_agreement":null},{"id":"W3175294244","doi":"10.1002/jcph.1829","title":"Pediatric Dose Selection for Therapeutic Proteins","year":2021,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Canadian Institutes of Health Research","keywords":"Dosing; Pharmacokinetics; Medicine; Context (archaeology); Pharmacology; Population; Pharmacodynamics; Drug development; Drug; Intensive care medicine; Biology","score_opus":0.4405057188521444,"score_gpt":0.6222148885577327,"score_spread":0.18170916970558826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3175294244","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006349017,0.99009264,0.0002428107,0.0040241294,0.0038108695,0.0015399494,0.0000070924852,0.00001084798,0.00020814556],"genre_scores_gemma":[0.00006253461,0.98152155,0.00027663744,0.003179347,0.014578419,0.00004872444,0.0000034973261,0.000040484043,0.00028880782],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947038,0.0021624365,0.0023196824,0.00019463667,0.00028720492,0.00033223175],"domain_scores_gemma":[0.98475426,0.011797812,0.0025352563,0.00012624597,0.00053146755,0.00025493806],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0059972275,0.0002846911,0.0030397312,0.00009978783,0.00015644952,0.000013876861,0.0003148097,0.00037651267,0.00059037417],"category_scores_gemma":[0.0012794818,0.00014271331,0.0016275952,0.00037264993,0.00013394357,0.00006832084,0.00009175176,0.0026049241,0.0000260418],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011938137,0.0007126251,0.000039262297,0.0050554243,0.003189387,0.000039000206,0.000015856845,0.0000011200298,0.0000047393733,0.000016411104,0.04182108,0.94791126],"study_design_scores_gemma":[0.002339918,0.0017556046,0.000025296407,0.00053614407,0.038338825,0.0010075461,0.000009282838,0.000020845831,0.0000039776187,0.000053915548,0.95578235,0.00012629136],"about_ca_topic_score_codex":0.0000014964655,"about_ca_topic_score_gemma":6.9645387e-7,"teacher_disagreement_score":0.94778496,"about_ca_system_score_codex":0.00007215126,"about_ca_system_score_gemma":0.0012647982,"threshold_uncertainty_score":0.99969614},"labels":[],"label_agreement":null},{"id":"W3192943827","doi":"10.1002/jcph.1951","title":"Physiologically Based Pharmacokinetic Modeling to Assess the Impact of CYP2D6‐Mediated Drug‐Drug Interactions on Tramadol and O‐Desmethyltramadol Exposures via Allosteric and Competitive Inhibition","year":2021,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Veterinary Pharmacology and Anesthesia","field":"Veterinary","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Tramadol; Quinidine; Pharmacology; CYP2D6; Pharmacokinetics; Drug interaction; Active metabolite; Chemistry; Oral administration; Propoxyphene; Drug; Medicine; Analgesic; Cytochrome P450; Metabolism; Biochemistry","score_opus":0.1831215674548552,"score_gpt":0.4810299608556376,"score_spread":0.2979083934007824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3192943827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923424,0.00024739013,0.000715208,0.0054493286,0.0007290048,0.00037799103,0.000023134337,0.000017627219,0.00009787854],"genre_scores_gemma":[0.99344146,0.00050953263,0.00023717365,0.005193126,0.0005521841,0.000015710464,0.0000061445803,0.000023209184,0.000021456484],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9933982,0.0045281854,0.001282222,0.0002753156,0.00021155018,0.00030453893],"domain_scores_gemma":[0.9915691,0.006939232,0.0007194564,0.00015941529,0.0003697885,0.00024303512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002304621,0.00028358315,0.00077874825,0.00012139517,0.00019552466,0.000020994295,0.00029513054,0.00009391862,0.00063805847],"category_scores_gemma":[0.00026582537,0.00016057114,0.00033292282,0.0002147805,0.00045335793,0.00015874667,0.00014511819,0.0013274511,0.000012429216],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018867955,0.001507298,0.0015101514,0.000046339923,0.0008395338,0.00080713804,0.0007674222,0.018333422,0.9528246,0.000014017863,0.0022382562,0.0022438855],"study_design_scores_gemma":[0.03826097,0.047873203,0.4779933,0.001060222,0.0062461067,0.019936329,0.0036885438,0.3066194,0.090903714,0.0027770991,0.0026259369,0.0020151641],"about_ca_topic_score_codex":0.000014365859,"about_ca_topic_score_gemma":0.0000023832288,"teacher_disagreement_score":0.8619209,"about_ca_system_score_codex":0.000036328544,"about_ca_system_score_gemma":0.00016132118,"threshold_uncertainty_score":0.6986293},"labels":[],"label_agreement":null},{"id":"W3196156655","doi":"10.1002/jcph.1937","title":"The Epidemiology of Drug Abuse","year":2021,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Substance Abuse Treatment and Outcomes","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Epidemiology; Psychosocial; Recreational Drug; Pandemic; Psychiatry; Psychological intervention; Medicine; Addiction; Substance abuse; Drug; Recreation; Substance use; Disease; Psychology; Coronavirus disease 2019 (COVID-19); Infectious disease (medical specialty); Political science","score_opus":0.30052645784665954,"score_gpt":0.5699602311900364,"score_spread":0.2694337733433768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196156655","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025547848,0.9886646,0.000005515265,0.0029581264,0.005241026,0.00041208803,0.000001887629,0.0000062423624,0.00015572489],"genre_scores_gemma":[0.00018034883,0.9938409,0.00011538363,0.002203664,0.0024851835,0.0000065678823,0.000003509821,0.00003218063,0.0011323136],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98908436,0.005663494,0.0045146034,0.00016279335,0.00023040644,0.0003443363],"domain_scores_gemma":[0.93441266,0.06026286,0.0043514953,0.00041623457,0.00036400338,0.0001927347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010255903,0.00030072912,0.0058745136,0.00008812871,0.00009148304,0.0000017914118,0.00066485885,0.00033855872,0.00035180454],"category_scores_gemma":[0.003058454,0.000113228976,0.0025736245,0.00023892893,0.000781753,0.000031575157,0.00007295889,0.0020452393,0.00003922406],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095775333,0.0004759393,0.002747735,0.00086638157,0.0076200697,0.00037946147,0.0002841146,0.0000019145955,6.0978965e-7,0.00010761714,0.14272892,0.84382945],"study_design_scores_gemma":[0.002348734,0.00037229806,0.00023712167,0.0024451427,0.014419283,0.0008693588,0.00012215225,0.0000014262612,0.000003722451,0.000102269085,0.9789922,0.00008627341],"about_ca_topic_score_codex":0.0000013639697,"about_ca_topic_score_gemma":0.000004522252,"teacher_disagreement_score":0.8437432,"about_ca_system_score_codex":0.000058924958,"about_ca_system_score_gemma":0.00096822425,"threshold_uncertainty_score":0.8885661},"labels":[],"label_agreement":null},{"id":"W3196938042","doi":"10.1002/jcph.1961","title":"Clinical Outcome Data of First Cohort of Chronic Pain Patients Treated With Cannabis‐Based Sublingual Oils in the United Kingdom: Analysis From the UK Medical Cannabis Registry","year":2021,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute for Health and Care Research","keywords":"Medicine; Cannabis; Chronic pain; Brief Pain Inventory; Visual analogue scale; Quality of life (healthcare); Adverse effect; Anxiety; McGill Pain Questionnaire; Cohort; Physical therapy; Psychiatry; Internal medicine","score_opus":0.13767218119410576,"score_gpt":0.47932767940698784,"score_spread":0.3416554982128821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196938042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90551317,0.00040432502,0.00012596899,0.092869334,0.0004128476,0.00045762293,0.00017344783,0.0000051741763,0.000038135237],"genre_scores_gemma":[0.99081236,0.00048480014,0.000038819577,0.006865885,0.0012992976,0.000011039417,0.00028853992,0.000025947533,0.00017328831],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98551506,0.007517696,0.004114077,0.0004291196,0.0019297785,0.00049425213],"domain_scores_gemma":[0.9877509,0.0056528235,0.0024141588,0.0016886032,0.0020074013,0.00048614584],"candidate_categories":["metaresearch","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.028641274,0.0002727557,0.001967383,0.00027409624,0.00012161836,0.000018322005,0.0021883142,0.00038819193,0.0014693104],"category_scores_gemma":[0.015333929,0.00012220266,0.0006780827,0.0023645095,0.0019101459,0.000059559236,0.000363686,0.00294035,0.0000014062912],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005254836,0.0017944422,0.84075624,0.00005895203,0.0028107692,0.00048066286,0.00009288157,0.00019086078,0.000034194258,0.0000027861524,0.14739423,0.0011291661],"study_design_scores_gemma":[0.0131261675,0.0030069042,0.937215,0.00018054098,0.0066318098,0.000055792938,0.00025883483,0.007449419,0.0002330799,0.000007464926,0.03168492,0.00015009081],"about_ca_topic_score_codex":0.0057879444,"about_ca_topic_score_gemma":0.006740395,"teacher_disagreement_score":0.115709305,"about_ca_system_score_codex":0.00012621947,"about_ca_system_score_gemma":0.0041083023,"threshold_uncertainty_score":0.9994435},"labels":[],"label_agreement":null},{"id":"W3201455773","doi":"10.1002/jcph.1966","title":"Dosing Regimen Prediction and Confirmation With Rivaroxaban for Thromboprophylaxis in Children After the Fontan Procedure: Insights From the Phase III UNIVERSE Study","year":2021,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; BC Children's Hospital; University of Toronto","funders":"","keywords":"Rivaroxaban; Medicine; Regimen; Dosing; Pharmacokinetics; Pharmacodynamics; Population; Pharmacology; Internal medicine; Warfarin; Atrial fibrillation","score_opus":0.04027497650451648,"score_gpt":0.3775215059186179,"score_spread":0.3372465294141014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201455773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99178904,0.0002528633,0.00036186035,0.0059922393,0.00037226273,0.0011872489,0.0000074256986,0.0000070305978,0.0000300377],"genre_scores_gemma":[0.99662745,0.00016410403,0.00008426943,0.0024220084,0.00065372814,0.0000124541575,0.000007359112,0.000011437794,0.000017213233],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816394,0.00069725316,0.00066874456,0.0001370446,0.00022239542,0.00011063887],"domain_scores_gemma":[0.9982029,0.0008406511,0.00045308867,0.00015220721,0.00027666675,0.00007448579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001065127,0.00010881295,0.00038807653,0.000037183672,0.00014470772,0.00001722783,0.00012185012,0.00007511868,0.00007654718],"category_scores_gemma":[0.00012211534,0.000047382706,0.00007442336,0.00016193137,0.00016423895,0.000120452234,0.000052116247,0.0005145324,9.798991e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12826173,0.023872513,0.71308637,0.00008522391,0.011103711,0.00022699668,0.04145914,0.00022789548,0.044854593,0.00084275217,0.009840524,0.026138525],"study_design_scores_gemma":[0.054726347,0.005211823,0.9295472,0.00008217766,0.0025419258,0.00021011119,0.0030163743,0.00082671846,0.0021235324,0.0010952258,0.0005267119,0.000091845424],"about_ca_topic_score_codex":0.00001841535,"about_ca_topic_score_gemma":0.000055231765,"teacher_disagreement_score":0.21646081,"about_ca_system_score_codex":0.000026481546,"about_ca_system_score_gemma":0.00018795134,"threshold_uncertainty_score":0.22354159},"labels":[],"label_agreement":null},{"id":"W3212705536","doi":"10.1002/jcph.2002","title":"Effect of Anti‐VEGF Therapy on the Disease Progression of Neovascular Age‐Related Macular Degeneration: A Systematic Review and Model‐Based Meta‐Analysis","year":2021,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Macular degeneration; Medicine; Meta-analysis; VEGF receptors; Oncology; Ranibizumab; Disease; Internal medicine; Ophthalmology; Bevacizumab; Chemotherapy","score_opus":0.15278332571369319,"score_gpt":0.5262571782959821,"score_spread":0.3734738525822889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212705536","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029346913,0.99270815,0.000037149755,0.00082984887,0.00009720323,0.003356501,0.000024866113,0.000003802332,0.000007820512],"genre_scores_gemma":[0.012112148,0.98677975,0.00003315948,0.00080546224,0.000072209616,0.00010394739,0.00003623776,0.000028030901,0.000029082305],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98503876,0.0108800335,0.0030831029,0.00023331493,0.00061025267,0.00015454169],"domain_scores_gemma":[0.99050736,0.0045647956,0.0037586086,0.0005623535,0.0003447332,0.00026212362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067184716,0.00040147922,0.00998455,0.00015416599,0.00006137638,0.0000078756075,0.00031604432,0.0001722932,0.0002728028],"category_scores_gemma":[0.0007327147,0.0001386189,0.0077784737,0.0005549406,0.0002669937,0.000025145091,0.000051201838,0.000647328,0.0000017921244],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011367494,0.0013376479,0.000028218508,0.52734935,0.45841601,0.0007620034,0.000010356946,0.0003630076,0.000006288341,0.000014366025,0.00031077839,0.0102651855],"study_design_scores_gemma":[0.0017896387,0.001729232,0.000010316462,0.06553191,0.9292829,0.00006841211,7.7283363e-7,0.0008939235,0.000023733503,0.000008783129,0.0005649249,0.000095477444],"about_ca_topic_score_codex":9.730279e-7,"about_ca_topic_score_gemma":5.7614955e-8,"teacher_disagreement_score":0.47086686,"about_ca_system_score_codex":0.000021861593,"about_ca_system_score_gemma":0.0004391672,"threshold_uncertainty_score":0.7844799},"labels":[],"label_agreement":null},{"id":"W4210268673","doi":"10.1002/jcph.2034","title":"Physiologically Based Pharmacokinetic Modeling of Metformin in Children and Adolescents With Obesity","year":2022,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of General Medical Sciences; National Institutes of Health","keywords":"Physiologically based pharmacokinetic modelling; Metformin; Obesity; Medicine; Overweight; Pharmacokinetics; Childhood obesity; Population; Pediatrics; Pharmacology; Internal medicine; Endocrinology; Physiology; Environmental health; Diabetes mellitus","score_opus":0.09068643256873583,"score_gpt":0.4426168972715347,"score_spread":0.3519304647027989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210268673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951096,0.0015238634,0.00013637131,0.0026365246,0.00020074891,0.00030705874,0.0000042866136,0.000004039643,0.00007748858],"genre_scores_gemma":[0.9926824,0.0020731578,0.00019834039,0.004796873,0.00023252664,0.0000035544674,6.7061285e-7,0.000007928287,0.000004544641],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974787,0.0010027229,0.00089652865,0.000119500764,0.0003050097,0.00019754165],"domain_scores_gemma":[0.99829036,0.0007892716,0.0005919615,0.000073477684,0.00011217594,0.00014274585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033481522,0.00011143475,0.0006442262,0.000065473876,0.00009249887,0.0000020152627,0.00021631413,0.00003751772,0.0002667812],"category_scores_gemma":[0.00017949595,0.00006043986,0.000111998226,0.00018446308,0.00021917862,0.00005690301,0.00017568389,0.0013083209,6.654112e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0879207,0.0074421987,0.7908103,0.00020226504,0.0014714886,0.00027133262,0.00023606379,0.06860763,0.019302871,0.000010485881,0.00166264,0.022062017],"study_design_scores_gemma":[0.03838205,0.0098661035,0.79448724,0.0001519292,0.0034909383,0.001073374,0.00023712203,0.14824343,0.0015679164,0.0002602945,0.0019746362,0.00026494177],"about_ca_topic_score_codex":0.000017151666,"about_ca_topic_score_gemma":8.3077276e-7,"teacher_disagreement_score":0.07963581,"about_ca_system_score_codex":0.000024766874,"about_ca_system_score_gemma":0.00011538769,"threshold_uncertainty_score":0.5684076},"labels":[],"label_agreement":null},{"id":"W4232967244","doi":"10.1002/jcph.87","title":"Issue Information","year":2013,"lang":"en","type":"paratext","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; University of Manitoba","funders":"","keywords":"Citation; Computer science; Information retrieval; World Wide Web; Library science","score_opus":0.06266177250645658,"score_gpt":0.4773903518258223,"score_spread":0.4147285793193657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232967244","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32635766,0.019057028,0.00052246987,0.12026477,0.22410733,0.0038905588,0.00010877216,0.000053678206,0.30563772],"genre_scores_gemma":[0.124467455,0.120668806,0.00078379456,0.21025018,0.059123125,0.00005486119,0.00021545688,0.000102327445,0.484334],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99600697,0.0010221072,0.002240137,0.00009845188,0.00032884136,0.00030351744],"domain_scores_gemma":[0.9948093,0.0017538667,0.0022472553,0.00019477382,0.0006474638,0.00034733771],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0022445135,0.00026790675,0.001393204,0.00018785412,0.000097321594,0.000010636046,0.0004363725,0.00068775675,0.05571399],"category_scores_gemma":[0.00023805362,0.00014596262,0.00053684134,0.00011310023,0.00037924884,0.0002479948,0.00010819559,0.0028865763,0.04787405],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025474012,0.0005213211,0.00007428795,0.00010734785,0.0017323904,0.00004525272,0.00013523223,0.000049188,0.00020935264,0.0000018652044,0.9856106,0.008965774],"study_design_scores_gemma":[0.0065751513,0.0020674241,0.0016691042,0.00007470223,0.0036527934,0.0006201506,0.00004415034,0.000052248193,0.0010884736,0.000034542987,0.98400396,0.00011727156],"about_ca_topic_score_codex":0.000009651272,"about_ca_topic_score_gemma":2.5937467e-7,"teacher_disagreement_score":0.20189022,"about_ca_system_score_codex":0.00009113493,"about_ca_system_score_gemma":0.00085185823,"threshold_uncertainty_score":0.9994138},"labels":[],"label_agreement":null},{"id":"W4234129648","doi":"10.1002/jcph.72","title":"Issue Information","year":2013,"lang":"en","type":"paratext","venue":"The Journal of Clinical Pharmacology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; University of Manitoba","funders":"","keywords":"Citation; Computer science; Information retrieval; World Wide Web","score_opus":0.07487596288625405,"score_gpt":0.4982250255603367,"score_spread":0.4233490626740827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234129648","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11281134,0.023783745,0.0002707632,0.12401096,0.30469117,0.0037014917,0.0001715668,0.000046426823,0.43051252],"genre_scores_gemma":[0.043188803,0.115968086,0.0003808298,0.12498387,0.085283086,0.00005407141,0.00024873004,0.00010104698,0.6297915],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961542,0.00077420345,0.0023404125,0.000099823956,0.0003287312,0.00030265824],"domain_scores_gemma":[0.994656,0.0017057518,0.0024447779,0.00018623337,0.00068953214,0.00031768548],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0016834268,0.00027119534,0.0014473659,0.00020235976,0.00006909346,0.000014016254,0.00040276418,0.0005648856,0.09370755],"category_scores_gemma":[0.00015038344,0.0001503282,0.00057072175,0.00014300473,0.00033057661,0.00022819494,0.00009132256,0.0024256248,0.029912995],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033694038,0.00038264663,0.000052817075,0.0001094276,0.0015207846,0.000022720367,0.00012491441,0.000035480225,0.0002282893,0.0000015455105,0.97699004,0.017161949],"study_design_scores_gemma":[0.00722751,0.0030278498,0.00059093226,0.00006208321,0.0032993625,0.0004811278,0.000034937813,0.000041728326,0.00049460994,0.000024595482,0.9845948,0.00012045241],"about_ca_topic_score_codex":0.000026443497,"about_ca_topic_score_gemma":8.050566e-7,"teacher_disagreement_score":0.2194081,"about_ca_system_score_codex":0.00010324807,"about_ca_system_score_gemma":0.0010109168,"threshold_uncertainty_score":0.99987584},"labels":[],"label_agreement":null},{"id":"W4248028102","doi":"10.1177/00912700122010960","title":"Evaluating Possible Pharmacokinetic Interactions between Tobramycin, Piperacillin, and a Combination of Piperacillin and Tazobactam in Patients with Various Degrees of Renal Impairment","year":2001,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Piperacillin; Tobramycin; Piperacillin/tazobactam; Pharmacokinetics; Medicine; Renal function; Crossover study; Tazobactam; Pharmacology; Antibacterial agent; Internal medicine; Antibiotics; Chemistry; Gentamicin; Pathology","score_opus":0.07063823566904713,"score_gpt":0.4405121916659936,"score_spread":0.36987395599694645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248028102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974009,0.0003083489,0.00028630035,0.0011985474,0.00025802723,0.0004662149,0.000007986465,0.000003932442,0.00006974298],"genre_scores_gemma":[0.99715686,0.0014615385,0.000842055,0.0002569878,0.00023011286,0.0000010711426,0.000004839397,0.000015685193,0.0000308469],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971642,0.00048600428,0.0016074778,0.00015370449,0.00037957876,0.00020906852],"domain_scores_gemma":[0.99645746,0.0014962077,0.0011079252,0.000103841405,0.00064787373,0.00018668237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022877748,0.00016277231,0.0007594501,0.00021771762,0.000052231084,0.000006694723,0.00013233439,0.000077605924,0.00012162697],"category_scores_gemma":[0.00025140756,0.00010296933,0.00009002349,0.00023773577,0.00032296745,0.00010369074,0.000077102304,0.0007277994,7.822944e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010099152,0.002896328,0.9316877,0.00011801732,0.00062853855,0.000027674723,0.0006394167,0.0027891141,0.01642759,0.000007968053,0.0003213663,0.034357112],"study_design_scores_gemma":[0.021275477,0.0076638474,0.95561624,0.00023063572,0.0014671088,0.00009589494,0.00007315317,0.0109442305,0.0023129259,0.000052738014,0.00016036638,0.00010738021],"about_ca_topic_score_codex":0.000024238887,"about_ca_topic_score_gemma":0.0000046924138,"teacher_disagreement_score":0.03424973,"about_ca_system_score_codex":0.00003218667,"about_ca_system_score_gemma":0.00013461735,"threshold_uncertainty_score":0.41989675},"labels":[],"label_agreement":null},{"id":"W4248288235","doi":"10.1002/jcph.70","title":"Issue Information","year":2013,"lang":"en","type":"paratext","venue":"The Journal of Clinical Pharmacology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Impact","funders":"","keywords":"Citation; Computer science; Information retrieval; World Wide Web","score_opus":0.07487596288625405,"score_gpt":0.4982250255603367,"score_spread":0.4233490626740827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248288235","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11281134,0.023783745,0.0002707632,0.12401096,0.30469117,0.0037014917,0.0001715668,0.000046426823,0.43051252],"genre_scores_gemma":[0.043188803,0.115968086,0.0003808298,0.12498387,0.085283086,0.00005407141,0.00024873004,0.00010104698,0.6297915],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961542,0.00077420345,0.0023404125,0.000099823956,0.0003287312,0.00030265824],"domain_scores_gemma":[0.994656,0.0017057518,0.0024447779,0.00018623337,0.00068953214,0.00031768548],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0016834268,0.00027119534,0.0014473659,0.00020235976,0.00006909346,0.000014016254,0.00040276418,0.0005648856,0.09370755],"category_scores_gemma":[0.00015038344,0.0001503282,0.00057072175,0.00014300473,0.00033057661,0.00022819494,0.00009132256,0.0024256248,0.029912995],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033694038,0.00038264663,0.000052817075,0.0001094276,0.0015207846,0.000022720367,0.00012491441,0.000035480225,0.0002282893,0.0000015455105,0.97699004,0.017161949],"study_design_scores_gemma":[0.00722751,0.0030278498,0.00059093226,0.00006208321,0.0032993625,0.0004811278,0.000034937813,0.000041728326,0.00049460994,0.000024595482,0.9845948,0.00012045241],"about_ca_topic_score_codex":0.000026443497,"about_ca_topic_score_gemma":8.050566e-7,"teacher_disagreement_score":0.2194081,"about_ca_system_score_codex":0.00010324807,"about_ca_system_score_gemma":0.0010109168,"threshold_uncertainty_score":0.99987584},"labels":[],"label_agreement":null},{"id":"W4322616597","doi":"10.1002/jcph.2220","title":"Population Pharmacokinetics of Monalizumab in Patients With Advanced Solid Tumors","year":2023,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Pharmacokinetics; Population pharmacokinetics; Medicine; Solid tumor; Population; Pharmacology; Oncology; Internal medicine; Cancer","score_opus":0.027450406560598748,"score_gpt":0.3742140065343328,"score_spread":0.346763599973734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322616597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99329466,0.00017254087,0.000022810342,0.00040648872,0.005814946,0.00014831914,0.0000019232932,0.000010713483,0.0001276109],"genre_scores_gemma":[0.99867564,0.00034159643,0.00001143733,0.0004110487,0.00009053169,0.0000016001243,0.000020497097,0.00001028007,0.00043733572],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997762,0.0007247414,0.001194038,0.000080346515,0.000065061395,0.00017376363],"domain_scores_gemma":[0.99794763,0.0007529308,0.00096587057,0.000083077284,0.00023147468,0.000019004901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011351923,0.000093712675,0.00043186452,0.00017242333,0.00004235884,0.0000015500455,0.00019358873,0.00009909705,0.0006850851],"category_scores_gemma":[0.0001673307,0.000057789188,0.00010154372,0.0002408363,0.00014093204,0.00010681903,0.00004045493,0.00063570734,0.000072757255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08100455,0.0031128125,0.5290482,0.00007327632,0.0015025095,0.000028363613,0.0008052515,0.020743955,0.21095358,0.00006067939,0.09265391,0.060012903],"study_design_scores_gemma":[0.012985031,0.0026113011,0.9580485,0.000046497233,0.00017308755,0.000023066199,0.00011066522,0.000108444714,0.015598057,0.000061188155,0.010138908,0.00009525152],"about_ca_topic_score_codex":0.000009893433,"about_ca_topic_score_gemma":0.0000017965041,"teacher_disagreement_score":0.4290003,"about_ca_system_score_codex":0.000023675293,"about_ca_system_score_gemma":0.00004650342,"threshold_uncertainty_score":0.75012016},"labels":[],"label_agreement":null},{"id":"W4380627450","doi":"10.1002/jcph.2263","title":"Improving Racial and Ethnic Equity in Clinical Trials Enrolling Pregnant and Lactating Individuals","year":2023,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"National Institutes of Health; National Science Foundation","keywords":"Ethnic group; Generalizability theory; Clinical trial; Health equity; Equity (law); Inclusion (mineral); Medicine; Family medicine; Psychology; Nursing; Political science; Social psychology; Public health; Developmental psychology","score_opus":0.9337503286949025,"score_gpt":0.801550735169816,"score_spread":0.13219959352508648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380627450","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007948022,0.98413354,0.00004831102,0.002047065,0.0036748399,0.001994886,0.000022514614,0.000023010849,0.00010781962],"genre_scores_gemma":[0.0007727592,0.9900742,0.0005521253,0.0011840273,0.0070942068,0.000023799854,0.0000036276595,0.000092625975,0.00020262151],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9446541,0.033445913,0.018796217,0.0007358054,0.0014925841,0.00087535795],"domain_scores_gemma":[0.283962,0.7010454,0.012423286,0.00056495104,0.00078872405,0.0012156208],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaresearch","research_integrity"],"category_scores_codex":[0.4278544,0.00048991584,0.010116267,0.00050383946,0.00014779482,0.000053482647,0.0009637618,0.0026936515,0.00009729549],"category_scores_gemma":[0.41181582,0.00027404356,0.001691061,0.000595785,0.0017613256,0.00012264431,0.0019692983,0.024323558,0.000024366384],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011054806,0.0003486719,0.00060162455,0.011686124,0.0013555905,0.0003455857,0.00017971398,0.0000011400514,0.0000072802086,0.00004385733,0.00037204832,0.9839529],"study_design_scores_gemma":[0.07949775,0.026616119,0.011950721,0.27188638,0.08402948,0.0036649958,0.0010807611,0.0016579583,0.00001969582,0.03963933,0.47715208,0.0028047084],"about_ca_topic_score_codex":0.000018065484,"about_ca_topic_score_gemma":0.000045532124,"teacher_disagreement_score":0.9811482,"about_ca_system_score_codex":0.0001102188,"about_ca_system_score_gemma":0.004667462,"threshold_uncertainty_score":0.99997115},"labels":[{"model":"gemma","categories":["metaresearch"],"domain":"methods","study_design":"not_applicable","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":["metaresearch"],"domain":"methods","study_design":"design_other","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W4380627503","doi":"10.1002/jcph.2240","title":"Translating Clinical Pharmacology Data in Pregnancy to Evidence‐Based Guideline Recommendations: Perspectives From the HIV Field","year":2023,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Guideline; Medicine; Breastfeeding; Dosing; Pregnancy; Population; Drugs in pregnancy; Intensive care medicine; Family medicine; Pharmacology; Pediatrics; Pathology; Environmental health; Fetus","score_opus":0.6739421277657448,"score_gpt":0.6642842556393443,"score_spread":0.009657872126400457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380627503","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000059344995,0.79034466,0.0011657712,0.19994238,0.006504216,0.0017314834,0.00016303686,0.000030227127,0.000058890884],"genre_scores_gemma":[0.00015525875,0.9628363,0.0014699108,0.025219709,0.009918782,0.000056794826,0.00011514576,0.00005999061,0.00016809448],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9825554,0.008421778,0.007401685,0.00060575106,0.0005192997,0.0004961122],"domain_scores_gemma":[0.90680164,0.08696006,0.0039017193,0.0012760033,0.00045509904,0.0006054949],"candidate_categories":["metaresearch","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.02101089,0.00042728052,0.0034036497,0.00027674928,0.00013389609,0.000016866286,0.0026575348,0.0006348176,0.0021750433],"category_scores_gemma":[0.026544942,0.00022399011,0.0009706498,0.0007876054,0.00038203897,0.00024316553,0.00042015317,0.0051309275,0.00019964745],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007977395,0.0004613137,0.00016558751,0.00048820442,0.000989846,0.00009218802,0.00028609714,0.000007865854,0.0000039216006,0.0000016832665,0.37424743,0.6224581],"study_design_scores_gemma":[0.0039937105,0.0010742382,0.00023740515,0.045884043,0.008509206,0.000103047714,0.00029868213,0.00043717623,0.0000031583022,0.00004428565,0.9392008,0.00021422065],"about_ca_topic_score_codex":0.00003600286,"about_ca_topic_score_gemma":0.000031087737,"teacher_disagreement_score":0.6222439,"about_ca_system_score_codex":0.00012189114,"about_ca_system_score_gemma":0.0040047364,"threshold_uncertainty_score":0.9987371},"labels":[],"label_agreement":null},{"id":"W4385753428","doi":"10.1002/jcph.2328","title":"Investigation of the Effect of Lasmiditan on the Pharmacokinetics of P‐Glycoprotein and Breast Cancer Resistance Protein Substrates","year":2023,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"Eli Lilly and Company","keywords":"Medicine; Pharmacokinetics; Dabigatran; Pharmacology; Cmax; Bioequivalence; Rosuvastatin; Internal medicine","score_opus":0.04307763789947493,"score_gpt":0.3732406955613108,"score_spread":0.33016305766183585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385753428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98122734,0.00045249588,0.0000051348497,0.016908724,0.000569296,0.00071219134,0.000029079447,0.0000054254265,0.00009029613],"genre_scores_gemma":[0.99817294,0.0008927881,0.000024039384,0.00030724047,0.00031639173,0.000011494309,6.184018e-7,0.000013781805,0.00026069325],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974145,0.0008325099,0.0011045203,0.00009486994,0.00040218854,0.00015139052],"domain_scores_gemma":[0.99671346,0.001585046,0.0012175735,0.00016665246,0.00023699642,0.00008028769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00390861,0.00012562274,0.00059795455,0.000059347385,0.000055466546,0.0000018012647,0.00029375692,0.000092228,0.000095172305],"category_scores_gemma":[0.00017232177,0.00005113082,0.00020474981,0.00035759932,0.0008526383,0.000028198503,0.000029180937,0.0005994512,9.2264827e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010928894,0.00007882215,0.021623308,0.0006075037,0.00042580586,0.000015122291,0.00024008252,0.00012377443,0.96152693,0.00017225168,0.0033063109,0.0009511938],"study_design_scores_gemma":[0.0031257535,0.00094510854,0.11678276,0.00063278596,0.0007188965,0.000014082014,0.000064334294,0.00008125457,0.87666583,0.0006819697,0.00023940187,0.00004784052],"about_ca_topic_score_codex":0.000009495781,"about_ca_topic_score_gemma":0.000013819129,"teacher_disagreement_score":0.095159456,"about_ca_system_score_codex":0.000013040612,"about_ca_system_score_gemma":0.00017767378,"threshold_uncertainty_score":0.3141581},"labels":[],"label_agreement":null},{"id":"W4389869854","doi":"10.1002/jcph.2397","title":"Pharmacokinetics (PK) of Tiragolumab in First‐in‐Human Study in Patients with Mixed Solid Tumors (GO30103)","year":2023,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"F. Hoffmann-La Roche","keywords":"Atezolizumab; Pharmacokinetics; TIGIT; Dosing; Medicine; Pharmacology; Chemistry; Internal medicine; Cancer; Immunotherapy; Pembrolizumab","score_opus":0.09254291781798765,"score_gpt":0.4808868178622886,"score_spread":0.38834390004430097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389869854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966361,0.00004984787,0.0000011077332,0.0013792815,0.00060353667,0.0010499896,0.0000029593507,0.000008589649,0.0002685822],"genre_scores_gemma":[0.99866056,0.00030139866,0.000013998716,0.00034275517,0.00035032647,0.000009975717,0.0000023129403,0.000034677454,0.0002839747],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948896,0.0013971432,0.0022926172,0.00019787563,0.00074855523,0.0004741688],"domain_scores_gemma":[0.99665743,0.0019950252,0.00064080814,0.000227543,0.0002888119,0.00019037312],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0067281597,0.0001772,0.0011866011,0.0006633154,0.00003220065,0.000004549081,0.00047872672,0.000108050735,0.0010105211],"category_scores_gemma":[0.00036955057,0.00011590459,0.00014266354,0.0010528276,0.0003328563,0.000064080195,0.00015906492,0.0018597624,0.000014362536],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019434469,0.006224545,0.9588514,0.00006408102,0.00028591702,0.0007727169,0.0011027262,0.001664581,0.005496539,0.0000011021457,0.0029837012,0.0031182123],"study_design_scores_gemma":[0.0461553,0.008488831,0.94176185,0.00012337152,0.00017403605,0.000018149645,0.000399118,0.00054483,0.0017180574,0.000050025108,0.00046431695,0.00010212656],"about_ca_topic_score_codex":0.00006300134,"about_ca_topic_score_gemma":0.00022851505,"teacher_disagreement_score":0.02672083,"about_ca_system_score_codex":0.00011951156,"about_ca_system_score_gemma":0.00026915703,"threshold_uncertainty_score":0.99990267},"labels":[],"label_agreement":null},{"id":"W4391403778","doi":"10.1002/jcph.2401","title":"Population Pharmacokinetics of Nirsevimab in Preterm and Term Infants","year":2024,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Respiratory viral infections research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Sanofi; AstraZeneca","keywords":"Medicine; Dosing; Pharmacokinetics; Pediatrics; Population; Cohort; Birth weight; Incidence (geometry); Palivizumab; Respiratory system; Internal medicine; Pregnancy","score_opus":0.12044596364402149,"score_gpt":0.5460979611921483,"score_spread":0.42565199754812677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391403778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945139,0.0023126362,0.000028377732,0.0014638734,0.0010579823,0.00023135441,0.0000019297074,0.00000652746,0.0003833722],"genre_scores_gemma":[0.9961869,0.002440448,0.000056195157,0.00054848695,0.0006864924,0.0000016651165,4.6774764e-7,0.000010851248,0.00006845662],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99779093,0.000594791,0.0011700322,0.000087363886,0.00022039641,0.00013648154],"domain_scores_gemma":[0.99818593,0.0012598452,0.00023287398,0.0000860883,0.00012927804,0.00010595458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031150593,0.000074831936,0.0004237918,0.00025546746,0.0000186575,0.00000764855,0.000109121094,0.00008950413,0.00023390059],"category_scores_gemma":[0.00043106673,0.00004530917,0.00010105035,0.0002415954,0.00022479364,0.00011019241,0.000059877362,0.00092590705,0.0000056842155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006277,0.00067308015,0.63795567,0.0005661818,0.0007018656,0.00043075014,0.00034708143,0.0001992301,0.17510667,0.000049261773,0.0077928896,0.1699003],"study_design_scores_gemma":[0.005114666,0.0024493258,0.9704002,0.00027793937,0.00062220014,0.0005866179,0.00001761272,0.0041736676,0.009301784,0.00034081197,0.006636967,0.0000781931],"about_ca_topic_score_codex":0.000008790009,"about_ca_topic_score_gemma":0.00000215063,"teacher_disagreement_score":0.33244452,"about_ca_system_score_codex":0.000031198288,"about_ca_system_score_gemma":0.0001370991,"threshold_uncertainty_score":0.4022657},"labels":[],"label_agreement":null},{"id":"W4393277131","doi":"10.1002/jcph.2434","title":"Using Real‐World Data to Externally Evaluate Population Pharmacokinetic Models of Dexmedetomidine in Children and Infants","year":2024,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Anesthesia and Sedative Agents","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"Duke Clinical Research Institute; National Institute of Child Health and Human Development; Penn State College of Medicine; Wichita Medical Research and Education Foundation; Pennsylvania State University; GlaxoSmithKline; University of Louisville; Eunice Kennedy Shriver National Institute of Child Health and Human Development; University of North Carolina at Chapel Hill; National Institutes of Health; Cincinnati Children's Hospital Medical Center; University of Pennsylvania; University of North Carolina; Children's Hospital of Philadelphia","keywords":"Dexmedetomidine; Medicine; Pharmacokinetics; Anesthesia; Population pharmacokinetics; Population; Pediatrics; Pharmacology; Sedation; Environmental health","score_opus":0.3331833706014728,"score_gpt":0.5510731270892614,"score_spread":0.21788975648778858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393277131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964684,0.0007003194,0.00027047226,0.0018051866,0.00035895166,0.00032891653,0.000008176505,0.000005515715,0.000054014978],"genre_scores_gemma":[0.9951956,0.0019798868,0.0007660513,0.0013390549,0.0006427304,6.1830855e-7,0.0000062132126,0.00001605309,0.000053793283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975296,0.0006439732,0.0012202986,0.00016718621,0.00028135447,0.00015755923],"domain_scores_gemma":[0.99847966,0.0007089533,0.00037450469,0.00016935487,0.00010777983,0.0001597691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004170623,0.000110354355,0.0005908577,0.00026225805,0.000020461617,0.000006579187,0.00029032194,0.000042761825,0.00008864799],"category_scores_gemma":[0.00015457727,0.00006895544,0.000068238725,0.0002855147,0.00011408155,0.00018800455,0.00015063811,0.00047901066,0.0000031082313],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010617224,0.0005806786,0.83317244,0.000116537645,0.0012496175,0.000332033,0.0004941533,0.012182291,0.07137854,0.000052651856,0.004152606,0.06567126],"study_design_scores_gemma":[0.0019405542,0.00052350445,0.83263886,0.00023952436,0.001300912,0.00041050723,0.000010081758,0.16146642,0.00083410926,0.0004147925,0.00014367659,0.00007705394],"about_ca_topic_score_codex":0.00017331039,"about_ca_topic_score_gemma":0.000021076858,"teacher_disagreement_score":0.14928412,"about_ca_system_score_codex":0.000030158868,"about_ca_system_score_gemma":0.00013445014,"threshold_uncertainty_score":0.28119215},"labels":[],"label_agreement":null},{"id":"W4394961878","doi":"10.1002/jcph.2444","title":"Quantitative Assessment of Drug Efficacy and Emergence of Resistance in Patients with Metastatic Renal Cell Carcinoma Using a Longitudinal Exposure‐Tumor Growth Inhibition Model: Apitolisib (Dual PI3K/mTORC1/2 Inhibitor) Versus Everolimus (mTORC1 Inhibitor)","year":2024,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Everolimus; Discovery and development of mTOR inhibitors; mTORC1; Renal cell carcinoma; PI3K/AKT/mTOR pathway; Medicine; Oncology; Drug resistance; Cancer research; Drug; Sirolimus; Internal medicine; Pharmacology; Chemistry; Biology; Apoptosis","score_opus":0.07965369007208031,"score_gpt":0.4042599864395211,"score_spread":0.32460629636744076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394961878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950124,0.0025566972,0.0004717877,0.00021977755,0.000902068,0.00071184605,0.000033642373,0.000008944987,0.000082858125],"genre_scores_gemma":[0.9960168,0.00018837479,0.0033584235,0.000060970007,0.00030507657,0.000007285517,0.0000065554923,0.00004192112,0.000014568032],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948799,0.0011056719,0.002364095,0.0003744156,0.0009198663,0.00035607192],"domain_scores_gemma":[0.9951316,0.0022271262,0.0014293684,0.00020493059,0.0007530947,0.0002538768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023808896,0.00034079413,0.0012804436,0.00037675502,0.000063526706,0.00001221501,0.00015209819,0.00008918605,0.00003742364],"category_scores_gemma":[0.0002139505,0.00022144074,0.00024638744,0.00048696352,0.00056631386,0.00028173914,0.000111476285,0.0009777648,9.610085e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25534824,0.013043302,0.5204486,0.0044633094,0.0039698556,0.0040518255,0.0071844696,0.022575142,0.16189142,0.00065890525,0.0059923404,0.00037258514],"study_design_scores_gemma":[0.08604929,0.041618478,0.75641304,0.0026617518,0.010037288,0.00021637717,0.0012567108,0.014421099,0.08600059,0.00057058374,0.000020662956,0.0007341336],"about_ca_topic_score_codex":0.0000465521,"about_ca_topic_score_gemma":0.000024594021,"teacher_disagreement_score":0.23596443,"about_ca_system_score_codex":0.00021831032,"about_ca_system_score_gemma":0.0009373634,"threshold_uncertainty_score":0.9030092},"labels":[],"label_agreement":null},{"id":"W4396238112","doi":"10.1002/jcph.2446","title":"Assessing Pharmacogenomic <i>loci</i> Associated with the Pharmacokinetics of Vamorolone in Boys with Duchenne Muscular Dystrophy","year":2024,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Carleton University","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Child Health and Human Development; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of General Medical Sciences; National Institute of Neurological Disorders and Stroke; National Institutes of Health; Congressionally Directed Medical Research Programs; European Commission; U.S. Department of Defense","keywords":"Duchenne muscular dystrophy; Pharmacokinetics; Pharmacogenomics; Muscular dystrophy; Medicine; Pharmacology; Internal medicine","score_opus":0.029416546559572168,"score_gpt":0.37590091025527056,"score_spread":0.3464843636956984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396238112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991933,0.002960324,0.0005015665,0.0036406126,0.00059181,0.00021266862,0.000008055499,0.0000064166347,0.00014556615],"genre_scores_gemma":[0.99584824,0.0012618623,0.00007097052,0.0020724805,0.0006658037,0.0000061564856,0.000009052598,0.000030095202,0.000035342135],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972427,0.0012237312,0.0008207484,0.00021457124,0.00019549072,0.0003027582],"domain_scores_gemma":[0.99822795,0.0007221181,0.00058804406,0.00017577555,0.00019588739,0.0000902001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026413426,0.0002019582,0.00047775026,0.00006674693,0.00007434228,0.000017406797,0.00051124353,0.00016054059,0.000065223765],"category_scores_gemma":[0.00011705124,0.00010113006,0.00019885728,0.00025680597,0.0007303477,0.000019926503,0.00009168101,0.00091313635,0.0000019854583],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00683077,0.0006679027,0.0034933216,0.00005947011,0.0023358352,0.00014160736,0.00018066546,0.010759665,0.9575457,0.00001901866,0.015002345,0.002963718],"study_design_scores_gemma":[0.06833615,0.027920675,0.18948407,0.0006399808,0.0135200955,0.0013727162,0.002399488,0.013485638,0.53566265,0.00097411795,0.1438686,0.002335806],"about_ca_topic_score_codex":0.0000069850985,"about_ca_topic_score_gemma":0.000010977806,"teacher_disagreement_score":0.42188302,"about_ca_system_score_codex":0.000016005177,"about_ca_system_score_gemma":0.0003545995,"threshold_uncertainty_score":0.41239643},"labels":[],"label_agreement":null},{"id":"W4396661720","doi":"10.1002/jcph.2449","title":"A Simulation‐Based Assessment of Levetiracetam Concentrations Following Fixed and Weight‐Based Loading Doses: A Meta‐Regression and Pharmacokinetic Modeling Analysis","year":2024,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Dosing; Pharmacokinetics; Dose; Medicine; Levetiracetam; Therapeutic index; Status epilepticus; Loading dose; Pharmacology; Anesthesia; Epilepsy; Drug","score_opus":0.32061941574936764,"score_gpt":0.5961760026929708,"score_spread":0.27555658694360313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396661720","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007347999,0.98142016,0.008786869,0.0009141625,0.00048104508,0.00096859917,0.000034554687,0.000012499849,0.000034123466],"genre_scores_gemma":[0.41560757,0.58290464,0.0009903,0.00016864852,0.00025107322,0.000018186996,0.000015878006,0.000022005619,0.000021707927],"study_design_codex":"meta_analysis","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99425685,0.002062904,0.0024949762,0.0003092626,0.00058499415,0.00029102113],"domain_scores_gemma":[0.98754835,0.010273488,0.0012700583,0.00020409317,0.00028837522,0.00041561786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038355987,0.00039434503,0.0040989374,0.0006199796,0.00011824697,0.000028157683,0.00019322983,0.00022268074,0.00022963742],"category_scores_gemma":[0.0005188034,0.00018672732,0.0023129669,0.00070873357,0.00021670712,0.000076774886,0.00009011759,0.0014288923,0.0000016927751],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031817355,0.003911391,0.0045552403,0.02889221,0.36977458,0.0019923549,0.00022221496,0.3154726,0.00044544644,0.000030043719,0.00081925053,0.27070293],"study_design_scores_gemma":[0.003857442,0.00082530716,0.000055905573,0.002611668,0.33405846,0.000020492416,0.000012369916,0.6488508,0.000012010778,0.00002172157,0.009544476,0.00012934365],"about_ca_topic_score_codex":0.0000064840574,"about_ca_topic_score_gemma":0.0000016616685,"teacher_disagreement_score":0.40825957,"about_ca_system_score_codex":0.000092013885,"about_ca_system_score_gemma":0.0012232763,"threshold_uncertainty_score":0.76145196},"labels":[],"label_agreement":null},{"id":"W4401442309","doi":"10.1002/jcph.6108","title":"Pharmacokinetics of Dexamethasone in Children and Adolescents with Obesity","year":2024,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Adrenal Hormones and Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"Duke Clinical Research Institute; National Institute of Child Health and Human Development; University of North Carolina at Chapel Hill; Pennsylvania State University; University of Louisville; University of Pennsylvania; Wichita Medical Research and Education Foundation; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Penn State College of Medicine; Children's Hospital of Philadelphia","keywords":"Medicine; Dexamethasone; Dosing; Pharmacokinetics; Population; Obesity; NONMEM; Internal medicine","score_opus":0.027996596203942375,"score_gpt":0.40349595216099476,"score_spread":0.3754993559570524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401442309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918081,0.00564757,0.00019826704,0.0018088678,0.00027911746,0.00018105897,0.00000203898,0.000004924962,0.00007003124],"genre_scores_gemma":[0.9931199,0.005357406,0.00015426625,0.00095554424,0.00038082953,3.9178371e-7,3.8767473e-7,0.0000104664805,0.00002078431],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986758,0.00022954539,0.0007032783,0.00008659962,0.00017360457,0.00013113196],"domain_scores_gemma":[0.9991224,0.00038760196,0.00021914083,0.000060395447,0.00008262222,0.00012783102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013694965,0.000088027096,0.0004492789,0.000090281996,0.000013172855,0.0000028435477,0.000105001134,0.000065655986,0.00005634763],"category_scores_gemma":[0.000077310346,0.00004632868,0.00008818113,0.00016747933,0.0003042784,0.000044305383,0.000042722808,0.00071532134,0.0000022276095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008880269,0.0011493021,0.9560148,0.00017721014,0.00060422654,0.00020624122,0.00021123502,0.00012509534,0.0039274846,0.00001936633,0.004851474,0.023833258],"study_design_scores_gemma":[0.006963305,0.0018817595,0.98656404,0.0002947811,0.0010887285,0.0009289977,0.000047760037,0.00064137584,0.0009997509,0.00014982706,0.00037602676,0.00006365961],"about_ca_topic_score_codex":0.000013499433,"about_ca_topic_score_gemma":0.000002094475,"teacher_disagreement_score":0.030549191,"about_ca_system_score_codex":0.000009756631,"about_ca_system_score_gemma":0.00012743141,"threshold_uncertainty_score":0.3107755},"labels":[],"label_agreement":null},{"id":"W4401573100","doi":"10.1002/jcph.6106","title":"Multiple‐dose pharmacokinetics of cenerimod and the effect of charcoal on its elimination","year":2024,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fluidigm (Canada)","funders":"Idorsia Pharmaceuticals","keywords":"Pharmacokinetics; Pharmacology; Activated charcoal; Enterohepatic circulation; Oral administration; Pharmacodynamics; Medicine; Dosing; Chemistry; Internal medicine; Metabolism","score_opus":0.03504640256780736,"score_gpt":0.40463055372229934,"score_spread":0.36958415115449195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401573100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98855215,0.0078086,0.00018743501,0.0011346968,0.002023601,0.00018838086,0.000008835988,0.0000023055845,0.00009397381],"genre_scores_gemma":[0.99092185,0.0067281984,0.000028129798,0.00041395117,0.0018556516,0.0000024762896,0.000001888482,0.000012558484,0.000035281024],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976902,0.0011155421,0.0007929014,0.000108938984,0.00017012557,0.0001222788],"domain_scores_gemma":[0.9971201,0.0021521787,0.00043445555,0.00010220787,0.0001311917,0.000059879378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004418651,0.000113033435,0.00041454338,0.000051141953,0.000033992488,0.00000551297,0.00027143388,0.00010396683,0.00002542958],"category_scores_gemma":[0.0007702072,0.000055282104,0.0002277685,0.000073733274,0.00035427086,0.000005223273,0.00008420589,0.00036011002,0.0000012617762],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009786667,0.00007420261,0.00027583513,0.00010289529,0.00040302408,0.0000050728004,0.00012022276,0.0010451836,0.97258157,0.00009833377,0.0019800244,0.013526945],"study_design_scores_gemma":[0.008158868,0.002058767,0.0017507264,0.000046519785,0.0007619989,0.000048299225,0.000020024803,0.005926854,0.97251374,0.00003737512,0.008607498,0.00006933779],"about_ca_topic_score_codex":0.0000021101146,"about_ca_topic_score_gemma":2.461321e-7,"teacher_disagreement_score":0.0134576075,"about_ca_system_score_codex":0.0000027453343,"about_ca_system_score_gemma":0.000056288965,"threshold_uncertainty_score":0.22543387},"labels":[],"label_agreement":null},{"id":"W4403498878","doi":"10.1002/jcph.6139","title":"Pharmacokinetics and Safety of Intravenous Candidate Biosimilar CT‐P47 and Reference Tocilizumab: A Randomized, Double‐Blind, Phase 1 Study","year":2024,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Celltrion","keywords":"Tocilizumab; Medicine; Adverse effect; Internal medicine; Pharmacokinetics; Randomized controlled trial; Bioequivalence; Clinical endpoint; Area under the curve; Confidence interval; Pharmacodynamics; Gastroenterology; Pharmacology; Rheumatoid arthritis","score_opus":0.09548188791577344,"score_gpt":0.4630843294698259,"score_spread":0.3676024415540525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403498878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96592623,0.023566663,0.00042282089,0.0055619036,0.00308395,0.001037564,0.000059504953,0.000019211648,0.00032216645],"genre_scores_gemma":[0.9780284,0.020398399,0.00014647555,0.000948793,0.00027294477,0.000006411296,0.0000020909326,0.00001581636,0.0001806793],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9939121,0.003301677,0.0021072086,0.00026843502,0.0000977758,0.000312781],"domain_scores_gemma":[0.9932301,0.005654101,0.0006306695,0.00016296207,0.00020425106,0.000117935204],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.009623537,0.00024969774,0.0015254652,0.00015521495,0.00011888844,0.000019796697,0.0003699793,0.00020280373,0.0009163134],"category_scores_gemma":[0.00034433333,0.00013548041,0.00023616207,0.00020163025,0.002229538,0.000077435834,0.00021615395,0.0015303466,0.000008338116],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.84320444,0.0024828962,0.00028996266,0.00016496301,0.006787366,0.00030775074,0.0010434537,0.000007836598,0.052777916,0.00052483554,0.010007119,0.08240147],"study_design_scores_gemma":[0.867583,0.009208482,0.0005257805,0.00017468561,0.0118858,0.0022828677,0.0007153847,0.0005093905,0.035677377,0.0017333594,0.06924223,0.00046165223],"about_ca_topic_score_codex":0.000031224175,"about_ca_topic_score_gemma":0.0000074366453,"teacher_disagreement_score":0.08193982,"about_ca_system_score_codex":0.000016186077,"about_ca_system_score_gemma":0.00017284733,"threshold_uncertainty_score":0.99999696},"labels":[],"label_agreement":null},{"id":"W4403761371","doi":"10.1002/jcph.6147","title":"Exposure–Response Analysis of Tofacitinib in Active Psoriatic Arthritis: Results from Two Phase 3 Studies","year":2024,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"Pfizer","keywords":"Tofacitinib; Psoriatic arthritis; Medicine; Dermatology; Internal medicine; Pharmacology; Psoriasis; Rheumatoid arthritis","score_opus":0.11727472354318765,"score_gpt":0.521850241729808,"score_spread":0.40457551818662035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403761371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96187216,0.031047588,0.000011820706,0.0042647845,0.0021341373,0.00021998538,0.00036852338,0.000010061676,0.00007091363],"genre_scores_gemma":[0.9733371,0.025180358,0.000103019825,0.00054863346,0.00074602437,0.000005465003,0.000011507683,0.000011725312,0.00005614982],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99578947,0.0012983534,0.0021898057,0.00020240754,0.00030220737,0.00021774838],"domain_scores_gemma":[0.98686016,0.011918751,0.0006515293,0.00016869108,0.00027820497,0.00012263989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035795204,0.00016449911,0.0015949256,0.0003795559,0.00004398348,0.000005675138,0.00014036204,0.00008022419,0.00028381697],"category_scores_gemma":[0.0023307556,0.00009987778,0.0005859778,0.0007159073,0.00035085357,0.00008323286,0.00007057885,0.0006283142,0.000011368623],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3355301,0.0041281767,0.007786825,0.000050470375,0.09095498,0.008012819,0.011691737,0.0005088034,0.0063581215,0.000025401347,0.0077790255,0.5271735],"study_design_scores_gemma":[0.38180405,0.03542349,0.41397732,0.0027257404,0.091917634,0.0005490956,0.015565749,0.0032824865,0.014826619,0.002508573,0.03671786,0.0007013787],"about_ca_topic_score_codex":0.000046359226,"about_ca_topic_score_gemma":0.000093891336,"teacher_disagreement_score":0.52647215,"about_ca_system_score_codex":0.00007244078,"about_ca_system_score_gemma":0.0002118155,"threshold_uncertainty_score":0.40728977},"labels":[],"label_agreement":null},{"id":"W4405994302","doi":"10.1002/jcph.6178","title":"Physiologically Based Pharmacokinetic Modeling and Simulation to Support a Change in the FDA‐Labeled Dosing Frequency of RHB‐105 Low‐Dose Rifabutin Triple Therapy for <i>Helicobacter pylori</i> Eradication","year":2025,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Drug Research and Development","funders":"U.S. Department of Veterans Affairs","keywords":"Dosing; Rifabutin; Pharmacokinetics; Omeprazole; Pharmacology; Medicine; Physiologically based pharmacokinetic modelling; Amoxicillin; Helicobacter pylori; Antibacterial agent; Antibiotics; Chemistry; Clarithromycin; Internal medicine","score_opus":0.1081579009403272,"score_gpt":0.44559644932832276,"score_spread":0.3374385483879956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405994302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.963041,0.00047239003,0.0028493127,0.031105239,0.0008137434,0.0016775472,0.0000102408485,0.000011646531,0.000018863288],"genre_scores_gemma":[0.95913935,0.001046566,0.00068534986,0.038412485,0.0006164619,0.00007143221,0.0000068641707,0.000014730633,0.0000067566166],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9963485,0.001089155,0.0017678232,0.00023217336,0.00021360787,0.00034875234],"domain_scores_gemma":[0.9958955,0.0025883752,0.0006824192,0.00019143317,0.00053343934,0.00010884215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041852677,0.00021221892,0.000857638,0.00023084051,0.00009880331,0.0000075581024,0.0003285706,0.00017867202,0.00003763168],"category_scores_gemma":[0.00076023064,0.000119902856,0.0002045585,0.0003788288,0.0002231473,0.000098664445,0.000055112672,0.0008109352,0.0000015466328],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08823722,0.006542289,0.1968954,0.00043229017,0.0032259081,0.00007170981,0.005405569,0.03783342,0.55016845,0.000037015227,0.0046138703,0.10653685],"study_design_scores_gemma":[0.078306526,0.016741829,0.5801357,0.00054358074,0.003067,0.00006298064,0.00027005415,0.31085482,0.0065627294,0.00077651313,0.0022969805,0.0003812859],"about_ca_topic_score_codex":0.000013952641,"about_ca_topic_score_gemma":0.0000057902625,"teacher_disagreement_score":0.5436057,"about_ca_system_score_codex":0.00004943448,"about_ca_system_score_gemma":0.00017000438,"threshold_uncertainty_score":0.48894966},"labels":[],"label_agreement":null},{"id":"W4406147362","doi":"10.1002/jcph.6179","title":"Pharmacokinetics and Pharmacodynamics of Intravenous Magnesium Sulfate in Pediatric Acute Asthma Exacerbations","year":2025,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Magnesium in Health and Disease","field":"Nursing","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Maternal and Child Health Bureau; School of Medicine, Emory University; National Center for Advancing Translational Sciences; Health Resources and Services Administration; University at Buffalo; Scheme for Promotion of Academic and Research Collaboration; National Heart, Lung, and Blood Institute; Seattle Children's Research Institute; National Institutes of Health; U.S. Department of Health and Human Services; Cincinnati Children's Hospital Medical Center; Emory University; Nationwide Children's Hospital","keywords":"Medicine; Emergency department; Asthma; Exacerbation; Asthma exacerbations; Acute severe asthma; Pharmacokinetics; Anesthesia; Dosing; Pharmacodynamics; Placebo; Area under the curve; Refractory (planetary science); Intensive care medicine; Internal medicine; Respiratory disease; Lung","score_opus":0.02480889781505559,"score_gpt":0.41977642117432146,"score_spread":0.3949675233592659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406147362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97826314,0.0024666633,0.00020015419,0.011161556,0.006892882,0.00036885162,0.000018604573,0.000011443215,0.0006167342],"genre_scores_gemma":[0.9926006,0.0022304307,0.00020048107,0.0037573928,0.0010904907,0.000004545068,0.0000016052666,0.0000147211495,0.00009968934],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961233,0.001044001,0.0020963554,0.00016105614,0.00021856456,0.00035671436],"domain_scores_gemma":[0.9960155,0.0023399934,0.00092397677,0.00014108325,0.00031100912,0.0002684616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027935798,0.00017303022,0.0006171847,0.00036548503,0.00010121715,0.000009543287,0.0004274637,0.00013929061,0.00019546981],"category_scores_gemma":[0.00028575392,0.00013162129,0.00014319626,0.00054873416,0.00029621847,0.000111695896,0.00010554585,0.000967419,0.0000035416824],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09997016,0.010583268,0.56199247,0.006779117,0.0007271255,0.0007197704,0.002366464,0.010096647,0.040964298,0.0007584545,0.08237762,0.18266462],"study_design_scores_gemma":[0.044398174,0.0052342154,0.8671534,0.00006514436,0.011438296,0.0003181572,0.000240497,0.042153213,0.0073520406,0.0060973302,0.014841729,0.00070778193],"about_ca_topic_score_codex":0.000023085251,"about_ca_topic_score_gemma":0.000010655413,"teacher_disagreement_score":0.30516097,"about_ca_system_score_codex":0.000040922503,"about_ca_system_score_gemma":0.00028452714,"threshold_uncertainty_score":0.536736},"labels":[],"label_agreement":null},{"id":"W4407758778","doi":"10.1002/jcph.70007","title":"The Impact of Augmented Renal Clearance on the Pharmacokinetics of Levetiracetam in Critically Ill Patients: A Literature Review","year":2025,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta; University of Alberta","keywords":"Levetiracetam; Medicine; Pharmacokinetics; Dosing; Regimen; Renal function; Arc (geometry); Creatinine; Pharmacology; Internal medicine; Intensive care medicine; Epilepsy","score_opus":0.10100579507946728,"score_gpt":0.5480106442864586,"score_spread":0.44700484920699135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407758778","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012589339,0.9864097,0.000002422282,0.009182593,0.0005378833,0.0020612676,0.00009246882,0.0000028316028,0.0004518966],"genre_scores_gemma":[0.0013244802,0.99407697,0.000021184287,0.003877129,0.00041962508,0.000030086525,0.000010880901,0.000023176663,0.00021645006],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9894145,0.0055713346,0.003723,0.0001971885,0.00068257825,0.00041140986],"domain_scores_gemma":[0.9769019,0.017443262,0.0022096157,0.0004899331,0.0027253584,0.00022996406],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.005965816,0.00036933596,0.0032405644,0.00017191317,0.00006875631,0.000009030799,0.00091373414,0.00023995247,0.00024501907],"category_scores_gemma":[0.010913283,0.00012647311,0.0019803974,0.000746931,0.00068202795,0.000035134526,0.0001574042,0.0035173874,0.0000084105695],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008378547,0.0040453207,0.00030547671,0.02533907,0.0049715373,0.00026159585,0.000040781277,0.0000069175962,0.000013097787,0.00004608243,0.14409493,0.81249666],"study_design_scores_gemma":[0.009619825,0.013239567,0.004152899,0.26263124,0.011292405,0.00025910264,0.00001296225,0.000028018268,0.000029690253,0.00013115813,0.69838524,0.00021789281],"about_ca_topic_score_codex":0.0000036644599,"about_ca_topic_score_gemma":8.351846e-7,"teacher_disagreement_score":0.81227875,"about_ca_system_score_codex":0.0001362869,"about_ca_system_score_gemma":0.0013858906,"threshold_uncertainty_score":0.99878156},"labels":[],"label_agreement":null},{"id":"W4409504187","doi":"10.1002/jcph.70033","title":"A Retrospective Analysis of PK and Response of Oral Ibuprofen in the Treatment of a Patent Ductus Arteriosus in Extremely Low Gestational Age Neonates","year":2025,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Cardiovascular Conditions and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Impact; McMaster University; McMaster Children's Hospital","funders":"","keywords":"Ibuprofen; Medicine; Gestational age; Ductus arteriosus; Pharmacokinetics; Regimen; Population; Area under the curve; Gastroenterology; Retrospective cohort study; Anesthesia; Internal medicine; Pharmacology; Pregnancy","score_opus":0.07737114255945572,"score_gpt":0.43298089711152093,"score_spread":0.3556097545520652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409504187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99706966,0.0012178452,0.00002270264,0.0012509928,0.000111838046,0.00026332267,0.000029930836,7.786938e-7,0.00003293273],"genre_scores_gemma":[0.9976533,0.0020652607,0.00009504963,0.00012416541,0.000022724182,0.000006784306,0.0000049871956,0.0000028965978,0.000024798119],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99746567,0.0011794422,0.0009899947,0.0000875064,0.00018780364,0.000089587425],"domain_scores_gemma":[0.99767375,0.0015318748,0.00044606696,0.00013310993,0.00018365234,0.00003151892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021317417,0.000081601705,0.0008886371,0.0003955584,0.00001565368,0.0000016255823,0.000079017955,0.00005362217,0.00004990779],"category_scores_gemma":[0.00022000472,0.00004285065,0.00042626093,0.00054664374,0.00027166566,0.000023601857,0.000016256467,0.00016193616,1.6292425e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03870355,0.0057749664,0.91357917,0.000044940898,0.017878927,0.0017769453,0.0037069223,0.0006530161,0.009790356,0.00008087874,0.00016837519,0.00784195],"study_design_scores_gemma":[0.009591635,0.0022057495,0.98084056,0.000047347505,0.005532368,0.00006878534,0.0003901828,0.00024129791,0.0006873767,0.00032951613,0.000040049494,0.00002512488],"about_ca_topic_score_codex":0.00009241639,"about_ca_topic_score_gemma":0.00009782093,"teacher_disagreement_score":0.0672614,"about_ca_system_score_codex":0.000080498794,"about_ca_system_score_gemma":0.00018304103,"threshold_uncertainty_score":0.17473988},"labels":[],"label_agreement":null},{"id":"W4409900749","doi":"10.1002/jcph.70027","title":"Expansion of a Pharmacokinetic Model for Diazepam to Characterize Real‐World IV and Oral Data in Children With and Without Obesity","year":2025,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Duke Clinical Research Institute; National Institute of Child Health and Human Development; National Institute on Alcohol Abuse and Alcoholism; Eunice Kennedy Shriver National Institute of Child Health and Human Development; University of North Carolina at Chapel Hill; National Institutes of Health; School of Medicine; Children's Mercy Hospital; Penn State College of Medicine; Wichita Medical Research and Education Foundation; University of South Carolina; Pennsylvania State University; University of Pennsylvania; Seattle Children's Research Institute; University of Louisville; Hospital for Sick Children; Tulane University; Children's Hospital of Philadelphia","keywords":"Dosing; Pharmacokinetics; Volume of distribution; Diazepam; Medicine; Status epilepticus; Population; Bolus (digestion); Obesity; NONMEM; Oral administration; Anesthesia; Pharmacology; Internal medicine; Epilepsy","score_opus":0.12106081851955071,"score_gpt":0.4889283812446854,"score_spread":0.3678675627251347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409900749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919368,0.00022611319,0.00062607863,0.006202253,0.00007862621,0.00084723445,0.00003765459,0.0000033502083,0.00004188301],"genre_scores_gemma":[0.99348134,0.0030612913,0.0015554412,0.0015750494,0.00013160026,0.0000093666795,0.000008131128,0.000008415936,0.0001693734],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985318,0.00027435223,0.0006656017,0.00016908186,0.00015370759,0.00020546297],"domain_scores_gemma":[0.99851763,0.0006954363,0.00023326553,0.00019044982,0.00013219699,0.00023104172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022844905,0.00010543818,0.00064533006,0.00015914676,0.000033611894,0.0000043931377,0.00020231283,0.00004388024,0.000014461333],"category_scores_gemma":[0.0002070924,0.000057741498,0.000041847547,0.00014742976,0.00019878137,0.000073832234,0.0001916174,0.00037531293,3.3035218e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020840801,0.00074165576,0.9582174,0.000069756265,0.0006520877,0.000011033167,0.000086427965,0.000049752005,0.00538494,0.000009275915,0.0022464634,0.011690426],"study_design_scores_gemma":[0.015373523,0.0020426533,0.9606328,0.00013331407,0.0010251508,0.000051998068,0.000011426528,0.01951491,0.0008684314,0.00012388846,0.0001680326,0.000053870044],"about_ca_topic_score_codex":0.00005110681,"about_ca_topic_score_gemma":0.00007104401,"teacher_disagreement_score":0.019465158,"about_ca_system_score_codex":0.000019681578,"about_ca_system_score_gemma":0.00029349164,"threshold_uncertainty_score":0.235463},"labels":[],"label_agreement":null},{"id":"W4412653397","doi":"10.1002/jcph.70084","title":"Four Pharmacogenomic Variants Strongly Linked to Corticosteroid‐Induced Avascular Necrosis in Children with Cancer","year":2025,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Bone and Joint Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"Health Canada; Genome British Columbia; Provincial Health Services Authority; BC Children's Hospital; Canadian Institutes of Health Research; Genome Canada","keywords":"Pharmacogenomics; Avascular necrosis; Corticosteroid; Medicine; Cancer; Oncology; Pharmacogenetics; Necrosis; Internal medicine; Pharmacology; Bioinformatics; Biology; Surgery; Genetics; Genotype; Gene","score_opus":0.0648231306296028,"score_gpt":0.424983250689048,"score_spread":0.3601601200594452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412653397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851107,0.00068066904,0.000121290475,0.012201618,0.0010721028,0.0006625435,0.000008439177,0.000010833816,0.00013179965],"genre_scores_gemma":[0.9821994,0.0010055202,0.0001246242,0.015575401,0.0008408061,0.000014644301,0.0000011413155,0.000019072448,0.00021941986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974488,0.0005472115,0.0012522262,0.00018959361,0.00023356674,0.00032859176],"domain_scores_gemma":[0.99832666,0.00049635017,0.00043108652,0.00018837587,0.00022273678,0.0003347795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001465323,0.0001743282,0.0008506995,0.0001978491,0.00005534233,0.000010497178,0.00028406866,0.000108419874,0.00046750426],"category_scores_gemma":[0.00020622864,0.000105160194,0.00024700753,0.00026607257,0.00010587021,0.00007639338,0.00008784284,0.00093595794,0.000021590506],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02369169,0.0018067566,0.7865471,0.00004613675,0.004893164,0.0002965724,0.00017505157,0.0011691239,0.121901534,0.0000042324527,0.030447237,0.029021345],"study_design_scores_gemma":[0.016234707,0.0013352612,0.97531855,0.00016095278,0.0031916408,0.00016708182,0.000028194703,0.00018557311,0.001998394,0.000035845584,0.0012293112,0.00011449078],"about_ca_topic_score_codex":0.0001181786,"about_ca_topic_score_gemma":0.000030749758,"teacher_disagreement_score":0.1887714,"about_ca_system_score_codex":0.00008439305,"about_ca_system_score_gemma":0.00088048377,"threshold_uncertainty_score":0.5118844},"labels":[],"label_agreement":null},{"id":"W4414575052","doi":"10.1002/jcph.70114","title":"In Vitro and Clinical Evaluation of Potential Interactions of Bemnifosbuvir with Drug Transporters","year":2025,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Altasciences (Canada)","funders":"","keywords":"Digoxin; Rosuvastatin; Dosing; Prodrug; Therapeutic index; Organic anion-transporting polypeptide; Drug; In vitro","score_opus":0.043455882481146235,"score_gpt":0.4596680914543474,"score_spread":0.41621220897320116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414575052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896578,0.00031866852,0.0010114822,0.006776705,0.0016584161,0.0002732642,0.0000038893836,0.000002062476,0.00029768833],"genre_scores_gemma":[0.99771345,0.000807158,0.0004244325,0.00068208924,0.00021674104,0.0000014593805,0.0000014247717,0.000005739245,0.00014751316],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9970668,0.0005993458,0.0018203806,0.00009693437,0.00031096846,0.000105580315],"domain_scores_gemma":[0.99791795,0.000768376,0.0007366224,0.000095969066,0.00040385278,0.000077245226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006514094,0.00008291252,0.00072086084,0.00015188544,0.000019683488,0.0000010789653,0.00011808216,0.000078238016,0.00012080453],"category_scores_gemma":[0.00008905789,0.000047575413,0.00021853209,0.00016131732,0.00039950098,0.000069275666,0.000008747076,0.0006820831,3.3778295e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24504931,0.0114381965,0.11682536,0.0007674705,0.006902703,0.00045357295,0.0019367151,0.0016255494,0.50050056,0.00019554526,0.008545032,0.105759986],"study_design_scores_gemma":[0.06658106,0.0033421083,0.77972233,0.00089566404,0.022326201,0.00025636447,0.0018132447,0.0054527665,0.11445895,0.0023486686,0.0025799053,0.00022272975],"about_ca_topic_score_codex":0.000009789901,"about_ca_topic_score_gemma":0.000027274584,"teacher_disagreement_score":0.662897,"about_ca_system_score_codex":0.000017537051,"about_ca_system_score_gemma":0.00045297068,"threshold_uncertainty_score":0.29633495},"labels":[],"label_agreement":null},{"id":"W4414608578","doi":"10.1002/jcph.70107","title":"Physiologically Based Pharmacokinetic Modeling of Oxcarbazepine to Characterize Its Disposition in Children with Obesity","year":2025,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","keywords":"Dosing; Physiologically based pharmacokinetic modelling; Oxcarbazepine; Pharmacokinetics; Population; Clinical trial; Obesity","score_opus":0.061016524939805354,"score_gpt":0.43088721315978307,"score_spread":0.3698706882199777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414608578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906419,0.00021579453,0.0009080866,0.0073152008,0.00015204695,0.0006375733,0.000008109607,0.000006154611,0.00011513794],"genre_scores_gemma":[0.99507946,0.00056120026,0.00031391787,0.0037265092,0.00026323638,0.000009502971,0.000006079052,0.0000070859787,0.000033039403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978301,0.00062527665,0.00093842216,0.000136204,0.00023968895,0.00023032622],"domain_scores_gemma":[0.99849576,0.00058793323,0.0002848996,0.00011930487,0.0003183406,0.00019375798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015184544,0.00012276121,0.0006845864,0.00016661188,0.000031711243,0.000002851546,0.0002170658,0.000071667746,0.00015454291],"category_scores_gemma":[0.00022785657,0.000064398315,0.00015501952,0.0003008662,0.00010012712,0.000044150787,0.000057953876,0.0006478657,0.0000055487726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06591745,0.008360588,0.53628784,0.0001580263,0.002055073,0.00017855862,0.00007359695,0.022464504,0.35328054,0.000026651269,0.0011460929,0.010051081],"study_design_scores_gemma":[0.011656747,0.004689109,0.9517138,0.00022137008,0.0006668981,0.000037589944,0.000007039848,0.019465163,0.011383183,0.000053070322,0.000041912564,0.00006410464],"about_ca_topic_score_codex":0.000011882872,"about_ca_topic_score_gemma":0.0000020581863,"teacher_disagreement_score":0.41542596,"about_ca_system_score_codex":0.00004610595,"about_ca_system_score_gemma":0.00030007938,"threshold_uncertainty_score":0.28146902},"labels":[],"label_agreement":null}]}